data_2gdx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gdx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 120.782 0.325 . . . . 3.4700000000000002 111.068 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' A' ' 32' ' ' ILE . . . -82.91 130.07 35.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.044 -0.526 . . . . 3.4700000000000002 111.05 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -85.15 20.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 4.0800000000000001 110.519 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -125.05 46.01 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 2.3599999999999999 111.126 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.55 2.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 2.5 111.058 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.07 110.25 3.98 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 2.5099999999999998 111.45 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -91.03 158.93 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.592 2.195 . . . . 2.2999999999999998 111.975 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.23 -44.24 8.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 2.52 111.082 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.04 156.36 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 2.5800000000000001 110.976 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.49 64.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 2.0099999999999998 111.296 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -64.89 -41.95 93.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 2.5099999999999998 111.168 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.22 -38.45 78.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 1.95 111.027 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -42.02 96.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.79 110.986 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -68.18 -48.79 64.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 3.48 111.258 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -47.2 85.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 2.4199999999999999 110.957 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.18 80.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.511 . . . . 1.6000000000000001 111.367 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -66.05 -51.7 55.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 2.6899999999999999 111.501 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 26' ' ' VAL . 60.9 mt -66.81 -34.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.09 0.404 . . . . 2.4300000000000002 112.09 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -76.38 -44.2 37.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.666 0.617 . . . . 1.55 112.666 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.47 9.65 12.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.908 0.336 . . . . 2.7799999999999998 111.908 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.46 ' HB2' HH11 ' A' ' 25' ' ' ARG . 5.6 ttm105 -118.46 -21.74 7.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 4.9000000000000004 110.853 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.4 t -109.41 -24.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 2.4900000000000002 111.133 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.74 -61.37 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 3.3100000000000001 111.517 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -59.61 9.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 1.8799999999999999 113.319 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t 59.09 12.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.03 0.443 . . . . 2.4500000000000002 110.85 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.7 m -98.46 -68.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 2.21 111.01 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.54 33.97 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.754 -0.736 . . . . 1.6399999999999999 111.932 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.46 ' HA ' ' HB1' ' A' ' 6' ' ' ALA . 1.1 pt -88.44 -173.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 3.9700000000000002 111.308 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.55 -109.23 0.23 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.868 -0.682 . . . . 2.3199999999999998 112.413 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.28 49.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.724 0.297 . . . . 3.1299999999999999 111.189 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.98 9.85 6.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.497 -0.32 . . . . 3.02 111.318 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.13 150.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 4.2000000000000002 110.443 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.545 HD21 ' H ' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -177.76 -96.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 4.9299999999999997 111.117 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.545 ' H ' HD21 ' A' ' 37' ' ' ASN . 9.7 p90 -119.95 -28.11 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.357 -0.383 . . . . 2.75 111.264 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.411 ' HB3' HE21 ' A' ' 40' ' ' GLN . 14.0 t80 -78.67 -83.89 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.294 -0.412 . . . . 2.46 111.676 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -73.86 82.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 2.5699999999999998 111.247 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 tp -172.03 -36.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.849 0.315 . . . . 3.7999999999999998 111.849 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.96 -30.46 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.252 -0.975 . . . . 2.4900000000000002 112.98 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.12 120.43 18.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.613 -0.803 . . . . 2.46 112.297 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -98.76 26.56 5.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.751 0.275 . . . . 2.9300000000000002 111.387 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 31.16 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.99 0.737 . . . . 1.3600000000000001 112.99 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.92 31.57 0.94 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.214 -0.448 . . . . 2.9199999999999999 110.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -105.3 169.6 8.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 2.7200000000000002 111.205 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.2 79.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.013 -0.54 . . . . 2.0800000000000001 111.229 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.6 ttt -58.9 -32.11 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.414 . . . . 3.1600000000000001 110.606 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.47 -47.17 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 1.6000000000000001 110.652 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.52 -34.48 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 2.0099999999999998 110.089 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -65.48 -43.28 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.639 . . . . 1.5700000000000001 110.275 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -26.42 67.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.02 -0.536 . . . . 1.3700000000000001 110.483 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -44.6 61.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.805 -0.634 . . . . 2.3399999999999999 110.801 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.0 t -76.55 -26.49 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 2.3900000000000001 111.282 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -77.61 2.68 15.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 2.5299999999999998 111.154 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.534 ' HB2' HG23 ' A' ' 67' ' ' VAL . 20.9 tpt85 -133.58 8.27 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.37 . . . . 4.1200000000000001 111.537 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 68.39 53.8 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 3.6400000000000001 111.31 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 57.74 88.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 4.96 111.8 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.429 HE21 ' HB2' ' A' ' 60' ' ' GLN . 0.4 OUTLIER -67.68 -30.1 69.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.649 -0.501 . . . . 2.7999999999999998 109.649 178.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.2 t 65.86 -72.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 115.322 -0.854 . . . . 3.4900000000000002 111.861 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -92.81 -84.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.506 0.558 . . . . 4.5599999999999996 112.506 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.06 135.14 20.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.206 0.447 . . . . 3.52 112.206 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -88.24 58.36 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.769 2.313 . . . . 2.1699999999999999 111.125 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.95 119.08 5.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.587 -0.733 . . . . 2.9700000000000002 112.241 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mttp 47.15 83.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 2.8700000000000001 112.123 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 57' ' ' ARG . 13.7 p -155.62 -44.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.288 -0.414 . . . . 2.5899999999999999 111.051 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.524 ' HA ' HD11 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -178.27 -39.53 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.549 -0.296 . . . . 2.6499999999999999 111.499 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -91.97 -52.72 4.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.066 0.395 . . . . 2.4700000000000002 112.066 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.9 71.56 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.954 0.353 . . . . 1.52 111.954 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.613 HE21 ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 176.42 115.27 0.13 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.148 -0.478 . . . . 3.8300000000000001 110.582 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.613 ' HD2' HE21 ' A' ' 71' ' ' GLN . 73.4 Cg_endo -75.99 41.35 0.83 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.434 2.09 . . . . 2.1200000000000001 112.879 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.91 74.54 0.73 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.146 0.498 . . . . 2.7999999999999998 110.23 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.08 -40.79 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.648 -0.705 . . . . 2.5899999999999999 112.296 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -30.83 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 4.2400000000000002 111.146 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.09 68.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.734 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 68' ' ' LEU . 30.7 mt -72.82 -27.33 61.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.049 -0.523 . . . . 2.9700000000000002 110.602 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.61 -34.28 74.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 1.97 111.106 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.427 ' C ' ' HG1' ' A' ' 83' ' ' THR . 13.6 pt20 -103.31 21.61 15.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 3.27 111.041 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 1.0 OUTLIER -129.91 -69.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 3.1000000000000001 111.094 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 t -94.1 -39.26 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 2.6800000000000002 111.332 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.64 -16.86 61.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 2.0299999999999998 111.348 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.427 ' HG1' ' C ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.971 -0.381 . . . . 3.1099999999999999 109.971 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 1.014 ' HA ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.62 0.724 . . . . 3.4700000000000002 112.174 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.81 146.65 9.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.455 -0.793 . . . . 3.4700000000000002 110.148 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -122.69 33.79 5.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.514 0.674 . . . . 4.0800000000000001 109.196 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.481 ' HE2' HG22 ' A' ' 34' ' ' ILE . 5.1 t80 -116.12 17.23 15.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.371 -0.831 . . . . 2.3599999999999999 111.334 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.43 67.03 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.403 1.096 . . . . 2.5 110.122 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -106.41 105.29 53.88 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.106 -0.952 . . . . 2.5099999999999998 110.515 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 1.1 Cg_endo -83.52 156.61 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.121 2.547 . . . . 2.2999999999999998 111.974 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.56 -44.92 3.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.237 0.541 . . . . 2.52 109.645 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -114.59 177.49 4.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.511 -0.768 . . . . 2.5800000000000001 109.832 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.42 -15.57 54.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.896 0.379 . . . . 2.0099999999999998 110.768 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.78 -57.52 10.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.922 -0.581 . . . . 2.5099999999999998 111.039 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.895 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 12.6 pm0 -72.75 -22.71 60.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.23 -0.441 . . . . 1.95 110.699 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.66 -48.5 79.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 1.79 110.097 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -61.08 -45.18 95.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 3.48 110.856 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.38 -56.07 16.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 2.4199999999999999 111.395 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -67.12 -43.8 81.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.669 -0.696 . . . . 1.6000000000000001 112.092 -173.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.05 -37.21 83.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.604 0.24 . . . . 2.6899999999999999 111.314 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.43 ' O ' HG21 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -71.13 -46.99 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.045 -0.262 . . . . 2.4300000000000002 110.595 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -69.28 -27.36 65.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.55 110.563 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.1 tm-20 -58.83 -52.03 67.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 2.7799999999999998 110.471 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -19.35 60.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.726 0.298 . . . . 4.9000000000000004 111.364 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 22' ' ' ILE . 53.6 t -85.63 -49.27 15.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.497 -0.319 . . . . 2.4900000000000002 111.409 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.45 -31.69 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.686 0.624 . . . . 3.3100000000000001 112.686 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 -82.1 0.47 Allowed Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.656 -0.783 . . . . 1.8799999999999999 113.723 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 74.56 4.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.011 0.924 . . . . 2.4500000000000002 110.92 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 1.014 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 15.2 m -112.5 -17.0 12.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.703 -0.68 . . . . 2.21 111.965 -172.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 34.78 8.34 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.651 -0.98 . . . . 1.6399999999999999 110.651 -174.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.618 HG23 ' HE2' ' A' ' 38' ' ' PHE . 1.3 pt -78.94 170.52 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.273 0.559 . . . . 3.9700000000000002 112.085 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.77 158.19 7.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.52 -0.764 . . . . 2.3199999999999998 111.619 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.481 HG22 ' HE2' ' A' ' 8' ' ' TYR . 36.4 mm 66.27 -79.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.011 0.525 . . . . 3.1299999999999999 111.272 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.966 -0.383 . . . . 3.02 109.966 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 17.7 t0 41.75 -92.73 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.362 1.039 . . . . 4.2000000000000002 112.906 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 92.74 -7.39 0.17 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.711 1.257 . . . . 4.9299999999999997 111.761 175.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.618 ' HE2' HG23 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -109.67 -55.53 2.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.537 -0.542 . . . . 2.75 109.537 173.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.489 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 29.7 t80 -91.75 -73.13 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.378 -0.828 . . . . 2.46 109.909 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.532 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.8 mt-30 -70.43 96.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 2.5699999999999998 109.963 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.5 tp 168.69 -18.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 3.7999999999999998 110.029 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.55 35.55 3.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.666 -0.778 . . . . 2.4900000000000002 111.418 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.13 124.75 7.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.679 -0.772 . . . . 2.46 111.746 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -84.7 74.75 10.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 2.9300000000000002 110.556 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.53 161.45 30.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.868 -0.605 . . . . 1.3600000000000001 110.835 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 67.43 6.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 2.9199999999999999 110.596 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -139.33 160.16 40.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.726 -0.67 . . . . 2.7200000000000002 109.761 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.09 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.445 0.466 . . . . 2.0800000000000001 112.159 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tpt -60.85 -31.55 71.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.329 . . . . 3.1600000000000001 111.305 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -71.74 -37.01 70.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.438 -0.346 . . . . 1.6000000000000001 111.196 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 2.0099999999999998 110.057 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.17 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.09 -0.505 . . . . 1.5700000000000001 110.151 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.7 ' HB1' HG21 ' A' ' 67' ' ' VAL . . . -69.78 -26.67 64.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.91 -0.586 . . . . 1.3700000000000001 110.672 176.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -79.71 -22.56 43.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 2.3399999999999999 110.897 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.91 -15.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 2.3900000000000001 111.607 -176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.68 40.89 1.05 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.295 0.569 . . . . 2.5299999999999998 110.873 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 177.81 -150.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.672 -1.233 . . . . 4.1200000000000001 107.672 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.06 164.62 14.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.579 -0.897 . . . . 3.6400000000000001 108.579 168.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.37 82.96 2.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.278 0.561 . . . . 4.96 109.974 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.7 2.02 7.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.934 -1.03 . . . . 2.7999999999999998 112.871 -173.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.1 t 58.82 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 122.834 0.454 . . . . 3.4900000000000002 111.442 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 55.0 mm-40 -121.71 23.78 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.552 -0.295 . . . . 4.5599999999999996 110.983 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.45 68.98 60.88 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.403 . . . . 3.52 110.857 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 62' ' ' GLU . 5.6 Cg_endo -87.38 73.03 2.9 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.196 2.597 . . . . 2.1699999999999999 111.991 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.0 tp -82.46 129.46 34.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.12 -0.491 . . . . 2.9700000000000002 110.847 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 58.13 34.19 23.92 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.766 0.666 . . . . 2.8700000000000001 111.127 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.7 HG21 ' HB1' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -94.99 -174.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.525 -0.761 . . . . 2.5899999999999999 110.433 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.441 ' N ' HG13 ' A' ' 67' ' ' VAL . 5.4 mt -53.84 -21.29 7.27 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.247 0.832 . . . . 2.6499999999999999 113.247 -174.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.653 ' H ' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -138.93 44.51 2.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.106 0.479 . . . . 2.4700000000000002 111.287 175.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB3' ' H ' ' A' ' 67' ' ' VAL . . . -120.98 47.7 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.899 0.381 . . . . 1.52 110.66 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.571 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -162.16 144.99 8.82 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.206 -0.906 . . . . 3.8300000000000001 108.792 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.49 1.19 3.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.927 2.418 . . . . 2.1200000000000001 113.119 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -128.94 89.43 2.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.741 0.305 . . . . 2.7999999999999998 110.577 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 tp -58.43 -32.61 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.059 -0.519 . . . . 2.5899999999999999 112.255 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.895 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -62.59 -38.86 91.79 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.228 -0.295 . . . . 4.2400000000000002 110.79 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.26 -31.97 73.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 1.7 110.676 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD21 ' HB2' ' A' ' 71' ' ' GLN . 12.7 mt -78.42 -36.82 45.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.986 -0.552 . . . . 2.9700000000000002 110.61 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.2 66.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 1.97 110.633 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -91.55 -0.05 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.621 . . . . 3.27 110.614 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -114.04 -88.89 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 3.1000000000000001 111.121 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 m -82.29 21.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 2.6800000000000002 112.044 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.437 ' HB3' HD23 ' A' ' 68' ' ' LEU . . . -130.1 -4.24 4.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 2.0299999999999998 110.867 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 3.1099999999999999 111.153 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 120.825 0.345 . . . . 3.4700000000000002 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.39 144.65 27.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.021 -0.536 . . . . 3.4700000000000002 110.082 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.16 91.37 3.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.896 0.379 . . . . 4.0800000000000001 110.887 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.442 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 7.0 t80 -146.43 2.57 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.003 -0.544 . . . . 2.3599999999999999 111.18 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 2.8 p -79.15 93.44 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 2.5 111.327 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.06 74.98 1.69 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.511 -0.768 . . . . 2.5099999999999998 110.424 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HB2' ' OE2' ' A' ' 16' ' ' GLU . 2.1 Cg_endo -81.61 -133.69 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.088 2.525 . . . . 2.2999999999999998 112.226 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.429 ' H ' ' HB2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -123.63 -48.11 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.118 0.485 . . . . 2.52 111.798 -177.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.735 HD22 ' HB ' ' A' ' 15' ' ' VAL . 1.8 t30 -98.27 132.4 43.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.872 -0.604 . . . . 2.5800000000000001 110.503 -172.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.28 68.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.671 -0.695 . . . . 2.0099999999999998 112.0 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.735 ' HB ' HD22 ' A' ' 13' ' ' ASN . 48.1 t -70.17 -48.42 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 2.5099999999999998 110.958 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.498 ' OE1' ' HB3' ' A' ' 13' ' ' ASN . 1.7 pt-20 -67.8 -32.31 72.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.947 0.404 . . . . 1.95 110.32 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.408 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.3 m -69.48 -35.84 75.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.894 -0.594 . . . . 1.79 110.205 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -64.95 -41.78 95.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 3.48 110.737 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -46.4 90.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 2.4199999999999999 110.652 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.02 92.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 1.6000000000000001 111.282 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -40.43 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 2.6899999999999999 111.696 -176.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -38.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 120.97 -0.292 . . . . 2.4300000000000002 110.973 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -66.7 -45.25 79.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.089 0.471 . . . . 1.55 110.166 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -83.45 19.42 1.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.392 0.615 . . . . 2.7799999999999998 111.301 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.528 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -120.17 -0.87 10.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.771 -0.649 . . . . 4.9000000000000004 109.317 170.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -128.2 -25.13 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.862 -0.608 . . . . 2.4900000000000002 111.852 -177.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.418 ' N ' HG12 ' A' ' 26' ' ' VAL . 11.9 tp -93.04 -81.13 0.36 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.501 0.191 . . . . 3.3100000000000001 111.364 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.4 -39.87 6.64 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.66 -0.781 . . . . 1.8799999999999999 111.644 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t 70.18 53.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.774 0.797 . . . . 2.4500000000000002 110.648 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.64 -35.85 3.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 2.21 109.775 173.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.22 42.77 2.93 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.732 -0.667 . . . . 1.6399999999999999 112.383 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -87.69 -80.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.803 0.335 . . . . 3.9700000000000002 111.156 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.25 -69.71 3.08 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.932 -0.651 . . . . 2.3199999999999998 111.589 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -107.31 152.09 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.172 -1.048 . . . . 3.1299999999999999 108.172 174.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 44.3 1.53 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.359 -0.978 . . . . 3.02 108.359 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -70.46 174.52 5.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.23 -1.35 . . . . 4.2000000000000002 111.957 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -140.85 -8.12 1.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 4.9299999999999997 111.08 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.411 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 26.7 p90 -148.34 -33.81 0.23 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.002 0.742 . . . . 2.75 113.002 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -96.53 -83.09 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.047 -0.408 . . . . 2.46 111.66 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -29.42 67.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.5699999999999998 112.018 -173.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 tp -115.1 -2.0 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.417 . . . . 3.7999999999999998 111.52 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 38' ' ' PHE . . . -92.51 -95.95 1.4 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.437 -0.887 . . . . 2.4900000000000002 112.71 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.12 -138.29 2.65 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.667 -0.778 . . . . 2.46 112.397 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -97.01 122.96 40.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.241 0.543 . . . . 2.9300000000000002 111.366 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.33 -178.11 6.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 1.3600000000000001 109.986 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -89.15 45.68 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.049 0.452 . . . . 2.9199999999999999 110.947 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.58 163.74 22.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.393 -0.367 . . . . 2.7200000000000002 111.418 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.96 94.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 2.0800000000000001 111.534 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ttt -60.33 -34.58 74.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.402 . . . . 3.1600000000000001 110.456 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . . . -69.95 -40.58 75.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 1.6000000000000001 110.846 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.634 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -71.69 -34.88 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 2.0099999999999998 110.616 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.461 ' N ' HG13 ' A' ' 51' ' ' VAL . . . -73.35 -29.94 62.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 1.5700000000000001 110.807 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -73.8 -38.68 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 1.3700000000000001 111.271 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.634 ' NE2' ' HA ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -68.73 -38.42 80.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.011 -0.276 . . . . 2.3399999999999999 110.936 -177.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 51' ' ' VAL . 35.7 m -92.83 19.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 2.3900000000000001 110.973 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.437 ' HE1' ' O ' ' A' ' 81' ' ' VAL . 15.5 t-160 -88.13 -18.13 29.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.07 -0.513 . . . . 2.5299999999999998 110.456 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.723 ' HG3' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -106.25 -63.9 1.22 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.041 0.448 . . . . 4.1200000000000001 110.682 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.3 -151.97 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.632 -0.713 . . . . 3.6400000000000001 109.298 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -75.82 64.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.414 0.626 . . . . 4.96 110.194 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.18 91.99 3.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 2.7999999999999998 109.177 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.29 -55.75 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.7 -0.682 . . . . 3.4900000000000002 112.185 -170.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -63.72 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 4.5599999999999996 111.652 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.72 111.66 54.11 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 3.52 110.672 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.9 127.54 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.557 2.171 . . . . 2.1699999999999999 111.226 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tp -123.73 96.22 4.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 2.9700000000000002 110.506 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 0.5 OUTLIER 54.67 62.62 2.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.908 -0.587 . . . . 2.8700000000000001 111.377 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.723 HG22 ' HG3' ' A' ' 57' ' ' ARG . 11.3 p -132.04 -29.66 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.171 -0.468 . . . . 2.5899999999999999 111.178 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.61 -51.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.92 -0.77 . . . . 2.6499999999999999 108.92 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 50' ' ' ALA . 1.1 m-85 -104.67 172.31 6.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.217 -0.901 . . . . 2.4700000000000002 109.172 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 71' ' ' GLN . . . 60.35 43.67 13.22 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.91 0.756 . . . . 1.52 111.266 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 167.06 123.57 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 O-C-N 124.215 0.947 . . . . 3.8300000000000001 109.752 176.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.44 28.95 0.54 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.813 2.342 . . . . 2.1200000000000001 113.061 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.47 39.75 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.06 0.457 . . . . 2.7999999999999998 110.629 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.457 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -57.51 -39.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 2.5899999999999999 111.846 -175.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.468 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -64.86 -43.07 94.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.788 0.328 . . . . 4.2400000000000002 110.814 -178.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.05 74.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 1.7 110.992 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.23 -43.2 95.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.345 -0.389 . . . . 2.9700000000000002 111.36 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.46 -4.62 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 1.97 111.493 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.29 -57.67 2.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.966 0.412 . . . . 3.27 110.781 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -74.11 -42.35 60.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 3.1000000000000001 111.836 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.437 ' O ' ' HE1' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -108.78 30.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.84 0.353 . . . . 2.6800000000000002 111.425 -174.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.96 30.32 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.091 0.472 . . . . 2.0299999999999998 110.443 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 3.1099999999999999 111.244 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.9 mt-10 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 111.894 0.331 . . . . 3.4700000000000002 111.894 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.492 ' H ' ' HB3' ' A' ' 5' ' ' GLU . . . -152.91 83.96 1.22 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.931 0.396 . . . . 3.4700000000000002 111.051 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -92.59 -9.64 40.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 4.0800000000000001 110.097 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.567 ' HB3' HD12 ' A' ' 35' ' ' LEU . 10.4 t80 -91.55 -54.86 3.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 2.3599999999999999 110.052 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.665 HG11 ' HD3' ' A' ' 11' ' ' PRO . 2.2 t 56.73 -100.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.944 -0.571 . . . . 2.5 111.415 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 57.02 65.63 3.65 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.596 0.591 . . . . 2.5099999999999998 112.596 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.665 ' HD3' HG11 ' A' ' 9' ' ' VAL . 73.9 Cg_endo -88.97 143.44 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.55 2.166 . . . . 2.2999999999999998 111.518 176.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.432 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -107.75 -34.64 6.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.858 0.361 . . . . 2.52 111.313 -177.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.35 151.07 49.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.32 -0.4 . . . . 2.5800000000000001 110.764 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.35 68.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 2.0099999999999998 111.297 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.17 -44.95 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 2.5099999999999998 110.738 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -43.09 89.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 1.95 110.849 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -69.69 -43.95 71.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.541 . . . . 1.79 111.207 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.79 -40.51 83.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.682 -0.235 . . . . 3.48 111.213 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -45.0 96.57 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.761 0.315 . . . . 2.4199999999999999 110.219 177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.41 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 1.6000000000000001 110.903 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.76 -47.52 84.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 2.6899999999999999 110.873 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.3 mt -71.89 -49.46 44.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.327 -0.397 . . . . 2.4300000000000002 110.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.605 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 4.0 m95 -56.94 -52.5 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 1.55 111.609 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -63.0 -44.48 95.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.101 -0.5 . . . . 2.7799999999999998 111.022 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 1.7 mmp_? -73.06 -2.84 22.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.958 0.355 . . . . 4.9000000000000004 111.958 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.26 -45.07 8.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.6 -0.273 . . . . 2.4900000000000002 111.246 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.455 HD13 ' HD3' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -114.1 -4.59 13.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.918 0.71 . . . . 3.3100000000000001 112.918 -173.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.3 -78.74 0.3 Allowed Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 120.088 -1.053 . . . . 1.8799999999999999 112.917 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 29' ' ' VAL . 0.5 OUTLIER 80.96 -6.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.935 0.894 . . . . 2.4500000000000002 110.627 -178.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -44.78 78.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.516 -0.765 . . . . 2.21 111.479 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' GLU . . . 110.97 25.29 5.16 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.057 -0.592 . . . . 1.6399999999999999 112.391 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.3 129.01 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.688 -0.301 . . . . 3.9700000000000002 110.621 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.44 -80.56 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.299 -0.953 . . . . 2.3199999999999998 112.608 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.08 85.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 3.1299999999999999 110.699 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -166.33 -135.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.16 -0.927 . . . . 3.02 108.91 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.9 106.53 1.25 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.207 -1.035 . . . . 4.2000000000000002 108.207 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.544 ' HB3' HG23 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -78.87 135.27 36.97 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.991 0.737 . . . . 4.9299999999999997 112.991 -164.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -121.67 7.83 10.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.989 -1.005 . . . . 2.75 109.043 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -125.91 -62.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.226 -0.897 . . . . 2.46 110.651 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' A' ' 72' ' ' PRO . 7.7 mt-30 -85.02 53.63 2.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.487 . . . . 2.5699999999999998 110.655 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.544 HG23 ' HB3' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -140.81 38.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 3.7999999999999998 109.971 178.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.88 -71.21 0.3 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.195 -0.762 . . . . 2.4900000000000002 111.195 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 -95.35 0.57 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.878 -0.677 . . . . 2.46 112.711 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER 56.34 33.89 23.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.002 1.382 . . . . 2.9300000000000002 109.929 -174.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 171.7 13.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.253 -1.34 . . . . 1.3600000000000001 111.732 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.03 65.83 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 2.9199999999999999 110.518 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HD3' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -133.72 152.82 51.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 2.7200000000000002 110.261 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.29 85.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.0800000000000001 111.574 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.605 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -60.09 -35.06 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 3.1600000000000001 110.825 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.6 -36.86 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 1.6000000000000001 110.296 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.455 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 91.3 t -62.16 -40.23 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.837 -0.62 . . . . 2.0099999999999998 110.431 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 55' ' ' VAL . . . -63.62 -39.07 93.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 1.5700000000000001 110.842 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.05 83.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.354 -0.384 . . . . 1.3700000000000001 110.786 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.651 ' HA ' ' NE2' ' A' ' 60' ' ' GLN . 3.0 pt20 -88.94 12.35 15.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 2.3399999999999999 111.342 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 52' ' ' ALA . 1.4 p -123.46 -13.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.167 0.508 . . . . 2.3900000000000001 110.432 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -94.22 -8.83 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.625 0.726 . . . . 2.5299999999999998 109.368 173.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' HG2' ' N ' ' A' ' 58' ' ' GLU . 18.6 ttt-85 -145.35 163.72 33.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.262 -1.384 . . . . 4.1200000000000001 107.262 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.544 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -49.98 144.31 6.87 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 117.776 0.262 . . . . 3.6400000000000001 110.983 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -48.7 117.91 2.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.722 0.639 . . . . 4.96 111.674 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.878 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 1.5 mt-30 -92.15 73.81 5.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.46 -0.791 . . . . 2.7999999999999998 110.994 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -80.76 -22.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 3.4900000000000002 109.758 176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.76 -78.41 0.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.241 -0.89 . . . . 4.5599999999999996 110.719 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.34 112.2 8.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.744 0.307 . . . . 3.52 111.64 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.878 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 14.7 Cg_exo -71.62 68.2 2.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.458 2.772 . . . . 2.1699999999999999 111.473 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tp -81.82 133.63 35.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 2.9700000000000002 112.489 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.71 19.48 11.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.533 0.938 . . . . 2.8700000000000001 113.533 169.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' H ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -101.48 -54.75 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.811 -0.356 . . . . 2.5899999999999999 110.365 174.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.883 ' HA ' HD11 ' A' ' 77' ' ' LEU . 1.6 mt -169.08 -40.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 2.6499999999999999 110.462 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -82.24 2.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 2.4700000000000002 112.429 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 64' ' ' PRO . . . -133.65 52.62 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.732 0.301 . . . . 1.52 111.399 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.59 ' HB3' HD12 ' A' ' 77' ' ' LEU . 36.1 tp60 -177.39 113.14 0.24 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.592 -0.731 . . . . 3.8300000000000001 109.734 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.446 ' HA ' ' OE1' ' A' ' 40' ' ' GLN . 13.3 Cg_exo -71.15 48.01 0.85 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.335 2.69 . . . . 2.1200000000000001 112.166 177.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.4 m -156.95 83.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.785 -0.643 . . . . 2.7999999999999998 109.468 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.4 mm -65.05 -37.09 79.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.536 -0.756 . . . . 2.5899999999999999 111.259 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HD3' ' HB ' ' A' ' 12' ' ' THR . 2.3 ttpt -56.34 -39.11 72.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 4.2400000000000002 111.36 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 79' ' ' GLN . . . -66.92 -46.33 75.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.331 . . . . 1.7 111.052 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.883 HD11 ' HA ' ' A' ' 68' ' ' LEU . 3.4 mt -70.09 -27.07 64.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.874 0.369 . . . . 2.9700000000000002 110.908 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.28 -32.32 73.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.97 111.019 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 1.1 pt20 -97.37 15.06 24.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 3.27 110.551 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -119.8 -80.29 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.113 0.482 . . . . 3.1000000000000001 110.662 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.46 -35.52 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.783 -0.644 . . . . 2.6800000000000002 111.417 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.13 -28.25 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 2.0299999999999998 111.495 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.446 -0.343 . . . . 3.1099999999999999 110.83 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 108.776 -0.824 . . . . 3.4700000000000002 108.776 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.447 ' C ' ' H ' ' A' ' 8' ' ' TYR . . . -127.76 146.55 50.55 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.736 -0.386 . . . . 3.4700000000000002 111.434 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.65 37.22 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 4.0800000000000001 110.107 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.447 ' H ' ' C ' ' A' ' 6' ' ' ALA . 5.4 t80 -152.86 43.05 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.384 -0.825 . . . . 2.3599999999999999 109.13 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.675 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 10.0 p -102.4 35.05 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.086 0.946 . . . . 2.5 110.096 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.18 112.44 38.69 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.314 -0.857 . . . . 2.5099999999999998 109.84 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.52 131.33 27.57 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.683 2.256 . . . . 2.2999999999999998 112.094 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.7 0.85 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.726 -0.67 . . . . 2.52 109.997 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.567 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -158.03 148.23 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.158 -0.928 . . . . 2.5800000000000001 109.572 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.32 72.76 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.173 0.434 . . . . 2.0099999999999998 112.173 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 43.0 t -68.33 -26.28 33.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.479 -0.328 . . . . 2.5099999999999998 110.482 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.549 ' HG3' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -64.0 -49.12 73.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 1.95 110.395 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -64.56 -40.48 95.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.76 -0.654 . . . . 1.79 111.286 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -46.89 64.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 3.48 111.098 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 23' ' ' TRP . 3.0 tp -63.67 -54.58 33.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.964 -0.562 . . . . 2.4199999999999999 111.087 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -61.11 -29.1 69.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.446 . . . . 1.6000000000000001 111.453 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -68.93 -67.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 2.6899999999999999 110.65 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.681 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 37.5 mm -59.23 -47.71 89.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.436 -0.347 . . . . 2.4300000000000002 111.37 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.674 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 3.8 m95 -57.67 -46.33 84.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 1.55 110.716 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 3.2 mm-40 -89.6 28.14 1.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 2.7799999999999998 111.757 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.681 ' HD2' ' HA ' ' A' ' 22' ' ' ILE . 9.4 mtt180 -114.68 -14.26 12.04 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.109 -1.071 . . . . 4.9000000000000004 108.109 161.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.04 -37.96 3.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.003 -0.998 . . . . 2.4900000000000002 111.778 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HB3' ' H ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -95.98 -97.33 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.109 0.411 . . . . 3.3100000000000001 112.109 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 27' ' ' LEU . . . -87.96 -28.0 24.64 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.762 -0.732 . . . . 1.8799999999999999 112.304 -173.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 2.9 t 63.84 41.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.537 0.684 . . . . 2.4500000000000002 110.789 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.443 ' HB2' ' H ' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -98.11 -98.02 0.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 2.21 111.115 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' ' 30' ' ' SER . . . 140.96 76.72 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.908 -0.663 . . . . 1.6399999999999999 111.689 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.614 HD12 ' HB3' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -117.81 132.09 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.012 0.435 . . . . 3.9700000000000002 111.37 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . -100.18 -123.43 5.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 2.3199999999999998 111.844 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mt -79.68 68.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.506 0.67 . . . . 3.1299999999999999 110.322 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.614 ' HB3' HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -148.64 4.17 0.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.387 -0.824 . . . . 3.02 110.504 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.726 ' HA ' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m-20 54.0 -109.9 0.51 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.102 -0.499 . . . . 4.2000000000000002 111.1 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.8 -73.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.432 0.693 . . . . 4.9299999999999997 112.705 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.02 -51.39 3.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.308 -0.405 . . . . 2.75 111.024 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -98.99 -70.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 2.46 112.153 -170.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.726 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 29.9 mp0 -60.31 -21.45 62.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.722 -0.672 . . . . 2.5699999999999998 112.602 -170.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 3.9 tp -63.93 -21.87 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 3.7999999999999998 111.366 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.759 ' HA2' ' HB3' ' A' ' 69' ' ' PHE . . . 108.0 45.68 1.08 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.579 -0.82 . . . . 2.4900000000000002 112.26 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.76 107.19 2.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.702 -0.761 . . . . 2.46 112.134 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -72.81 86.39 1.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 2.9300000000000002 110.294 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.93 178.25 8.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.81 -0.632 . . . . 1.3600000000000001 111.178 -178.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.51 29.33 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 2.9199999999999999 110.387 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -107.37 163.51 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.854 -0.612 . . . . 2.7200000000000002 110.842 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.88 86.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.59 . . . . 2.0800000000000001 112.227 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.674 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 11.2 ttt -61.27 -34.78 75.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 3.1600000000000001 111.036 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.21 -0.45 . . . . 1.6000000000000001 110.538 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.471 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 18.0 t -72.67 -42.29 62.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 2.0099999999999998 109.923 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.58 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.876 -0.602 . . . . 1.5700000000000001 110.88 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 64' ' ' PRO . . . -74.06 -43.61 57.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.909 -0.587 . . . . 1.3700000000000001 110.928 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.471 ' OE1' ' HA ' ' A' ' 51' ' ' VAL . 2.1 pt20 -75.64 -24.39 56.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.901 0.382 . . . . 2.3399999999999999 110.808 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -14.95 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.112 0.482 . . . . 2.3900000000000001 110.4 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.587 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -64.62 -32.75 74.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 2.5299999999999998 110.807 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.851 ' HD2' HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.18 -0.76 13.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 4.1200000000000001 109.807 175.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER 50.23 84.99 0.04 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.847 -1.069 . . . . 3.6400000000000001 111.717 -177.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 11.6 m-30 69.95 76.22 0.21 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.237 -0.892 . . . . 4.96 111.433 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.667 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 6.0 pm0 -97.37 -37.5 10.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.107 -0.331 . . . . 2.7999999999999998 110.107 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 2.4 p 159.46 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.806 -1.183 . . . . 3.4900000000000002 107.806 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -58.35 -49.08 78.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.089 0.404 . . . . 4.5599999999999996 111.265 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 47.7 mt -89.37 134.14 33.39 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.03 0.443 . . . . 3.52 111.174 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.3 Cg_exo -81.06 59.72 7.56 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.219 2.613 . . . . 2.1699999999999999 112.496 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.725 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -69.56 116.31 9.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 2.9700000000000002 111.793 -176.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.16 19.13 10.42 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.615 -0.72 . . . . 2.8700000000000001 111.608 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.851 HG11 ' HD2' ' A' ' 57' ' ' ARG . 1.7 t -106.78 -20.95 5.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.326 0.584 . . . . 2.5899999999999999 109.978 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 77' ' ' LEU . 1.5 mt 180.0 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.589 -1.187 . . . . 2.6499999999999999 108.579 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.759 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 95.2 m-85 -112.94 -177.23 3.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 2.4700000000000002 109.81 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.725 ' HB1' ' HA ' ' A' ' 65' ' ' LEU . . . 60.87 55.32 3.21 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.338 0.59 . . . . 1.52 110.849 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -149.99 100.15 3.25 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.37 -0.832 . . . . 3.8300000000000001 110.208 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.501 ' O ' ' HB ' ' A' ' 73' ' ' THR . 47.5 Cg_exo -56.53 105.95 0.19 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.766 2.311 . . . . 2.1200000000000001 110.949 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 77.2 m 72.33 103.5 0.07 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.318 -0.623 . . . . 2.7999999999999998 109.318 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.549 HD13 ' HG3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -84.44 12.81 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 2.5899999999999999 111.071 -172.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.567 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -58.27 -50.37 73.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 4.2400000000000002 110.807 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.21 93.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.947 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -67.17 -36.11 81.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.122 -0.49 . . . . 2.9700000000000002 110.65 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.673 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . -62.89 -33.29 74.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.083 -0.508 . . . . 1.97 111.576 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.39 16.81 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.816 0.341 . . . . 3.27 110.711 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -126.47 -86.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.275 -0.42 . . . . 3.1000000000000001 110.942 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.1 -25.87 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.416 -0.356 . . . . 2.6800000000000002 111.436 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . -71.04 -28.14 64.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.67 -0.241 . . . . 2.0299999999999998 111.305 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.296 0.57 . . . . 3.1099999999999999 110.853 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 N-CA-C 109.246 -0.649 . . . . 3.4700000000000002 109.246 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.32 122.4 41.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.146 0.498 . . . . 3.4700000000000002 112.115 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.65 70.47 2.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 4.0800000000000001 110.021 174.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.407 ' CD2' HD22 ' A' ' 35' ' ' LEU . 43.3 t80 -134.92 -47.5 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.873 -0.603 . . . . 2.3599999999999999 110.853 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 49.35 -134.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.671 -0.695 . . . . 2.5 110.903 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB2' HG12 ' A' ' 34' ' ' ILE . . . -178.63 94.04 0.22 Allowed Pre-proline 0 N--CA 1.463 0.199 0 O-C-N 123.128 0.268 . . . . 2.5099999999999998 111.126 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -92.25 46.47 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.775 2.316 . . . . 2.2999999999999998 111.875 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -86.73 106.44 17.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.768 0.655 . . . . 2.52 112.768 -173.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t30 40.53 54.88 2.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.043 1.127 . . . . 2.5800000000000001 114.043 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 70.64 -52.29 0.67 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.743 1.016 . . . . 2.0099999999999998 113.743 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.25 -60.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 2.5099999999999998 111.314 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HA ' HD12 ' A' ' 19' ' ' LEU . 3.2 mp0 -62.22 -31.08 71.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.21 -0.45 . . . . 1.95 110.997 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -40.07 90.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.938 0.399 . . . . 1.79 110.814 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -41.77 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.834 -0.621 . . . . 3.48 110.519 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 16' ' ' GLU . 28.1 mt -61.87 -43.75 98.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.064 -0.517 . . . . 2.4199999999999999 110.01 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -56.44 -55.03 38.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.647 -0.706 . . . . 1.6000000000000001 111.507 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 10.9 pt-20 -64.6 -46.75 81.32 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 111.706 0.261 . . . . 2.6899999999999999 111.706 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -68.0 -47.95 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.62 -0.264 . . . . 2.4300000000000002 111.219 -175.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -76.8 -14.16 59.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 1.55 111.001 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.6 mm-40 -69.04 -50.1 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.089 -0.338 . . . . 2.7799999999999998 110.089 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -75.28 -24.51 57.55 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.833 -0.347 . . . . 4.9000000000000004 111.935 -174.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.45 33.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.687 -0.405 . . . . 2.4900000000000002 111.894 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tp -171.99 -73.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.847 0.314 . . . . 3.3100000000000001 111.847 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.78 -62.62 2.62 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.984 -0.627 . . . . 1.8799999999999999 113.88 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 t 53.77 32.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.031 0.532 . . . . 2.4500000000000002 110.804 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -143.08 11.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 2.21 111.523 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.41 60.49 3.02 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.892 -0.883 . . . . 1.6399999999999999 110.892 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.56 81.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 3.9700000000000002 111.519 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.41 155.73 50.46 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.701 -0.682 . . . . 2.3199999999999998 112.151 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 10' ' ' ALA . 7.0 mm -80.05 56.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.764 0.792 . . . . 3.1299999999999999 111.483 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.407 HD22 ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -117.89 -42.07 2.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.184 -0.916 . . . . 3.02 108.614 171.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -156.54 128.02 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.02 -0.991 . . . . 4.2000000000000002 108.562 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.5 ' O ' HG12 ' A' ' 41' ' ' ILE . 43.7 t30 -173.22 149.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.885 -0.413 . . . . 4.9299999999999997 109.885 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 29.25 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.974 0.416 . . . . 2.75 111.295 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.427 ' H ' ' C ' ' A' ' 37' ' ' ASN . 42.8 t80 -117.07 -66.98 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.296 -0.411 . . . . 2.46 110.15 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.643 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.4 pm0 -79.84 13.11 2.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.936 -0.575 . . . . 2.5699999999999998 112.003 -176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 37' ' ' ASN . 14.5 pt -106.97 7.49 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 3.7999999999999998 110.181 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 33.03 10.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.821 -0.704 . . . . 2.4900000000000002 112.025 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.32 151.0 35.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 2.46 111.996 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 73.51 10.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.072 0.463 . . . . 2.9300000000000002 111.014 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.04 125.3 28.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.915 -0.584 . . . . 1.3600000000000001 110.35 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tp -73.72 71.74 1.46 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.002 0.43 . . . . 2.9199999999999999 111.992 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -145.44 152.4 39.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.915 -0.584 . . . . 2.7200000000000002 109.489 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -32.72 73.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 2.0800000000000001 111.523 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.3 ttt -61.81 -35.49 78.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 3.1600000000000001 110.991 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.94 -36.57 67.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 1.6000000000000001 110.546 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 t -66.58 -42.53 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.568 . . . . 2.0099999999999998 110.361 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.8 94.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 1.5700000000000001 110.845 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.68 84.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 1.3700000000000001 110.825 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -10.93 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 2.3399999999999999 111.162 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.484 ' O ' HG12 ' A' ' 55' ' ' VAL . 64.9 t -104.0 -22.9 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.286 -0.415 . . . . 2.3900000000000001 110.865 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.796 ' HE1' ' HA ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -74.72 55.14 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.925 0.713 . . . . 2.5299999999999998 112.925 -172.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -176.85 -70.6 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.158 -0.682 . . . . 4.1200000000000001 109.158 175.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -170.87 40.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 3.6400000000000001 110.624 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 59.26 78.7 0.25 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.99 -0.55 . . . . 4.96 110.631 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.456 ' OE1' ' HB3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -77.95 76.88 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.522 -0.763 . . . . 2.7999999999999998 110.874 -176.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -76.18 -18.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.792 -0.64 . . . . 3.4900000000000002 111.009 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -97.84 43.97 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 4.5599999999999996 110.024 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.19 129.43 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.171 -0.922 . . . . 3.52 111.047 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.2 73.65 4.36 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.696 2.264 . . . . 2.1699999999999999 112.461 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 67' ' ' VAL . 2.1 tp -59.53 113.69 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 2.9700000000000002 110.363 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.735 ' H ' ' HB1' ' A' ' 70' ' ' ALA . 19.2 mttt 58.42 -110.1 0.49 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.886 -0.597 . . . . 2.8700000000000001 110.383 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 65' ' ' LEU . 46.3 t 59.64 -85.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.223 0.609 . . . . 2.5899999999999999 111.843 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.586 HD11 ' HA ' ' A' ' 78' ' ' ALA . 5.5 tp -148.2 10.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 2.6499999999999999 110.879 -176.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 -56.15 0.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.251 0.463 . . . . 2.4700000000000002 112.251 -173.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.735 ' HB1' ' H ' ' A' ' 66' ' ' LYS . . . -80.71 66.43 6.23 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.121 0.415 . . . . 1.52 112.121 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.495 ' HB2' HD23 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -166.74 126.85 1.18 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.8300000000000001 109.837 176.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.437 ' C ' ' HG1' ' A' ' 73' ' ' THR . 14.0 Cg_exo -71.73 42.39 0.49 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.505 2.804 . . . . 2.1200000000000001 113.408 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -159.02 72.12 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.756 -0.831 . . . . 2.7999999999999998 108.756 175.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.79 -34.36 46.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.339 -0.846 . . . . 2.5899999999999999 111.236 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.421 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -60.28 -32.2 70.96 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.939 0.399 . . . . 4.2400000000000002 110.589 178.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.56 -44.14 35.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 1.7 110.805 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 71' ' ' GLN . 1.0 OUTLIER -63.29 -43.37 98.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 2.9700000000000002 110.737 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.586 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.81 -18.42 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.619 . . . . 1.97 111.49 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.76 -7.42 58.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 3.27 110.245 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.78 -70.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 3.1000000000000001 111.399 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.44 51.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.828 0.347 . . . . 2.6800000000000002 111.378 -173.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.796 ' HA ' ' HE1' ' A' ' 56' ' ' HIS . . . -157.58 -33.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.247 -0.433 . . . . 2.0299999999999998 111.501 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.416 . . . . 3.1099999999999999 111.708 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.585 -0.524 . . . . 3.4700000000000002 109.585 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.48 116.66 7.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.092 -0.504 . . . . 3.4700000000000002 111.006 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -83.27 49.02 1.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 4.0800000000000001 109.682 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.61 -89.75 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.724 . . . . 2.3599999999999999 111.273 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.562 HG12 ' HD3' ' A' ' 11' ' ' PRO . 11.9 t 63.64 -86.33 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.012 -0.54 . . . . 2.5 110.687 -173.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 49.74 69.9 2.38 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 123.02 0.528 . . . . 2.5099999999999998 111.948 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 9' ' ' VAL . 97.7 Cg_endo -88.5 155.0 6.48 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.766 2.311 . . . . 2.2999999999999998 112.653 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.14 -67.32 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.54 -0.3 . . . . 2.52 111.18 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -153.91 118.19 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.46 0.541 . . . . 2.5800000000000001 112.46 -176.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.77 -79.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.879 1.066 . . . . 2.0099999999999998 113.879 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -63.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.694 0.627 . . . . 2.5099999999999998 112.694 -169.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' HA ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -62.79 -37.58 87.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.95 111.473 -176.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -45.98 83.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.095 -0.502 . . . . 1.79 111.269 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -38.14 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.028 -0.533 . . . . 3.48 111.367 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -47.72 79.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 2.4199999999999999 110.854 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.92 82.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 1.6000000000000001 110.494 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.55 -48.74 79.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 2.6899999999999999 111.478 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.473 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 2.5 tt -67.93 -36.32 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.929 -0.308 . . . . 2.4300000000000002 111.765 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -81.75 -53.38 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 1.55 111.838 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.612 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -78.02 -7.74 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.092 0.404 . . . . 2.7799999999999998 112.092 -172.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.612 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 1.4 mmm180 -115.56 -0.25 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.255 -0.578 . . . . 4.9000000000000004 111.658 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -115.63 -23.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 2.4900000000000002 111.177 175.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 tp -122.86 -76.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 3.3100000000000001 110.77 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.456 ' HA3' ' HZ ' ' A' ' 38' ' ' PHE . . . -85.93 62.35 4.39 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.774 -0.727 . . . . 1.8799999999999999 112.92 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 1.6 p -67.68 105.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.564 0.697 . . . . 2.4500000000000002 110.645 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.16 -32.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.217 -0.901 . . . . 2.21 110.141 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.61 96.08 2.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.897 -0.668 . . . . 1.6399999999999999 111.646 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.668 HD13 ' HB3' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -131.64 -40.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.97 0.414 . . . . 3.9700000000000002 110.691 -178.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.53 ' C ' HG12 ' A' ' 34' ' ' ILE . . . 65.0 -99.62 0.38 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.937 -0.574 . . . . 2.3199999999999998 112.729 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.53 HG12 ' C ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -142.31 52.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.092 0.472 . . . . 3.1299999999999999 110.932 -177.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mt -129.72 -111.49 0.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.244 -0.285 . . . . 3.02 111.033 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -88.91 71.64 8.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 4.2000000000000002 110.288 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.668 ' HB3' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -114.18 164.45 13.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.643 -0.708 . . . . 4.9299999999999997 110.994 -176.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.456 ' HZ ' ' HA3' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -82.32 -14.96 54.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.008 -0.542 . . . . 2.75 110.634 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.466 ' HB3' ' OE1' ' A' ' 40' ' ' GLN . 18.7 t80 -81.97 -90.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.088 -0.506 . . . . 2.46 110.277 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.466 ' OE1' ' HB3' ' A' ' 39' ' ' PHE . 3.6 mp0 -68.09 125.42 26.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.574 -0.528 . . . . 2.5699999999999998 109.574 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.512 ' O ' HG21 ' A' ' 41' ' ' ILE . 0.0 OUTLIER 78.52 -9.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 123.978 0.799 . . . . 3.7999999999999998 110.972 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.46 -58.29 3.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.975 -0.631 . . . . 2.4900000000000002 112.256 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.734 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . 147.67 -76.13 0.26 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.385 -0.912 . . . . 2.46 112.613 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -165.81 119.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.039 0.447 . . . . 2.9300000000000002 110.992 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.03 144.34 26.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 1.3600000000000001 110.176 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.11 92.57 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.995 0.426 . . . . 2.9199999999999999 111.243 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -171.48 164.64 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 2.7200000000000002 110.285 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.75 65.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 2.0800000000000001 111.854 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -39.16 83.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.362 . . . . 3.1600000000000001 110.742 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.02 -37.59 61.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 1.6000000000000001 110.472 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.81 -42.96 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 2.0099999999999998 110.677 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.48 96.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 1.5700000000000001 110.903 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.453 . . . . 1.3700000000000001 110.32 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -49.3 73.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.604 -0.726 . . . . 2.3399999999999999 111.098 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 m -75.15 -33.0 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.929 -0.308 . . . . 2.3900000000000001 111.73 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -31.13 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.881 -0.328 . . . . 2.5299999999999998 111.224 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 -9.81 53.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.893 -0.41 . . . . 4.1200000000000001 109.893 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER 67.33 62.4 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.216 -0.902 . . . . 3.6400000000000001 110.882 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 1.2 m-85 78.91 109.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 4.96 111.65 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.07 -20.04 18.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.021 -0.99 . . . . 2.7999999999999998 109.695 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.7 t 66.05 -111.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.226 -0.897 . . . . 3.4900000000000002 110.185 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.65 8.55 4.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 4.5599999999999996 110.358 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 92.82 39.7 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 3.52 110.46 -175.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.734 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 49.8 Cg_endo -70.58 128.22 14.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.425 2.084 . . . . 2.1699999999999999 112.029 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.11 137.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 2.9700000000000002 109.436 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.51 47.35 16.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.712 0.633 . . . . 2.8700000000000001 110.442 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG13 ' H ' ' A' ' 69' ' ' PHE . 2.7 p -156.08 175.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.5899999999999999 109.808 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.5 ' HG ' HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -53.83 -36.88 63.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.286 0.476 . . . . 2.6499999999999999 112.286 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.535 ' H ' HG13 ' A' ' 67' ' ' VAL . 86.0 m-85 -84.09 3.21 35.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.46 -0.336 . . . . 2.4700000000000002 111.66 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.31 73.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.782 0.325 . . . . 1.52 111.459 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.93 141.48 1.21 Allowed Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.134 -0.691 . . . . 3.8300000000000001 109.134 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 73' ' ' THR . 23.0 Cg_exo -64.62 -86.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.539 2.16 . . . . 2.1200000000000001 111.867 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.7 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -80.92 136.72 36.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.713 0.292 . . . . 2.7999999999999998 110.541 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.497 HD11 HD21 ' A' ' 77' ' ' LEU . 38.0 mm -64.69 -25.05 36.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 2.5899999999999999 111.097 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.7 ' HD3' ' HB ' ' A' ' 73' ' ' THR . 1.1 pttt -50.48 -34.56 25.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.301 -0.409 . . . . 4.2400000000000002 111.801 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.543 ' N ' ' HG2' ' A' ' 75' ' ' LYS . . . -70.41 -50.75 35.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.037 0.446 . . . . 1.7 111.005 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.5 HD11 ' HG ' ' A' ' 68' ' ' LEU . 1.8 pp -73.06 -15.51 61.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 2.9700000000000002 110.71 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.56 -31.71 60.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 1.97 110.735 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.32 5.94 47.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 3.27 111.45 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.02 -48.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.529 0.566 . . . . 3.1000000000000001 112.529 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.53 -51.38 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.085 0.402 . . . . 2.6800000000000002 112.085 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.89 -16.15 63.59 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.075 0.398 . . . . 2.0299999999999998 112.075 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.046 0.451 . . . . 3.1099999999999999 110.824 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 2.2 mt-10 . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.743 -0.466 . . . . 3.4700000000000002 109.743 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 32' ' ' ILE . . . -80.33 128.76 33.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.909 0.385 . . . . 3.4700000000000002 111.055 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.78 -19.46 41.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.236 0.541 . . . . 4.0800000000000001 110.301 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -91.04 57.61 3.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.925 -0.579 . . . . 2.3599999999999999 110.111 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.09 67.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 122.193 0.997 . . . . 2.5 110.431 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -143.51 110.38 5.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.196 -0.911 . . . . 2.5099999999999998 110.288 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 5.5 Cg_exo -78.73 171.05 17.23 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.257 2.638 . . . . 2.2999999999999998 112.382 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.87 -47.48 4.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.121 0.486 . . . . 2.52 110.666 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.441 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 24.0 t-20 -108.08 154.08 22.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 2.5800000000000001 110.669 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.97 -29.12 69.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 2.0099999999999998 111.246 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.04 -35.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.21 0.528 . . . . 2.5099999999999998 110.27 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.491 ' HA ' HD13 ' A' ' 74' ' ' ILE . 73.5 mt-10 -73.13 -36.74 66.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.713 -0.676 . . . . 1.95 110.598 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -35.22 74.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 1.79 110.53 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -45.07 78.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.091 -0.504 . . . . 3.48 110.757 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.74 -37.29 87.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 2.4199999999999999 110.129 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.74 -30.8 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 1.6000000000000001 110.595 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.625 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 16.5 tt0 -61.96 -47.17 86.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.981 -0.378 . . . . 2.6899999999999999 109.981 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.2 mt -69.92 -55.16 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.333 -0.394 . . . . 2.4300000000000002 111.158 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.535 ' CH2' ' HD2' ' A' ' 47' ' ' LYS . 64.1 m95 -68.56 -49.1 62.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.257 0.465 . . . . 1.55 112.257 -172.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.89 -50.24 24.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.438 0.162 . . . . 2.7799999999999998 111.438 -174.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 1.1 mmt85 -66.6 -27.38 67.66 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.694 -0.402 . . . . 4.9000000000000004 111.643 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.17 -55.75 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.219 -0.193 . . . . 2.4900000000000002 111.288 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.89 -44.32 5.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.404 0.52 . . . . 3.3100000000000001 112.404 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.57 -59.82 10.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.353 -0.451 . . . . 1.8799999999999999 113.57 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.1 t 72.12 -56.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 123.329 0.652 . . . . 2.4500000000000002 111.897 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.463 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 2.4 m -74.35 -41.04 61.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 2.21 111.16 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.1 127.38 3.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.758 -0.734 . . . . 1.6399999999999999 112.096 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.48 ' HA ' ' HB1' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -164.44 161.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.94 -0.393 . . . . 3.9700000000000002 109.94 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.45 -103.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.038 -1.077 . . . . 2.3199999999999998 113.552 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.451 HG22 HD13 ' A' ' 34' ' ' ILE . 3.2 mm -81.16 65.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.146 0.498 . . . . 3.1299999999999999 111.637 -171.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.97 171.63 15.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.112 -0.495 . . . . 3.02 110.139 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.53 112.87 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.095 -0.502 . . . . 4.2000000000000002 109.751 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.491 HD22 ' NE2' ' A' ' 40' ' ' GLN . 3.4 p30 -146.95 172.31 13.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.175 0.512 . . . . 4.9299999999999997 111.682 -174.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -63.45 153.17 36.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.129 -0.941 . . . . 2.75 112.717 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.9 -39.08 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.931 0.892 . . . . 2.46 112.891 171.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.491 ' NE2' HD22 ' A' ' 37' ' ' ASN . 38.4 mt-30 -65.32 -36.31 83.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.803 0.335 . . . . 2.5699999999999998 111.19 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -99.03 15.85 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 3.7999999999999998 111.546 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.23 135.88 2.56 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.664 -0.779 . . . . 2.4900000000000002 112.129 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.65 70.76 1.02 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.686 -0.768 . . . . 2.46 111.338 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.473 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 24.6 p80 -60.75 150.67 31.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.78 0.324 . . . . 2.9300000000000002 111.135 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -179.24 4.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 1.3600000000000001 110.993 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 35.15 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 2.9199999999999999 111.21 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HD2' ' CH2' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -129.09 171.23 12.59 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.988 -0.285 . . . . 2.7200000000000002 110.985 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.24 69.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 2.0800000000000001 112.408 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -37.87 64.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.041 0.448 . . . . 3.1600000000000001 111.066 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 44' ' ' HIS . . . -76.62 -40.69 48.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 1.6000000000000001 110.89 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.04 -41.55 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 2.0099999999999998 110.546 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.11 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 1.5700000000000001 111.04 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.41 -36.46 74.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 1.3700000000000001 111.022 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' A' ' 61' ' ' VAL . 3.0 pt20 -76.49 -18.33 58.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 2.3399999999999999 111.626 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.6 p -115.86 0.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.094 0.405 . . . . 2.3900000000000001 112.094 -175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -32.57 72.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.412 . . . . 2.5299999999999998 112.114 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.29 -76.65 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.891 -0.323 . . . . 4.1200000000000001 110.751 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.46 55.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 3.6400000000000001 110.065 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.3 72.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.252 -0.885 . . . . 4.96 111.789 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.51 -14.94 29.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.7 -0.682 . . . . 2.7999999999999998 110.143 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.55 ' HA ' ' HB2' ' A' ' 54' ' ' GLN . 5.9 t 60.15 -92.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.268 -0.878 . . . . 3.4900000000000002 112.066 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.1 15.11 26.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.729 0.3 . . . . 4.5599999999999996 111.238 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.42 79.74 37.35 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.063 0.458 . . . . 3.52 110.463 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.641 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 85.7 Cg_endo -96.89 16.06 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.008 2.472 . . . . 2.1699999999999999 112.638 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.76 117.76 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 2.9700000000000002 111.496 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt 68.52 3.71 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.265 -0.879 . . . . 2.8700000000000001 112.202 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.13 -53.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.715 -0.476 . . . . 2.5899999999999999 109.715 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.641 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -171.9 154.56 3.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.461 -0.94 . . . . 2.6499999999999999 108.461 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 75.0 -56.06 0.64 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.314 0.487 . . . . 2.4700000000000002 112.314 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.22 67.86 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.347 0.499 . . . . 1.52 112.347 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.719 ' HB2' HD11 ' A' ' 77' ' ' LEU . 3.0 mm-40 -155.46 128.24 4.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.153 -0.684 . . . . 3.8300000000000001 109.153 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 23.7 Cg_exo -64.29 -11.87 30.11 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.988 2.459 . . . . 2.1200000000000001 112.98 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 t -132.22 115.31 15.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.412 0.625 . . . . 2.7999999999999998 110.085 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 16' ' ' GLU . 1.1 mt -77.88 -17.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.653 -0.703 . . . . 2.5899999999999999 110.786 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 4.4 tttt -56.47 -50.38 71.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.278 -0.419 . . . . 4.2400000000000002 110.49 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -62.95 -41.68 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.675 -0.693 . . . . 1.7 110.967 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 71' ' ' GLN . 6.2 mt -63.09 -46.31 87.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 2.9700000000000002 111.269 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.94 -29.07 70.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 1.97 112.003 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -101.37 8.65 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.681 -0.408 . . . . 3.27 111.249 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 1.7 m-85 -119.28 -93.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.508 -0.314 . . . . 3.1000000000000001 110.719 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.491 ' H ' HG21 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -84.02 43.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 2.6800000000000002 111.321 -175.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.48 -40.65 1.58 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.657 -0.701 . . . . 2.0299999999999998 109.675 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.587 -0.733 . . . . 3.1099999999999999 110.907 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.77 0.319 . . . . 3.4700000000000002 110.912 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.66 ' H ' HG21 ' A' ' 32' ' ' ILE . . . -94.01 179.92 5.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 3.4700000000000002 110.507 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -112.43 95.88 5.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 4.0800000000000001 110.522 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.522 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 2.7 t80 -155.23 -103.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 2.3599999999999999 110.542 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.5 OUTLIER 71.2 -7.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.595 0.758 . . . . 2.5 112.214 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.18 31.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 2.5099999999999998 110.737 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.863 ' HA ' HD12 ' A' ' 34' ' ' ILE . 59.5 Cg_endo -94.98 172.15 1.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.285 2.656 . . . . 2.2999999999999998 113.167 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 -40.21 8.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.083 -0.71 . . . . 2.52 109.083 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -119.6 151.55 38.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.224 -0.898 . . . . 2.5800000000000001 109.299 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.49 -33.7 70.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.907 0.336 . . . . 2.0099999999999998 111.907 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 16' ' ' GLU . 9.8 p -65.04 -27.34 42.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 2.5099999999999998 111.56 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.754 ' HA ' HD11 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.0 -58.82 6.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.005 0.431 . . . . 1.95 111.166 -175.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -79.46 -12.43 59.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.365 -0.38 . . . . 1.79 111.283 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -51.52 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.57 -0.53 . . . . 3.48 109.57 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.514 ' HA ' HD11 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -62.7 -41.85 99.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 2.4199999999999999 110.329 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.39 77.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 1.6000000000000001 110.857 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.622 ' HG2' ' HG3' ' A' ' 25' ' ' ARG . 2.3 tt0 -63.33 -31.37 72.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.236 -0.438 . . . . 2.6899999999999999 111.206 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 20.9 mt -62.13 -42.73 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.109 0.481 . . . . 2.4300000000000002 110.301 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.798 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 36.7 m95 -79.54 -46.76 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.085 -0.507 . . . . 1.55 111.781 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 pt-20 -76.41 -8.56 57.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.839 0.681 . . . . 2.7799999999999998 112.839 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 2.1 mtp85 -120.89 -4.98 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.607 -0.437 . . . . 4.9000000000000004 111.74 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.558 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 6.5 t -108.71 -49.83 7.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.4900000000000002 110.467 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.446 HD13 ' HG3' ' A' ' 47' ' ' LYS . 80.9 mt -95.73 -85.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.078 0.466 . . . . 3.3100000000000001 110.568 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.19 89.61 1.48 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.688 -0.767 . . . . 1.8799999999999999 111.502 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 58.4 t -62.8 105.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.968 0.414 . . . . 2.4500000000000002 110.206 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.26 -64.92 0.71 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.204 -0.453 . . . . 2.21 111.409 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.3 85.45 1.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.83 -0.7 . . . . 1.6399999999999999 111.413 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.66 HG21 ' H ' ' A' ' 6' ' ' ALA . 0.4 OUTLIER -137.47 -58.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.872 0.368 . . . . 3.9700000000000002 111.654 -174.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . 101.65 -138.09 13.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.711 -0.757 . . . . 2.3199999999999998 111.476 -172.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.863 HD12 ' HA ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -120.06 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.347 . . . . 3.1299999999999999 110.98 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.855 ' HG ' ' H ' ' A' ' 36' ' ' ASP . 1.3 pt? -152.73 -66.07 0.16 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.502 -0.317 . . . . 3.02 111.118 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.855 ' H ' ' HG ' ' A' ' 35' ' ' LEU . 5.9 t70 -176.76 173.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 4.2000000000000002 110.047 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER 65.73 23.51 11.53 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.51 0.724 . . . . 4.9299999999999997 112.815 173.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' HB3' HD13 ' A' ' 32' ' ' ILE . 20.9 t80 173.18 138.04 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.509 -0.769 . . . . 2.75 109.108 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 67.15 -72.25 0.09 Allowed 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.034 0.834 . . . . 2.46 110.558 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.35 59.67 2.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 2.5699999999999998 110.484 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 -48.98 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.654 -0.703 . . . . 3.7999999999999998 110.181 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.68 116.63 2.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.4900000000000002 111.641 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.33 -159.24 24.52 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.795 -0.717 . . . . 2.46 112.042 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -125.66 73.86 1.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.874 0.369 . . . . 2.9300000000000002 110.561 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.45 145.62 49.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.193 -0.458 . . . . 1.3600000000000001 110.496 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 46' ' ' LEU . 3.1 mt -92.31 66.74 4.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 2.9199999999999999 111.416 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HG3' HD13 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -144.01 155.5 44.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.403 -0.362 . . . . 2.7200000000000002 110.312 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.79 -43.73 63.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.491 0.552 . . . . 2.0800000000000001 112.491 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.798 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 6.2 tpt -62.86 -34.76 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.802 0.334 . . . . 3.1600000000000001 111.179 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.41 -37.58 56.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 1.6000000000000001 110.488 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.69 -40.24 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.927 -0.579 . . . . 2.0099999999999998 110.257 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -61.2 -36.83 80.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 1.5700000000000001 110.983 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.573 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -73.12 -35.23 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.424 -0.353 . . . . 1.3700000000000001 110.617 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.455 ' NE2' ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -65.06 -38.7 91.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 2.3399999999999999 110.873 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.85 -26.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 2.3900000000000001 110.502 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -66.21 -38.29 87.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 2.5299999999999998 109.906 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.44 173.16 11.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.423 -0.584 . . . . 4.1200000000000001 109.423 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -82.23 48.32 1.25 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.436 -0.347 . . . . 3.6400000000000001 110.226 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 79.7 m-85 56.26 78.94 0.19 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.769 0.795 . . . . 4.96 109.692 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 17.4 pm0 -71.44 -11.79 61.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 2.7999999999999998 113.06 -169.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 t 63.3 -82.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 123.292 0.37 . . . . 3.4900000000000002 111.113 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -131.53 5.87 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.535 0.198 . . . . 4.5599999999999996 111.535 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -122.64 78.46 47.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 3.52 111.133 -178.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.53 54.35 4.7 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.355 2.704 . . . . 2.1699999999999999 112.237 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.78 130.42 42.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.436 -0.802 . . . . 2.9700000000000002 111.719 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.689 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 2.2 mptm? 46.15 54.82 7.86 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.187 0.929 . . . . 2.8700000000000001 113.247 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.96 -33.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.728 0.299 . . . . 2.5899999999999999 110.775 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.576 ' HA ' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -174.04 -62.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.198 0.523 . . . . 2.6499999999999999 110.048 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.89 -21.79 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.597 -0.729 . . . . 2.4700000000000002 111.454 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.689 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -116.06 40.67 2.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.458 -0.337 . . . . 1.52 111.04 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.503 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -170.09 84.5 0.58 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 3.8300000000000001 109.621 175.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.88 59.16 3.47 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.739 2.959 . . . . 2.1200000000000001 112.993 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.43 79.89 1.45 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 2.7999999999999998 109.391 176.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.754 HD11 ' HA ' ' A' ' 16' ' ' GLU . 80.2 mt -61.87 -41.89 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.689 -0.687 . . . . 2.5899999999999999 112.541 -169.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -44.58 84.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.435 -0.506 . . . . 4.2400000000000002 110.42 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.86 -34.03 77.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 1.7 110.68 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.576 HD13 ' HA ' ' A' ' 68' ' ' LEU . 18.3 mt -61.98 -32.03 72.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 2.9700000000000002 110.837 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 -22.29 61.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.97 110.991 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.28 5.25 42.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.353 -0.385 . . . . 3.27 110.434 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -119.72 -75.95 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 3.1000000000000001 111.475 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.95 -46.53 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 2.6800000000000002 111.315 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.83 67.33 1.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 2.0299999999999998 110.307 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.92 -0.582 . . . . 3.1099999999999999 111.168 -175.502 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.96 0.409 . . . . 3.4700000000000002 110.367 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.95 88.6 3.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 3.4700000000000002 110.516 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -75.41 71.49 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 4.0800000000000001 110.281 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.509 ' HB3' HD22 ' A' ' 35' ' ' LEU . 83.2 t80 -162.62 23.43 0.1 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.664 0.745 . . . . 2.3599999999999999 109.275 -175.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.51 65.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.899 0.857 . . . . 2.5 111.526 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.39 70.34 39.44 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.812 -1.085 . . . . 2.5099999999999998 108.546 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.802 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 31.3 Cg_exo -61.08 146.69 97.34 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.651 2.901 . . . . 2.2999999999999998 113.788 -171.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -28.19 37.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 2.52 110.575 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -123.88 146.98 48.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.5800000000000001 109.936 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -21.63 66.46 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.317 0.386 . . . . 2.0099999999999998 111.408 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.64 -37.74 80.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.213 -0.449 . . . . 2.5099999999999998 110.537 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.802 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . 36.3 mt-10 -70.66 -34.77 72.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 1.95 110.271 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.12 79.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.076 0.465 . . . . 1.79 110.627 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG3' HD11 ' A' ' 22' ' ' ILE . 2.2 tptm -72.71 -43.77 62.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 3.48 110.373 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -47.29 77.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.599 -0.728 . . . . 2.4199999999999999 110.599 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.787 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . . . -57.87 -55.1 39.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.5 -0.773 . . . . 1.6000000000000001 111.275 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.79 -42.86 85.03 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.805 0.298 . . . . 2.6899999999999999 111.805 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.488 HD11 ' HG3' ' A' ' 18' ' ' LYS . 53.9 mt -69.43 -55.61 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 2.4300000000000002 111.266 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.66 -35.57 81.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 1.55 111.492 -175.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.526 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 3.3 tp10 -63.62 -46.7 84.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.196 -0.456 . . . . 2.7799999999999998 110.965 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -5.32 41.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 4.9000000000000004 111.583 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.18 -60.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.462 -0.335 . . . . 2.4900000000000002 111.32 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -35.27 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.532 0.567 . . . . 3.3100000000000001 112.532 -171.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.594 ' HA3' HG12 ' A' ' 32' ' ' ILE . . . -77.32 -69.83 1.36 Allowed Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.578 -0.82 . . . . 1.8799999999999999 113.505 -172.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t 56.51 54.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.729 . . . . 2.4500000000000002 110.129 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.41 -32.9 0.04 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.14 -0.936 . . . . 2.21 110.567 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.47 65.34 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.181 -0.767 . . . . 1.6399999999999999 111.181 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.634 HG22 ' HE1' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -131.1 -178.09 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.564 0.221 . . . . 3.9700000000000002 111.413 -175.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.787 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . 120.96 31.98 1.13 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.934 -0.651 . . . . 2.3199999999999998 113.269 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -156.87 -65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 117.343 0.571 . . . . 3.1299999999999999 111.982 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 8' ' ' TYR . 1.9 pt? -142.37 33.03 1.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.975 0.893 . . . . 3.02 110.052 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.96 1.61 4.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.5 -1.227 . . . . 4.2000000000000002 112.487 -174.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.439 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 21.2 t-20 74.12 -60.8 0.51 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.111 0.564 . . . . 4.9299999999999997 112.278 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.634 ' HE1' HG22 ' A' ' 32' ' ' ILE . 25.9 p90 -64.64 -22.71 67.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.331 0.493 . . . . 2.75 112.331 -172.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.439 ' CE2' ' HE2' ' A' ' 69' ' ' PHE . 15.9 t80 -108.16 -16.9 14.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.947 0.403 . . . . 2.46 110.812 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -110.48 0.93 17.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 2.5699999999999998 111.751 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 37' ' ' ASN . 5.1 tp -88.93 -23.19 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.136 0.493 . . . . 3.7999999999999998 110.604 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 55.31 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.87 -0.892 . . . . 2.4900000000000002 110.87 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.87 128.74 29.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.984 -0.627 . . . . 2.46 112.74 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.83 59.4 1.37 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.374 0.607 . . . . 2.9300000000000002 110.352 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -179.31 6.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.346 -0.843 . . . . 1.3600000000000001 110.313 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.2 63.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.075 0.464 . . . . 2.9199999999999999 110.153 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -130.66 165.8 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.834 -0.621 . . . . 2.7200000000000002 110.428 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.04 87.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 2.0800000000000001 111.534 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.556 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -62.53 -38.08 88.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.171 -0.468 . . . . 3.1600000000000001 110.824 177.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -71.04 -45.36 64.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 1.6000000000000001 111.405 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.3 m -70.72 -22.4 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.58 -0.282 . . . . 2.0099999999999998 110.979 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.42 88.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 1.5700000000000001 110.01 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.49 76.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 1.3700000000000001 110.647 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -60.23 -55.97 27.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 2.3399999999999999 111.041 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.38 9.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.108 0.48 . . . . 2.3900000000000001 111.095 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.435 ' NE2' ' HA ' ' A' ' 82' ' ' ALA . 1.5 t-80 -88.56 -9.93 50.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 2.5299999999999998 110.744 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 57' ' ' ARG . 3.9 ttm180 -137.18 9.41 2.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.609 . . . . 4.1200000000000001 109.52 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 72.48 -12.97 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.249 -0.887 . . . . 3.6400000000000001 112.043 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.409 ' H ' ' C ' ' A' ' 57' ' ' ARG . 8.3 p90 -169.23 176.08 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.379 . . . . 4.96 110.517 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.99 -52.5 0.19 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 2.7999999999999998 109.112 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 41.8 57.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.132 0.973 . . . . 3.4900000000000002 112.921 175.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.27 9.51 6.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.482 -0.781 . . . . 4.5599999999999996 112.555 172.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 61' ' ' VAL . 0.3 OUTLIER -126.95 73.19 76.36 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.759 0.314 . . . . 3.52 110.73 176.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 6.5 Cg_endo -87.92 117.99 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.075 2.516 . . . . 2.1699999999999999 112.265 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -143.95 122.16 12.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.204 -0.295 . . . . 2.9700000000000002 110.204 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 tttt 53.58 55.53 8.46 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.58 0.55 . . . . 2.8700000000000001 111.123 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.37 -76.1 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.094 -0.503 . . . . 2.5899999999999999 110.69 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.09 -42.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.302 -0.863 . . . . 2.6499999999999999 109.049 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.556 ' CZ ' ' HG2' ' A' ' 49' ' ' MET . 52.4 m-85 -97.55 18.05 16.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.416 -0.811 . . . . 2.4700000000000002 109.962 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 71' ' ' GLN . . . -144.1 134.86 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.877 -1.056 . . . . 1.52 108.233 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 12.7 mp0 70.55 97.1 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 O-C-N 124.324 1.015 . . . . 3.8300000000000001 109.198 -169.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.57 70.59 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.728 2.952 . . . . 2.1200000000000001 113.066 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.26 53.96 1.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 2.7999999999999998 108.968 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.479 ' H ' HG12 ' A' ' 74' ' ' ILE . 2.0 mm -51.35 -49.8 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.698 -1.137 . . . . 2.5899999999999999 112.319 -172.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -64.41 -47.4 79.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 4.2400000000000002 111.066 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 1.7 111.18 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.47 -36.01 81.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.222 -0.444 . . . . 2.9700000000000002 110.983 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . -72.05 -36.89 69.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 1.97 111.296 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -9.81 59.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.949 0.404 . . . . 3.27 111.062 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -103.95 -76.85 0.58 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 3.1000000000000001 111.014 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.7 -40.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.681 . . . . 2.6800000000000002 111.421 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . -79.94 54.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 2.0299999999999998 111.794 -175.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.998 -0.546 . . . . 3.1099999999999999 110.466 178.627 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.976 0.417 . . . . 3.4700000000000002 110.394 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.05 118.23 15.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.022 -0.536 . . . . 3.4700000000000002 110.113 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -81.13 22.58 0.64 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.418 -0.355 . . . . 4.0800000000000001 111.464 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -66.44 -56.48 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.06 -0.718 . . . . 2.3599999999999999 109.06 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p 21.95 65.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 124.892 1.37 . . . . 2.5 113.156 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.76 76.39 74.49 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 2.5099999999999998 110.999 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 23.3 Cg_exo -65.23 115.69 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.304 2.002 . . . . 2.2999999999999998 110.5 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -34.68 75.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 2.52 111.955 -171.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.94 150.73 27.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.741 0.305 . . . . 2.5800000000000001 110.971 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.09 70.35 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.576 . . . . 2.0099999999999998 112.006 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.448 ' H ' HG23 ' A' ' 15' ' ' VAL . 1.9 t -62.51 -36.56 75.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.157 0.503 . . . . 2.5099999999999998 110.696 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.627 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 21.0 mt-10 -79.53 -23.34 42.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.658 -0.701 . . . . 1.95 111.102 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -71.07 -45.45 63.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.372 . . . . 1.79 110.411 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -63.7 -38.98 93.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.119 0.485 . . . . 3.48 110.666 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.487 ' HA ' HD13 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -63.64 -47.1 82.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 2.4199999999999999 110.079 177.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.3 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 1.6000000000000001 111.083 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -56.23 -53.9 51.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 2.6899999999999999 110.876 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.7 mm -68.86 -43.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.156 -0.475 . . . . 2.4300000000000002 111.323 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.877 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 64.4 m95 -71.7 -39.82 69.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.616 0.598 . . . . 1.55 112.616 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 1.6 pt-20 -77.11 -33.48 56.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.904 -0.318 . . . . 2.7799999999999998 111.413 -177.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 8.4 mmp_? -90.08 -57.48 2.84 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.141 0.423 . . . . 4.9000000000000004 112.141 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.23 -43.23 12.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.064 0.394 . . . . 2.4900000000000002 112.064 -171.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.877 ' HB2' ' HA ' ' A' ' 23' ' ' TRP . 1.4 mm? -70.54 -69.79 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.998 0.427 . . . . 3.3100000000000001 111.962 -174.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.59 -22.27 31.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.9 -0.667 . . . . 1.8799999999999999 113.401 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t 55.76 52.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.678 0.751 . . . . 2.4500000000000002 110.076 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.4 141.66 32.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.394 -0.821 . . . . 2.21 110.096 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.7 77.27 2.08 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.588 -0.815 . . . . 1.6399999999999999 111.36 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.523 ' HB ' ' H ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -118.89 -147.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.022 0.439 . . . . 3.9700000000000002 111.133 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.523 ' H ' ' HB ' ' A' ' 32' ' ' ILE . . . 174.58 -174.97 46.82 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.285 -0.726 . . . . 2.3199999999999998 111.285 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.474 HG23 HD11 ' A' ' 74' ' ' ILE . 5.9 mm -80.56 83.26 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.421 . . . . 3.1299999999999999 110.295 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.696 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.95 -51.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 3.02 110.671 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.696 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 t0 178.1 -175.06 0.17 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.864 -0.421 . . . . 4.2000000000000002 109.864 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 74.22 -3.45 2.54 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.003 0.815 . . . . 4.9299999999999997 111.86 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 t80 178.57 163.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.736 0.648 . . . . 2.75 109.333 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.425 ' HD1' ' HA ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 70.58 -70.23 0.16 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.906 0.754 . . . . 2.46 111.017 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.11 72.34 10.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.851 0.357 . . . . 2.5699999999999998 110.526 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 172.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.207 -0.451 . . . . 3.7999999999999998 110.822 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.478 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . -76.41 94.61 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.029 -0.605 . . . . 2.4900000000000002 112.887 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.71 -159.65 32.99 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.952 -0.642 . . . . 2.46 112.001 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -165.57 127.74 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 2.9300000000000002 110.219 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.19 162.19 22.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.075 -0.512 . . . . 1.3600000000000001 110.97 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.77 67.2 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.489 -0.323 . . . . 2.9199999999999999 110.92 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.16 127.42 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.357 -0.383 . . . . 2.7200000000000002 111.379 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 23.6 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.498 1.519 . . . . 2.0800000000000001 114.64 171.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.5 ttt -54.05 -42.42 69.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.965 -0.561 . . . . 3.1600000000000001 112.235 -173.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.41 74.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 1.6000000000000001 110.838 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.31 -46.28 87.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.765 -0.457 . . . . 2.0099999999999998 109.765 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.442 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -64.82 -24.99 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 1.5700000000000001 111.206 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.52 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 1.3700000000000001 110.543 177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -25.51 47.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.19 0.519 . . . . 2.3399999999999999 110.317 177.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -93.03 13.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.863 -0.608 . . . . 2.3900000000000001 110.161 177.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.99 4.78 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.741 -0.663 . . . . 2.5299999999999998 109.689 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.536 ' HD2' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -154.99 -165.38 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.114 -0.948 . . . . 4.1200000000000001 109.175 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -79.62 38.47 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.417 -0.356 . . . . 3.6400000000000001 111.542 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 60.6 78.39 0.28 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.647 0.737 . . . . 4.96 109.524 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 19.2 pm0 -77.68 23.3 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.943 -1.026 . . . . 2.7999999999999998 112.826 -171.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 t 55.0 -100.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.446 0.298 . . . . 3.4900000000000002 110.877 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -134.23 32.1 3.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 4.5599999999999996 110.605 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.556 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 12.8 mt -104.4 100.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 3.52 110.114 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.478 ' HG3' ' HA2' ' A' ' 42' ' ' GLY . 87.2 Cg_endo -84.4 3.08 7.75 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.856 2.371 . . . . 2.1699999999999999 113.184 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.86 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.206 0.941 . . . . 2.9700000000000002 112.64 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 58.31 23.63 10.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.68 -0.691 . . . . 2.8700000000000001 112.471 175.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.536 HG21 ' HD2' ' A' ' 57' ' ' ARG . 7.5 t -97.06 -51.74 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.153 0.501 . . . . 2.5899999999999999 109.991 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.64 -54.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.499 -0.773 . . . . 2.6499999999999999 110.012 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -84.08 35.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 2.4700000000000002 111.262 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.14 47.52 0.69 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.989 -0.745 . . . . 1.52 108.989 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.03 104.81 0.49 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.326 -1.306 . . . . 3.8300000000000001 108.692 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.84 40.46 0.65 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.016 2.478 . . . . 2.1200000000000001 113.485 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.74 94.6 2.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.628 -0.508 . . . . 2.7999999999999998 109.628 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.627 ' HB ' ' HG2' ' A' ' 16' ' ' GLU . 2.6 mt -67.14 -35.09 73.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.304 -0.407 . . . . 2.5899999999999999 110.78 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -36.03 79.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 4.2400000000000002 110.283 176.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.77 83.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 1.7 110.379 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.74 -33.38 75.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 2.9700000000000002 110.547 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.8 -17.07 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.97 111.625 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -110.2 12.95 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 3.27 110.299 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -126.79 -88.9 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.945 -0.571 . . . . 3.1000000000000001 110.865 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.36 -17.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.963 0.357 . . . . 2.6800000000000002 111.963 -175.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.05 39.28 3.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 2.0299999999999998 110.787 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 3.1099999999999999 111.284 -177.412 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.638 0.256 . . . . 3.4700000000000002 110.384 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.81 39.99 29.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.823 -0.626 . . . . 3.4700000000000002 111.19 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -70.49 -57.32 4.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.703 -0.681 . . . . 4.0800000000000001 111.039 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 1.2 t80 -103.42 -88.27 0.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 2.3599999999999999 111.406 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.443 ' H ' ' HB3' ' A' ' 8' ' ' TYR . 2.1 t 56.0 52.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.287 0.565 . . . . 2.5 110.822 -174.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.6 86.38 53.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.014 -0.539 . . . . 2.5099999999999998 110.692 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 96.3 Cg_endo -89.95 -168.78 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.929 2.42 . . . . 2.2999999999999998 111.945 177.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -77.68 -69.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.122 -0.231 . . . . 2.52 111.15 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -173.43 140.2 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.861 0.319 . . . . 2.5800000000000001 111.861 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.15 -84.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.743 1.016 . . . . 2.0099999999999998 113.743 168.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.536 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -61.02 -55.85 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 2.5099999999999998 111.88 -171.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 13.2 mt-10 -63.89 -35.88 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.007 -0.542 . . . . 1.95 111.187 -176.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.97 -47.0 79.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.121 -0.49 . . . . 1.79 111.315 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -74.09 -37.66 64.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.31 -0.405 . . . . 3.48 110.899 -178.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.63 -49.9 74.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 2.4199999999999999 110.932 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.67 97.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 1.6000000000000001 110.679 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.37 -57.14 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.769 -0.65 . . . . 2.6899999999999999 111.024 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.2 mt -65.0 -52.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.092 -0.504 . . . . 2.4300000000000002 111.29 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -61.62 -51.29 69.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.402 0.519 . . . . 1.55 112.402 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -74.88 -10.59 59.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.894 0.331 . . . . 2.7799999999999998 111.894 -173.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.36 -22.3 15.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.741 -0.384 . . . . 4.9000000000000004 111.608 177.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.52 -50.33 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 2.4900000000000002 111.437 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -27.52 62.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 3.3100000000000001 110.318 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.0 -168.76 14.03 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.037 -0.825 . . . . 1.8799999999999999 111.037 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.01 56.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.481 1.134 . . . . 2.4500000000000002 109.018 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -113.49 -127.52 0.29 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.029 -0.987 . . . . 2.21 111.28 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.52 50.26 0.3 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.713 -0.955 . . . . 1.6399999999999999 110.713 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.59 -43.77 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.677 0.275 . . . . 3.9700000000000002 110.733 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.14 -132.7 13.8 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.75 -0.738 . . . . 2.3199999999999998 112.729 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG21 HD12 ' A' ' 34' ' ' ILE . 3.0 mm -75.32 93.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.852 0.358 . . . . 3.1299999999999999 111.475 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -173.87 -65.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.059 -0.719 . . . . 3.02 109.059 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -133.03 49.24 2.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.383 -0.969 . . . . 4.2000000000000002 108.383 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.9 96.36 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.371 -1.286 . . . . 4.9299999999999997 111.969 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -66.8 -17.9 65.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 2.75 111.009 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -93.66 -64.27 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.138 -0.483 . . . . 2.46 110.577 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.735 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -84.94 58.98 5.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 2.5699999999999998 111.726 -173.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.735 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 3.6 tp 156.63 -24.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.934 0.894 . . . . 3.7999999999999998 110.48 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.27 -25.92 74.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.995 -0.622 . . . . 2.4900000000000002 112.769 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.88 -104.4 0.25 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.824 -0.703 . . . . 2.46 111.932 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.14 149.28 15.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.56 0.219 . . . . 2.9300000000000002 110.606 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.69 178.33 8.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.737 -0.468 . . . . 1.3600000000000001 109.737 174.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -119.15 59.87 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.37 0.605 . . . . 2.9199999999999999 110.224 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 179.04 6.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.539 -0.755 . . . . 2.7200000000000002 110.059 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.59 73.77 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.048 0.388 . . . . 2.0800000000000001 112.048 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -36.43 72.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 3.1600000000000001 111.057 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -75.06 -38.93 61.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.976 -0.556 . . . . 1.6000000000000001 110.805 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.8 -41.59 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 2.0099999999999998 110.236 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -59.93 -39.51 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.577 . . . . 1.5700000000000001 110.83 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.597 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -69.46 -34.46 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 1.3700000000000001 110.673 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -50.83 69.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 2.3399999999999999 110.716 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 t -70.4 -36.85 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 2.3900000000000001 111.098 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -49.91 -45.73 51.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.668 -0.696 . . . . 2.5299999999999998 111.573 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.459 ' C ' ' HG2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -87.08 -103.68 0.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.381 -0.372 . . . . 4.1200000000000001 111.034 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.459 ' HG2' ' C ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -140.53 36.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.549 -0.296 . . . . 3.6400000000000001 111.225 -175.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 53.04 64.58 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.264 0.555 . . . . 4.96 110.363 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -38.1 78.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.629 -0.714 . . . . 2.7999999999999998 111.79 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t 70.48 -50.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 123.669 0.606 . . . . 3.4900000000000002 110.963 -175.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.52 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -80.92 -131.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 4.5599999999999996 111.057 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.52 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -71.71 132.17 85.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.159 0.504 . . . . 3.52 110.864 -177.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.583 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.1 Cg_exo -78.53 69.82 7.55 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 123.516 2.811 . . . . 2.1699999999999999 111.917 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.09 117.57 5.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 2.9700000000000002 111.817 -176.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.05 50.63 17.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.501 -0.772 . . . . 2.8700000000000001 112.213 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.597 HG13 ' HB2' ' A' ' 53' ' ' ALA . 2.2 p -126.97 -35.66 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.528 -0.469 . . . . 2.5899999999999999 110.931 173.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.545 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.0 OUTLIER 177.09 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.443 0.464 . . . . 2.6499999999999999 110.781 178.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.583 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 22.1 m-85 -72.59 -51.89 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.233 0.457 . . . . 2.4700000000000002 112.233 -173.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 64' ' ' PRO . . . -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.921 0.391 . . . . 1.52 111.546 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.443 ' HB3' HD11 ' A' ' 77' ' ' LEU . 9.2 tp60 -179.51 97.58 0.2 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 3.8300000000000001 109.63 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.446 ' C ' ' HG1' ' A' ' 73' ' ' THR . 9.5 Cg_exo -71.84 54.37 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.286 2.657 . . . . 2.1200000000000001 112.707 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.446 ' HG1' ' C ' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -150.97 59.67 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.921 -0.77 . . . . 2.7999999999999998 108.921 176.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.502 HG13 ' HG2' ' A' ' 16' ' ' GLU . 17.9 pt -64.61 -21.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 2.5899999999999999 112.446 -170.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -39.65 92.01 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.064 0.459 . . . . 4.2400000000000002 110.493 175.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.77 73.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.923 -0.58 . . . . 1.7 110.648 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 68' ' ' LEU . 25.5 mt -72.82 -25.31 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.264 -0.425 . . . . 2.9700000000000002 110.441 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.5 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 1.97 111.331 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -104.53 -39.79 6.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.392 -0.523 . . . . 3.27 111.055 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.14 -65.42 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.995 0.369 . . . . 3.1000000000000001 111.995 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.92 -25.01 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 2.6800000000000002 111.57 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.55 33.83 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 2.0299999999999998 111.477 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.278 0.561 . . . . 3.1099999999999999 110.707 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.496 0.665 . . . . 3.4700000000000002 111.127 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.34 125.02 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.422 -0.808 . . . . 3.4700000000000002 110.939 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -80.32 58.78 3.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.222 0.534 . . . . 4.0800000000000001 110.332 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.492 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -141.58 -94.14 0.14 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.67 -0.696 . . . . 2.3599999999999999 109.925 178.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.864 HG21 ' HA3' ' A' ' 33' ' ' GLY . 13.0 p 33.09 62.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.295 0.997 . . . . 2.5 112.697 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.09 100.96 53.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.781 -0.645 . . . . 2.5099999999999998 110.691 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.1 139.16 23.71 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.147 2.564 . . . . 2.2999999999999998 112.425 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -47.09 8.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 2.52 110.238 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.6 t-20 -102.95 149.64 24.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.374 -0.83 . . . . 2.5800000000000001 109.821 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.88 81.73 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.266 0.469 . . . . 2.0099999999999998 112.266 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -29.38 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.52 -0.309 . . . . 2.5099999999999998 110.516 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 51.9 mt-10 -60.03 -40.18 88.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 1.95 109.808 175.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -37.76 79.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.034 -0.53 . . . . 1.79 110.325 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.17 91.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 3.48 110.374 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -67.05 -53.59 29.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.712 -0.676 . . . . 2.4199999999999999 110.978 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.24 99.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 1.6000000000000001 112.092 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -63.25 -53.5 52.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.856 -0.156 . . . . 2.6899999999999999 111.132 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.604 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 33.5 mm -58.5 -47.95 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 2.4300000000000002 111.169 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -67.46 -53.53 28.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.786 0.327 . . . . 1.55 111.677 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 32' ' ' ILE . 4.6 tp10 -71.91 -52.15 18.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.548 -0.297 . . . . 2.7799999999999998 111.743 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -0.69 24.09 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.933 -0.48 . . . . 4.9000000000000004 111.781 -172.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 5.1 t -108.59 -43.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.075 -0.25 . . . . 2.4900000000000002 110.758 173.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.08 -51.99 2.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 3.3100000000000001 111.852 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.476 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -61.07 -45.2 97.06 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.255 -0.498 . . . . 1.8799999999999999 113.003 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 33.7 t 76.56 -51.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.553 0.741 . . . . 2.4500000000000002 111.809 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.93 -54.76 42.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.958 0.355 . . . . 2.21 111.958 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.31 57.97 0.66 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.151 -1.023 . . . . 1.6399999999999999 111.88 -175.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.414 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 22.8 mm -90.64 -52.8 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.639 -0.504 . . . . 3.9700000000000002 109.639 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.864 ' HA3' HG21 ' A' ' 9' ' ' VAL . . . 56.32 -117.06 8.32 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.488 -0.778 . . . . 2.3199999999999998 113.152 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.432 ' H ' ' HA ' ' A' ' 9' ' ' VAL . 13.3 mm -81.52 87.78 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 3.1299999999999999 111.078 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -166.07 26.45 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 3.02 109.327 174.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.866 ' HA ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 p-10 38.47 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.909 -1.041 . . . . 4.2000000000000002 111.983 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.13 -69.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.23 0.826 . . . . 4.9299999999999997 113.23 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -56.67 15.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.795 0.331 . . . . 2.75 111.588 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.84 -72.15 0.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.288 -0.415 . . . . 2.46 111.698 -174.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.866 ' HG2' ' HA ' ' A' ' 36' ' ' ASP . 1.9 pm0 -73.62 81.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 2.5699999999999998 111.803 -174.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 42' ' ' GLY . 2.2 tp 179.08 -26.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.336 -0.847 . . . . 3.7999999999999998 110.013 174.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' N ' HG21 ' A' ' 41' ' ' ILE . . . -167.01 28.07 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.945 -0.645 . . . . 2.4900000000000002 112.235 178.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.94 103.23 1.1 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 2.46 112.467 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -130.24 61.62 1.59 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.448 . . . . 2.9300000000000002 110.305 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.16 162.47 29.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.79 -0.641 . . . . 1.3600000000000001 110.735 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.61 61.5 4.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.484 0.659 . . . . 2.9199999999999999 110.719 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 155.79 49.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.373 -0.83 . . . . 2.7200000000000002 109.774 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.98 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.565 0.222 . . . . 2.0800000000000001 111.506 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.86 -42.51 75.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 3.1600000000000001 111.203 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -76.85 -36.51 56.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 1.6000000000000001 111.124 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 55' ' ' VAL . 46.5 t -64.15 -42.96 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 2.0099999999999998 110.4 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.45 84.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 1.5700000000000001 111.019 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.84 -35.12 79.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 1.3700000000000001 111.147 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.66 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 3.5 tt0 -67.64 -40.86 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 2.3399999999999999 111.017 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 51' ' ' VAL . 22.5 t -79.53 -38.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.845 -0.616 . . . . 2.3900000000000001 111.483 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -58.57 -30.86 67.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.472 -0.331 . . . . 2.5299999999999998 111.304 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -87.15 16.03 5.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.746 -0.206 . . . . 4.1200000000000001 111.283 -178.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 56.44 65.92 1.31 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.321 -0.4 . . . . 3.6400000000000001 110.328 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 64.45 76.92 0.33 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.705 -0.68 . . . . 4.96 110.566 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.66 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -84.38 -11.96 55.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 2.7999999999999998 111.028 -178.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.413 ' HB ' ' H ' ' A' ' 62' ' ' GLU . 2.4 t 53.32 -111.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.027 -0.533 . . . . 3.4900000000000002 110.385 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.42 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 2.1 tp10 -127.26 28.93 5.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.08 0.467 . . . . 4.5599999999999996 110.121 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.02 87.9 20.3 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 3.52 110.961 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 9.3 Cg_endo -91.82 105.49 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.639 2.893 . . . . 2.1699999999999999 112.208 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 mt -118.03 -30.11 5.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.026 0.441 . . . . 2.9700000000000002 110.884 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -153.83 82.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 2.8700000000000001 110.301 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.42 ' H ' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -149.26 -169.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.897 -0.592 . . . . 2.5899999999999999 110.137 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -32.3 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 2.6499999999999999 111.037 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' ' 50' ' ' ALA . 89.1 m-85 -110.17 36.62 2.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 2.4700000000000002 110.61 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 67' ' ' VAL . . . -158.9 56.54 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.367 . . . . 1.52 110.969 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -164.52 128.34 1.77 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 3.8300000000000001 109.954 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 6.5 Cg_exo -75.5 13.82 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.994 2.463 . . . . 2.1200000000000001 112.363 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -153.85 115.65 4.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.3 -0.63 . . . . 2.7999999999999998 109.3 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.554 ' HA ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -89.94 -28.83 5.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.44 . . . . 2.5899999999999999 111.344 -171.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 13' ' ' ASN . 17.6 pttt -57.92 -36.69 72.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.588 -0.278 . . . . 4.2400000000000002 111.169 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.16 -39.26 89.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.076 0.465 . . . . 1.7 110.801 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 74' ' ' ILE . 5.4 mt -72.47 -45.41 59.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 2.9700000000000002 110.133 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.443 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . . . -59.22 -42.5 91.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.97 111.749 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.26 1.25 41.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 3.27 111.566 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -129.78 -90.2 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.726 -0.39 . . . . 3.1000000000000001 111.69 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.3 m -70.6 -18.6 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.51 0.559 . . . . 2.6800000000000002 112.51 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.443 ' HB1' ' HA ' ' A' ' 78' ' ' ALA . . . -102.25 15.29 29.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.331 . . . . 2.0299999999999998 111.77 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 120.839 -0.344 . . . . 3.1099999999999999 111.219 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.434 -0.58 . . . . 3.4700000000000002 109.434 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.31 -99.19 0.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.499 -0.319 . . . . 3.4700000000000002 110.904 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.26 -58.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.68 0.276 . . . . 4.0800000000000001 110.884 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.539 ' O ' HG12 ' A' ' 9' ' ' VAL . 8.6 t80 -46.97 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.231 -0.895 . . . . 2.3599999999999999 112.577 -173.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 8' ' ' TYR . 4.2 p 42.74 36.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.094 0.949 . . . . 2.5 112.524 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.38 84.32 56.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.89 -0.595 . . . . 2.5099999999999998 111.531 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.544 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 31.3 Cg_exo -59.71 133.96 54.55 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.353 2.036 . . . . 2.2999999999999998 111.103 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -45.96 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.651 0.612 . . . . 2.52 112.651 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -136.47 107.36 6.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.706 1.002 . . . . 2.5800000000000001 113.706 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 42.09 -85.88 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.961 1.467 . . . . 2.0099999999999998 114.961 163.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -53.29 -34.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.072 -0.513 . . . . 2.5099999999999998 111.204 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.97 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 39.5 mt-10 -61.81 -45.97 91.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.463 -0.789 . . . . 1.95 110.69 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -63.25 -35.49 80.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 1.79 110.997 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -60.59 -60.07 4.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 3.48 110.976 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.57 -40.01 77.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 2.4199999999999999 111.427 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 16' ' ' GLU . . . -64.53 -50.72 66.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.362 -0.381 . . . . 1.6000000000000001 111.454 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 26.2 mt-10 -62.53 -41.03 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.497 0.189 . . . . 2.6899999999999999 111.428 -175.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.85 -43.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 2.4300000000000002 110.362 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -72.79 -48.72 35.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.09 -0.504 . . . . 1.55 112.065 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.81 -26.49 25.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.585 0.587 . . . . 2.7799999999999998 112.585 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -99.22 -48.05 4.97 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 4.9000000000000004 111.552 -177.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.85 -47.68 16.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.688 0.28 . . . . 2.4900000000000002 111.618 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.54 -65.58 0.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 3.3100000000000001 111.872 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.09 -41.7 17.38 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.942 -0.647 . . . . 1.8799999999999999 113.306 -175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t 63.77 83.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.16 0.505 . . . . 2.4500000000000002 110.214 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.28 -83.49 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 2.21 111.778 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.14 72.31 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.231 -1.147 . . . . 1.6399999999999999 110.231 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.58 HG13 ' H ' ' A' ' 33' ' ' GLY . 4.8 tp -96.75 173.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.369 0.604 . . . . 3.9700000000000002 112.415 -167.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.58 ' H ' HG13 ' A' ' 32' ' ' ILE . . . -152.47 173.85 31.46 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.825 -0.625 . . . . 2.3199999999999998 111.651 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 72' ' ' PRO . 19.3 mm -85.97 68.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.369 0.604 . . . . 3.1299999999999999 110.559 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -141.64 -67.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.491 -0.777 . . . . 3.02 109.041 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -131.07 147.39 52.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.47 -0.937 . . . . 4.2000000000000002 108.47 173.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -144.71 160.96 40.36 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 121.062 -0.255 . . . . 4.9299999999999997 110.859 -174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -100.96 -17.17 16.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.136 -0.484 . . . . 2.75 110.475 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.417 ' CD2' ' HG3' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -129.66 -45.44 1.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.947 -0.57 . . . . 2.46 110.683 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.417 ' HG3' ' CD2' ' A' ' 39' ' ' PHE . 26.2 mt-30 -82.65 62.23 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.25 -0.281 . . . . 2.5699999999999998 110.662 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 tp -169.5 -22.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 111.916 0.339 . . . . 3.7999999999999998 111.916 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.22 -36.96 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.426 -0.892 . . . . 2.4900000000000002 112.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.35 131.21 41.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.037 -0.602 . . . . 2.46 111.884 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -113.19 100.71 8.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.043 0.449 . . . . 2.9300000000000002 110.336 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.0 154.73 25.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.573 -0.74 . . . . 1.3600000000000001 111.032 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.83 91.46 1.96 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 2.9199999999999999 110.485 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.32 156.12 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 2.7200000000000002 110.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -25.6 64.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 2.0800000000000001 111.064 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 ttt -63.1 -34.75 78.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 3.1600000000000001 110.601 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HA ' ' HZ ' ' A' ' 69' ' ' PHE . . . -72.29 -38.75 68.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 1.6000000000000001 110.355 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.5 t -64.25 -38.58 82.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 2.0099999999999998 110.315 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.26 93.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 1.5700000000000001 110.719 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.92 96.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 1.3700000000000001 110.47 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.449 ' HA ' ' HG3' ' A' ' 60' ' ' GLN . 4.0 mm-40 -58.36 -49.63 76.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.701 . . . . 2.3399999999999999 110.716 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.7 t -64.63 -31.25 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 2.3900000000000001 110.769 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -68.79 -18.96 64.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 2.5299999999999998 111.924 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.578 ' HD2' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -120.8 19.18 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.715 0.293 . . . . 4.1200000000000001 110.642 178.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 51.44 60.62 3.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.544 -0.753 . . . . 3.6400000000000001 111.302 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 68.54 73.29 0.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.315 -0.857 . . . . 4.96 110.879 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.449 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -79.68 97.33 6.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.152 -0.931 . . . . 2.7999999999999998 110.024 178.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.49 ' H ' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -70.11 88.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.393 . . . . 3.4900000000000002 111.115 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.22 43.46 26.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.724 -0.671 . . . . 4.5599999999999996 111.179 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.504 ' HA ' HD11 ' A' ' 63' ' ' LEU . 13.6 tp -154.62 75.0 5.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 3.52 110.584 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.7 Cg_endo -87.03 47.68 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.517 2.811 . . . . 2.1699999999999999 112.432 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -56.83 101.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.682 -0.69 . . . . 2.9700000000000002 112.268 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.765 ' H ' ' HB2' ' A' ' 70' ' ' ALA . 11.4 mtmm 58.3 31.3 20.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.457 -0.792 . . . . 2.8700000000000001 112.213 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.578 HG21 ' HD2' ' A' ' 57' ' ' ARG . 1.7 p -115.92 -21.37 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.945 -0.302 . . . . 2.5899999999999999 110.948 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -175.04 -74.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.101 0.477 . . . . 2.6499999999999999 109.727 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.705 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 11.0 m-85 -84.49 53.14 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 2.4700000000000002 111.056 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.765 ' HB2' ' H ' ' A' ' 66' ' ' LYS . . . -172.09 134.08 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.92 -0.582 . . . . 1.52 109.607 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 65.7 tp60 72.88 88.51 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 124.199 0.937 . . . . 3.8300000000000001 110.455 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.645 ' HB2' HG23 ' A' ' 34' ' ' ILE . 7.6 Cg_exo -72.97 63.59 4.07 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.443 2.762 . . . . 2.1200000000000001 112.429 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.1 93.88 2.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.827 -0.624 . . . . 2.7999999999999998 109.506 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.97 ' HB ' ' HG2' ' A' ' 16' ' ' GLU . 1.8 mt -64.88 -35.88 76.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 2.5899999999999999 111.293 -173.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HD2' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -59.17 -43.6 92.12 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.923 0.392 . . . . 4.2400000000000002 110.648 175.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -42.92 69.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 1.7 110.68 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.31 -25.95 67.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 2.9700000000000002 110.809 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.17 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.192 -0.458 . . . . 1.97 111.002 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.36 -13.63 59.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.017 0.437 . . . . 3.27 110.551 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.25 -72.93 0.48 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 3.1000000000000001 111.226 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.29 -43.52 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 2.6800000000000002 110.976 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.63 30.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.347 0.594 . . . . 2.0299999999999998 110.841 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 3.1099999999999999 110.129 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.111 -0.7 . . . . 3.4700000000000002 109.111 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.31 -21.05 50.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 3.4700000000000002 112.426 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 68.48 -58.84 0.46 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.272 0.629 . . . . 4.0800000000000001 111.153 -175.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.83 72.9 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 2.3599999999999999 110.893 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 34' ' ' ILE . 6.5 p -125.99 5.52 4.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.399 0.619 . . . . 2.5 110.464 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.59 109.53 24.66 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 2.5099999999999998 110.658 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.515 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 5.1 Cg_exo -81.43 -172.41 1.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.385 2.723 . . . . 2.2999999999999998 111.871 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.98 -49.18 2.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 2.52 110.885 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.517 HD22 HG22 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -99.85 159.38 15.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 2.5800000000000001 110.717 -175.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.8 95.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.48 . . . . 2.0099999999999998 112.12 -175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.517 HG22 HD22 ' A' ' 13' ' ' ASN . 15.3 t -64.09 -39.82 86.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 2.5099999999999998 110.667 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 27.7 mt-10 -57.36 -42.34 81.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.774 -0.648 . . . . 1.95 110.458 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -75.16 -31.28 60.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 1.79 111.428 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -56.03 22.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 3.48 111.043 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.55 -32.64 73.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 2.4199999999999999 110.612 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.7 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 1.6000000000000001 110.691 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -56.39 -50.96 70.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.536 . . . . 2.6899999999999999 111.055 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.21 -52.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.693 -0.685 . . . . 2.4300000000000002 111.129 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -64.07 -42.83 96.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.444 -0.343 . . . . 1.55 111.417 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.705 ' HB2' HG12 ' A' ' 32' ' ' ILE . 5.5 tp10 -60.21 -44.8 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.584 -0.28 . . . . 2.7799999999999998 111.169 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -20.75 39.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 4.9000000000000004 112.295 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -97.07 -52.39 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.842 0.312 . . . . 2.4900000000000002 111.842 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.73 -31.47 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.948 0.351 . . . . 3.3100000000000001 111.948 -174.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.81 -73.84 0.42 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.306 -0.473 . . . . 1.8799999999999999 112.72 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t 69.15 -63.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.049 0.54 . . . . 2.4500000000000002 111.926 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 m -66.57 -32.76 74.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 2.21 110.616 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.83 127.54 2.76 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.762 -0.733 . . . . 1.6399999999999999 112.654 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.705 HG12 ' HB2' ' A' ' 24' ' ' GLU . 1.3 pt -104.2 172.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 3.9700000000000002 110.535 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.65 163.34 33.53 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.044 -0.598 . . . . 2.3199999999999998 111.78 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -92.49 -7.53 10.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.038 0.446 . . . . 3.1299999999999999 110.821 -178.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.611 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -87.18 -43.16 12.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.509 -0.314 . . . . 3.02 110.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.611 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 20.3 t70 -174.71 161.51 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.141 -0.689 . . . . 4.2000000000000002 109.141 -177.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.595 ' ND2' ' HA ' ' A' ' 32' ' ' ILE . 6.5 t-20 -169.64 164.11 10.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.207 -0.294 . . . . 4.9299999999999997 110.207 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -77.51 -24.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 2.75 110.807 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -88.2 -33.69 18.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.083 -0.508 . . . . 2.46 111.042 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.4 mt-30 -84.63 33.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.333 . . . . 2.5699999999999998 111.779 -172.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.417 ' HB ' ' H ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -151.25 -127.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.693 -0.484 . . . . 3.7999999999999998 109.693 176.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' H ' ' HB ' ' A' ' 41' ' ' ILE . . . -84.89 53.91 4.87 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.914 -0.66 . . . . 2.4900000000000002 111.949 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -139.73 55.44 0.65 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.617 -0.593 . . . . 2.46 111.617 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -73.61 135.36 43.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.626 0.25 . . . . 2.9300000000000002 110.799 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.99 171.43 14.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 1.3600000000000001 110.266 175.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.15 67.95 3.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.219 0.533 . . . . 2.9199999999999999 109.562 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -126.41 170.8 11.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 2.7200000000000002 110.6 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.71 71.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 2.0800000000000001 110.766 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 49' ' ' MET . 10.3 tpp -60.38 -35.34 75.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.903 -0.589 . . . . 3.1600000000000001 110.674 176.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -70.13 -44.08 69.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 1.6000000000000001 110.264 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.01 -44.5 91.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.05 -0.523 . . . . 2.0099999999999998 110.319 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.91 73.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 1.5700000000000001 111.089 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -64.2 -51.09 65.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 1.3700000000000001 111.147 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.488 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -68.11 -33.1 73.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.042 -0.263 . . . . 2.3399999999999999 111.178 -178.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.15 -44.1 81.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.356 . . . . 2.3900000000000001 110.421 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -71.46 -28.01 63.66 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.901 0.381 . . . . 2.5299999999999998 110.698 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -78.93 -32.63 45.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 4.1200000000000001 110.695 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER 70.1 9.75 7.15 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.742 0.651 . . . . 3.6400000000000001 110.903 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -172.66 156.63 3.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.033 -1.099 . . . . 4.96 108.033 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.518 ' HA ' ' NE2' ' A' ' 60' ' ' GLN . 3.1 tp60 -143.67 -36.65 0.35 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.103 -0.639 . . . . 2.7999999999999998 112.096 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.1 t 69.01 -73.89 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 123.579 0.549 . . . . 3.4900000000000002 109.733 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.78 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.483 0.713 . . . . 4.5599999999999996 109.422 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -105.66 107.74 60.02 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.821 -0.627 . . . . 3.52 110.33 178.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 18.6 Cg_endo -92.38 99.27 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.466 2.778 . . . . 2.1699999999999999 111.915 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.97 -19.65 47.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.717 0.265 . . . . 2.9700000000000002 111.717 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.78 115.94 3.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.645 -0.252 . . . . 2.8700000000000001 110.364 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 68' ' ' LEU . 2.1 p -171.25 -55.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.46 -0.336 . . . . 2.5899999999999999 110.781 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.523 ' HA ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -167.02 -37.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.009 0.433 . . . . 2.6499999999999999 110.225 -176.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -83.0 -67.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 2.4700000000000002 111.106 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 40' ' ' GLN . . . -76.58 88.96 3.3 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.041 0.448 . . . . 1.52 111.625 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.589 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -175.45 85.08 0.3 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.166 -0.925 . . . . 3.8300000000000001 109.455 175.038 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.12 70.74 0.55 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.433 2.755 . . . . 2.1200000000000001 112.034 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.52 -24.57 0.09 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.246 -0.888 . . . . 2.7999999999999998 109.555 177.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 mt 71.35 -68.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.501 -0.772 . . . . 2.5899999999999999 111.955 174.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HB2' ' HG3' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -72.28 -15.68 61.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.698 0.259 . . . . 4.2400000000000002 111.698 -174.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.52 13.77 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.024 0.44 . . . . 1.7 110.8 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 71' ' ' GLN . 0.7 OUTLIER -63.44 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 2.9700000000000002 109.96 178.237 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.709 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . . . -75.15 0.42 16.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 1.97 111.529 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -32.41 11.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 3.27 110.454 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.49 -64.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.276 -0.569 . . . . 3.1000000000000001 112.381 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.45 -40.28 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 2.6800000000000002 110.96 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.709 ' HB1' ' HA ' ' A' ' 78' ' ' ALA . . . -105.91 159.12 16.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.809 -0.632 . . . . 2.0299999999999998 109.482 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 123.038 0.535 . . . . 3.1099999999999999 111.551 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 121.186 0.517 . . . . 3.4700000000000002 110.389 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.63 125.61 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.462 -0.79 . . . . 3.4700000000000002 111.42 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.61 63.09 4.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 4.0800000000000001 111.131 -177.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.603 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t80 -121.89 -86.37 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.938 -0.764 . . . . 2.3599999999999999 108.938 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.463 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 94.7 t 73.13 -55.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.759 0.662 . . . . 2.5 111.872 173.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.32 108.69 12.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.58 0.229 . . . . 2.5099999999999998 111.033 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.759 ' HG2' ' HB3' ' A' ' 16' ' ' GLU . 20.4 Cg_endo -95.64 -99.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.593 2.862 . . . . 2.2999999999999998 111.559 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 p -98.87 -80.4 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.866 0.365 . . . . 2.52 110.239 174.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -134.24 -174.86 3.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 2.5800000000000001 110.873 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.92 -33.4 56.54 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.63 0.974 . . . . 2.0099999999999998 113.63 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.82 -34.33 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.955 0.407 . . . . 2.5099999999999998 110.701 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.759 ' HB3' ' HG2' ' A' ' 11' ' ' PRO . 4.6 tt0 -79.95 -38.01 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.253 -0.43 . . . . 1.95 110.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -63.62 -39.01 93.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.403 . . . . 1.79 110.884 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HE3' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -69.59 -31.66 69.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.448 -0.342 . . . . 3.48 110.803 178.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 tp -64.92 -46.13 82.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.605 -0.517 . . . . 2.4199999999999999 109.605 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.575 ' O ' ' HB3' ' A' ' 24' ' ' GLU . . . -60.19 -33.87 72.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.484 -0.78 . . . . 1.6000000000000001 110.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 17' ' ' SER . 85.5 mt-10 -57.79 -47.23 83.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 2.6899999999999999 111.092 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.524 HD13 ' HE3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -71.83 -48.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.042 0.449 . . . . 2.4300000000000002 111.066 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -68.57 -47.08 67.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.551 . . . . 1.55 112.035 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.575 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -69.79 -45.55 67.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.623 -0.262 . . . . 2.7799999999999998 111.17 -175.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 2.1 mmt180 -71.89 -37.85 70.08 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.005 0.372 . . . . 4.9000000000000004 112.005 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.29 -59.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.096 0.406 . . . . 2.4900000000000002 112.096 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 40.3 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.1 0.476 . . . . 3.3100000000000001 111.349 -173.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.538 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -172.83 -46.41 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.645 -0.788 . . . . 1.8799999999999999 112.207 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 7.2 t 78.4 -37.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.352 0.661 . . . . 2.4500000000000002 110.572 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.7 144.77 43.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.128 -0.487 . . . . 2.21 110.406 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.58 71.74 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.722 . . . . 1.6399999999999999 113.08 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 36.1 mm -101.96 91.34 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.453 0.644 . . . . 3.9700000000000002 110.359 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 34' ' ' ILE . . . -79.7 79.98 1.62 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.648 -0.787 . . . . 2.3199999999999998 112.246 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 33' ' ' GLY . 38.8 mm 78.05 -43.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.399 0.68 . . . . 3.1299999999999999 112.504 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.603 ' HG ' ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -35.86 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 3.02 113.527 -174.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.72 110.71 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 4.2000000000000002 111.089 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.05 95.7 6.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.068 -0.515 . . . . 4.9299999999999997 109.88 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -96.59 -24.58 15.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 2.75 112.637 -174.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -131.79 -9.21 3.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.632 -0.427 . . . . 2.46 111.637 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 8.1 mp0 -72.0 -57.71 4.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.337 -0.392 . . . . 2.5699999999999998 111.329 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mt -105.62 74.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.998 0.428 . . . . 3.7999999999999998 111.281 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.95 -82.55 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.369 -0.92 . . . . 2.4900000000000002 113.257 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.45 80.81 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.133 -0.556 . . . . 2.46 112.733 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -65.21 141.7 58.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.01 0.433 . . . . 2.9300000000000002 110.483 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.74 29.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 1.3600000000000001 111.206 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 mt -87.24 -10.96 51.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.104 -0.702 . . . . 2.9199999999999999 109.104 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -56.21 150.53 14.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.595 -1.184 . . . . 2.7200000000000002 110.989 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -17.83 51.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.197 -0.456 . . . . 2.0800000000000001 111.964 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -63.1 -48.23 79.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 3.1600000000000001 110.786 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.71 -28.39 50.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 1.6000000000000001 110.431 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.18 -40.13 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 2.0099999999999998 110.272 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.82 92.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 1.5700000000000001 110.533 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.678 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -64.52 -42.24 95.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 1.3700000000000001 110.415 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.669 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 tt0 -59.84 -46.92 87.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.587 -0.733 . . . . 2.3399999999999999 110.777 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -65.95 -39.24 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 2.3900000000000001 110.903 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -72.71 5.3 3.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 2.5299999999999998 111.897 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.51 ' HA ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -137.29 24.66 2.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.977 0.418 . . . . 4.1200000000000001 110.362 175.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.08 49.73 11.1 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.438 -0.801 . . . . 3.6400000000000001 111.965 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.669 ' HA ' ' HG3' ' A' ' 54' ' ' GLN . 21.7 m-30 66.8 87.97 0.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.692 -0.685 . . . . 4.96 112.147 171.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.43 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 1.0 OUTLIER -77.76 -17.79 57.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.607 -0.724 . . . . 2.7999999999999998 110.988 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 53.6 t 77.03 -57.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 123.388 0.675 . . . . 3.4900000000000002 112.264 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 -70.45 0.79 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.823 0.305 . . . . 4.5599999999999996 111.823 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.51 140.9 28.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.569 -0.287 . . . . 3.52 110.899 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.425 ' HA ' ' OE1' ' A' ' 60' ' ' GLN . 74.5 Cg_endo -75.84 62.39 6.51 Favored 'Trans proline' 0 C--O 1.237 0.466 0 C-N-CA 122.933 2.422 . . . . 2.1699999999999999 111.731 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.794 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 22.3 tp -77.08 126.55 31.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 2.9700000000000002 111.679 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt 64.48 14.9 9.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.416 -0.811 . . . . 2.8700000000000001 112.487 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.678 HG11 ' HB1' ' A' ' 53' ' ' ALA . 7.2 p -98.35 -35.15 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.759 -0.376 . . . . 2.5899999999999999 110.188 174.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.505 ' N ' HG13 ' A' ' 67' ' ' VAL . 0.5 OUTLIER 175.43 -58.8 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.164 0 O-C-N 123.612 0.57 . . . . 2.6499999999999999 110.585 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.4 m-85 -66.74 -50.9 61.27 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.964 0.727 . . . . 2.4700000000000002 112.964 -171.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.794 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . . . -77.95 70.55 4.33 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.184 0.438 . . . . 1.52 112.184 -173.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.71 130.22 1.52 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.58 -0.736 . . . . 3.8300000000000001 109.509 174.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.644 ' O ' ' HB ' ' A' ' 73' ' ' THR . 39.5 Cg_exo -61.27 105.15 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.499 2.132 . . . . 2.1200000000000001 111.282 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER 81.94 113.54 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.18 0.925 . . . . 2.7999999999999998 109.35 -171.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mm -83.12 -22.69 8.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.044 -0.98 . . . . 2.5899999999999999 110.322 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HD2' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -54.08 -37.12 63.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.633 -0.712 . . . . 4.2400000000000002 111.681 -178.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.06 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.7 110.968 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.66 -27.74 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 2.9700000000000002 110.646 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . -60.83 -49.71 76.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 1.97 111.865 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.82 -0.29 57.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.742 -0.383 . . . . 3.27 111.412 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -101.43 -69.08 0.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.94 -0.304 . . . . 3.1000000000000001 111.283 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -13.43 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 111.854 0.316 . . . . 2.6800000000000002 111.854 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . -99.05 21.9 11.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 2.0299999999999998 111.124 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.501 0.667 . . . . 3.1099999999999999 110.692 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.678 0.275 . . . . 8.8300000000000001 110.87 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 54.81 21.95 24.72 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.461 -0.876 . . . . 5.5899999999999999 111.733 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.3 m -52.8 -17.62 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 120.957 0.408 . . . . 6.5800000000000001 110.911 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p -42.47 149.06 0.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.429 -0.805 . . . . 4.0300000000000002 111.316 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -44.54 118.32 1.53 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.89 -0.595 . . . . 3.4700000000000002 111.068 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' A' ' 32' ' ' ILE . . . -82.91 130.07 35.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.044 -0.526 . . . . 3.4700000000000002 111.05 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -85.15 20.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 4.0800000000000001 110.519 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -125.05 46.01 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 2.3599999999999999 111.126 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.55 2.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 2.5 111.058 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.07 110.25 3.98 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 2.5099999999999998 111.45 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -91.03 158.93 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.592 2.195 . . . . 2.2999999999999998 111.975 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.23 -44.24 8.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 2.52 111.082 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.04 156.36 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 2.5800000000000001 110.976 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.49 64.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 2.0099999999999998 111.296 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -64.89 -41.95 93.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 2.5099999999999998 111.168 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.22 -38.45 78.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 1.95 111.027 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -42.02 96.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.79 110.986 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -68.18 -48.79 64.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 3.48 111.258 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -47.2 85.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 2.4199999999999999 110.957 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.18 80.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.511 . . . . 1.6000000000000001 111.367 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -66.05 -51.7 55.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 2.6899999999999999 111.501 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 26' ' ' VAL . 60.9 mt -66.81 -34.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.09 0.404 . . . . 2.4300000000000002 112.09 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -76.38 -44.2 37.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.666 0.617 . . . . 1.55 112.666 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.47 9.65 12.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.908 0.336 . . . . 2.7799999999999998 111.908 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.46 ' HB2' HH11 ' A' ' 25' ' ' ARG . 5.6 ttm105 -118.46 -21.74 7.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 4.9000000000000004 110.853 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 22' ' ' ILE . 60.4 t -109.41 -24.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 2.4900000000000002 111.133 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.74 -61.37 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 3.3100000000000001 111.517 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -59.61 9.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 1.8799999999999999 113.319 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t 59.09 12.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.03 0.443 . . . . 2.4500000000000002 110.85 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.7 m -98.46 -68.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 2.21 111.01 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.54 33.97 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.754 -0.736 . . . . 1.6399999999999999 111.932 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.46 ' HA ' ' HB1' ' A' ' 6' ' ' ALA . 1.1 pt -88.44 -173.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 3.9700000000000002 111.308 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.55 -109.23 0.23 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.868 -0.682 . . . . 2.3199999999999998 112.413 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.28 49.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.724 0.297 . . . . 3.1299999999999999 111.189 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.98 9.85 6.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.497 -0.32 . . . . 3.02 111.318 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.13 150.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 4.2000000000000002 110.443 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.545 HD21 ' H ' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -177.76 -96.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 4.9299999999999997 111.117 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.545 ' H ' HD21 ' A' ' 37' ' ' ASN . 9.7 p90 -119.95 -28.11 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.357 -0.383 . . . . 2.75 111.264 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.411 ' HB3' HE21 ' A' ' 40' ' ' GLN . 14.0 t80 -78.67 -83.89 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.294 -0.412 . . . . 2.46 111.676 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -73.86 82.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 2.5699999999999998 111.247 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 tp -172.03 -36.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.849 0.315 . . . . 3.7999999999999998 111.849 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.96 -30.46 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.252 -0.975 . . . . 2.4900000000000002 112.98 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.12 120.43 18.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.613 -0.803 . . . . 2.46 112.297 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -98.76 26.56 5.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.751 0.275 . . . . 2.9300000000000002 111.387 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 31.16 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.99 0.737 . . . . 1.3600000000000001 112.99 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.92 31.57 0.94 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.214 -0.448 . . . . 2.9199999999999999 110.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -105.3 169.6 8.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 2.7200000000000002 111.205 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.2 79.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.013 -0.54 . . . . 2.0800000000000001 111.229 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.6 ttt -58.9 -32.11 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.414 . . . . 3.1600000000000001 110.606 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.47 -47.17 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 1.6000000000000001 110.652 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.52 -34.48 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 2.0099999999999998 110.089 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -65.48 -43.28 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.639 . . . . 1.5700000000000001 110.275 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -26.42 67.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.02 -0.536 . . . . 1.3700000000000001 110.483 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -44.6 61.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.805 -0.634 . . . . 2.3399999999999999 110.801 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.0 t -76.55 -26.49 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 2.3900000000000001 111.282 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -77.61 2.68 15.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 2.5299999999999998 111.154 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.534 ' HB2' HG23 ' A' ' 67' ' ' VAL . 20.9 tpt85 -133.58 8.27 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.37 . . . . 4.1200000000000001 111.537 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 68.39 53.8 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 3.6400000000000001 111.31 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 57.74 88.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 4.96 111.8 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.429 HE21 ' HB2' ' A' ' 60' ' ' GLN . 0.4 OUTLIER -67.68 -30.1 69.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.649 -0.501 . . . . 2.7999999999999998 109.649 178.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.2 t 65.86 -72.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 115.322 -0.854 . . . . 3.4900000000000002 111.861 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -92.81 -84.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.506 0.558 . . . . 4.5599999999999996 112.506 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.06 135.14 20.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.206 0.447 . . . . 3.52 112.206 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -88.24 58.36 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.769 2.313 . . . . 2.1699999999999999 111.125 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.95 119.08 5.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.587 -0.733 . . . . 2.9700000000000002 112.241 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mttp 47.15 83.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 2.8700000000000001 112.123 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.534 HG23 ' HB2' ' A' ' 57' ' ' ARG . 13.7 p -155.62 -44.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.288 -0.414 . . . . 2.5899999999999999 111.051 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.524 ' HA ' HD11 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -178.27 -39.53 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.549 -0.296 . . . . 2.6499999999999999 111.499 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -91.97 -52.72 4.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.066 0.395 . . . . 2.4700000000000002 112.066 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.9 71.56 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.954 0.353 . . . . 1.52 111.954 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.613 HE21 ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 176.42 115.27 0.13 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.148 -0.478 . . . . 3.8300000000000001 110.582 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.613 ' HD2' HE21 ' A' ' 71' ' ' GLN . 73.4 Cg_endo -75.99 41.35 0.83 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.434 2.09 . . . . 2.1200000000000001 112.879 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.91 74.54 0.73 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.146 0.498 . . . . 2.7999999999999998 110.23 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.08 -40.79 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.648 -0.705 . . . . 2.5899999999999999 112.296 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -30.83 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 4.2400000000000002 111.146 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.09 68.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.734 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 68' ' ' LEU . 30.7 mt -72.82 -27.33 61.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.049 -0.523 . . . . 2.9700000000000002 110.602 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.61 -34.28 74.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 1.97 111.106 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' C ' ' HG1' ' A' ' 83' ' ' THR . 13.6 pt20 -103.31 21.61 15.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 3.27 111.041 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 1.0 OUTLIER -129.91 -69.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 3.1000000000000001 111.094 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 t -94.1 -39.26 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 2.6800000000000002 111.332 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.64 -16.86 61.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 2.0299999999999998 111.348 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.427 ' HG1' ' C ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -55.82 -27.53 51.84 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.971 -0.381 . . . . 3.1099999999999999 109.971 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.439 ' NH2' ' HA ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 58.4 -83.89 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.268 -0.878 . . . . 7.8499999999999996 110.305 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.439 ' HA ' ' NH2' ' A' ' 84' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.141 -0.933 . . . . 5.9800000000000004 110.507 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.818 -0.438 . . . . 8.8300000000000001 109.818 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.56 -118.51 15.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.005 -0.617 . . . . 5.5899999999999999 111.97 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.456 ' H ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.53 -28.76 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.875 -0.417 . . . . 6.5800000000000001 109.875 176.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.419 ' HB ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER 60.2 -124.86 1.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.547 -0.752 . . . . 4.0300000000000002 110.106 -176.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 1.014 ' HA ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER 66.39 165.25 0.2 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.62 0.724 . . . . 3.4700000000000002 112.174 177.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.81 146.65 9.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.455 -0.793 . . . . 3.4700000000000002 110.148 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -122.69 33.79 5.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.514 0.674 . . . . 4.0800000000000001 109.196 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.481 ' HE2' HG22 ' A' ' 34' ' ' ILE . 5.1 t80 -116.12 17.23 15.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.371 -0.831 . . . . 2.3599999999999999 111.334 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.43 67.03 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.403 1.096 . . . . 2.5 110.122 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -106.41 105.29 53.88 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.106 -0.952 . . . . 2.5099999999999998 110.515 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 1.1 Cg_endo -83.52 156.61 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.121 2.547 . . . . 2.2999999999999998 111.974 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.56 -44.92 3.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.237 0.541 . . . . 2.52 109.645 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -114.59 177.49 4.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.511 -0.768 . . . . 2.5800000000000001 109.832 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.42 -15.57 54.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.896 0.379 . . . . 2.0099999999999998 110.768 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.78 -57.52 10.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.922 -0.581 . . . . 2.5099999999999998 111.039 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.895 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 12.6 pm0 -72.75 -22.71 60.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.23 -0.441 . . . . 1.95 110.699 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.66 -48.5 79.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 1.79 110.097 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -61.08 -45.18 95.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 3.48 110.856 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.38 -56.07 16.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 2.4199999999999999 111.395 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -67.12 -43.8 81.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.669 -0.696 . . . . 1.6000000000000001 112.092 -173.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.05 -37.21 83.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.604 0.24 . . . . 2.6899999999999999 111.314 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.43 ' O ' HG21 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -71.13 -46.99 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.045 -0.262 . . . . 2.4300000000000002 110.595 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -69.28 -27.36 65.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.55 110.563 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.1 tm-20 -58.83 -52.03 67.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 2.7799999999999998 110.471 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -19.35 60.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.726 0.298 . . . . 4.9000000000000004 111.364 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 22' ' ' ILE . 53.6 t -85.63 -49.27 15.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.497 -0.319 . . . . 2.4900000000000002 111.409 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.45 -31.69 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.686 0.624 . . . . 3.3100000000000001 112.686 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 -82.1 0.47 Allowed Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.656 -0.783 . . . . 1.8799999999999999 113.723 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 74.56 4.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.011 0.924 . . . . 2.4500000000000002 110.92 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 1.014 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 15.2 m -112.5 -17.0 12.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.703 -0.68 . . . . 2.21 111.965 -172.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 34.78 8.34 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.651 -0.98 . . . . 1.6399999999999999 110.651 -174.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.618 HG23 ' HE2' ' A' ' 38' ' ' PHE . 1.3 pt -78.94 170.52 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.273 0.559 . . . . 3.9700000000000002 112.085 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.77 158.19 7.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.52 -0.764 . . . . 2.3199999999999998 111.619 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.481 HG22 ' HE2' ' A' ' 8' ' ' TYR . 36.4 mm 66.27 -79.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.011 0.525 . . . . 3.1299999999999999 111.272 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.966 -0.383 . . . . 3.02 109.966 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 17.7 t0 41.75 -92.73 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.362 1.039 . . . . 4.2000000000000002 112.906 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 92.74 -7.39 0.17 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.711 1.257 . . . . 4.9299999999999997 111.761 175.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.618 ' HE2' HG23 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -109.67 -55.53 2.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.537 -0.542 . . . . 2.75 109.537 173.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.489 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 29.7 t80 -91.75 -73.13 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.378 -0.828 . . . . 2.46 109.909 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.532 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.8 mt-30 -70.43 96.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 2.5699999999999998 109.963 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.5 tp 168.69 -18.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 3.7999999999999998 110.029 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.55 35.55 3.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.666 -0.778 . . . . 2.4900000000000002 111.418 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.13 124.75 7.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.679 -0.772 . . . . 2.46 111.746 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -84.7 74.75 10.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 2.9300000000000002 110.556 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.53 161.45 30.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.868 -0.605 . . . . 1.3600000000000001 110.835 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 67.43 6.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 2.9199999999999999 110.596 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -139.33 160.16 40.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.726 -0.67 . . . . 2.7200000000000002 109.761 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.09 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.445 0.466 . . . . 2.0800000000000001 112.159 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tpt -60.85 -31.55 71.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.329 . . . . 3.1600000000000001 111.305 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -71.74 -37.01 70.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.438 -0.346 . . . . 1.6000000000000001 111.196 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 2.0099999999999998 110.057 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.17 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.09 -0.505 . . . . 1.5700000000000001 110.151 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.7 ' HB1' HG21 ' A' ' 67' ' ' VAL . . . -69.78 -26.67 64.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.91 -0.586 . . . . 1.3700000000000001 110.672 176.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -79.71 -22.56 43.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 2.3399999999999999 110.897 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -94.91 -15.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 2.3900000000000001 111.607 -176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.68 40.89 1.05 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.295 0.569 . . . . 2.5299999999999998 110.873 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 177.81 -150.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.672 -1.233 . . . . 4.1200000000000001 107.672 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.06 164.62 14.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.579 -0.897 . . . . 3.6400000000000001 108.579 168.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.37 82.96 2.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.278 0.561 . . . . 4.96 109.974 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.7 2.02 7.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.934 -1.03 . . . . 2.7999999999999998 112.871 -173.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.1 t 58.82 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 122.834 0.454 . . . . 3.4900000000000002 111.442 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 55.0 mm-40 -121.71 23.78 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.552 -0.295 . . . . 4.5599999999999996 110.983 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.45 68.98 60.88 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.403 . . . . 3.52 110.857 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 62' ' ' GLU . 5.6 Cg_endo -87.38 73.03 2.9 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.196 2.597 . . . . 2.1699999999999999 111.991 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.0 tp -82.46 129.46 34.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.12 -0.491 . . . . 2.9700000000000002 110.847 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 58.13 34.19 23.92 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.766 0.666 . . . . 2.8700000000000001 111.127 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.7 HG21 ' HB1' ' A' ' 53' ' ' ALA . 0.8 OUTLIER -94.99 -174.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.525 -0.761 . . . . 2.5899999999999999 110.433 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.441 ' N ' HG13 ' A' ' 67' ' ' VAL . 5.4 mt -53.84 -21.29 7.27 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.247 0.832 . . . . 2.6499999999999999 113.247 -174.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.653 ' H ' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -138.93 44.51 2.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.106 0.479 . . . . 2.4700000000000002 111.287 175.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB3' ' H ' ' A' ' 67' ' ' VAL . . . -120.98 47.7 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.899 0.381 . . . . 1.52 110.66 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.571 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -162.16 144.99 8.82 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.206 -0.906 . . . . 3.8300000000000001 108.792 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.49 1.19 3.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.927 2.418 . . . . 2.1200000000000001 113.119 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -128.94 89.43 2.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.741 0.305 . . . . 2.7999999999999998 110.577 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 tp -58.43 -32.61 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.059 -0.519 . . . . 2.5899999999999999 112.255 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.895 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -62.59 -38.86 91.79 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.228 -0.295 . . . . 4.2400000000000002 110.79 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.26 -31.97 73.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 1.7 110.676 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD21 ' HB2' ' A' ' 71' ' ' GLN . 12.7 mt -78.42 -36.82 45.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.986 -0.552 . . . . 2.9700000000000002 110.61 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.2 66.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 1.97 110.633 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -91.55 -0.05 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.621 . . . . 3.27 110.614 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -114.04 -88.89 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 3.1000000000000001 111.121 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 m -82.29 21.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 2.6800000000000002 112.044 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.437 ' HB3' HD23 ' A' ' 68' ' ' LEU . . . -130.1 -4.24 4.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 2.0299999999999998 110.867 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.69 -55.95 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 3.1099999999999999 111.153 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -118.24 85.16 2.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 7.8499999999999996 110.964 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.105 -0.95 . . . . 5.9800000000000004 110.036 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' HB3' ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.325 -0.25 . . . . 8.8300000000000001 110.325 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' H ' ' HB3' ' A' ' 1' ' ' MET . . . -86.24 139.88 17.13 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.755 -0.736 . . . . 5.5899999999999999 112.305 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.37 103.62 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.948 0.404 . . . . 6.5800000000000001 110.593 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.72 125.77 44.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.008 -0.542 . . . . 4.0300000000000002 110.598 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -71.77 139.76 49.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.125 -0.488 . . . . 3.4700000000000002 110.91 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.39 144.65 27.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.021 -0.536 . . . . 3.4700000000000002 110.082 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.16 91.37 3.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.896 0.379 . . . . 4.0800000000000001 110.887 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.442 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 7.0 t80 -146.43 2.57 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.003 -0.544 . . . . 2.3599999999999999 111.18 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 2.8 p -79.15 93.44 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 2.5 111.327 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.06 74.98 1.69 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.511 -0.768 . . . . 2.5099999999999998 110.424 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HB2' ' OE2' ' A' ' 16' ' ' GLU . 2.1 Cg_endo -81.61 -133.69 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.088 2.525 . . . . 2.2999999999999998 112.226 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.429 ' H ' ' HB2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -123.63 -48.11 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.118 0.485 . . . . 2.52 111.798 -177.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.735 HD22 ' HB ' ' A' ' 15' ' ' VAL . 1.8 t30 -98.27 132.4 43.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.872 -0.604 . . . . 2.5800000000000001 110.503 -172.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.28 68.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.671 -0.695 . . . . 2.0099999999999998 112.0 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.735 ' HB ' HD22 ' A' ' 13' ' ' ASN . 48.1 t -70.17 -48.42 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 2.5099999999999998 110.958 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.498 ' OE1' ' HB3' ' A' ' 13' ' ' ASN . 1.7 pt-20 -67.8 -32.31 72.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.947 0.404 . . . . 1.95 110.32 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.408 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.3 m -69.48 -35.84 75.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.894 -0.594 . . . . 1.79 110.205 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -64.95 -41.78 95.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 3.48 110.737 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -46.4 90.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 2.4199999999999999 110.652 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.02 92.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 1.6000000000000001 111.282 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -40.43 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 2.6899999999999999 111.696 -176.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -38.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 120.97 -0.292 . . . . 2.4300000000000002 110.973 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -66.7 -45.25 79.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.089 0.471 . . . . 1.55 110.166 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -83.45 19.42 1.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.392 0.615 . . . . 2.7799999999999998 111.301 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.528 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -120.17 -0.87 10.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.771 -0.649 . . . . 4.9000000000000004 109.317 170.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -128.2 -25.13 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.862 -0.608 . . . . 2.4900000000000002 111.852 -177.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.418 ' N ' HG12 ' A' ' 26' ' ' VAL . 11.9 tp -93.04 -81.13 0.36 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.501 0.191 . . . . 3.3100000000000001 111.364 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.4 -39.87 6.64 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.66 -0.781 . . . . 1.8799999999999999 111.644 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t 70.18 53.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.774 0.797 . . . . 2.4500000000000002 110.648 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.64 -35.85 3.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 2.21 109.775 173.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.22 42.77 2.93 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.732 -0.667 . . . . 1.6399999999999999 112.383 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -87.69 -80.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.803 0.335 . . . . 3.9700000000000002 111.156 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.25 -69.71 3.08 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.932 -0.651 . . . . 2.3199999999999998 111.589 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -107.31 152.09 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.172 -1.048 . . . . 3.1299999999999999 108.172 174.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 44.3 1.53 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.359 -0.978 . . . . 3.02 108.359 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -70.46 174.52 5.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.23 -1.35 . . . . 4.2000000000000002 111.957 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -140.85 -8.12 1.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 4.9299999999999997 111.08 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.411 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 26.7 p90 -148.34 -33.81 0.23 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.002 0.742 . . . . 2.75 113.002 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -96.53 -83.09 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.047 -0.408 . . . . 2.46 111.66 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -29.42 67.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.5699999999999998 112.018 -173.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 tp -115.1 -2.0 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.417 . . . . 3.7999999999999998 111.52 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 38' ' ' PHE . . . -92.51 -95.95 1.4 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.437 -0.887 . . . . 2.4900000000000002 112.71 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.12 -138.29 2.65 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.667 -0.778 . . . . 2.46 112.397 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -97.01 122.96 40.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.241 0.543 . . . . 2.9300000000000002 111.366 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.33 -178.11 6.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 1.3600000000000001 109.986 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -89.15 45.68 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.049 0.452 . . . . 2.9199999999999999 110.947 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.58 163.74 22.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.393 -0.367 . . . . 2.7200000000000002 111.418 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.96 94.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 2.0800000000000001 111.534 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ttt -60.33 -34.58 74.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.402 . . . . 3.1600000000000001 110.456 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . . . -69.95 -40.58 75.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 1.6000000000000001 110.846 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.634 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -71.69 -34.88 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 2.0099999999999998 110.616 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.461 ' N ' HG13 ' A' ' 51' ' ' VAL . . . -73.35 -29.94 62.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 1.5700000000000001 110.807 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -73.8 -38.68 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 1.3700000000000001 111.271 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.634 ' NE2' ' HA ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -68.73 -38.42 80.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.011 -0.276 . . . . 2.3399999999999999 110.936 -177.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 51' ' ' VAL . 35.7 m -92.83 19.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 2.3900000000000001 110.973 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.437 ' HE1' ' O ' ' A' ' 81' ' ' VAL . 15.5 t-160 -88.13 -18.13 29.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.07 -0.513 . . . . 2.5299999999999998 110.456 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.723 ' HG3' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -106.25 -63.9 1.22 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.041 0.448 . . . . 4.1200000000000001 110.682 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.3 -151.97 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.632 -0.713 . . . . 3.6400000000000001 109.298 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -75.82 64.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.414 0.626 . . . . 4.96 110.194 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.18 91.99 3.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 2.7999999999999998 109.177 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.29 -55.75 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.7 -0.682 . . . . 3.4900000000000002 112.185 -170.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -63.72 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 4.5599999999999996 111.652 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.72 111.66 54.11 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 3.52 110.672 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.9 127.54 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.557 2.171 . . . . 2.1699999999999999 111.226 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tp -123.73 96.22 4.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 2.9700000000000002 110.506 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 0.5 OUTLIER 54.67 62.62 2.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.908 -0.587 . . . . 2.8700000000000001 111.377 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.723 HG22 ' HG3' ' A' ' 57' ' ' ARG . 11.3 p -132.04 -29.66 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.171 -0.468 . . . . 2.5899999999999999 111.178 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.61 -51.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.92 -0.77 . . . . 2.6499999999999999 108.92 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 50' ' ' ALA . 1.1 m-85 -104.67 172.31 6.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.217 -0.901 . . . . 2.4700000000000002 109.172 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 71' ' ' GLN . . . 60.35 43.67 13.22 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.91 0.756 . . . . 1.52 111.266 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 167.06 123.57 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 O-C-N 124.215 0.947 . . . . 3.8300000000000001 109.752 176.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.44 28.95 0.54 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.813 2.342 . . . . 2.1200000000000001 113.061 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.47 39.75 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.06 0.457 . . . . 2.7999999999999998 110.629 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.457 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -57.51 -39.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 2.5899999999999999 111.846 -175.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.468 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -64.86 -43.07 94.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.788 0.328 . . . . 4.2400000000000002 110.814 -178.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.05 74.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 1.7 110.992 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.23 -43.2 95.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.345 -0.389 . . . . 2.9700000000000002 111.36 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.46 -4.62 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 1.97 111.493 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.29 -57.67 2.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.966 0.412 . . . . 3.27 110.781 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -74.11 -42.35 60.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 3.1000000000000001 111.836 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.437 ' O ' ' HE1' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -108.78 30.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.84 0.353 . . . . 2.6800000000000002 111.425 -174.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.96 30.32 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.091 0.472 . . . . 2.0299999999999998 110.443 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -34.11 61.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 3.1099999999999999 111.244 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.33 32.9 16.79 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 123.721 0.638 . . . . 7.8499999999999996 110.529 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.291 -0.862 . . . . 5.9800000000000004 110.131 -177.113 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 110.106 -0.331 . . . . 8.8300000000000001 110.106 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.9 -127.78 1.19 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.872 -0.68 . . . . 5.5899999999999999 111.839 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -86.15 81.06 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.807 0.337 . . . . 6.5800000000000001 111.067 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -20.19 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.421 . . . . 4.0300000000000002 110.25 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 6' ' ' ALA . 3.9 mt-10 56.42 -146.33 0.57 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.079 -0.964 . . . . 3.4700000000000002 111.894 174.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.492 ' H ' ' HB3' ' A' ' 5' ' ' GLU . . . -152.91 83.96 1.22 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.931 0.396 . . . . 3.4700000000000002 111.051 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -92.59 -9.64 40.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 4.0800000000000001 110.097 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.567 ' HB3' HD12 ' A' ' 35' ' ' LEU . 10.4 t80 -91.55 -54.86 3.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 2.3599999999999999 110.052 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.665 HG11 ' HD3' ' A' ' 11' ' ' PRO . 2.2 t 56.73 -100.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.944 -0.571 . . . . 2.5 111.415 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 57.02 65.63 3.65 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.596 0.591 . . . . 2.5099999999999998 112.596 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.665 ' HD3' HG11 ' A' ' 9' ' ' VAL . 73.9 Cg_endo -88.97 143.44 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.55 2.166 . . . . 2.2999999999999998 111.518 176.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.432 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -107.75 -34.64 6.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.858 0.361 . . . . 2.52 111.313 -177.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.35 151.07 49.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.32 -0.4 . . . . 2.5800000000000001 110.764 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.35 68.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 2.0099999999999998 111.297 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.17 -44.95 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 2.5099999999999998 110.738 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -43.09 89.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 1.95 110.849 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -69.69 -43.95 71.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.541 . . . . 1.79 111.207 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.79 -40.51 83.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.682 -0.235 . . . . 3.48 111.213 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -45.0 96.57 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.761 0.315 . . . . 2.4199999999999999 110.219 177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.41 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 1.6000000000000001 110.903 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.76 -47.52 84.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 2.6899999999999999 110.873 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.3 mt -71.89 -49.46 44.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.327 -0.397 . . . . 2.4300000000000002 110.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.605 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 4.0 m95 -56.94 -52.5 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 1.55 111.609 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -63.0 -44.48 95.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.101 -0.5 . . . . 2.7799999999999998 111.022 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 1.7 mmp_? -73.06 -2.84 22.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.958 0.355 . . . . 4.9000000000000004 111.958 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.26 -45.07 8.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.6 -0.273 . . . . 2.4900000000000002 111.246 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.455 HD13 ' HD3' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -114.1 -4.59 13.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.918 0.71 . . . . 3.3100000000000001 112.918 -173.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.3 -78.74 0.3 Allowed Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 120.088 -1.053 . . . . 1.8799999999999999 112.917 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 29' ' ' VAL . 0.5 OUTLIER 80.96 -6.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.935 0.894 . . . . 2.4500000000000002 110.627 -178.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -44.78 78.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.516 -0.765 . . . . 2.21 111.479 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' GLU . . . 110.97 25.29 5.16 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.057 -0.592 . . . . 1.6399999999999999 112.391 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.3 129.01 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.688 -0.301 . . . . 3.9700000000000002 110.621 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.44 -80.56 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.299 -0.953 . . . . 2.3199999999999998 112.608 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.08 85.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 3.1299999999999999 110.699 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -166.33 -135.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.16 -0.927 . . . . 3.02 108.91 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.9 106.53 1.25 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.207 -1.035 . . . . 4.2000000000000002 108.207 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.544 ' HB3' HG23 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -78.87 135.27 36.97 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.991 0.737 . . . . 4.9299999999999997 112.991 -164.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -121.67 7.83 10.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.989 -1.005 . . . . 2.75 109.043 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -125.91 -62.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.226 -0.897 . . . . 2.46 110.651 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' A' ' 72' ' ' PRO . 7.7 mt-30 -85.02 53.63 2.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.487 . . . . 2.5699999999999998 110.655 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.544 HG23 ' HB3' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -140.81 38.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 3.7999999999999998 109.971 178.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.88 -71.21 0.3 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.195 -0.762 . . . . 2.4900000000000002 111.195 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 -95.35 0.57 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.878 -0.677 . . . . 2.46 112.711 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER 56.34 33.89 23.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.002 1.382 . . . . 2.9300000000000002 109.929 -174.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 171.7 13.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.253 -1.34 . . . . 1.3600000000000001 111.732 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.03 65.83 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 2.9199999999999999 110.518 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HD3' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -133.72 152.82 51.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 2.7200000000000002 110.261 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.29 85.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.0800000000000001 111.574 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.605 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -60.09 -35.06 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 3.1600000000000001 110.825 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.6 -36.86 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 1.6000000000000001 110.296 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.455 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 91.3 t -62.16 -40.23 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.837 -0.62 . . . . 2.0099999999999998 110.431 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 55' ' ' VAL . . . -63.62 -39.07 93.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 1.5700000000000001 110.842 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.05 83.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.354 -0.384 . . . . 1.3700000000000001 110.786 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.651 ' HA ' ' NE2' ' A' ' 60' ' ' GLN . 3.0 pt20 -88.94 12.35 15.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 2.3399999999999999 111.342 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 52' ' ' ALA . 1.4 p -123.46 -13.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.167 0.508 . . . . 2.3900000000000001 110.432 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -94.22 -8.83 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.625 0.726 . . . . 2.5299999999999998 109.368 173.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' HG2' ' N ' ' A' ' 58' ' ' GLU . 18.6 ttt-85 -145.35 163.72 33.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.262 -1.384 . . . . 4.1200000000000001 107.262 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.544 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -49.98 144.31 6.87 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 117.776 0.262 . . . . 3.6400000000000001 110.983 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -48.7 117.91 2.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.722 0.639 . . . . 4.96 111.674 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.878 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 1.5 mt-30 -92.15 73.81 5.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.46 -0.791 . . . . 2.7999999999999998 110.994 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -80.76 -22.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 3.4900000000000002 109.758 176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.76 -78.41 0.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.241 -0.89 . . . . 4.5599999999999996 110.719 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.34 112.2 8.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.744 0.307 . . . . 3.52 111.64 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.878 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 14.7 Cg_exo -71.62 68.2 2.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.458 2.772 . . . . 2.1699999999999999 111.473 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tp -81.82 133.63 35.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 2.9700000000000002 112.489 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.71 19.48 11.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.533 0.938 . . . . 2.8700000000000001 113.533 169.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' H ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -101.48 -54.75 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.811 -0.356 . . . . 2.5899999999999999 110.365 174.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.883 ' HA ' HD11 ' A' ' 77' ' ' LEU . 1.6 mt -169.08 -40.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 2.6499999999999999 110.462 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -82.24 2.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 2.4700000000000002 112.429 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 64' ' ' PRO . . . -133.65 52.62 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.732 0.301 . . . . 1.52 111.399 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.59 ' HB3' HD12 ' A' ' 77' ' ' LEU . 36.1 tp60 -177.39 113.14 0.24 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.592 -0.731 . . . . 3.8300000000000001 109.734 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.446 ' HA ' ' OE1' ' A' ' 40' ' ' GLN . 13.3 Cg_exo -71.15 48.01 0.85 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.335 2.69 . . . . 2.1200000000000001 112.166 177.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.4 m -156.95 83.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.785 -0.643 . . . . 2.7999999999999998 109.468 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.4 mm -65.05 -37.09 79.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.536 -0.756 . . . . 2.5899999999999999 111.259 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HD3' ' HB ' ' A' ' 12' ' ' THR . 2.3 ttpt -56.34 -39.11 72.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 4.2400000000000002 111.36 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 79' ' ' GLN . . . -66.92 -46.33 75.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.331 . . . . 1.7 111.052 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.883 HD11 ' HA ' ' A' ' 68' ' ' LEU . 3.4 mt -70.09 -27.07 64.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.874 0.369 . . . . 2.9700000000000002 110.908 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.28 -32.32 73.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.97 111.019 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 1.1 pt20 -97.37 15.06 24.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 3.27 110.551 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -119.8 -80.29 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.113 0.482 . . . . 3.1000000000000001 110.662 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.46 -35.52 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.783 -0.644 . . . . 2.6800000000000002 111.417 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.13 -28.25 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 2.0299999999999998 111.495 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.14 -21.58 22.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.446 -0.343 . . . . 3.1099999999999999 110.83 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.81 -73.37 0.1 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.53 -0.759 . . . . 7.8499999999999996 111.42 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.414 -0.803 . . . . 5.9800000000000004 110.839 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.908 0.385 . . . . 8.8300000000000001 110.38 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.79 166.37 34.41 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.713 -0.756 . . . . 5.5899999999999999 112.013 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.63 104.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.321 0.581 . . . . 6.5800000000000001 110.384 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.473 ' N ' ' HB3' ' A' ' 30' ' ' SER . 5.3 m -99.52 81.32 2.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.813 -0.63 . . . . 4.0300000000000002 111.431 -177.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.63 144.27 29.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.776 -0.824 . . . . 3.4700000000000002 108.776 171.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' C ' ' H ' ' A' ' 8' ' ' TYR . . . -127.76 146.55 50.55 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.736 -0.386 . . . . 3.4700000000000002 111.434 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.65 37.22 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 4.0800000000000001 110.107 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.447 ' H ' ' C ' ' A' ' 6' ' ' ALA . 5.4 t80 -152.86 43.05 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.384 -0.825 . . . . 2.3599999999999999 109.13 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.675 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 10.0 p -102.4 35.05 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.086 0.946 . . . . 2.5 110.096 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.18 112.44 38.69 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.314 -0.857 . . . . 2.5099999999999998 109.84 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.52 131.33 27.57 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.683 2.256 . . . . 2.2999999999999998 112.094 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.7 0.85 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.726 -0.67 . . . . 2.52 109.997 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.567 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -158.03 148.23 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.158 -0.928 . . . . 2.5800000000000001 109.572 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.32 72.76 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.173 0.434 . . . . 2.0099999999999998 112.173 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 43.0 t -68.33 -26.28 33.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.479 -0.328 . . . . 2.5099999999999998 110.482 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.549 ' HG3' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -64.0 -49.12 73.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 1.95 110.395 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -64.56 -40.48 95.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.76 -0.654 . . . . 1.79 111.286 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -46.89 64.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 3.48 111.098 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 23' ' ' TRP . 3.0 tp -63.67 -54.58 33.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.964 -0.562 . . . . 2.4199999999999999 111.087 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -61.11 -29.1 69.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.446 . . . . 1.6000000000000001 111.453 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -68.93 -67.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 2.6899999999999999 110.65 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.681 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 37.5 mm -59.23 -47.71 89.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.436 -0.347 . . . . 2.4300000000000002 111.37 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.674 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 3.8 m95 -57.67 -46.33 84.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 1.55 110.716 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 3.2 mm-40 -89.6 28.14 1.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 2.7799999999999998 111.757 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.681 ' HD2' ' HA ' ' A' ' 22' ' ' ILE . 9.4 mtt180 -114.68 -14.26 12.04 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.109 -1.071 . . . . 4.9000000000000004 108.109 161.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.04 -37.96 3.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.003 -0.998 . . . . 2.4900000000000002 111.778 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HB3' ' H ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -95.98 -97.33 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.109 0.411 . . . . 3.3100000000000001 112.109 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 27' ' ' LEU . . . -87.96 -28.0 24.64 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.762 -0.732 . . . . 1.8799999999999999 112.304 -173.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 2.9 t 63.84 41.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.537 0.684 . . . . 2.4500000000000002 110.789 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.473 ' HB3' ' N ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -98.11 -98.02 0.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 2.21 111.115 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' ' 30' ' ' SER . . . 140.96 76.72 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.908 -0.663 . . . . 1.6399999999999999 111.689 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.614 HD12 ' HB3' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -117.81 132.09 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.012 0.435 . . . . 3.9700000000000002 111.37 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . -100.18 -123.43 5.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 2.3199999999999998 111.844 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mt -79.68 68.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.506 0.67 . . . . 3.1299999999999999 110.322 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.614 ' HB3' HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -148.64 4.17 0.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.387 -0.824 . . . . 3.02 110.504 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.726 ' HA ' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m-20 54.0 -109.9 0.51 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.102 -0.499 . . . . 4.2000000000000002 111.1 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.8 -73.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.432 0.693 . . . . 4.9299999999999997 112.705 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.02 -51.39 3.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.308 -0.405 . . . . 2.75 111.024 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -98.99 -70.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 2.46 112.153 -170.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.726 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 29.9 mp0 -60.31 -21.45 62.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.722 -0.672 . . . . 2.5699999999999998 112.602 -170.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 3.9 tp -63.93 -21.87 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 3.7999999999999998 111.366 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.759 ' HA2' ' HB3' ' A' ' 69' ' ' PHE . . . 108.0 45.68 1.08 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.579 -0.82 . . . . 2.4900000000000002 112.26 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.76 107.19 2.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.702 -0.761 . . . . 2.46 112.134 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -72.81 86.39 1.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 2.9300000000000002 110.294 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.93 178.25 8.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.81 -0.632 . . . . 1.3600000000000001 111.178 -178.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.51 29.33 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 2.9199999999999999 110.387 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -107.37 163.51 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.854 -0.612 . . . . 2.7200000000000002 110.842 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.88 86.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.59 . . . . 2.0800000000000001 112.227 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.674 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 11.2 ttt -61.27 -34.78 75.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 3.1600000000000001 111.036 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.21 -0.45 . . . . 1.6000000000000001 110.538 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.471 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 18.0 t -72.67 -42.29 62.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 2.0099999999999998 109.923 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.58 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.876 -0.602 . . . . 1.5700000000000001 110.88 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 64' ' ' PRO . . . -74.06 -43.61 57.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.909 -0.587 . . . . 1.3700000000000001 110.928 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.471 ' OE1' ' HA ' ' A' ' 51' ' ' VAL . 2.1 pt20 -75.64 -24.39 56.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.901 0.382 . . . . 2.3399999999999999 110.808 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -14.95 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.112 0.482 . . . . 2.3900000000000001 110.4 177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.587 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -64.62 -32.75 74.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 2.5299999999999998 110.807 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.851 ' HD2' HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.18 -0.76 13.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 4.1200000000000001 109.807 175.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER 50.23 84.99 0.04 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.847 -1.069 . . . . 3.6400000000000001 111.717 -177.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 11.6 m-30 69.95 76.22 0.21 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.237 -0.892 . . . . 4.96 111.433 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.667 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 6.0 pm0 -97.37 -37.5 10.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.107 -0.331 . . . . 2.7999999999999998 110.107 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 2.4 p 159.46 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.806 -1.183 . . . . 3.4900000000000002 107.806 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -58.35 -49.08 78.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.089 0.404 . . . . 4.5599999999999996 111.265 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 47.7 mt -89.37 134.14 33.39 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.03 0.443 . . . . 3.52 111.174 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.3 Cg_exo -81.06 59.72 7.56 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.219 2.613 . . . . 2.1699999999999999 112.496 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.725 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -69.56 116.31 9.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 2.9700000000000002 111.793 -176.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.16 19.13 10.42 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.615 -0.72 . . . . 2.8700000000000001 111.608 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.851 HG11 ' HD2' ' A' ' 57' ' ' ARG . 1.7 t -106.78 -20.95 5.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.326 0.584 . . . . 2.5899999999999999 109.978 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 77' ' ' LEU . 1.5 mt 180.0 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.589 -1.187 . . . . 2.6499999999999999 108.579 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.759 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 95.2 m-85 -112.94 -177.23 3.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 2.4700000000000002 109.81 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.725 ' HB1' ' HA ' ' A' ' 65' ' ' LEU . . . 60.87 55.32 3.21 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.338 0.59 . . . . 1.52 110.849 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -149.99 100.15 3.25 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.37 -0.832 . . . . 3.8300000000000001 110.208 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.501 ' O ' ' HB ' ' A' ' 73' ' ' THR . 47.5 Cg_exo -56.53 105.95 0.19 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.766 2.311 . . . . 2.1200000000000001 110.949 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 77.2 m 72.33 103.5 0.07 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.318 -0.623 . . . . 2.7999999999999998 109.318 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.549 HD13 ' HG3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -84.44 12.81 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 2.5899999999999999 111.071 -172.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.567 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -58.27 -50.37 73.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 4.2400000000000002 110.807 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.21 93.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.947 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -67.17 -36.11 81.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.122 -0.49 . . . . 2.9700000000000002 110.65 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.673 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . -62.89 -33.29 74.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.083 -0.508 . . . . 1.97 111.576 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.39 16.81 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.816 0.341 . . . . 3.27 110.711 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -126.47 -86.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.275 -0.42 . . . . 3.1000000000000001 110.942 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.1 -25.87 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.416 -0.356 . . . . 2.6800000000000002 111.436 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . -71.04 -28.14 64.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.67 -0.241 . . . . 2.0299999999999998 111.305 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.06 56.56 2.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.296 0.57 . . . . 3.1099999999999999 110.853 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -137.49 23.96 2.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 7.8499999999999996 110.054 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.438 -0.791 . . . . 5.9800000000000004 110.592 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.474 ' H2 ' ' CG ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.693 0.282 . . . . 8.8300000000000001 110.659 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.86 3.65 2.54 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.495 -0.86 . . . . 5.5899999999999999 113.563 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 36' ' ' ASP . 6.9 p -83.77 80.09 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 122.147 0.975 . . . . 6.5800000000000001 110.732 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -69.85 0.73 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.443 -0.799 . . . . 4.0300000000000002 110.703 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -170.74 76.89 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.728 . . . . 3.4700000000000002 109.246 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.32 122.4 41.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.146 0.498 . . . . 3.4700000000000002 112.115 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.65 70.47 2.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 4.0800000000000001 110.021 174.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.407 ' CD2' HD22 ' A' ' 35' ' ' LEU . 43.3 t80 -134.92 -47.5 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.873 -0.603 . . . . 2.3599999999999999 110.853 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 49.35 -134.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.671 -0.695 . . . . 2.5 110.903 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB2' HG12 ' A' ' 34' ' ' ILE . . . -178.63 94.04 0.22 Allowed Pre-proline 0 N--CA 1.463 0.199 0 O-C-N 123.128 0.268 . . . . 2.5099999999999998 111.126 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -92.25 46.47 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.775 2.316 . . . . 2.2999999999999998 111.875 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -86.73 106.44 17.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.768 0.655 . . . . 2.52 112.768 -173.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t30 40.53 54.88 2.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.043 1.127 . . . . 2.5800000000000001 114.043 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 70.64 -52.29 0.67 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.743 1.016 . . . . 2.0099999999999998 113.743 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.25 -60.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 2.5099999999999998 111.314 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HA ' HD12 ' A' ' 19' ' ' LEU . 3.2 mp0 -62.22 -31.08 71.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.21 -0.45 . . . . 1.95 110.997 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -40.07 90.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.938 0.399 . . . . 1.79 110.814 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -41.77 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.834 -0.621 . . . . 3.48 110.519 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 16' ' ' GLU . 28.1 mt -61.87 -43.75 98.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.064 -0.517 . . . . 2.4199999999999999 110.01 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -56.44 -55.03 38.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.647 -0.706 . . . . 1.6000000000000001 111.507 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 10.9 pt-20 -64.6 -46.75 81.32 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 111.706 0.261 . . . . 2.6899999999999999 111.706 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -68.0 -47.95 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.62 -0.264 . . . . 2.4300000000000002 111.219 -175.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -76.8 -14.16 59.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 1.55 111.001 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.6 mm-40 -69.04 -50.1 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.089 -0.338 . . . . 2.7799999999999998 110.089 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -75.28 -24.51 57.55 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.833 -0.347 . . . . 4.9000000000000004 111.935 -174.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.45 33.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.687 -0.405 . . . . 2.4900000000000002 111.894 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tp -171.99 -73.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.847 0.314 . . . . 3.3100000000000001 111.847 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.78 -62.62 2.62 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.984 -0.627 . . . . 1.8799999999999999 113.88 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 t 53.77 32.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.031 0.532 . . . . 2.4500000000000002 110.804 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -143.08 11.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 2.21 111.523 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.41 60.49 3.02 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.892 -0.883 . . . . 1.6399999999999999 110.892 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.56 81.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 3.9700000000000002 111.519 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.41 155.73 50.46 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.701 -0.682 . . . . 2.3199999999999998 112.151 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 10' ' ' ALA . 7.0 mm -80.05 56.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.764 0.792 . . . . 3.1299999999999999 111.483 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.407 HD22 ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -117.89 -42.07 2.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.184 -0.916 . . . . 3.02 108.614 171.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 12.0 t70 -156.54 128.02 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.02 -0.991 . . . . 4.2000000000000002 108.562 174.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.5 ' O ' HG12 ' A' ' 41' ' ' ILE . 43.7 t30 -173.22 149.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.885 -0.413 . . . . 4.9299999999999997 109.885 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 29.25 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.974 0.416 . . . . 2.75 111.295 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.427 ' H ' ' C ' ' A' ' 37' ' ' ASN . 42.8 t80 -117.07 -66.98 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.296 -0.411 . . . . 2.46 110.15 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.643 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.4 pm0 -79.84 13.11 2.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.936 -0.575 . . . . 2.5699999999999998 112.003 -176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 37' ' ' ASN . 14.5 pt -106.97 7.49 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 3.7999999999999998 110.181 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 33.03 10.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.821 -0.704 . . . . 2.4900000000000002 112.025 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.32 151.0 35.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 2.46 111.996 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 73.51 10.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.072 0.463 . . . . 2.9300000000000002 111.014 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.04 125.3 28.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.915 -0.584 . . . . 1.3600000000000001 110.35 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tp -73.72 71.74 1.46 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.002 0.43 . . . . 2.9199999999999999 111.992 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -145.44 152.4 39.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.915 -0.584 . . . . 2.7200000000000002 109.489 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -32.72 73.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 2.0800000000000001 111.523 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.3 ttt -61.81 -35.49 78.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 3.1600000000000001 110.991 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.94 -36.57 67.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 1.6000000000000001 110.546 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 t -66.58 -42.53 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.568 . . . . 2.0099999999999998 110.361 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.8 94.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 1.5700000000000001 110.845 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.68 84.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 1.3700000000000001 110.825 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -10.93 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 2.3399999999999999 111.162 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.484 ' O ' HG12 ' A' ' 55' ' ' VAL . 64.9 t -104.0 -22.9 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.286 -0.415 . . . . 2.3900000000000001 110.865 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.796 ' HE1' ' HA ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -74.72 55.14 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.925 0.713 . . . . 2.5299999999999998 112.925 -172.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -176.85 -70.6 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.158 -0.682 . . . . 4.1200000000000001 109.158 175.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -170.87 40.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 3.6400000000000001 110.624 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 59.26 78.7 0.25 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.99 -0.55 . . . . 4.96 110.631 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.456 ' OE1' ' HB3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -77.95 76.88 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.522 -0.763 . . . . 2.7999999999999998 110.874 -176.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -76.18 -18.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.792 -0.64 . . . . 3.4900000000000002 111.009 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -97.84 43.97 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 4.5599999999999996 110.024 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.19 129.43 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.171 -0.922 . . . . 3.52 111.047 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.2 73.65 4.36 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.696 2.264 . . . . 2.1699999999999999 112.461 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 67' ' ' VAL . 2.1 tp -59.53 113.69 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 2.9700000000000002 110.363 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.735 ' H ' ' HB1' ' A' ' 70' ' ' ALA . 19.2 mttt 58.42 -110.1 0.49 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.886 -0.597 . . . . 2.8700000000000001 110.383 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 65' ' ' LEU . 46.3 t 59.64 -85.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.223 0.609 . . . . 2.5899999999999999 111.843 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.586 HD11 ' HA ' ' A' ' 78' ' ' ALA . 5.5 tp -148.2 10.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 2.6499999999999999 110.879 -176.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 -56.15 0.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.251 0.463 . . . . 2.4700000000000002 112.251 -173.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.735 ' HB1' ' H ' ' A' ' 66' ' ' LYS . . . -80.71 66.43 6.23 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.121 0.415 . . . . 1.52 112.121 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.495 ' HB2' HD23 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -166.74 126.85 1.18 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.8300000000000001 109.837 176.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.437 ' C ' ' HG1' ' A' ' 73' ' ' THR . 14.0 Cg_exo -71.73 42.39 0.49 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.505 2.804 . . . . 2.1200000000000001 113.408 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -159.02 72.12 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.756 -0.831 . . . . 2.7999999999999998 108.756 175.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.79 -34.36 46.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.339 -0.846 . . . . 2.5899999999999999 111.236 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.421 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -60.28 -32.2 70.96 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.939 0.399 . . . . 4.2400000000000002 110.589 178.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.56 -44.14 35.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 1.7 110.805 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 71' ' ' GLN . 1.0 OUTLIER -63.29 -43.37 98.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 2.9700000000000002 110.737 -179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.586 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.81 -18.42 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.619 . . . . 1.97 111.49 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.76 -7.42 58.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 3.27 110.245 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.78 -70.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 3.1000000000000001 111.399 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.44 51.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.828 0.347 . . . . 2.6800000000000002 111.378 -173.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.796 ' HA ' ' HE1' ' A' ' 56' ' ' HIS . . . -157.58 -33.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.247 -0.433 . . . . 2.0299999999999998 111.501 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -40.44 95.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.416 . . . . 3.1099999999999999 111.708 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 58.91 27.07 15.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.436 0.636 . . . . 7.8499999999999996 110.608 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.327 -0.844 . . . . 5.9800000000000004 109.936 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.963 -0.384 . . . . 8.8300000000000001 109.963 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.06 -64.67 0.16 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.817 -0.706 . . . . 5.5899999999999999 111.769 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -145.76 108.72 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.28 0.562 . . . . 6.5800000000000001 110.866 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -86.0 60.18 6.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.288 0.566 . . . . 4.0300000000000002 110.787 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.66 110.29 0.74 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.552 -0.749 . . . . 3.4700000000000002 109.585 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.48 116.66 7.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.092 -0.504 . . . . 3.4700000000000002 111.006 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -83.27 49.02 1.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 4.0800000000000001 109.682 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.61 -89.75 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.724 . . . . 2.3599999999999999 111.273 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.562 HG12 ' HD3' ' A' ' 11' ' ' PRO . 11.9 t 63.64 -86.33 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.012 -0.54 . . . . 2.5 110.687 -173.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 49.74 69.9 2.38 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 123.02 0.528 . . . . 2.5099999999999998 111.948 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 9' ' ' VAL . 97.7 Cg_endo -88.5 155.0 6.48 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.766 2.311 . . . . 2.2999999999999998 112.653 -178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.14 -67.32 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.54 -0.3 . . . . 2.52 111.18 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -153.91 118.19 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.46 0.541 . . . . 2.5800000000000001 112.46 -176.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.77 -79.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.879 1.066 . . . . 2.0099999999999998 113.879 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -63.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.694 0.627 . . . . 2.5099999999999998 112.694 -169.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' HA ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -62.79 -37.58 87.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.95 111.473 -176.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -45.98 83.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.095 -0.502 . . . . 1.79 111.269 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -38.14 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.028 -0.533 . . . . 3.48 111.367 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -47.72 79.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 2.4199999999999999 110.854 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.92 82.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 1.6000000000000001 110.494 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.55 -48.74 79.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 2.6899999999999999 111.478 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.473 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 2.5 tt -67.93 -36.32 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.929 -0.308 . . . . 2.4300000000000002 111.765 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -81.75 -53.38 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 1.55 111.838 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.612 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -78.02 -7.74 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.092 0.404 . . . . 2.7799999999999998 112.092 -172.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.612 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 1.4 mmm180 -115.56 -0.25 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.255 -0.578 . . . . 4.9000000000000004 111.658 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -115.63 -23.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 2.4900000000000002 111.177 175.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 tp -122.86 -76.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 3.3100000000000001 110.77 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.456 ' HA3' ' HZ ' ' A' ' 38' ' ' PHE . . . -85.93 62.35 4.39 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.774 -0.727 . . . . 1.8799999999999999 112.92 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 1.6 p -67.68 105.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.564 0.697 . . . . 2.4500000000000002 110.645 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.16 -32.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.217 -0.901 . . . . 2.21 110.141 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.61 96.08 2.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.897 -0.668 . . . . 1.6399999999999999 111.646 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.668 HD13 ' HB3' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -131.64 -40.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.97 0.414 . . . . 3.9700000000000002 110.691 -178.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.53 ' C ' HG12 ' A' ' 34' ' ' ILE . . . 65.0 -99.62 0.38 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.937 -0.574 . . . . 2.3199999999999998 112.729 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.53 HG12 ' C ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -142.31 52.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.092 0.472 . . . . 3.1299999999999999 110.932 -177.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mt -129.72 -111.49 0.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.244 -0.285 . . . . 3.02 111.033 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -88.91 71.64 8.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 4.2000000000000002 110.288 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.668 ' HB3' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -114.18 164.45 13.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.643 -0.708 . . . . 4.9299999999999997 110.994 -176.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.456 ' HZ ' ' HA3' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -82.32 -14.96 54.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.008 -0.542 . . . . 2.75 110.634 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.466 ' HB3' ' OE1' ' A' ' 40' ' ' GLN . 18.7 t80 -81.97 -90.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.088 -0.506 . . . . 2.46 110.277 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.466 ' OE1' ' HB3' ' A' ' 39' ' ' PHE . 3.6 mp0 -68.09 125.42 26.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.574 -0.528 . . . . 2.5699999999999998 109.574 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.512 ' O ' HG21 ' A' ' 41' ' ' ILE . 0.0 OUTLIER 78.52 -9.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 123.978 0.799 . . . . 3.7999999999999998 110.972 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.46 -58.29 3.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.975 -0.631 . . . . 2.4900000000000002 112.256 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.734 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . 147.67 -76.13 0.26 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.385 -0.912 . . . . 2.46 112.613 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -165.81 119.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.039 0.447 . . . . 2.9300000000000002 110.992 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.03 144.34 26.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 1.3600000000000001 110.176 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.11 92.57 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.995 0.426 . . . . 2.9199999999999999 111.243 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -171.48 164.64 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 2.7200000000000002 110.285 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.75 65.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 2.0800000000000001 111.854 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -39.16 83.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.362 . . . . 3.1600000000000001 110.742 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.02 -37.59 61.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 1.6000000000000001 110.472 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.81 -42.96 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 2.0099999999999998 110.677 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.48 96.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 1.5700000000000001 110.903 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.453 . . . . 1.3700000000000001 110.32 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -49.3 73.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.604 -0.726 . . . . 2.3399999999999999 111.098 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 m -75.15 -33.0 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.929 -0.308 . . . . 2.3900000000000001 111.73 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -31.13 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.881 -0.328 . . . . 2.5299999999999998 111.224 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 -9.81 53.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.893 -0.41 . . . . 4.1200000000000001 109.893 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER 67.33 62.4 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.216 -0.902 . . . . 3.6400000000000001 110.882 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 1.2 m-85 78.91 109.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 4.96 111.65 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.07 -20.04 18.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.021 -0.99 . . . . 2.7999999999999998 109.695 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.7 t 66.05 -111.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.226 -0.897 . . . . 3.4900000000000002 110.185 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.65 8.55 4.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 4.5599999999999996 110.358 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 92.82 39.7 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 3.52 110.46 -175.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.734 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 49.8 Cg_endo -70.58 128.22 14.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.425 2.084 . . . . 2.1699999999999999 112.029 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.11 137.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 2.9700000000000002 109.436 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.51 47.35 16.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.712 0.633 . . . . 2.8700000000000001 110.442 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG13 ' H ' ' A' ' 69' ' ' PHE . 2.7 p -156.08 175.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.5899999999999999 109.808 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.5 ' HG ' HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -53.83 -36.88 63.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.286 0.476 . . . . 2.6499999999999999 112.286 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.535 ' H ' HG13 ' A' ' 67' ' ' VAL . 86.0 m-85 -84.09 3.21 35.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.46 -0.336 . . . . 2.4700000000000002 111.66 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.31 73.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.782 0.325 . . . . 1.52 111.459 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.93 141.48 1.21 Allowed Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.134 -0.691 . . . . 3.8300000000000001 109.134 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 73' ' ' THR . 23.0 Cg_exo -64.62 -86.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.539 2.16 . . . . 2.1200000000000001 111.867 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.7 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -80.92 136.72 36.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.713 0.292 . . . . 2.7999999999999998 110.541 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.497 HD11 HD21 ' A' ' 77' ' ' LEU . 38.0 mm -64.69 -25.05 36.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 2.5899999999999999 111.097 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.7 ' HD3' ' HB ' ' A' ' 73' ' ' THR . 1.1 pttt -50.48 -34.56 25.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.301 -0.409 . . . . 4.2400000000000002 111.801 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.543 ' N ' ' HG2' ' A' ' 75' ' ' LYS . . . -70.41 -50.75 35.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.037 0.446 . . . . 1.7 111.005 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.5 HD11 ' HG ' ' A' ' 68' ' ' LEU . 1.8 pp -73.06 -15.51 61.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 2.9700000000000002 110.71 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.56 -31.71 60.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 1.97 110.735 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.32 5.94 47.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 3.27 111.45 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.02 -48.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.529 0.566 . . . . 3.1000000000000001 112.529 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.53 -51.38 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.085 0.402 . . . . 2.6800000000000002 112.085 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.89 -16.15 63.59 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.075 0.398 . . . . 2.0299999999999998 112.075 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -17.6 59.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.046 0.451 . . . . 3.1099999999999999 110.824 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -88.8 80.13 7.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.926 -0.579 . . . . 7.8499999999999996 110.292 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.875 -1.059 . . . . 5.9800000000000004 109.491 177.363 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.849 0.357 . . . . 8.8300000000000001 110.705 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.486 ' HA2' ' CD1' ' A' ' 38' ' ' PHE . . . -129.11 27.7 4.23 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.955 -0.64 . . . . 5.5899999999999999 112.229 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.24 48.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.151 -0.685 . . . . 6.5800000000000001 109.151 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.08 143.6 30.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.553 -0.749 . . . . 4.0300000000000002 111.59 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 2.2 mt-10 -92.65 101.65 14.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.094 -0.503 . . . . 3.4700000000000002 109.743 175.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 32' ' ' ILE . . . -80.33 128.76 33.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.909 0.385 . . . . 3.4700000000000002 111.055 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.78 -19.46 41.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.236 0.541 . . . . 4.0800000000000001 110.301 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -91.04 57.61 3.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.925 -0.579 . . . . 2.3599999999999999 110.111 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.09 67.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 122.193 0.997 . . . . 2.5 110.431 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -143.51 110.38 5.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.196 -0.911 . . . . 2.5099999999999998 110.288 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 5.5 Cg_exo -78.73 171.05 17.23 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.257 2.638 . . . . 2.2999999999999998 112.382 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.87 -47.48 4.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.121 0.486 . . . . 2.52 110.666 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.441 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 24.0 t-20 -108.08 154.08 22.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 2.5800000000000001 110.669 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.97 -29.12 69.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 2.0099999999999998 111.246 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.04 -35.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.21 0.528 . . . . 2.5099999999999998 110.27 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.491 ' HA ' HD13 ' A' ' 74' ' ' ILE . 73.5 mt-10 -73.13 -36.74 66.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.713 -0.676 . . . . 1.95 110.598 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -35.22 74.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 1.79 110.53 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -45.07 78.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.091 -0.504 . . . . 3.48 110.757 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.74 -37.29 87.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 2.4199999999999999 110.129 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.74 -30.8 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 1.6000000000000001 110.595 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.625 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 16.5 tt0 -61.96 -47.17 86.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.981 -0.378 . . . . 2.6899999999999999 109.981 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.2 mt -69.92 -55.16 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.333 -0.394 . . . . 2.4300000000000002 111.158 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.535 ' CH2' ' HD2' ' A' ' 47' ' ' LYS . 64.1 m95 -68.56 -49.1 62.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.257 0.465 . . . . 1.55 112.257 -172.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.89 -50.24 24.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.438 0.162 . . . . 2.7799999999999998 111.438 -174.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.625 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 1.1 mmt85 -66.6 -27.38 67.66 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.694 -0.402 . . . . 4.9000000000000004 111.643 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.17 -55.75 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.219 -0.193 . . . . 2.4900000000000002 111.288 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.89 -44.32 5.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.404 0.52 . . . . 3.3100000000000001 112.404 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.57 -59.82 10.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.353 -0.451 . . . . 1.8799999999999999 113.57 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.1 t 72.12 -56.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 123.329 0.652 . . . . 2.4500000000000002 111.897 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.463 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 2.4 m -74.35 -41.04 61.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 2.21 111.16 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.1 127.38 3.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.758 -0.734 . . . . 1.6399999999999999 112.096 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.48 ' HA ' ' HB1' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -164.44 161.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.94 -0.393 . . . . 3.9700000000000002 109.94 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.45 -103.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.038 -1.077 . . . . 2.3199999999999998 113.552 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.451 HG22 HD13 ' A' ' 34' ' ' ILE . 3.2 mm -81.16 65.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.146 0.498 . . . . 3.1299999999999999 111.637 -171.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.97 171.63 15.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.112 -0.495 . . . . 3.02 110.139 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.53 112.87 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.095 -0.502 . . . . 4.2000000000000002 109.751 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.491 HD22 ' NE2' ' A' ' 40' ' ' GLN . 3.4 p30 -146.95 172.31 13.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.175 0.512 . . . . 4.9299999999999997 111.682 -174.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.486 ' CD1' ' HA2' ' A' ' 2' ' ' GLY . 19.8 p90 -63.45 153.17 36.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.129 -0.941 . . . . 2.75 112.717 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.9 -39.08 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.931 0.892 . . . . 2.46 112.891 171.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.491 ' NE2' HD22 ' A' ' 37' ' ' ASN . 38.4 mt-30 -65.32 -36.31 83.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.803 0.335 . . . . 2.5699999999999998 111.19 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -99.03 15.85 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 3.7999999999999998 111.546 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.23 135.88 2.56 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.664 -0.779 . . . . 2.4900000000000002 112.129 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.65 70.76 1.02 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.686 -0.768 . . . . 2.46 111.338 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.473 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 24.6 p80 -60.75 150.67 31.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.78 0.324 . . . . 2.9300000000000002 111.135 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -179.24 4.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 1.3600000000000001 110.993 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 35.15 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 2.9199999999999999 111.21 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HD2' ' CH2' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -129.09 171.23 12.59 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.988 -0.285 . . . . 2.7200000000000002 110.985 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.24 69.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 2.0800000000000001 112.408 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -37.87 64.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.041 0.448 . . . . 3.1600000000000001 111.066 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 44' ' ' HIS . . . -76.62 -40.69 48.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 1.6000000000000001 110.89 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.04 -41.55 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 2.0099999999999998 110.546 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.11 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 1.5700000000000001 111.04 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.41 -36.46 74.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 1.3700000000000001 111.022 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' A' ' 61' ' ' VAL . 3.0 pt20 -76.49 -18.33 58.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 2.3399999999999999 111.626 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.6 p -115.86 0.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.094 0.405 . . . . 2.3900000000000001 112.094 -175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -32.57 72.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.412 . . . . 2.5299999999999998 112.114 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.29 -76.65 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.891 -0.323 . . . . 4.1200000000000001 110.751 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.46 55.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 3.6400000000000001 110.065 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.3 72.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.252 -0.885 . . . . 4.96 111.789 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.51 -14.94 29.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.7 -0.682 . . . . 2.7999999999999998 110.143 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.55 ' HA ' ' HB2' ' A' ' 54' ' ' GLN . 5.9 t 60.15 -92.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.268 -0.878 . . . . 3.4900000000000002 112.066 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.1 15.11 26.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.729 0.3 . . . . 4.5599999999999996 111.238 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.42 79.74 37.35 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.063 0.458 . . . . 3.52 110.463 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.641 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 85.7 Cg_endo -96.89 16.06 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.008 2.472 . . . . 2.1699999999999999 112.638 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.76 117.76 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 2.9700000000000002 111.496 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt 68.52 3.71 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.265 -0.879 . . . . 2.8700000000000001 112.202 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.13 -53.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.715 -0.476 . . . . 2.5899999999999999 109.715 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.641 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -171.9 154.56 3.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.461 -0.94 . . . . 2.6499999999999999 108.461 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 75.0 -56.06 0.64 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.314 0.487 . . . . 2.4700000000000002 112.314 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.22 67.86 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.347 0.499 . . . . 1.52 112.347 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.719 ' HB2' HD11 ' A' ' 77' ' ' LEU . 3.0 mm-40 -155.46 128.24 4.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.153 -0.684 . . . . 3.8300000000000001 109.153 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 23.7 Cg_exo -64.29 -11.87 30.11 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.988 2.459 . . . . 2.1200000000000001 112.98 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 t -132.22 115.31 15.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.412 0.625 . . . . 2.7999999999999998 110.085 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 16' ' ' GLU . 1.1 mt -77.88 -17.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.653 -0.703 . . . . 2.5899999999999999 110.786 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 4.4 tttt -56.47 -50.38 71.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.278 -0.419 . . . . 4.2400000000000002 110.49 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -62.95 -41.68 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.675 -0.693 . . . . 1.7 110.967 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 71' ' ' GLN . 6.2 mt -63.09 -46.31 87.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 2.9700000000000002 111.269 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.94 -29.07 70.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 1.97 112.003 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -101.37 8.65 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.681 -0.408 . . . . 3.27 111.249 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 1.7 m-85 -119.28 -93.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.508 -0.314 . . . . 3.1000000000000001 110.719 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.491 ' H ' HG21 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -84.02 43.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 2.6800000000000002 111.321 -175.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.48 -40.65 1.58 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.657 -0.701 . . . . 2.0299999999999998 109.675 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 133.28 50.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.587 -0.733 . . . . 3.1099999999999999 110.907 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -82.25 83.87 7.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.032 0.444 . . . . 7.8499999999999996 110.231 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.231 -0.89 . . . . 5.9800000000000004 110.231 179.694 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.373 -0.232 . . . . 8.8300000000000001 110.373 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.75 64.99 2.32 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.112 -0.566 . . . . 5.5899999999999999 112.478 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -144.1 90.1 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.372 . . . . 6.5800000000000001 110.867 179.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.33 138.05 32.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 4.0300000000000002 110.761 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.96 106.82 3.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.462 -0.336 . . . . 3.4700000000000002 110.912 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.66 ' H ' HG21 ' A' ' 32' ' ' ILE . . . -94.01 179.92 5.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 3.4700000000000002 110.507 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -112.43 95.88 5.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 4.0800000000000001 110.522 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.522 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 2.7 t80 -155.23 -103.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 2.3599999999999999 110.542 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.5 OUTLIER 71.2 -7.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.595 0.758 . . . . 2.5 112.214 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.18 31.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 2.5099999999999998 110.737 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.863 ' HA ' HD12 ' A' ' 34' ' ' ILE . 59.5 Cg_endo -94.98 172.15 1.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.285 2.656 . . . . 2.2999999999999998 113.167 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 -40.21 8.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.083 -0.71 . . . . 2.52 109.083 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -119.6 151.55 38.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.224 -0.898 . . . . 2.5800000000000001 109.299 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.49 -33.7 70.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.907 0.336 . . . . 2.0099999999999998 111.907 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 16' ' ' GLU . 9.8 p -65.04 -27.34 42.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 2.5099999999999998 111.56 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.754 ' HA ' HD11 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.0 -58.82 6.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.005 0.431 . . . . 1.95 111.166 -175.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -79.46 -12.43 59.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.365 -0.38 . . . . 1.79 111.283 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -51.52 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.57 -0.53 . . . . 3.48 109.57 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.514 ' HA ' HD11 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -62.7 -41.85 99.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 2.4199999999999999 110.329 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.39 77.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 1.6000000000000001 110.857 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.622 ' HG2' ' HG3' ' A' ' 25' ' ' ARG . 2.3 tt0 -63.33 -31.37 72.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.236 -0.438 . . . . 2.6899999999999999 111.206 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 20.9 mt -62.13 -42.73 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.109 0.481 . . . . 2.4300000000000002 110.301 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.798 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 36.7 m95 -79.54 -46.76 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.085 -0.507 . . . . 1.55 111.781 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 pt-20 -76.41 -8.56 57.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.839 0.681 . . . . 2.7799999999999998 112.839 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 2.1 mtp85 -120.89 -4.98 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.607 -0.437 . . . . 4.9000000000000004 111.74 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.558 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 6.5 t -108.71 -49.83 7.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.4900000000000002 110.467 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.446 HD13 ' HG3' ' A' ' 47' ' ' LYS . 80.9 mt -95.73 -85.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.078 0.466 . . . . 3.3100000000000001 110.568 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.19 89.61 1.48 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.688 -0.767 . . . . 1.8799999999999999 111.502 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 58.4 t -62.8 105.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.968 0.414 . . . . 2.4500000000000002 110.206 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.26 -64.92 0.71 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.204 -0.453 . . . . 2.21 111.409 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.3 85.45 1.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.83 -0.7 . . . . 1.6399999999999999 111.413 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.66 HG21 ' H ' ' A' ' 6' ' ' ALA . 0.4 OUTLIER -137.47 -58.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.872 0.368 . . . . 3.9700000000000002 111.654 -174.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . 101.65 -138.09 13.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.711 -0.757 . . . . 2.3199999999999998 111.476 -172.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.863 HD12 ' HA ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -120.06 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.347 . . . . 3.1299999999999999 110.98 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.855 ' HG ' ' H ' ' A' ' 36' ' ' ASP . 1.3 pt? -152.73 -66.07 0.16 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.502 -0.317 . . . . 3.02 111.118 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.855 ' H ' ' HG ' ' A' ' 35' ' ' LEU . 5.9 t70 -176.76 173.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 4.2000000000000002 110.047 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 0.7 OUTLIER 65.73 23.51 11.53 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.51 0.724 . . . . 4.9299999999999997 112.815 173.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' HB3' HD13 ' A' ' 32' ' ' ILE . 20.9 t80 173.18 138.04 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.509 -0.769 . . . . 2.75 109.108 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 67.15 -72.25 0.09 Allowed 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.034 0.834 . . . . 2.46 110.558 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.35 59.67 2.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 2.5699999999999998 110.484 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 -48.98 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.654 -0.703 . . . . 3.7999999999999998 110.181 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.68 116.63 2.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.4900000000000002 111.641 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.33 -159.24 24.52 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.795 -0.717 . . . . 2.46 112.042 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -125.66 73.86 1.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.874 0.369 . . . . 2.9300000000000002 110.561 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.45 145.62 49.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.193 -0.458 . . . . 1.3600000000000001 110.496 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 46' ' ' LEU . 3.1 mt -92.31 66.74 4.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 2.9199999999999999 111.416 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HG3' HD13 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -144.01 155.5 44.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.403 -0.362 . . . . 2.7200000000000002 110.312 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.79 -43.73 63.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.491 0.552 . . . . 2.0800000000000001 112.491 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.798 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 6.2 tpt -62.86 -34.76 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.802 0.334 . . . . 3.1600000000000001 111.179 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.41 -37.58 56.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 1.6000000000000001 110.488 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.69 -40.24 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.927 -0.579 . . . . 2.0099999999999998 110.257 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -61.2 -36.83 80.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 1.5700000000000001 110.983 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.573 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -73.12 -35.23 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.424 -0.353 . . . . 1.3700000000000001 110.617 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.455 ' NE2' ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -65.06 -38.7 91.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 2.3399999999999999 110.873 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.85 -26.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 2.3900000000000001 110.502 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -66.21 -38.29 87.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 2.5299999999999998 109.906 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.44 173.16 11.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.423 -0.584 . . . . 4.1200000000000001 109.423 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -82.23 48.32 1.25 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.436 -0.347 . . . . 3.6400000000000001 110.226 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 79.7 m-85 56.26 78.94 0.19 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.769 0.795 . . . . 4.96 109.692 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 17.4 pm0 -71.44 -11.79 61.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 2.7999999999999998 113.06 -169.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 t 63.3 -82.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 123.292 0.37 . . . . 3.4900000000000002 111.113 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -131.53 5.87 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.535 0.198 . . . . 4.5599999999999996 111.535 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -122.64 78.46 47.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 3.52 111.133 -178.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.53 54.35 4.7 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.355 2.704 . . . . 2.1699999999999999 112.237 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.78 130.42 42.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.436 -0.802 . . . . 2.9700000000000002 111.719 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.689 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 2.2 mptm? 46.15 54.82 7.86 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.187 0.929 . . . . 2.8700000000000001 113.247 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.96 -33.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.728 0.299 . . . . 2.5899999999999999 110.775 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.576 ' HA ' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -174.04 -62.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.198 0.523 . . . . 2.6499999999999999 110.048 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.89 -21.79 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.597 -0.729 . . . . 2.4700000000000002 111.454 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.689 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -116.06 40.67 2.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.458 -0.337 . . . . 1.52 111.04 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.503 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -170.09 84.5 0.58 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 3.8300000000000001 109.621 175.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.88 59.16 3.47 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.739 2.959 . . . . 2.1200000000000001 112.993 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.43 79.89 1.45 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 2.7999999999999998 109.391 176.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.754 HD11 ' HA ' ' A' ' 16' ' ' GLU . 80.2 mt -61.87 -41.89 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.689 -0.687 . . . . 2.5899999999999999 112.541 -169.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -44.58 84.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.435 -0.506 . . . . 4.2400000000000002 110.42 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.86 -34.03 77.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 1.7 110.68 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.576 HD13 ' HA ' ' A' ' 68' ' ' LEU . 18.3 mt -61.98 -32.03 72.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 2.9700000000000002 110.837 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 -22.29 61.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.97 110.991 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.28 5.25 42.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.353 -0.385 . . . . 3.27 110.434 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -119.72 -75.95 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 3.1000000000000001 111.475 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.95 -46.53 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 2.6800000000000002 111.315 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.83 67.33 1.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 2.0299999999999998 110.307 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t -109.38 -18.94 13.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.92 -0.582 . . . . 3.1099999999999999 111.168 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 68.1 -68.15 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.58 0.55 . . . . 7.8499999999999996 110.697 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.0 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.799 -0.619 . . . . 5.9800000000000004 109.481 177.776 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.132 -0.321 . . . . 8.8300000000000001 110.132 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.71 -40.08 3.03 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.004 -0.617 . . . . 5.5899999999999999 113.585 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.65 99.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 6.5800000000000001 111.341 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.32 80.78 8.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.158 -0.474 . . . . 4.0300000000000002 110.819 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -177.49 115.18 0.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.96 -0.563 . . . . 3.4700000000000002 110.367 175.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.95 88.6 3.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 3.4700000000000002 110.516 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -75.41 71.49 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 4.0800000000000001 110.281 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.509 ' HB3' HD22 ' A' ' 35' ' ' LEU . 83.2 t80 -162.62 23.43 0.1 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.664 0.745 . . . . 2.3599999999999999 109.275 -175.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.51 65.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.899 0.857 . . . . 2.5 111.526 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.39 70.34 39.44 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.812 -1.085 . . . . 2.5099999999999998 108.546 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.802 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 31.3 Cg_exo -61.08 146.69 97.34 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.651 2.901 . . . . 2.2999999999999998 113.788 -171.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -28.19 37.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 2.52 110.575 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -123.88 146.98 48.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.5800000000000001 109.936 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -21.63 66.46 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.317 0.386 . . . . 2.0099999999999998 111.408 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.64 -37.74 80.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.213 -0.449 . . . . 2.5099999999999998 110.537 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.802 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . 36.3 mt-10 -70.66 -34.77 72.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 1.95 110.271 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.12 79.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.076 0.465 . . . . 1.79 110.627 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG3' HD11 ' A' ' 22' ' ' ILE . 2.2 tptm -72.71 -43.77 62.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 3.48 110.373 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -47.29 77.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.599 -0.728 . . . . 2.4199999999999999 110.599 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.787 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . . . -57.87 -55.1 39.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.5 -0.773 . . . . 1.6000000000000001 111.275 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.79 -42.86 85.03 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.805 0.298 . . . . 2.6899999999999999 111.805 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.488 HD11 ' HG3' ' A' ' 18' ' ' LYS . 53.9 mt -69.43 -55.61 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 2.4300000000000002 111.266 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.66 -35.57 81.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 1.55 111.492 -175.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.526 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 3.3 tp10 -63.62 -46.7 84.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.196 -0.456 . . . . 2.7799999999999998 110.965 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -5.32 41.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 4.9000000000000004 111.583 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.18 -60.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.462 -0.335 . . . . 2.4900000000000002 111.32 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -35.27 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.532 0.567 . . . . 3.3100000000000001 112.532 -171.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.594 ' HA3' HG12 ' A' ' 32' ' ' ILE . . . -77.32 -69.83 1.36 Allowed Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.578 -0.82 . . . . 1.8799999999999999 113.505 -172.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t 56.51 54.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.729 . . . . 2.4500000000000002 110.129 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.41 -32.9 0.04 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.14 -0.936 . . . . 2.21 110.567 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.47 65.34 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.181 -0.767 . . . . 1.6399999999999999 111.181 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.634 HG22 ' HE1' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -131.1 -178.09 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.564 0.221 . . . . 3.9700000000000002 111.413 -175.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.787 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . 120.96 31.98 1.13 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.934 -0.651 . . . . 2.3199999999999998 113.269 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -156.87 -65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 117.343 0.571 . . . . 3.1299999999999999 111.982 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 8' ' ' TYR . 1.9 pt? -142.37 33.03 1.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.975 0.893 . . . . 3.02 110.052 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.96 1.61 4.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.5 -1.227 . . . . 4.2000000000000002 112.487 -174.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.439 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 21.2 t-20 74.12 -60.8 0.51 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.111 0.564 . . . . 4.9299999999999997 112.278 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.634 ' HE1' HG22 ' A' ' 32' ' ' ILE . 25.9 p90 -64.64 -22.71 67.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.331 0.493 . . . . 2.75 112.331 -172.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.439 ' CE2' ' HE2' ' A' ' 69' ' ' PHE . 15.9 t80 -108.16 -16.9 14.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.947 0.403 . . . . 2.46 110.812 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -110.48 0.93 17.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 2.5699999999999998 111.751 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 37' ' ' ASN . 5.1 tp -88.93 -23.19 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.136 0.493 . . . . 3.7999999999999998 110.604 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 55.31 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.87 -0.892 . . . . 2.4900000000000002 110.87 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.87 128.74 29.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.984 -0.627 . . . . 2.46 112.74 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.83 59.4 1.37 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.374 0.607 . . . . 2.9300000000000002 110.352 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -179.31 6.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.346 -0.843 . . . . 1.3600000000000001 110.313 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.2 63.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.075 0.464 . . . . 2.9199999999999999 110.153 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -130.66 165.8 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.834 -0.621 . . . . 2.7200000000000002 110.428 -178.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.04 87.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 2.0800000000000001 111.534 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.556 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -62.53 -38.08 88.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.171 -0.468 . . . . 3.1600000000000001 110.824 177.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.4 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -71.04 -45.36 64.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 1.6000000000000001 111.405 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.3 m -70.72 -22.4 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.58 -0.282 . . . . 2.0099999999999998 110.979 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.42 88.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 1.5700000000000001 110.01 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.49 76.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 1.3700000000000001 110.647 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -60.23 -55.97 27.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 2.3399999999999999 111.041 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.38 9.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.108 0.48 . . . . 2.3900000000000001 111.095 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.435 ' NE2' ' HA ' ' A' ' 82' ' ' ALA . 1.5 t-80 -88.56 -9.93 50.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 2.5299999999999998 110.744 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 57' ' ' ARG . 3.9 ttm180 -137.18 9.41 2.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.609 . . . . 4.1200000000000001 109.52 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 72.48 -12.97 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.249 -0.887 . . . . 3.6400000000000001 112.043 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.409 ' H ' ' C ' ' A' ' 57' ' ' ARG . 8.3 p90 -169.23 176.08 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.379 . . . . 4.96 110.517 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.99 -52.5 0.19 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 2.7999999999999998 109.112 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 41.8 57.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.132 0.973 . . . . 3.4900000000000002 112.921 175.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.27 9.51 6.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.482 -0.781 . . . . 4.5599999999999996 112.555 172.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 61' ' ' VAL . 0.3 OUTLIER -126.95 73.19 76.36 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.759 0.314 . . . . 3.52 110.73 176.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 6.5 Cg_endo -87.92 117.99 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.075 2.516 . . . . 2.1699999999999999 112.265 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -143.95 122.16 12.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.204 -0.295 . . . . 2.9700000000000002 110.204 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 tttt 53.58 55.53 8.46 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.58 0.55 . . . . 2.8700000000000001 111.123 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.37 -76.1 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.094 -0.503 . . . . 2.5899999999999999 110.69 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.09 -42.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.302 -0.863 . . . . 2.6499999999999999 109.049 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.556 ' CZ ' ' HG2' ' A' ' 49' ' ' MET . 52.4 m-85 -97.55 18.05 16.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.416 -0.811 . . . . 2.4700000000000002 109.962 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 71' ' ' GLN . . . -144.1 134.86 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.877 -1.056 . . . . 1.52 108.233 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 12.7 mp0 70.55 97.1 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 O-C-N 124.324 1.015 . . . . 3.8300000000000001 109.198 -169.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.57 70.59 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.728 2.952 . . . . 2.1200000000000001 113.066 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.26 53.96 1.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 2.7999999999999998 108.968 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.479 ' H ' HG12 ' A' ' 74' ' ' ILE . 2.0 mm -51.35 -49.8 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.698 -1.137 . . . . 2.5899999999999999 112.319 -172.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -64.41 -47.4 79.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 4.2400000000000002 111.066 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 1.7 111.18 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.47 -36.01 81.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.222 -0.444 . . . . 2.9700000000000002 110.983 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . -72.05 -36.89 69.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 1.97 111.296 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -9.81 59.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.949 0.404 . . . . 3.27 111.062 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -103.95 -76.85 0.58 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 3.1000000000000001 111.014 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.7 -40.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.681 . . . . 2.6800000000000002 111.421 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . -79.94 54.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 2.0299999999999998 111.794 -175.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.8 t -168.63 -28.01 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.998 -0.546 . . . . 3.1099999999999999 110.466 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.89 48.54 7.07 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.185 0.594 . . . . 7.8499999999999996 111.509 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.848 -0.596 . . . . 5.9800000000000004 109.763 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HG3' ' N ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.67 0.272 . . . . 8.8300000000000001 110.82 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 37' ' ' ASN . . . -174.46 38.65 0.12 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.139 -1.029 . . . . 5.5899999999999999 112.399 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.41 38.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.936 0.398 . . . . 6.5800000000000001 110.624 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 m -143.56 131.55 21.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.096 -0.502 . . . . 4.0300000000000002 110.539 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.06 138.99 30.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.976 0.417 . . . . 3.4700000000000002 110.394 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.05 118.23 15.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.022 -0.536 . . . . 3.4700000000000002 110.113 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -81.13 22.58 0.64 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.418 -0.355 . . . . 4.0800000000000001 111.464 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -66.44 -56.48 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.06 -0.718 . . . . 2.3599999999999999 109.06 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p 21.95 65.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 124.892 1.37 . . . . 2.5 113.156 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.76 76.39 74.49 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 2.5099999999999998 110.999 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 23.3 Cg_exo -65.23 115.69 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.304 2.002 . . . . 2.2999999999999998 110.5 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -34.68 75.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 2.52 111.955 -171.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.94 150.73 27.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.741 0.305 . . . . 2.5800000000000001 110.971 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.09 70.35 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.576 . . . . 2.0099999999999998 112.006 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.448 ' H ' HG23 ' A' ' 15' ' ' VAL . 1.9 t -62.51 -36.56 75.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.157 0.503 . . . . 2.5099999999999998 110.696 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.627 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 21.0 mt-10 -79.53 -23.34 42.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.658 -0.701 . . . . 1.95 111.102 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -71.07 -45.45 63.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.372 . . . . 1.79 110.411 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -63.7 -38.98 93.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.119 0.485 . . . . 3.48 110.666 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -63.64 -47.1 82.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 2.4199999999999999 110.079 177.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.3 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 1.6000000000000001 111.083 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -56.23 -53.9 51.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 2.6899999999999999 110.876 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.7 mm -68.86 -43.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.156 -0.475 . . . . 2.4300000000000002 111.323 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.877 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 64.4 m95 -71.7 -39.82 69.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.616 0.598 . . . . 1.55 112.616 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 1.6 pt-20 -77.11 -33.48 56.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.904 -0.318 . . . . 2.7799999999999998 111.413 -177.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 8.4 mmp_? -90.08 -57.48 2.84 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.141 0.423 . . . . 4.9000000000000004 112.141 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.23 -43.23 12.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.064 0.394 . . . . 2.4900000000000002 112.064 -171.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.877 ' HB2' ' HA ' ' A' ' 23' ' ' TRP . 1.4 mm? -70.54 -69.79 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.998 0.427 . . . . 3.3100000000000001 111.962 -174.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.59 -22.27 31.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.9 -0.667 . . . . 1.8799999999999999 113.401 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t 55.76 52.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.678 0.751 . . . . 2.4500000000000002 110.076 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.4 141.66 32.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.394 -0.821 . . . . 2.21 110.096 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.7 77.27 2.08 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.588 -0.815 . . . . 1.6399999999999999 111.36 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.523 ' HB ' ' H ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -118.89 -147.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.022 0.439 . . . . 3.9700000000000002 111.133 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.523 ' H ' ' HB ' ' A' ' 32' ' ' ILE . . . 174.58 -174.97 46.82 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.285 -0.726 . . . . 2.3199999999999998 111.285 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.474 HG23 HD11 ' A' ' 74' ' ' ILE . 5.9 mm -80.56 83.26 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.421 . . . . 3.1299999999999999 110.295 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.696 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.95 -51.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 3.02 110.671 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.696 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 t0 178.1 -175.06 0.17 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.864 -0.421 . . . . 4.2000000000000002 109.864 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.528 ' O ' ' HA2' ' A' ' 2' ' ' GLY . 35.0 m-20 74.22 -3.45 2.54 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.003 0.815 . . . . 4.9299999999999997 111.86 174.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 t80 178.57 163.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.736 0.648 . . . . 2.75 109.333 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.425 ' HD1' ' HA ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 70.58 -70.23 0.16 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.906 0.754 . . . . 2.46 111.017 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.11 72.34 10.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.851 0.357 . . . . 2.5699999999999998 110.526 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 172.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.207 -0.451 . . . . 3.7999999999999998 110.822 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.478 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . -76.41 94.61 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.029 -0.605 . . . . 2.4900000000000002 112.887 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.71 -159.65 32.99 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.952 -0.642 . . . . 2.46 112.001 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -165.57 127.74 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 2.9300000000000002 110.219 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.19 162.19 22.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.075 -0.512 . . . . 1.3600000000000001 110.97 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.77 67.2 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.489 -0.323 . . . . 2.9199999999999999 110.92 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.16 127.42 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.357 -0.383 . . . . 2.7200000000000002 111.379 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 23.6 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.498 1.519 . . . . 2.0800000000000001 114.64 171.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.5 ttt -54.05 -42.42 69.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.965 -0.561 . . . . 3.1600000000000001 112.235 -173.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.41 74.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 1.6000000000000001 110.838 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.31 -46.28 87.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.765 -0.457 . . . . 2.0099999999999998 109.765 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.442 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -64.82 -24.99 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 1.5700000000000001 111.206 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.52 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 1.3700000000000001 110.543 177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -25.51 47.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.19 0.519 . . . . 2.3399999999999999 110.317 177.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -93.03 13.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.863 -0.608 . . . . 2.3900000000000001 110.161 177.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.99 4.78 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.741 -0.663 . . . . 2.5299999999999998 109.689 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.536 ' HD2' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -154.99 -165.38 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.114 -0.948 . . . . 4.1200000000000001 109.175 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -79.62 38.47 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.417 -0.356 . . . . 3.6400000000000001 111.542 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 60.6 78.39 0.28 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.647 0.737 . . . . 4.96 109.524 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 19.2 pm0 -77.68 23.3 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.943 -1.026 . . . . 2.7999999999999998 112.826 -171.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 t 55.0 -100.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.446 0.298 . . . . 3.4900000000000002 110.877 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -134.23 32.1 3.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 4.5599999999999996 110.605 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.556 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 12.8 mt -104.4 100.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 3.52 110.114 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.478 ' HG3' ' HA2' ' A' ' 42' ' ' GLY . 87.2 Cg_endo -84.4 3.08 7.75 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.856 2.371 . . . . 2.1699999999999999 113.184 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.86 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.206 0.941 . . . . 2.9700000000000002 112.64 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 58.31 23.63 10.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.68 -0.691 . . . . 2.8700000000000001 112.471 175.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.536 HG21 ' HD2' ' A' ' 57' ' ' ARG . 7.5 t -97.06 -51.74 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.153 0.501 . . . . 2.5899999999999999 109.991 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.64 -54.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.499 -0.773 . . . . 2.6499999999999999 110.012 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -84.08 35.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 2.4700000000000002 111.262 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.14 47.52 0.69 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.989 -0.745 . . . . 1.52 108.989 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.03 104.81 0.49 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.326 -1.306 . . . . 3.8300000000000001 108.692 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.84 40.46 0.65 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.016 2.478 . . . . 2.1200000000000001 113.485 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.74 94.6 2.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.628 -0.508 . . . . 2.7999999999999998 109.628 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.627 ' HB ' ' HG2' ' A' ' 16' ' ' GLU . 2.6 mt -67.14 -35.09 73.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.304 -0.407 . . . . 2.5899999999999999 110.78 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -36.03 79.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 4.2400000000000002 110.283 176.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.77 83.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 1.7 110.379 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.74 -33.38 75.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 2.9700000000000002 110.547 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.8 -17.07 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.97 111.625 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -110.2 12.95 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 3.27 110.299 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -126.79 -88.9 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.945 -0.571 . . . . 3.1000000000000001 110.865 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.36 -17.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.963 0.357 . . . . 2.6800000000000002 111.963 -175.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.05 39.28 3.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 2.0299999999999998 110.787 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 14.0 t -80.21 -26.9 38.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 3.1099999999999999 111.284 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 83' ' ' THR . 48.8 mtm-85 73.23 -49.62 0.69 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.4 0.68 . . . . 7.8499999999999996 110.925 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.247 0.933 0 N-CA-C 109.314 -0.624 . . . . 5.9800000000000004 109.314 175.891 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 110.279 -0.267 . . . . 8.8300000000000001 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.37 89.36 0.16 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.644 -0.789 . . . . 5.5899999999999999 112.305 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.74 48.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.422 0.629 . . . . 6.5800000000000001 110.376 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.35 23.1 0.42 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.481 -0.782 . . . . 4.0300000000000002 109.861 177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -122.48 109.24 14.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 3.4700000000000002 110.384 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.81 39.99 29.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.823 -0.626 . . . . 3.4700000000000002 111.19 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -70.49 -57.32 4.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.703 -0.681 . . . . 4.0800000000000001 111.039 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 1.2 t80 -103.42 -88.27 0.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 2.3599999999999999 111.406 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' H ' ' HB3' ' A' ' 8' ' ' TYR . 2.1 t 56.0 52.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.287 0.565 . . . . 2.5 110.822 -174.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.6 86.38 53.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.014 -0.539 . . . . 2.5099999999999998 110.692 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 96.3 Cg_endo -89.95 -168.78 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.929 2.42 . . . . 2.2999999999999998 111.945 177.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -77.68 -69.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.122 -0.231 . . . . 2.52 111.15 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -173.43 140.2 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.861 0.319 . . . . 2.5800000000000001 111.861 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.15 -84.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.743 1.016 . . . . 2.0099999999999998 113.743 168.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.536 ' H ' HG22 ' A' ' 15' ' ' VAL . 0.8 OUTLIER -61.02 -55.85 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 2.5099999999999998 111.88 -171.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 13.2 mt-10 -63.89 -35.88 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.007 -0.542 . . . . 1.95 111.187 -176.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.97 -47.0 79.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.121 -0.49 . . . . 1.79 111.315 -178.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -74.09 -37.66 64.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.31 -0.405 . . . . 3.48 110.899 -178.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.63 -49.9 74.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 2.4199999999999999 110.932 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.67 97.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 1.6000000000000001 110.679 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.37 -57.14 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.769 -0.65 . . . . 2.6899999999999999 111.024 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.2 mt -65.0 -52.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.092 -0.504 . . . . 2.4300000000000002 111.29 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -61.62 -51.29 69.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.402 0.519 . . . . 1.55 112.402 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -74.88 -10.59 59.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.894 0.331 . . . . 2.7799999999999998 111.894 -173.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.36 -22.3 15.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.741 -0.384 . . . . 4.9000000000000004 111.608 177.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.52 -50.33 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 2.4900000000000002 111.437 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -27.52 62.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 3.3100000000000001 110.318 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.0 -168.76 14.03 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.037 -0.825 . . . . 1.8799999999999999 111.037 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.01 56.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.481 1.134 . . . . 2.4500000000000002 109.018 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -113.49 -127.52 0.29 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.029 -0.987 . . . . 2.21 111.28 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.52 50.26 0.3 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.713 -0.955 . . . . 1.6399999999999999 110.713 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.59 -43.77 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.677 0.275 . . . . 3.9700000000000002 110.733 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.14 -132.7 13.8 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.75 -0.738 . . . . 2.3199999999999998 112.729 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG21 HD12 ' A' ' 34' ' ' ILE . 3.0 mm -75.32 93.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.852 0.358 . . . . 3.1299999999999999 111.475 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -173.87 -65.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.059 -0.719 . . . . 3.02 109.059 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -133.03 49.24 2.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.383 -0.969 . . . . 4.2000000000000002 108.383 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.9 96.36 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.371 -1.286 . . . . 4.9299999999999997 111.969 -174.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -66.8 -17.9 65.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 2.75 111.009 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -93.66 -64.27 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.138 -0.483 . . . . 2.46 110.577 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.735 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -84.94 58.98 5.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 2.5699999999999998 111.726 -173.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.735 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 3.6 tp 156.63 -24.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.934 0.894 . . . . 3.7999999999999998 110.48 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.27 -25.92 74.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.995 -0.622 . . . . 2.4900000000000002 112.769 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.88 -104.4 0.25 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.824 -0.703 . . . . 2.46 111.932 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.14 149.28 15.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.56 0.219 . . . . 2.9300000000000002 110.606 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.69 178.33 8.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.737 -0.468 . . . . 1.3600000000000001 109.737 174.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -119.15 59.87 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.37 0.605 . . . . 2.9199999999999999 110.224 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 179.04 6.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.539 -0.755 . . . . 2.7200000000000002 110.059 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.59 73.77 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.048 0.388 . . . . 2.0800000000000001 112.048 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -36.43 72.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 3.1600000000000001 111.057 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -75.06 -38.93 61.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.976 -0.556 . . . . 1.6000000000000001 110.805 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.8 -41.59 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 2.0099999999999998 110.236 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -59.93 -39.51 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.577 . . . . 1.5700000000000001 110.83 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.597 ' HB2' HG13 ' A' ' 67' ' ' VAL . . . -69.46 -34.46 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 1.3700000000000001 110.673 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -50.83 69.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 2.3399999999999999 110.716 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 t -70.4 -36.85 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 2.3900000000000001 111.098 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -49.91 -45.73 51.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.668 -0.696 . . . . 2.5299999999999998 111.573 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.459 ' C ' ' HG2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -87.08 -103.68 0.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.381 -0.372 . . . . 4.1200000000000001 111.034 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.459 ' HG2' ' C ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -140.53 36.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.549 -0.296 . . . . 3.6400000000000001 111.225 -175.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 53.04 64.58 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.264 0.555 . . . . 4.96 110.363 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -38.1 78.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.629 -0.714 . . . . 2.7999999999999998 111.79 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t 70.48 -50.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 123.669 0.606 . . . . 3.4900000000000002 110.963 -175.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.52 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -80.92 -131.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 4.5599999999999996 111.057 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -71.71 132.17 85.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.159 0.504 . . . . 3.52 110.864 -177.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.583 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.1 Cg_exo -78.53 69.82 7.55 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 123.516 2.811 . . . . 2.1699999999999999 111.917 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.09 117.57 5.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 2.9700000000000002 111.817 -176.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.05 50.63 17.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.501 -0.772 . . . . 2.8700000000000001 112.213 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.597 HG13 ' HB2' ' A' ' 53' ' ' ALA . 2.2 p -126.97 -35.66 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.528 -0.469 . . . . 2.5899999999999999 110.931 173.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.545 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.0 OUTLIER 177.09 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.443 0.464 . . . . 2.6499999999999999 110.781 178.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.583 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 22.1 m-85 -72.59 -51.89 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.233 0.457 . . . . 2.4700000000000002 112.233 -173.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 64' ' ' PRO . . . -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.921 0.391 . . . . 1.52 111.546 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.443 ' HB3' HD11 ' A' ' 77' ' ' LEU . 9.2 tp60 -179.51 97.58 0.2 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 3.8300000000000001 109.63 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.446 ' C ' ' HG1' ' A' ' 73' ' ' THR . 9.5 Cg_exo -71.84 54.37 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.286 2.657 . . . . 2.1200000000000001 112.707 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.446 ' HG1' ' C ' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -150.97 59.67 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.921 -0.77 . . . . 2.7999999999999998 108.921 176.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.502 HG13 ' HG2' ' A' ' 16' ' ' GLU . 17.9 pt -64.61 -21.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 2.5899999999999999 112.446 -170.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -39.65 92.01 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.064 0.459 . . . . 4.2400000000000002 110.493 175.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.77 73.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.923 -0.58 . . . . 1.7 110.648 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 68' ' ' LEU . 25.5 mt -72.82 -25.31 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.264 -0.425 . . . . 2.9700000000000002 110.441 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.5 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 1.97 111.331 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -104.53 -39.79 6.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.392 -0.523 . . . . 3.27 111.055 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.14 -65.42 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.995 0.369 . . . . 3.1000000000000001 111.995 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.92 -25.01 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 2.6800000000000002 111.57 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.55 33.83 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 2.0299999999999998 111.477 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -27.95 68.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.278 0.561 . . . . 3.1099999999999999 110.707 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -117.6 69.03 0.76 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 7.8499999999999996 109.156 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.573 -0.727 . . . . 5.9800000000000004 111.002 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ttp . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.056 0.455 . . . . 8.8300000000000001 110.182 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.4 159.19 14.67 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.07 -0.586 . . . . 5.5899999999999999 111.771 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.88 -15.17 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.969 0.414 . . . . 6.5800000000000001 110.762 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 t -126.93 126.23 42.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.071 -0.513 . . . . 4.0300000000000002 110.067 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.92 93.36 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.68 -0.691 . . . . 3.4700000000000002 111.127 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.34 125.02 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.422 -0.808 . . . . 3.4700000000000002 110.939 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -80.32 58.78 3.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.222 0.534 . . . . 4.0800000000000001 110.332 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.492 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -141.58 -94.14 0.14 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.67 -0.696 . . . . 2.3599999999999999 109.925 178.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.864 HG21 ' HA3' ' A' ' 33' ' ' GLY . 13.0 p 33.09 62.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.295 0.997 . . . . 2.5 112.697 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.09 100.96 53.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.781 -0.645 . . . . 2.5099999999999998 110.691 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.1 139.16 23.71 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.147 2.564 . . . . 2.2999999999999998 112.425 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -47.09 8.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 2.52 110.238 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.6 t-20 -102.95 149.64 24.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.374 -0.83 . . . . 2.5800000000000001 109.821 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.88 81.73 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.266 0.469 . . . . 2.0099999999999998 112.266 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -29.38 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.52 -0.309 . . . . 2.5099999999999998 110.516 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 51.9 mt-10 -60.03 -40.18 88.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 1.95 109.808 175.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -37.76 79.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.034 -0.53 . . . . 1.79 110.325 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.17 91.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 3.48 110.374 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -67.05 -53.59 29.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.712 -0.676 . . . . 2.4199999999999999 110.978 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.24 99.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 1.6000000000000001 112.092 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -63.25 -53.5 52.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.856 -0.156 . . . . 2.6899999999999999 111.132 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.604 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 33.5 mm -58.5 -47.95 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 2.4300000000000002 111.169 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -67.46 -53.53 28.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.786 0.327 . . . . 1.55 111.677 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 32' ' ' ILE . 4.6 tp10 -71.91 -52.15 18.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.548 -0.297 . . . . 2.7799999999999998 111.743 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -0.69 24.09 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.933 -0.48 . . . . 4.9000000000000004 111.781 -172.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 5.1 t -108.59 -43.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.075 -0.25 . . . . 2.4900000000000002 110.758 173.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.08 -51.99 2.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 3.3100000000000001 111.852 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.476 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -61.07 -45.2 97.06 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.255 -0.498 . . . . 1.8799999999999999 113.003 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 33.7 t 76.56 -51.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.553 0.741 . . . . 2.4500000000000002 111.809 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.93 -54.76 42.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.958 0.355 . . . . 2.21 111.958 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.31 57.97 0.66 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.151 -1.023 . . . . 1.6399999999999999 111.88 -175.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.414 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 22.8 mm -90.64 -52.8 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.639 -0.504 . . . . 3.9700000000000002 109.639 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.864 ' HA3' HG21 ' A' ' 9' ' ' VAL . . . 56.32 -117.06 8.32 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.488 -0.778 . . . . 2.3199999999999998 113.152 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.432 ' H ' ' HA ' ' A' ' 9' ' ' VAL . 13.3 mm -81.52 87.78 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 3.1299999999999999 111.078 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -166.07 26.45 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 3.02 109.327 174.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.866 ' HA ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 p-10 38.47 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.909 -1.041 . . . . 4.2000000000000002 111.983 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.13 -69.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.23 0.826 . . . . 4.9299999999999997 113.23 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -56.67 15.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.795 0.331 . . . . 2.75 111.588 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.84 -72.15 0.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.288 -0.415 . . . . 2.46 111.698 -174.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.866 ' HG2' ' HA ' ' A' ' 36' ' ' ASP . 1.9 pm0 -73.62 81.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 2.5699999999999998 111.803 -174.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 42' ' ' GLY . 2.2 tp 179.08 -26.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.336 -0.847 . . . . 3.7999999999999998 110.013 174.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' N ' HG21 ' A' ' 41' ' ' ILE . . . -167.01 28.07 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.945 -0.645 . . . . 2.4900000000000002 112.235 178.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.94 103.23 1.1 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 2.46 112.467 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -130.24 61.62 1.59 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.448 . . . . 2.9300000000000002 110.305 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.16 162.47 29.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.79 -0.641 . . . . 1.3600000000000001 110.735 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.61 61.5 4.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.484 0.659 . . . . 2.9199999999999999 110.719 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 155.79 49.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.373 -0.83 . . . . 2.7200000000000002 109.774 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.98 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.565 0.222 . . . . 2.0800000000000001 111.506 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.86 -42.51 75.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 3.1600000000000001 111.203 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -76.85 -36.51 56.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 1.6000000000000001 111.124 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 55' ' ' VAL . 46.5 t -64.15 -42.96 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 2.0099999999999998 110.4 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.45 84.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 1.5700000000000001 111.019 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.84 -35.12 79.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 1.3700000000000001 111.147 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.66 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 3.5 tt0 -67.64 -40.86 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 2.3399999999999999 111.017 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 51' ' ' VAL . 22.5 t -79.53 -38.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.845 -0.616 . . . . 2.3900000000000001 111.483 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -58.57 -30.86 67.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.472 -0.331 . . . . 2.5299999999999998 111.304 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -87.15 16.03 5.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.746 -0.206 . . . . 4.1200000000000001 111.283 -178.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 56.44 65.92 1.31 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.321 -0.4 . . . . 3.6400000000000001 110.328 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 64.45 76.92 0.33 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.705 -0.68 . . . . 4.96 110.566 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.66 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -84.38 -11.96 55.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 2.7999999999999998 111.028 -178.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.413 ' HB ' ' H ' ' A' ' 62' ' ' GLU . 2.4 t 53.32 -111.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.027 -0.533 . . . . 3.4900000000000002 110.385 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.42 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 2.1 tp10 -127.26 28.93 5.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.08 0.467 . . . . 4.5599999999999996 110.121 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.02 87.9 20.3 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 3.52 110.961 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 9.3 Cg_endo -91.82 105.49 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.639 2.893 . . . . 2.1699999999999999 112.208 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 mt -118.03 -30.11 5.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.026 0.441 . . . . 2.9700000000000002 110.884 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -153.83 82.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 2.8700000000000001 110.301 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.42 ' H ' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -149.26 -169.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.897 -0.592 . . . . 2.5899999999999999 110.137 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -32.3 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 2.6499999999999999 111.037 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' ' 50' ' ' ALA . 89.1 m-85 -110.17 36.62 2.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 2.4700000000000002 110.61 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 67' ' ' VAL . . . -158.9 56.54 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.367 . . . . 1.52 110.969 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -164.52 128.34 1.77 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 3.8300000000000001 109.954 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 6.5 Cg_exo -75.5 13.82 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.994 2.463 . . . . 2.1200000000000001 112.363 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -153.85 115.65 4.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.3 -0.63 . . . . 2.7999999999999998 109.3 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.554 ' HA ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -89.94 -28.83 5.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.44 . . . . 2.5899999999999999 111.344 -171.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 13' ' ' ASN . 17.6 pttt -57.92 -36.69 72.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.588 -0.278 . . . . 4.2400000000000002 111.169 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.16 -39.26 89.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.076 0.465 . . . . 1.7 110.801 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 74' ' ' ILE . 5.4 mt -72.47 -45.41 59.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 2.9700000000000002 110.133 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.443 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . . . -59.22 -42.5 91.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.97 111.749 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.26 1.25 41.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 3.27 111.566 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -129.78 -90.2 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.726 -0.39 . . . . 3.1000000000000001 111.69 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.3 m -70.6 -18.6 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.51 0.559 . . . . 2.6800000000000002 112.51 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.443 ' HB1' ' HA ' ' A' ' 78' ' ' ALA . . . -102.25 15.29 29.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.331 . . . . 2.0299999999999998 111.77 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.79 9.0 42.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.839 -0.344 . . . . 3.1099999999999999 111.219 176.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 64.53 9.84 5.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.762 -0.653 . . . . 7.8499999999999996 112.516 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.963 0 CA-C-O 117.876 -1.059 . . . . 5.9800000000000004 109.821 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttp . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.722 0.296 . . . . 8.8300000000000001 110.34 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.72 23.61 27.8 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.947 -0.645 . . . . 5.5899999999999999 111.667 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.9 52.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.326 0.584 . . . . 6.5800000000000001 111.926 -174.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 m -116.6 -37.97 3.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.522 -0.763 . . . . 4.0300000000000002 109.776 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -154.35 118.82 4.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.717 -0.674 . . . . 3.4700000000000002 109.434 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.31 -99.19 0.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.499 -0.319 . . . . 3.4700000000000002 110.904 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.26 -58.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.68 0.276 . . . . 4.0800000000000001 110.884 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.539 ' O ' HG12 ' A' ' 9' ' ' VAL . 8.6 t80 -46.97 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.231 -0.895 . . . . 2.3599999999999999 112.577 -173.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 8' ' ' TYR . 4.2 p 42.74 36.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.094 0.949 . . . . 2.5 112.524 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.38 84.32 56.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.89 -0.595 . . . . 2.5099999999999998 111.531 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.544 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 31.3 Cg_exo -59.71 133.96 54.55 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.353 2.036 . . . . 2.2999999999999998 111.103 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -45.96 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.651 0.612 . . . . 2.52 112.651 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -136.47 107.36 6.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.706 1.002 . . . . 2.5800000000000001 113.706 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 42.09 -85.88 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.961 1.467 . . . . 2.0099999999999998 114.961 163.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -53.29 -34.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.072 -0.513 . . . . 2.5099999999999998 111.204 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.97 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 39.5 mt-10 -61.81 -45.97 91.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.463 -0.789 . . . . 1.95 110.69 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -63.25 -35.49 80.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 1.79 110.997 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -60.59 -60.07 4.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 3.48 110.976 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.57 -40.01 77.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 2.4199999999999999 111.427 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 16' ' ' GLU . . . -64.53 -50.72 66.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.362 -0.381 . . . . 1.6000000000000001 111.454 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 26.2 mt-10 -62.53 -41.03 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.497 0.189 . . . . 2.6899999999999999 111.428 -175.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.85 -43.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 2.4300000000000002 110.362 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -72.79 -48.72 35.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.09 -0.504 . . . . 1.55 112.065 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.81 -26.49 25.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.585 0.587 . . . . 2.7799999999999998 112.585 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -99.22 -48.05 4.97 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 4.9000000000000004 111.552 -177.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.85 -47.68 16.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.688 0.28 . . . . 2.4900000000000002 111.618 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.54 -65.58 0.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 3.3100000000000001 111.872 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.09 -41.7 17.38 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.942 -0.647 . . . . 1.8799999999999999 113.306 -175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t 63.77 83.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.16 0.505 . . . . 2.4500000000000002 110.214 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.28 -83.49 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 2.21 111.778 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.14 72.31 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.231 -1.147 . . . . 1.6399999999999999 110.231 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.58 HG13 ' H ' ' A' ' 33' ' ' GLY . 4.8 tp -96.75 173.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.369 0.604 . . . . 3.9700000000000002 112.415 -167.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.58 ' H ' HG13 ' A' ' 32' ' ' ILE . . . -152.47 173.85 31.46 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.825 -0.625 . . . . 2.3199999999999998 111.651 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 72' ' ' PRO . 19.3 mm -85.97 68.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.369 0.604 . . . . 3.1299999999999999 110.559 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -141.64 -67.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.491 -0.777 . . . . 3.02 109.041 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -131.07 147.39 52.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.47 -0.937 . . . . 4.2000000000000002 108.47 173.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -144.71 160.96 40.36 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 121.062 -0.255 . . . . 4.9299999999999997 110.859 -174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -100.96 -17.17 16.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.136 -0.484 . . . . 2.75 110.475 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.417 ' CD2' ' HG3' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -129.66 -45.44 1.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.947 -0.57 . . . . 2.46 110.683 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.417 ' HG3' ' CD2' ' A' ' 39' ' ' PHE . 26.2 mt-30 -82.65 62.23 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.25 -0.281 . . . . 2.5699999999999998 110.662 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 tp -169.5 -22.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 111.916 0.339 . . . . 3.7999999999999998 111.916 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.22 -36.96 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.426 -0.892 . . . . 2.4900000000000002 112.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.35 131.21 41.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.037 -0.602 . . . . 2.46 111.884 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -113.19 100.71 8.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.043 0.449 . . . . 2.9300000000000002 110.336 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.0 154.73 25.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.573 -0.74 . . . . 1.3600000000000001 111.032 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.83 91.46 1.96 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 2.9199999999999999 110.485 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.32 156.12 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 2.7200000000000002 110.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -25.6 64.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 2.0800000000000001 111.064 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 ttt -63.1 -34.75 78.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 3.1600000000000001 110.601 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HA ' ' HZ ' ' A' ' 69' ' ' PHE . . . -72.29 -38.75 68.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 1.6000000000000001 110.355 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.5 t -64.25 -38.58 82.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 2.0099999999999998 110.315 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.26 93.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 1.5700000000000001 110.719 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.92 96.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 1.3700000000000001 110.47 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.449 ' HA ' ' HG3' ' A' ' 60' ' ' GLN . 4.0 mm-40 -58.36 -49.63 76.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.701 . . . . 2.3399999999999999 110.716 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.7 t -64.63 -31.25 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 2.3900000000000001 110.769 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -68.79 -18.96 64.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 2.5299999999999998 111.924 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.578 ' HD2' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -120.8 19.18 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.715 0.293 . . . . 4.1200000000000001 110.642 178.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 51.44 60.62 3.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.544 -0.753 . . . . 3.6400000000000001 111.302 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 68.54 73.29 0.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.315 -0.857 . . . . 4.96 110.879 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.449 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -79.68 97.33 6.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.152 -0.931 . . . . 2.7999999999999998 110.024 178.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.49 ' H ' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -70.11 88.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.393 . . . . 3.4900000000000002 111.115 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.22 43.46 26.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.724 -0.671 . . . . 4.5599999999999996 111.179 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.504 ' HA ' HD11 ' A' ' 63' ' ' LEU . 13.6 tp -154.62 75.0 5.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 3.52 110.584 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.7 Cg_endo -87.03 47.68 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.517 2.811 . . . . 2.1699999999999999 112.432 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -56.83 101.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.682 -0.69 . . . . 2.9700000000000002 112.268 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.765 ' H ' ' HB2' ' A' ' 70' ' ' ALA . 11.4 mtmm 58.3 31.3 20.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.457 -0.792 . . . . 2.8700000000000001 112.213 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.578 HG21 ' HD2' ' A' ' 57' ' ' ARG . 1.7 p -115.92 -21.37 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.945 -0.302 . . . . 2.5899999999999999 110.948 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -175.04 -74.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.101 0.477 . . . . 2.6499999999999999 109.727 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.705 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 11.0 m-85 -84.49 53.14 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 2.4700000000000002 111.056 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.765 ' HB2' ' H ' ' A' ' 66' ' ' LYS . . . -172.09 134.08 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.92 -0.582 . . . . 1.52 109.607 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 65.7 tp60 72.88 88.51 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 124.199 0.937 . . . . 3.8300000000000001 110.455 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.645 ' HB2' HG23 ' A' ' 34' ' ' ILE . 7.6 Cg_exo -72.97 63.59 4.07 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.443 2.762 . . . . 2.1200000000000001 112.429 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.1 93.88 2.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.827 -0.624 . . . . 2.7999999999999998 109.506 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.97 ' HB ' ' HG2' ' A' ' 16' ' ' GLU . 1.8 mt -64.88 -35.88 76.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 2.5899999999999999 111.293 -173.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -59.17 -43.6 92.12 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.923 0.392 . . . . 4.2400000000000002 110.648 175.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -42.92 69.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 1.7 110.68 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.31 -25.95 67.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 2.9700000000000002 110.809 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.17 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.192 -0.458 . . . . 1.97 111.002 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.36 -13.63 59.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.017 0.437 . . . . 3.27 110.551 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.25 -72.93 0.48 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 3.1000000000000001 111.226 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.29 -43.52 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 2.6800000000000002 110.976 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.63 30.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.347 0.594 . . . . 2.0299999999999998 110.841 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.56 -14.16 59.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 3.1099999999999999 110.129 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.509 ' HB2' ' H ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -97.89 -145.49 0.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.655 -0.702 . . . . 7.8499999999999996 109.56 177.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.509 ' H ' ' HB2' ' A' ' 84' ' ' ARG . 3.3 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.615 -0.707 . . . . 5.9800000000000004 110.198 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.899 0.38 . . . . 8.8300000000000001 110.165 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.15 128.3 6.33 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.748 -0.739 . . . . 5.5899999999999999 112.036 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.98 133.43 64.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.648 0.261 . . . . 6.5800000000000001 110.411 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.07 -78.84 0.27 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.198 -0.456 . . . . 4.0300000000000002 110.273 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.49 98.17 9.95 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.111 -0.7 . . . . 3.4700000000000002 109.111 176.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.31 -21.05 50.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 3.4700000000000002 112.426 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 68.48 -58.84 0.46 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.272 0.629 . . . . 4.0800000000000001 111.153 -175.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.83 72.9 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 2.3599999999999999 110.893 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 34' ' ' ILE . 6.5 p -125.99 5.52 4.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.399 0.619 . . . . 2.5 110.464 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.59 109.53 24.66 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 2.5099999999999998 110.658 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.515 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 5.1 Cg_exo -81.43 -172.41 1.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.385 2.723 . . . . 2.2999999999999998 111.871 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.98 -49.18 2.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 2.52 110.885 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.517 HD22 HG22 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -99.85 159.38 15.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 2.5800000000000001 110.717 -175.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.8 95.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.48 . . . . 2.0099999999999998 112.12 -175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.517 HG22 HD22 ' A' ' 13' ' ' ASN . 15.3 t -64.09 -39.82 86.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 2.5099999999999998 110.667 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 27.7 mt-10 -57.36 -42.34 81.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.774 -0.648 . . . . 1.95 110.458 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -75.16 -31.28 60.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 1.79 111.428 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -56.03 22.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 3.48 111.043 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.55 -32.64 73.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 2.4199999999999999 110.612 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.7 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 1.6000000000000001 110.691 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -56.39 -50.96 70.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.536 . . . . 2.6899999999999999 111.055 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.21 -52.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.693 -0.685 . . . . 2.4300000000000002 111.129 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -64.07 -42.83 96.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.444 -0.343 . . . . 1.55 111.417 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.705 ' HB2' HG12 ' A' ' 32' ' ' ILE . 5.5 tp10 -60.21 -44.8 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.584 -0.28 . . . . 2.7799999999999998 111.169 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -20.75 39.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 4.9000000000000004 112.295 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -97.07 -52.39 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.842 0.312 . . . . 2.4900000000000002 111.842 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.73 -31.47 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.948 0.351 . . . . 3.3100000000000001 111.948 -174.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.81 -73.84 0.42 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.306 -0.473 . . . . 1.8799999999999999 112.72 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t 69.15 -63.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.049 0.54 . . . . 2.4500000000000002 111.926 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 m -66.57 -32.76 74.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 2.21 110.616 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.83 127.54 2.76 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.762 -0.733 . . . . 1.6399999999999999 112.654 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.705 HG12 ' HB2' ' A' ' 24' ' ' GLU . 1.3 pt -104.2 172.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 3.9700000000000002 110.535 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.65 163.34 33.53 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.044 -0.598 . . . . 2.3199999999999998 111.78 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -92.49 -7.53 10.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.038 0.446 . . . . 3.1299999999999999 110.821 -178.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.611 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -87.18 -43.16 12.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.509 -0.314 . . . . 3.02 110.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.611 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 20.3 t70 -174.71 161.51 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.141 -0.689 . . . . 4.2000000000000002 109.141 -177.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.595 ' ND2' ' HA ' ' A' ' 32' ' ' ILE . 6.5 t-20 -169.64 164.11 10.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.207 -0.294 . . . . 4.9299999999999997 110.207 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -77.51 -24.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 2.75 110.807 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -88.2 -33.69 18.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.083 -0.508 . . . . 2.46 111.042 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.4 mt-30 -84.63 33.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.333 . . . . 2.5699999999999998 111.779 -172.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.417 ' HB ' ' H ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -151.25 -127.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.693 -0.484 . . . . 3.7999999999999998 109.693 176.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' H ' ' HB ' ' A' ' 41' ' ' ILE . . . -84.89 53.91 4.87 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.914 -0.66 . . . . 2.4900000000000002 111.949 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -139.73 55.44 0.65 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.617 -0.593 . . . . 2.46 111.617 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -73.61 135.36 43.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.626 0.25 . . . . 2.9300000000000002 110.799 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.99 171.43 14.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 1.3600000000000001 110.266 175.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.15 67.95 3.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.219 0.533 . . . . 2.9199999999999999 109.562 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -126.41 170.8 11.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 2.7200000000000002 110.6 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.71 71.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 2.0800000000000001 110.766 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.504 ' HE1' ' HB2' ' A' ' 49' ' ' MET . 10.3 tpp -60.38 -35.34 75.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.903 -0.589 . . . . 3.1600000000000001 110.674 176.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -70.13 -44.08 69.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 1.6000000000000001 110.264 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.01 -44.5 91.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.05 -0.523 . . . . 2.0099999999999998 110.319 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.91 73.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 1.5700000000000001 111.089 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -64.2 -51.09 65.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 1.3700000000000001 111.147 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.488 ' H ' ' HG2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -68.11 -33.1 73.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.042 -0.263 . . . . 2.3399999999999999 111.178 -178.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.15 -44.1 81.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.356 . . . . 2.3900000000000001 110.421 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -71.46 -28.01 63.66 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.901 0.381 . . . . 2.5299999999999998 110.698 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -78.93 -32.63 45.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 4.1200000000000001 110.695 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER 70.1 9.75 7.15 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.742 0.651 . . . . 3.6400000000000001 110.903 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -172.66 156.63 3.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.033 -1.099 . . . . 4.96 108.033 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.518 ' HA ' ' NE2' ' A' ' 60' ' ' GLN . 3.1 tp60 -143.67 -36.65 0.35 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.103 -0.639 . . . . 2.7999999999999998 112.096 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.1 t 69.01 -73.89 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 123.579 0.549 . . . . 3.4900000000000002 109.733 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.78 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.483 0.713 . . . . 4.5599999999999996 109.422 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -105.66 107.74 60.02 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.821 -0.627 . . . . 3.52 110.33 178.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 18.6 Cg_endo -92.38 99.27 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.466 2.778 . . . . 2.1699999999999999 111.915 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.97 -19.65 47.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.717 0.265 . . . . 2.9700000000000002 111.717 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.78 115.94 3.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.645 -0.252 . . . . 2.8700000000000001 110.364 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 68' ' ' LEU . 2.1 p -171.25 -55.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.46 -0.336 . . . . 2.5899999999999999 110.781 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.523 ' HA ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -167.02 -37.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.009 0.433 . . . . 2.6499999999999999 110.225 -176.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -83.0 -67.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 2.4700000000000002 111.106 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 40' ' ' GLN . . . -76.58 88.96 3.3 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.041 0.448 . . . . 1.52 111.625 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.589 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -175.45 85.08 0.3 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.166 -0.925 . . . . 3.8300000000000001 109.455 175.038 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.12 70.74 0.55 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.433 2.755 . . . . 2.1200000000000001 112.034 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.52 -24.57 0.09 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.246 -0.888 . . . . 2.7999999999999998 109.555 177.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 mt 71.35 -68.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.501 -0.772 . . . . 2.5899999999999999 111.955 174.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HB2' ' HG3' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -72.28 -15.68 61.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.698 0.259 . . . . 4.2400000000000002 111.698 -174.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.52 13.77 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.024 0.44 . . . . 1.7 110.8 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 71' ' ' GLN . 0.7 OUTLIER -63.44 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 2.9700000000000002 109.96 178.237 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.709 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . . . -75.15 0.42 16.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 1.97 111.529 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -32.41 11.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 3.27 110.454 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.49 -64.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.276 -0.569 . . . . 3.1000000000000001 112.381 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.45 -40.28 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 2.6800000000000002 110.96 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.709 ' HB1' ' HA ' ' A' ' 78' ' ' ALA . . . -105.91 159.12 16.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.809 -0.632 . . . . 2.0299999999999998 109.482 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.68 -61.47 0.41 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.038 0.535 . . . . 3.1099999999999999 111.551 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -22.6 54.25 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.952 -0.388 . . . . 7.8499999999999996 109.952 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.022 -0.99 . . . . 5.9800000000000004 112.159 174.086 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 mmm . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.865 -0.42 . . . . 8.8300000000000001 109.865 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.27 76.47 0.31 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.693 -0.765 . . . . 5.5899999999999999 112.642 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.687 ' HA ' ' HB3' ' A' ' 30' ' ' SER . 0.2 OUTLIER -84.67 37.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.218 0.532 . . . . 6.5800000000000001 110.523 -179.41 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.6 -3.24 20.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.835 -0.621 . . . . 4.0300000000000002 111.38 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 57.59 77.71 0.27 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.186 0.517 . . . . 3.4700000000000002 110.389 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.63 125.61 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.462 -0.79 . . . . 3.4700000000000002 111.42 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.61 63.09 4.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 4.0800000000000001 111.131 -177.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.603 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t80 -121.89 -86.37 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.938 -0.764 . . . . 2.3599999999999999 108.938 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.463 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 94.7 t 73.13 -55.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.759 0.662 . . . . 2.5 111.872 173.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.32 108.69 12.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.58 0.229 . . . . 2.5099999999999998 111.033 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.759 ' HG2' ' HB3' ' A' ' 16' ' ' GLU . 20.4 Cg_endo -95.64 -99.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.593 2.862 . . . . 2.2999999999999998 111.559 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 p -98.87 -80.4 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.866 0.365 . . . . 2.52 110.239 174.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -134.24 -174.86 3.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 2.5800000000000001 110.873 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.92 -33.4 56.54 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.63 0.974 . . . . 2.0099999999999998 113.63 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.82 -34.33 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.955 0.407 . . . . 2.5099999999999998 110.701 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.759 ' HB3' ' HG2' ' A' ' 11' ' ' PRO . 4.6 tt0 -79.95 -38.01 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.253 -0.43 . . . . 1.95 110.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -63.62 -39.01 93.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.403 . . . . 1.79 110.884 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HE3' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -69.59 -31.66 69.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.448 -0.342 . . . . 3.48 110.803 178.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 tp -64.92 -46.13 82.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.605 -0.517 . . . . 2.4199999999999999 109.605 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.575 ' O ' ' HB3' ' A' ' 24' ' ' GLU . . . -60.19 -33.87 72.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.484 -0.78 . . . . 1.6000000000000001 110.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 17' ' ' SER . 85.5 mt-10 -57.79 -47.23 83.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 2.6899999999999999 111.092 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.524 HD13 ' HE3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -71.83 -48.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.042 0.449 . . . . 2.4300000000000002 111.066 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -68.57 -47.08 67.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.551 . . . . 1.55 112.035 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.575 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -69.79 -45.55 67.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.623 -0.262 . . . . 2.7799999999999998 111.17 -175.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HD3' ' HA ' ' A' ' 25' ' ' ARG . 2.1 mmt180 -71.89 -37.85 70.08 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.005 0.372 . . . . 4.9000000000000004 112.005 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.29 -59.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.096 0.406 . . . . 2.4900000000000002 112.096 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 40.3 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.1 0.476 . . . . 3.3100000000000001 111.349 -173.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.538 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -172.83 -46.41 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.645 -0.788 . . . . 1.8799999999999999 112.207 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 7.2 t 78.4 -37.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.352 0.661 . . . . 2.4500000000000002 110.572 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.687 ' HB3' ' HA ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -74.7 144.77 43.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.128 -0.487 . . . . 2.21 110.406 177.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.58 71.74 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.722 . . . . 1.6399999999999999 113.08 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 36.1 mm -101.96 91.34 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.453 0.644 . . . . 3.9700000000000002 110.359 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 34' ' ' ILE . . . -79.7 79.98 1.62 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.648 -0.787 . . . . 2.3199999999999998 112.246 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 33' ' ' GLY . 38.8 mm 78.05 -43.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.399 0.68 . . . . 3.1299999999999999 112.504 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.603 ' HG ' ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -35.86 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 3.02 113.527 -174.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.72 110.71 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 4.2000000000000002 111.089 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.05 95.7 6.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.068 -0.515 . . . . 4.9299999999999997 109.88 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -96.59 -24.58 15.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 2.75 112.637 -174.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -131.79 -9.21 3.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.632 -0.427 . . . . 2.46 111.637 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 8.1 mp0 -72.0 -57.71 4.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.337 -0.392 . . . . 2.5699999999999998 111.329 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mt -105.62 74.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.998 0.428 . . . . 3.7999999999999998 111.281 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.95 -82.55 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.369 -0.92 . . . . 2.4900000000000002 113.257 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.45 80.81 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.133 -0.556 . . . . 2.46 112.733 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -65.21 141.7 58.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.01 0.433 . . . . 2.9300000000000002 110.483 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.74 29.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 1.3600000000000001 111.206 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 mt -87.24 -10.96 51.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.104 -0.702 . . . . 2.9199999999999999 109.104 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -56.21 150.53 14.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.595 -1.184 . . . . 2.7200000000000002 110.989 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -17.83 51.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.197 -0.456 . . . . 2.0800000000000001 111.964 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -63.1 -48.23 79.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 3.1600000000000001 110.786 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.71 -28.39 50.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 1.6000000000000001 110.431 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.18 -40.13 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 2.0099999999999998 110.272 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.82 92.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 1.5700000000000001 110.533 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.678 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -64.52 -42.24 95.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 1.3700000000000001 110.415 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.669 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 tt0 -59.84 -46.92 87.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.587 -0.733 . . . . 2.3399999999999999 110.777 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -65.95 -39.24 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 2.3900000000000001 110.903 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -72.71 5.3 3.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 2.5299999999999998 111.897 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.51 ' HA ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -137.29 24.66 2.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.977 0.418 . . . . 4.1200000000000001 110.362 175.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.08 49.73 11.1 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.438 -0.801 . . . . 3.6400000000000001 111.965 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.669 ' HA ' ' HG3' ' A' ' 54' ' ' GLN . 21.7 m-30 66.8 87.97 0.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.692 -0.685 . . . . 4.96 112.147 171.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.43 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 1.0 OUTLIER -77.76 -17.79 57.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.607 -0.724 . . . . 2.7999999999999998 110.988 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 53.6 t 77.03 -57.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 123.388 0.675 . . . . 3.4900000000000002 112.264 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 -70.45 0.79 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.823 0.305 . . . . 4.5599999999999996 111.823 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.51 140.9 28.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.569 -0.287 . . . . 3.52 110.899 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.425 ' HA ' ' OE1' ' A' ' 60' ' ' GLN . 74.5 Cg_endo -75.84 62.39 6.51 Favored 'Trans proline' 0 C--O 1.237 0.466 0 C-N-CA 122.933 2.422 . . . . 2.1699999999999999 111.731 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.794 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 22.3 tp -77.08 126.55 31.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 2.9700000000000002 111.679 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt 64.48 14.9 9.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.416 -0.811 . . . . 2.8700000000000001 112.487 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.678 HG11 ' HB1' ' A' ' 53' ' ' ALA . 7.2 p -98.35 -35.15 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.759 -0.376 . . . . 2.5899999999999999 110.188 174.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.505 ' N ' HG13 ' A' ' 67' ' ' VAL . 0.5 OUTLIER 175.43 -58.8 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.164 0 O-C-N 123.612 0.57 . . . . 2.6499999999999999 110.585 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.4 m-85 -66.74 -50.9 61.27 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.964 0.727 . . . . 2.4700000000000002 112.964 -171.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.794 ' HB2' ' HA ' ' A' ' 65' ' ' LEU . . . -77.95 70.55 4.33 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.184 0.438 . . . . 1.52 112.184 -173.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.71 130.22 1.52 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.58 -0.736 . . . . 3.8300000000000001 109.509 174.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.644 ' O ' ' HB ' ' A' ' 73' ' ' THR . 39.5 Cg_exo -61.27 105.15 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.499 2.132 . . . . 2.1200000000000001 111.282 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER 81.94 113.54 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.18 0.925 . . . . 2.7999999999999998 109.35 -171.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mm -83.12 -22.69 8.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.044 -0.98 . . . . 2.5899999999999999 110.322 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HD2' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -54.08 -37.12 63.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.633 -0.712 . . . . 4.2400000000000002 111.681 -178.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.06 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.7 110.968 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.66 -27.74 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 2.9700000000000002 110.646 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . -60.83 -49.71 76.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 1.97 111.865 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.82 -0.29 57.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.742 -0.383 . . . . 3.27 111.412 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -101.43 -69.08 0.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.94 -0.304 . . . . 3.1000000000000001 111.283 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -13.43 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 111.854 0.316 . . . . 2.6800000000000002 111.854 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . -99.05 21.9 11.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 2.0299999999999998 111.124 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -8.35 54.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.501 0.667 . . . . 3.1099999999999999 110.692 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -95.73 -3.09 46.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.236 -0.893 . . . . 7.8499999999999996 109.924 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.46 -0.781 . . . . 5.9800000000000004 110.641 -176.02 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 120.782 0.325 . . . . 3.47 111.068 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . . . -82.91 130.07 35.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.044 -0.526 . . . . 3.01 111.05 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -85.15 20.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 3.51 110.519 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -125.05 46.01 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 2.32 111.126 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.55 2.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 2.13 111.058 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.07 110.25 3.98 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 2.09 111.45 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -91.03 158.93 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.592 2.195 . . . . 1.88 111.975 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.23 -44.24 8.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 2.04 111.082 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.04 156.36 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 2.24 110.976 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.49 64.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 1.42 111.296 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -64.89 -41.95 93.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 1.99 111.168 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.22 -38.45 78.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 1.93 111.027 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -64.52 -42.02 96.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.48 110.986 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -68.18 -48.79 64.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 2.96 111.258 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -47.2 85.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 1.81 110.957 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.18 80.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.511 . . . . 1.08 111.367 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 17' ' ' SER . 10.2 tt0 -66.05 -51.7 55.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 2.69 111.501 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.81 -34.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.09 0.404 . . . . 1.91 112.09 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -76.38 -44.2 37.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.666 0.617 . . . . 1.33 112.666 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.47 9.65 12.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.908 0.336 . . . . 2.78 111.908 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.48 ' HB2' HH11 ' A' ' 25' ' ' ARG . 5.6 ttm105 -118.46 -21.74 7.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 4.4 110.853 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.41 -24.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 2.01 111.133 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.74 -61.37 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 2.85 111.517 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -59.61 9.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 1.73 113.319 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t 59.09 12.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.03 0.443 . . . . 1.92 110.85 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.7 m -98.46 -68.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 2.21 111.01 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.54 33.97 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.754 -0.736 . . . . 1.58 111.932 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.452 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 1.1 pt -88.44 -173.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 3.56 111.308 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.55 -109.23 0.23 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.868 -0.682 . . . . 2.28 112.413 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.28 49.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.724 0.297 . . . . 2.67 111.189 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.98 9.85 6.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.497 -0.32 . . . . 2.46 111.318 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.13 150.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 4.2 110.443 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.428 ' ND2' ' HB ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -177.76 -96.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 4.13 111.117 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -119.95 -28.11 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.357 -0.383 . . . . 2.27 111.264 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -78.67 -83.89 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.294 -0.412 . . . . 2.01 111.676 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.86 82.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 2.39 111.247 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 tp -172.03 -36.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.849 0.315 . . . . 3.23 111.849 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.96 -30.46 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.252 -0.975 . . . . 2.06 112.98 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.12 120.43 18.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.613 -0.803 . . . . 2.17 112.297 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -98.76 26.56 5.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.751 0.275 . . . . 2.26 111.387 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 31.16 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.99 0.737 . . . . 1.31 112.99 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.92 31.57 0.94 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.214 -0.448 . . . . 2.37 110.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -105.3 169.6 8.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 2.27 111.205 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.2 79.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.013 -0.54 . . . . 1.64 111.229 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.6 ttt -58.9 -32.11 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.414 . . . . 2.58 110.606 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.47 -47.17 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 1.06 110.652 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 55' ' ' VAL . 19.8 t -57.52 -34.48 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 1.46 110.089 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -65.48 -43.28 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.639 . . . . 0.97 110.275 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -26.42 67.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.02 -0.536 . . . . 0.93 110.483 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -44.6 61.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.805 -0.634 . . . . 1.86 110.801 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 51' ' ' VAL . 13.0 t -76.55 -26.49 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 1.82 111.282 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -77.61 2.68 15.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 1.97 111.154 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -133.58 8.27 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.37 . . . . 3.57 111.537 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 68.39 53.8 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 3.64 111.31 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 57.74 88.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 4.58 111.8 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.782 ' NE2' HG11 ' A' ' 67' ' ' VAL . 5.7 mt-30 -67.68 -30.1 69.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.649 -0.501 . . . . 2.8 109.649 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.2 t 65.86 -72.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 115.322 -0.854 . . . . 3.13 111.861 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -92.81 -84.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.506 0.558 . . . . 4.56 112.506 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.06 135.14 20.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.206 0.447 . . . . 3.01 112.206 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 67' ' ' VAL . 84.4 Cg_endo -88.24 58.36 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.769 2.313 . . . . 1.91 111.125 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.95 119.08 5.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.587 -0.733 . . . . 2.46 112.241 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mttp 47.15 83.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 2.42 112.123 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.782 HG11 ' NE2' ' A' ' 60' ' ' GLN . 13.7 p -155.62 -44.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.288 -0.414 . . . . 2.11 111.051 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.432 ' N ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -178.27 -39.53 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.549 -0.296 . . . . 2.19 111.499 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -91.97 -52.72 4.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.066 0.395 . . . . 1.87 112.066 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.9 71.56 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.954 0.353 . . . . 1.09 111.954 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.623 ' HB2' HD11 ' A' ' 77' ' ' LEU . 0.0 OUTLIER 176.42 115.27 0.13 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.148 -0.478 . . . . 3.23 110.582 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.99 41.35 0.83 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.434 2.09 . . . . 1.77 112.879 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.91 74.54 0.73 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.146 0.498 . . . . 2.46 110.23 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.08 -40.79 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.648 -0.705 . . . . 2.08 112.296 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -30.83 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 3.8 111.146 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.09 68.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 1.08 110.734 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 71' ' ' GLN . 30.7 mt -72.82 -27.33 61.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.049 -0.523 . . . . 2.41 110.602 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.814 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -60.61 -34.28 74.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 1.57 111.106 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -103.31 21.61 15.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 2.74 111.041 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 1.0 OUTLIER -129.91 -69.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 2.85 111.094 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 t -94.1 -39.26 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 2.13 111.332 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -72.64 -16.86 61.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 1.9 111.348 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.971 -0.381 . . . . 2.65 109.971 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 1.018 ' HA ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.62 0.724 . . . . 3.47 112.174 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . . . -163.81 146.65 9.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.455 -0.793 . . . . 3.01 110.148 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -122.69 33.79 5.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.514 0.674 . . . . 3.51 109.196 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 34' ' ' ILE . 5.1 t80 -116.12 17.23 15.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.371 -0.831 . . . . 2.32 111.334 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.43 67.03 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.403 1.096 . . . . 2.13 110.122 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -106.41 105.29 53.88 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.106 -0.952 . . . . 2.09 110.515 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 1.1 Cg_endo -83.52 156.61 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.121 2.547 . . . . 1.88 111.974 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.56 -44.92 3.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.237 0.541 . . . . 2.04 109.645 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -114.59 177.49 4.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.511 -0.768 . . . . 2.24 109.832 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.42 -15.57 54.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.896 0.379 . . . . 1.42 110.768 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.78 -57.52 10.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.922 -0.581 . . . . 1.99 111.039 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.899 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 12.6 pm0 -72.75 -22.71 60.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.23 -0.441 . . . . 1.93 110.699 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.66 -48.5 79.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 1.48 110.097 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -61.08 -45.18 95.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 2.96 110.856 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.38 -56.07 16.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 1.81 111.395 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -67.12 -43.8 81.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.669 -0.696 . . . . 1.08 112.092 -173.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.05 -37.21 83.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.604 0.24 . . . . 2.69 111.314 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -46.99 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.045 -0.262 . . . . 1.91 110.595 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -69.28 -27.36 65.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.33 110.563 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.1 tm-20 -58.83 -52.03 67.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 2.78 110.471 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -19.35 60.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.726 0.298 . . . . 4.4 111.364 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.63 -49.27 15.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.497 -0.319 . . . . 2.01 111.409 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.45 -31.69 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.686 0.624 . . . . 2.85 112.686 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 -82.1 0.47 Allowed Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.656 -0.783 . . . . 1.73 113.723 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 74.56 4.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.011 0.924 . . . . 1.92 110.92 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.018 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 15.2 m -112.5 -17.0 12.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.703 -0.68 . . . . 2.21 111.965 -172.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 34.78 8.34 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.651 -0.98 . . . . 1.58 110.651 -174.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 30' ' ' SER . 1.3 pt -78.94 170.52 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.273 0.559 . . . . 3.56 112.085 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.77 158.19 7.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.52 -0.764 . . . . 2.28 111.619 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.453 HG21 ' HE2' ' A' ' 8' ' ' TYR . 36.4 mm 66.27 -79.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.011 0.525 . . . . 2.67 111.272 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.966 -0.383 . . . . 2.46 109.966 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 17.7 t0 41.75 -92.73 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.362 1.039 . . . . 4.2 112.906 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 92.74 -7.39 0.17 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.711 1.257 . . . . 4.13 111.761 175.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.627 ' HE2' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -109.67 -55.53 2.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.537 -0.542 . . . . 2.27 109.537 173.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.503 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 29.7 t80 -91.75 -73.13 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.378 -0.828 . . . . 2.01 109.909 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.536 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.8 mt-30 -70.43 96.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 2.39 109.963 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.5 tp 168.69 -18.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 3.23 110.029 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.55 35.55 3.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.666 -0.778 . . . . 2.06 111.418 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.13 124.75 7.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.679 -0.772 . . . . 2.17 111.746 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -84.7 74.75 10.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 2.26 110.556 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.53 161.45 30.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.868 -0.605 . . . . 1.31 110.835 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 67.43 6.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 2.37 110.596 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -139.33 160.16 40.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.726 -0.67 . . . . 2.27 109.761 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.09 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.445 0.466 . . . . 1.64 112.159 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tpt -60.85 -31.55 71.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.329 . . . . 2.58 111.305 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.521 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -71.74 -37.01 70.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.438 -0.346 . . . . 1.06 111.196 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 1.46 110.057 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -65.91 -35.17 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.09 -0.505 . . . . 0.97 110.151 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.432 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -69.78 -26.67 64.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.91 -0.586 . . . . 0.93 110.672 176.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -79.71 -22.56 43.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 1.86 110.897 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -94.91 -15.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 1.82 111.607 -176.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.68 40.89 1.05 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.295 0.569 . . . . 1.97 110.873 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 177.81 -150.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.672 -1.233 . . . . 3.57 107.672 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.06 164.62 14.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.579 -0.897 . . . . 3.64 108.579 168.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.37 82.96 2.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.278 0.561 . . . . 4.58 109.974 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.7 2.02 7.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.934 -1.03 . . . . 2.8 112.871 -173.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.436 ' HB ' ' H ' ' A' ' 62' ' ' GLU . 3.1 t 58.82 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 122.834 0.454 . . . . 3.13 111.442 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.441 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 55.0 mm-40 -121.71 23.78 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.552 -0.295 . . . . 4.56 110.983 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -125.45 68.98 60.88 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.403 . . . . 3.01 110.857 177.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 62' ' ' GLU . 5.6 Cg_endo -87.38 73.03 2.9 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.196 2.597 . . . . 1.91 111.991 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.0 tp -82.46 129.46 34.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.12 -0.491 . . . . 2.46 110.847 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 58.13 34.19 23.92 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.766 0.666 . . . . 2.42 111.127 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.603 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -94.99 -174.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.525 -0.761 . . . . 2.11 110.433 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.592 ' H ' HG22 ' A' ' 67' ' ' VAL . 5.4 mt -53.84 -21.29 7.27 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.247 0.832 . . . . 2.19 113.247 -174.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.521 ' HE2' ' HA ' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -138.93 44.51 2.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.106 0.479 . . . . 1.87 111.287 175.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.603 ' HB3' ' H ' ' A' ' 67' ' ' VAL . . . -120.98 47.7 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.899 0.381 . . . . 1.09 110.66 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.607 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -162.16 144.99 8.82 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.206 -0.906 . . . . 3.23 108.792 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.49 1.19 3.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.927 2.418 . . . . 1.77 113.119 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.595 HG22 ' HG3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -128.94 89.43 2.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.741 0.305 . . . . 2.46 110.577 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.506 ' HA ' HD12 ' A' ' 77' ' ' LEU . 2.7 tp -58.43 -32.61 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.059 -0.519 . . . . 2.08 112.255 -176.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.899 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -62.59 -38.86 91.79 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.228 -0.295 . . . . 3.8 110.79 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.26 -31.97 73.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 1.08 110.676 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.607 HD21 ' HB2' ' A' ' 71' ' ' GLN . 12.7 mt -78.42 -36.82 45.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.986 -0.552 . . . . 2.41 110.61 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.2 66.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 1.57 110.633 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -91.55 -0.05 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.621 . . . . 2.74 110.614 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -114.04 -88.89 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 2.85 111.121 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 m -82.29 21.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 2.13 112.044 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 68' ' ' LEU . . . -130.1 -4.24 4.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 1.9 110.867 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 2.65 111.153 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' HG3' ' HB3' ' A' ' 30' ' ' SER . 2.0 mp0 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 120.825 0.345 . . . . 3.47 110.91 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 32' ' ' ILE . . . -148.39 144.65 27.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.021 -0.536 . . . . 3.01 110.082 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -105.16 91.37 3.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.896 0.379 . . . . 3.51 110.887 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.434 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 7.0 t80 -146.43 2.57 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.003 -0.544 . . . . 2.32 111.18 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 2.8 p -79.15 93.44 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 2.13 111.327 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.06 74.98 1.69 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.511 -0.768 . . . . 2.09 110.424 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HB2' ' H ' ' A' ' 12' ' ' THR . 2.1 Cg_endo -81.61 -133.69 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.088 2.525 . . . . 1.88 112.226 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -123.63 -48.11 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.118 0.485 . . . . 2.04 111.798 -177.485 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.788 HD21 ' HB ' ' A' ' 15' ' ' VAL . 1.8 t30 -98.27 132.4 43.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.872 -0.604 . . . . 2.24 110.503 -172.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.28 68.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.671 -0.695 . . . . 1.42 112.0 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.788 ' HB ' HD21 ' A' ' 13' ' ' ASN . 48.1 t -70.17 -48.42 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 1.99 110.958 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.505 ' OE1' ' HB3' ' A' ' 13' ' ' ASN . 1.7 pt-20 -67.8 -32.31 72.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.947 0.404 . . . . 1.93 110.32 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.42 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.3 m -69.48 -35.84 75.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.894 -0.594 . . . . 1.48 110.205 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -64.95 -41.78 95.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 2.96 110.737 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -46.4 90.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 1.81 110.652 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.02 92.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 1.08 111.282 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -40.43 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 2.69 111.696 -176.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -38.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 120.97 -0.292 . . . . 1.91 110.973 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -66.7 -45.25 79.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.089 0.471 . . . . 1.33 110.166 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -83.45 19.42 1.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.392 0.615 . . . . 2.78 111.301 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.471 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -120.17 -0.87 10.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.771 -0.649 . . . . 4.4 109.317 170.225 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.2 -25.13 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.862 -0.608 . . . . 2.01 111.852 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 tp -93.04 -81.13 0.36 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.501 0.191 . . . . 2.85 111.364 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.4 -39.87 6.64 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.66 -0.781 . . . . 1.73 111.644 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t 70.18 53.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.774 0.797 . . . . 1.92 110.648 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HB3' ' HG3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -118.64 -35.85 3.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 2.21 109.775 173.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' CA ' HH21 ' A' ' 25' ' ' ARG . . . 98.22 42.77 2.93 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.732 -0.667 . . . . 1.58 112.383 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -87.69 -80.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.803 0.335 . . . . 3.56 111.156 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.25 -69.71 3.08 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.932 -0.651 . . . . 2.28 111.589 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' HB ' ' HD2' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -107.31 152.09 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.172 -1.048 . . . . 2.67 108.172 174.154 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 44.3 1.53 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.359 -0.978 . . . . 2.46 108.359 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -70.46 174.52 5.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.23 -1.35 . . . . 4.2 111.957 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -140.85 -8.12 1.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 4.13 111.08 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.41 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 26.7 p90 -148.34 -33.81 0.23 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.002 0.742 . . . . 2.27 113.002 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -96.53 -83.09 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.047 -0.408 . . . . 2.01 111.66 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -59.12 -29.42 67.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.39 112.018 -173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 tp -115.1 -2.0 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.417 . . . . 3.23 111.52 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 38' ' ' PHE . . . -92.51 -95.95 1.4 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.437 -0.887 . . . . 2.06 112.71 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.12 -138.29 2.65 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.667 -0.778 . . . . 2.17 112.397 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -97.01 122.96 40.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.241 0.543 . . . . 2.26 111.366 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.33 -178.11 6.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 1.31 109.986 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -89.15 45.68 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.049 0.452 . . . . 2.37 110.947 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.58 163.74 22.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.393 -0.367 . . . . 2.27 111.418 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.96 94.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 1.64 111.534 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ttt -60.33 -34.58 74.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.402 . . . . 2.58 110.456 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . . . -69.95 -40.58 75.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 1.06 110.846 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -71.69 -34.88 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 1.46 110.616 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.35 -29.94 62.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.97 110.807 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -38.68 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.93 111.271 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' A' ' 51' ' ' VAL . 5.2 pt20 -68.73 -38.42 80.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.011 -0.276 . . . . 1.86 110.936 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 51' ' ' VAL . 35.7 m -92.83 19.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 1.82 110.973 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -88.13 -18.13 29.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.07 -0.513 . . . . 1.97 110.456 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.59 ' HG3' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -106.25 -63.9 1.22 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.041 0.448 . . . . 3.57 110.682 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.3 -151.97 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.632 -0.713 . . . . 3.64 109.298 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -75.82 64.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.414 0.626 . . . . 4.58 110.194 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.543 HE22 HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -119.18 91.99 3.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 2.8 109.177 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.29 -55.75 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.7 -0.682 . . . . 3.13 112.185 -170.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -63.72 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 4.56 111.652 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.72 111.66 54.11 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 3.01 110.672 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.9 127.54 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.557 2.171 . . . . 1.91 111.226 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tp -123.73 96.22 4.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 2.46 110.506 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 0.5 OUTLIER 54.67 62.62 2.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.908 -0.587 . . . . 2.42 111.377 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' A' ' 57' ' ' ARG . 11.3 p -132.04 -29.66 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.171 -0.468 . . . . 2.11 111.178 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.61 -51.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.92 -0.77 . . . . 2.19 108.92 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 50' ' ' ALA . 1.1 m-85 -104.67 172.31 6.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.217 -0.901 . . . . 1.87 109.172 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 71' ' ' GLN . . . 60.35 43.67 13.22 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.91 0.756 . . . . 1.09 111.266 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 167.06 123.57 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 O-C-N 124.215 0.947 . . . . 3.23 109.752 176.406 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.44 28.95 0.54 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.813 2.342 . . . . 1.77 113.061 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.47 39.75 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.06 0.457 . . . . 2.46 110.629 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.535 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -57.51 -39.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 2.08 111.846 -175.08 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.513 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -64.86 -43.07 94.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.788 0.328 . . . . 3.8 110.814 -178.314 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.05 74.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 1.08 110.992 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.23 -43.2 95.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.345 -0.389 . . . . 2.41 111.36 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.46 -4.62 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 1.57 111.493 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.29 -57.67 2.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.966 0.412 . . . . 2.74 110.781 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -74.11 -42.35 60.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 2.85 111.836 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.78 30.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.84 0.353 . . . . 2.13 111.425 -174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.96 30.32 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.091 0.472 . . . . 1.9 110.443 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 2.65 111.244 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.9 mt-10 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 111.894 0.331 . . . . 3.47 111.894 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HA ' HD13 ' A' ' 35' ' ' LEU . . . -152.91 83.96 1.22 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.931 0.396 . . . . 3.01 111.051 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -92.59 -9.64 40.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 3.51 110.097 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -91.55 -54.86 3.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 2.32 110.052 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.53 HG12 ' HD3' ' A' ' 11' ' ' PRO . 2.2 t 56.73 -100.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.944 -0.571 . . . . 2.13 111.415 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.513 ' H ' ' HB ' ' A' ' 9' ' ' VAL . . . 57.02 65.63 3.65 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.596 0.591 . . . . 2.09 112.596 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.53 ' HD3' HG12 ' A' ' 9' ' ' VAL . 73.9 Cg_endo -88.97 143.44 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.55 2.166 . . . . 1.88 111.518 176.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.442 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -107.75 -34.64 6.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.858 0.361 . . . . 2.04 111.313 -177.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.35 151.07 49.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.32 -0.4 . . . . 2.24 110.764 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.35 68.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 1.42 111.297 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.17 -44.95 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 1.99 110.738 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -43.09 89.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 1.93 110.849 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -69.69 -43.95 71.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.541 . . . . 1.48 111.207 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.79 -40.51 83.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.682 -0.235 . . . . 2.96 111.213 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -45.0 96.57 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.761 0.315 . . . . 1.81 110.219 177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.41 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 1.08 110.903 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.76 -47.52 84.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 2.69 110.873 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.3 mt -71.89 -49.46 44.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.327 -0.397 . . . . 1.91 110.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.618 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 4.0 m95 -56.94 -52.5 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 1.33 111.609 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -63.0 -44.48 95.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.101 -0.5 . . . . 2.78 111.022 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 1.7 mmp_? -73.06 -2.84 22.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.958 0.355 . . . . 4.4 111.958 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.26 -45.07 8.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.6 -0.273 . . . . 2.01 111.246 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.1 -4.59 13.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.918 0.71 . . . . 2.85 112.918 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.3 -78.74 0.3 Allowed Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 120.088 -1.053 . . . . 1.73 112.917 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 80.96 -6.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.935 0.894 . . . . 1.92 110.627 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -44.78 78.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.516 -0.765 . . . . 2.21 111.479 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 5' ' ' GLU . . . 110.97 25.29 5.16 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.057 -0.592 . . . . 1.58 112.391 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.3 129.01 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.688 -0.301 . . . . 3.56 110.621 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.44 -80.56 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.299 -0.953 . . . . 2.28 112.608 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.461 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -96.08 85.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 2.67 110.699 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -166.33 -135.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.16 -0.927 . . . . 2.46 108.91 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.9 106.53 1.25 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.207 -1.035 . . . . 4.2 108.207 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.87 135.27 36.97 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.991 0.737 . . . . 4.13 112.991 -164.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -121.67 7.83 10.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.989 -1.005 . . . . 2.27 109.043 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.407 ' CD2' ' HG3' ' A' ' 40' ' ' GLN . 31.4 t80 -125.91 -62.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.226 -0.897 . . . . 2.01 110.651 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.63 ' NE2' ' HA ' ' A' ' 72' ' ' PRO . 5.1 mt-30 -85.02 53.63 2.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.487 . . . . 2.39 110.655 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.81 38.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 3.23 109.971 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.88 -71.21 0.3 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.195 -0.762 . . . . 2.06 111.195 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 -95.35 0.57 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.878 -0.677 . . . . 2.17 112.711 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER 56.34 33.89 23.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.002 1.382 . . . . 2.26 109.929 -174.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 171.7 13.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.253 -1.34 . . . . 1.31 111.732 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.03 65.83 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 2.37 110.518 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -133.72 152.82 51.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 2.27 110.261 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.29 85.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 1.64 111.574 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.618 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -60.09 -35.06 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 2.58 110.825 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.6 -36.86 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 1.06 110.296 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 91.3 t -62.16 -40.23 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.837 -0.62 . . . . 1.46 110.431 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -63.62 -39.07 93.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 0.97 110.842 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.05 83.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.354 -0.384 . . . . 0.93 110.786 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.654 ' HA ' ' NE2' ' A' ' 60' ' ' GLN . 3.0 pt20 -88.94 12.35 15.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 1.86 111.342 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 52' ' ' ALA . 1.4 p -123.46 -13.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.167 0.508 . . . . 1.82 110.432 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -94.22 -8.83 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.625 0.726 . . . . 1.97 109.368 173.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.538 ' HG2' ' N ' ' A' ' 58' ' ' GLU . 18.6 ttt-85 -145.35 163.72 33.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.262 -1.384 . . . . 3.57 107.262 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.538 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -49.98 144.31 6.87 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 117.776 0.262 . . . . 3.64 110.983 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -48.7 117.91 2.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.722 0.639 . . . . 4.58 111.674 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.837 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 1.5 mt-30 -92.15 73.81 5.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.46 -0.791 . . . . 2.8 110.994 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -80.76 -22.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 3.13 109.758 176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.76 -78.41 0.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.241 -0.89 . . . . 4.56 110.719 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.34 112.2 8.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.744 0.307 . . . . 3.01 111.64 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.837 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 14.7 Cg_exo -71.62 68.2 2.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.458 2.772 . . . . 1.91 111.473 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 3.7 tp -81.82 133.63 35.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 2.46 112.489 -172.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.71 19.48 11.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.533 0.938 . . . . 2.42 113.533 169.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -54.75 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.811 -0.356 . . . . 2.11 110.365 174.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.858 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.6 mt -169.08 -40.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 2.19 110.462 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -82.24 2.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 1.87 112.429 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . -133.65 52.62 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.732 0.301 . . . . 1.09 111.399 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.6 ' HB3' HD11 ' A' ' 77' ' ' LEU . 36.1 tp60 -177.39 113.14 0.24 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.592 -0.731 . . . . 3.23 109.734 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.63 ' HA ' ' NE2' ' A' ' 40' ' ' GLN . 13.3 Cg_exo -71.15 48.01 0.85 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.335 2.69 . . . . 1.77 112.166 177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.4 m -156.95 83.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.785 -0.643 . . . . 2.46 109.468 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.4 mm -65.05 -37.09 79.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.536 -0.756 . . . . 2.08 111.259 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HD3' ' HB ' ' A' ' 12' ' ' THR . 2.3 ttpt -56.34 -39.11 72.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 3.8 111.36 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' ' HG3' ' A' ' 79' ' ' GLN . . . -66.92 -46.33 75.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.331 . . . . 1.08 111.052 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.858 HD13 ' HA ' ' A' ' 68' ' ' LEU . 3.4 mt -70.09 -27.07 64.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.874 0.369 . . . . 2.41 110.908 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -65.28 -32.32 73.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.57 111.019 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 1.1 pt20 -97.37 15.06 24.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 2.74 110.551 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -119.8 -80.29 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.113 0.482 . . . . 2.85 110.662 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.46 -35.52 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.783 -0.644 . . . . 2.13 111.417 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -69.13 -28.25 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 1.9 111.495 -176.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.446 -0.343 . . . . 2.65 110.83 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 108.776 -0.824 . . . . 3.47 108.776 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 8' ' ' TYR . . . -127.76 146.55 50.55 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.736 -0.386 . . . . 3.01 111.434 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.65 37.22 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 3.51 110.107 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 6' ' ' ALA . 5.4 t80 -152.86 43.05 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.384 -0.825 . . . . 2.32 109.13 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.686 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 10.0 p -102.4 35.05 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.086 0.946 . . . . 2.13 110.096 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.18 112.44 38.69 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.314 -0.857 . . . . 2.09 109.84 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.52 131.33 27.57 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.683 2.256 . . . . 1.88 112.094 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.7 0.85 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.726 -0.67 . . . . 2.04 109.997 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.604 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -158.03 148.23 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.158 -0.928 . . . . 2.24 109.572 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.32 72.76 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.173 0.434 . . . . 1.42 112.173 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 43.0 t -68.33 -26.28 33.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.479 -0.328 . . . . 1.99 110.482 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -64.0 -49.12 73.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 1.93 110.395 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -64.56 -40.48 95.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.76 -0.654 . . . . 1.48 111.286 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -46.89 64.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 2.96 111.098 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 23' ' ' TRP . 3.0 tp -63.67 -54.58 33.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.964 -0.562 . . . . 1.81 111.087 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -61.11 -29.1 69.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.446 . . . . 1.08 111.453 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -68.93 -67.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 2.69 110.65 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.704 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 37.5 mm -59.23 -47.71 89.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.436 -0.347 . . . . 1.91 111.37 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.678 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 3.8 m95 -57.67 -46.33 84.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 1.33 110.716 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.712 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 3.2 mm-40 -89.6 28.14 1.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 2.78 111.757 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.704 ' HD2' ' HA ' ' A' ' 22' ' ' ILE . 9.4 mtt180 -114.68 -14.26 12.04 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.109 -1.071 . . . . 4.4 108.109 161.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.04 -37.96 3.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.003 -0.998 . . . . 2.01 111.778 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HB3' ' H ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -95.98 -97.33 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.109 0.411 . . . . 2.85 112.109 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 27' ' ' LEU . . . -87.96 -28.0 24.64 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.762 -0.732 . . . . 1.73 112.304 -173.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 2.9 t 63.84 41.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.537 0.684 . . . . 1.92 110.789 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -98.11 -98.02 0.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 2.21 111.115 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 30' ' ' SER . . . 140.96 76.72 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.908 -0.663 . . . . 1.58 111.689 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -117.81 132.09 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.012 0.435 . . . . 3.56 111.37 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . -100.18 -123.43 5.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 2.28 111.844 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mt -79.68 68.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.506 0.67 . . . . 2.67 110.322 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.752 ' HB3' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -148.64 4.17 0.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.387 -0.824 . . . . 2.46 110.504 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.741 ' HA ' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m-20 54.0 -109.9 0.51 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.102 -0.499 . . . . 4.2 111.1 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.8 -73.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.432 0.693 . . . . 4.13 112.705 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.02 -51.39 3.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.308 -0.405 . . . . 2.27 111.024 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -98.99 -70.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 2.01 112.153 -170.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.741 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 29.9 mp0 -60.31 -21.45 62.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.722 -0.672 . . . . 2.39 112.602 -170.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 3.9 tp -63.93 -21.87 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 3.23 111.366 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.783 ' HA2' ' HB3' ' A' ' 69' ' ' PHE . . . 108.0 45.68 1.08 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.579 -0.82 . . . . 2.06 112.26 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.76 107.19 2.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.702 -0.761 . . . . 2.17 112.134 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -72.81 86.39 1.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 2.26 110.294 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.93 178.25 8.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.81 -0.632 . . . . 1.31 111.178 -178.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.422 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -96.51 29.33 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 2.37 110.387 177.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -107.37 163.51 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.854 -0.612 . . . . 2.27 110.842 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.88 86.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.59 . . . . 1.64 112.227 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.678 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 11.2 ttt -61.27 -34.78 75.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 2.58 111.036 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.21 -0.45 . . . . 1.06 110.538 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.478 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 18.0 t -72.67 -42.29 62.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 1.46 109.923 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -63.35 -23.58 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.876 -0.602 . . . . 0.97 110.88 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.06 -43.61 57.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.909 -0.587 . . . . 0.93 110.928 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 51' ' ' VAL . 2.1 pt20 -75.64 -24.39 56.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.901 0.382 . . . . 1.86 110.808 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -87.65 -14.95 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.112 0.482 . . . . 1.82 110.4 177.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.817 ' HB3' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -64.62 -32.75 74.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 1.97 110.807 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.729 ' HD2' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.18 -0.76 13.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 3.57 109.807 175.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER 50.23 84.99 0.04 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.847 -1.069 . . . . 3.64 111.717 -177.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 11.6 m-30 69.95 76.22 0.21 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.237 -0.892 . . . . 4.58 111.433 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.68 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 6.0 pm0 -97.37 -37.5 10.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.107 -0.331 . . . . 2.8 110.107 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.68 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 2.4 p 159.46 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.806 -1.183 . . . . 3.13 107.806 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.614 ' H ' HG22 ' A' ' 61' ' ' VAL . 18.2 mp0 -58.35 -49.08 78.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.089 0.404 . . . . 4.56 111.265 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.505 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 47.7 mt -89.37 134.14 33.39 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.03 0.443 . . . . 3.01 111.174 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.3 Cg_exo -81.06 59.72 7.56 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.219 2.613 . . . . 1.91 112.496 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.599 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -69.56 116.31 9.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 2.46 111.793 -176.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.16 19.13 10.42 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.615 -0.72 . . . . 2.42 111.608 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 56' ' ' HIS . 1.7 t -106.78 -20.95 5.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.326 0.584 . . . . 2.11 109.978 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 mt 180.0 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.589 -1.187 . . . . 2.19 108.579 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.783 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 95.2 m-85 -112.94 -177.23 3.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 1.87 109.81 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . 60.87 55.32 3.21 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.338 0.59 . . . . 1.09 110.849 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -149.99 100.15 3.25 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.37 -0.832 . . . . 3.23 110.208 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.513 ' O ' ' HB ' ' A' ' 73' ' ' THR . 47.5 Cg_exo -56.53 105.95 0.19 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.766 2.311 . . . . 1.77 110.949 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 77.2 m 72.33 103.5 0.07 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.318 -0.623 . . . . 2.46 109.318 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -84.44 12.81 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 2.08 111.071 -172.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.604 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -58.27 -50.37 73.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 3.8 110.807 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.21 93.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 1.08 110.947 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -67.17 -36.11 81.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.122 -0.49 . . . . 2.41 110.65 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.877 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -62.89 -33.29 74.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.083 -0.508 . . . . 1.57 111.576 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.39 16.81 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.816 0.341 . . . . 2.74 110.711 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -126.47 -86.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.275 -0.42 . . . . 2.85 110.942 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.1 -25.87 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.416 -0.356 . . . . 2.13 111.436 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -71.04 -28.14 64.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.67 -0.241 . . . . 1.9 111.305 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.296 0.57 . . . . 2.65 110.853 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 N-CA-C 109.246 -0.649 . . . . 3.47 109.246 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.32 122.4 41.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.146 0.498 . . . . 3.01 112.115 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.65 70.47 2.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 3.51 110.021 174.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -134.92 -47.5 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.873 -0.603 . . . . 2.32 110.853 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG12 ' HB1' ' A' ' 20' ' ' ALA . 0.3 OUTLIER 49.35 -134.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.671 -0.695 . . . . 2.13 110.903 -177.414 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB2' HG12 ' A' ' 34' ' ' ILE . . . -178.63 94.04 0.22 Allowed Pre-proline 0 N--CA 1.463 0.199 0 O-C-N 123.128 0.268 . . . . 2.09 111.126 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -92.25 46.47 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.775 2.316 . . . . 1.88 111.875 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -86.73 106.44 17.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.768 0.655 . . . . 2.04 112.768 -173.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t30 40.53 54.88 2.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.043 1.127 . . . . 2.24 114.043 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 70.64 -52.29 0.67 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.743 1.016 . . . . 1.42 113.743 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.25 -60.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 1.99 111.314 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.471 ' HA ' HD12 ' A' ' 19' ' ' LEU . 3.2 mp0 -62.22 -31.08 71.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.21 -0.45 . . . . 1.93 110.997 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -40.07 90.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.938 0.399 . . . . 1.48 110.814 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -41.77 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.834 -0.621 . . . . 2.96 110.519 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 16' ' ' GLU . 28.1 mt -61.87 -43.75 98.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.064 -0.517 . . . . 1.81 110.01 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB1' HG12 ' A' ' 9' ' ' VAL . . . -56.44 -55.03 38.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.647 -0.706 . . . . 1.08 111.507 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.644 ' HG3' HD12 ' A' ' 22' ' ' ILE . 10.9 pt-20 -64.6 -46.75 81.32 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 111.706 0.261 . . . . 2.69 111.706 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.644 HD12 ' HG3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -68.0 -47.95 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.62 -0.264 . . . . 1.91 111.219 -175.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -76.8 -14.16 59.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 1.33 111.001 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.6 mm-40 -69.04 -50.1 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.089 -0.338 . . . . 2.78 110.089 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.498 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -75.28 -24.51 57.55 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.833 -0.347 . . . . 4.4 111.935 -174.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.45 33.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.687 -0.405 . . . . 2.01 111.894 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tp -171.99 -73.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.847 0.314 . . . . 2.85 111.847 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.78 -62.62 2.62 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.984 -0.627 . . . . 1.73 113.88 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 t 53.77 32.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.031 0.532 . . . . 1.92 110.804 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -143.08 11.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 2.21 111.523 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.41 60.49 3.02 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.892 -0.883 . . . . 1.58 110.892 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.56 81.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 3.56 111.519 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.41 155.73 50.46 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.701 -0.682 . . . . 2.28 112.151 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 10' ' ' ALA . 7.0 mm -80.05 56.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.764 0.792 . . . . 2.67 111.483 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.89 -42.07 2.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.184 -0.916 . . . . 2.46 108.614 171.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -156.54 128.02 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.02 -0.991 . . . . 4.2 108.562 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.505 ' O ' HG12 ' A' ' 41' ' ' ILE . 43.7 t30 -173.22 149.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.885 -0.413 . . . . 4.13 109.885 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 29.25 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.974 0.416 . . . . 2.27 111.295 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -117.07 -66.98 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.296 -0.411 . . . . 2.01 110.15 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.656 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.4 pm0 -79.84 13.11 2.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.936 -0.575 . . . . 2.39 112.003 -176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 37' ' ' ASN . 14.5 pt -106.97 7.49 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 3.23 110.181 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 33.03 10.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.821 -0.704 . . . . 2.06 112.025 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.32 151.0 35.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 2.17 111.996 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 73.51 10.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.072 0.463 . . . . 2.26 111.014 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.04 125.3 28.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.915 -0.584 . . . . 1.31 110.35 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 46' ' ' LEU . 8.5 tp -73.72 71.74 1.46 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.002 0.43 . . . . 2.37 111.992 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -145.44 152.4 39.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.915 -0.584 . . . . 2.27 109.489 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -32.72 73.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 1.64 111.523 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.3 ttt -61.81 -35.49 78.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 2.58 110.991 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.94 -36.57 67.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 1.06 110.546 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 t -66.58 -42.53 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.568 . . . . 1.46 110.361 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.8 94.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.97 110.845 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.68 84.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.93 110.825 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -10.93 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 1.86 111.162 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.9 t -104.0 -22.9 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.286 -0.415 . . . . 1.82 110.865 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -74.72 55.14 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.925 0.713 . . . . 1.97 112.925 -172.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.472 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -176.85 -70.6 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.158 -0.682 . . . . 3.57 109.158 175.26 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -170.87 40.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 3.64 110.624 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 59.26 78.7 0.25 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.99 -0.55 . . . . 4.58 110.631 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.472 ' OE1' ' HB3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -77.95 76.88 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.522 -0.763 . . . . 2.8 110.874 -176.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -76.18 -18.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.792 -0.64 . . . . 3.13 111.009 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -97.84 43.97 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 4.56 110.024 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.19 129.43 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.171 -0.922 . . . . 3.01 111.047 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.2 73.65 4.36 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.696 2.264 . . . . 1.91 112.461 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 67' ' ' VAL . 2.1 tp -59.53 113.69 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 2.46 110.363 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.791 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 19.2 mttt 58.42 -110.1 0.49 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.886 -0.597 . . . . 2.42 110.383 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 65' ' ' LEU . 46.3 t 59.64 -85.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.223 0.609 . . . . 2.11 111.843 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 78' ' ' ALA . 5.5 tp -148.2 10.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 2.19 110.879 -176.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 -56.15 0.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.251 0.463 . . . . 1.87 112.251 -173.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.791 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -80.71 66.43 6.23 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.121 0.415 . . . . 1.09 112.121 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -166.74 126.85 1.18 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.23 109.837 176.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 14.0 Cg_exo -71.73 42.39 0.49 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.505 2.804 . . . . 1.77 113.408 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.02 72.12 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.756 -0.831 . . . . 2.46 108.756 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.79 -34.36 46.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.339 -0.846 . . . . 2.08 111.236 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -60.28 -32.2 70.96 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.939 0.399 . . . . 3.8 110.589 178.107 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.56 -44.14 35.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 1.08 110.805 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.29 -43.37 98.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 2.41 110.737 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.561 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.81 -18.42 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.619 . . . . 1.57 111.49 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.76 -7.42 58.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 2.74 110.245 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.78 -70.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 2.85 111.399 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.44 51.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.828 0.347 . . . . 2.13 111.378 -173.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -157.58 -33.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.247 -0.433 . . . . 1.9 111.501 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.416 . . . . 2.65 111.708 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.585 -0.524 . . . . 3.47 109.585 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -146.48 116.66 7.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.092 -0.504 . . . . 3.01 111.006 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -83.27 49.02 1.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 3.51 109.682 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.61 -89.75 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.724 . . . . 2.32 111.273 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t 63.64 -86.33 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.012 -0.54 . . . . 2.13 110.687 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 49.74 69.9 2.38 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 123.02 0.528 . . . . 2.09 111.948 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -88.5 155.0 6.48 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.766 2.311 . . . . 1.88 112.653 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.14 -67.32 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.54 -0.3 . . . . 2.04 111.18 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -153.91 118.19 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.46 0.541 . . . . 2.24 112.46 -176.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.77 -79.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.879 1.066 . . . . 1.42 113.879 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -63.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.694 0.627 . . . . 1.99 112.694 -169.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' HA ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -62.79 -37.58 87.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.93 111.473 -176.308 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -45.98 83.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.095 -0.502 . . . . 1.48 111.269 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -38.14 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.028 -0.533 . . . . 2.96 111.367 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -47.72 79.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 1.81 110.854 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.92 82.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 1.08 110.494 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.55 -48.74 79.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 2.69 111.478 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.495 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 2.5 tt -67.93 -36.32 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.929 -0.308 . . . . 1.91 111.765 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -81.75 -53.38 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 1.33 111.838 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -78.02 -7.74 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.092 0.404 . . . . 2.78 112.092 -172.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.643 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 1.4 mmm180 -115.56 -0.25 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.255 -0.578 . . . . 4.4 111.658 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -115.63 -23.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 2.01 111.177 175.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 tp -122.86 -76.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 2.85 110.77 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.471 ' HA3' ' HZ ' ' A' ' 38' ' ' PHE . . . -85.93 62.35 4.39 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.774 -0.727 . . . . 1.73 112.92 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 1.6 p -67.68 105.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.564 0.697 . . . . 1.92 110.645 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.16 -32.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.217 -0.901 . . . . 2.21 110.141 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.61 96.08 2.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.897 -0.668 . . . . 1.58 111.646 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.63 HD13 ' HB3' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -131.64 -40.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.97 0.414 . . . . 3.56 110.691 -178.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.545 ' C ' HG12 ' A' ' 34' ' ' ILE . . . 65.0 -99.62 0.38 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.937 -0.574 . . . . 2.28 112.729 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' C ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -142.31 52.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.092 0.472 . . . . 2.67 110.932 -177.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 35' ' ' LEU . 5.2 mt -129.72 -111.49 0.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.244 -0.285 . . . . 2.46 111.033 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.466 ' H ' ' HB3' ' A' ' 35' ' ' LEU . 26.5 t0 -88.91 71.64 8.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 4.2 110.288 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.63 ' HB3' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -114.18 164.45 13.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.643 -0.708 . . . . 4.13 110.994 -176.385 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HZ ' ' HA3' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -82.32 -14.96 54.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.008 -0.542 . . . . 2.27 110.634 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.477 ' HB3' ' OE1' ' A' ' 40' ' ' GLN . 18.7 t80 -81.97 -90.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.088 -0.506 . . . . 2.01 110.277 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 39' ' ' PHE . 3.6 mp0 -68.09 125.42 26.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.574 -0.528 . . . . 2.39 109.574 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 78.52 -9.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 123.978 0.799 . . . . 3.23 110.972 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.46 -58.29 3.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.975 -0.631 . . . . 2.06 112.256 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.738 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . 147.67 -76.13 0.26 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.385 -0.912 . . . . 2.17 112.613 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -165.81 119.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.039 0.447 . . . . 2.26 110.992 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.03 144.34 26.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 1.31 110.176 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.11 92.57 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.995 0.426 . . . . 2.37 111.243 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -171.48 164.64 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 2.27 110.285 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.75 65.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 1.64 111.854 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -39.16 83.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.362 . . . . 2.58 110.742 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.02 -37.59 61.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 1.06 110.472 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.81 -42.96 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 1.46 110.677 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.48 96.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.97 110.903 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.453 . . . . 0.93 110.32 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -49.3 73.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.604 -0.726 . . . . 1.86 111.098 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 m -75.15 -33.0 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.929 -0.308 . . . . 1.82 111.73 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -31.13 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.881 -0.328 . . . . 1.97 111.224 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 -9.81 53.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.893 -0.41 . . . . 3.57 109.893 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER 67.33 62.4 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.216 -0.902 . . . . 3.64 110.882 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 1.2 m-85 78.91 109.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 4.58 111.65 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.07 -20.04 18.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.021 -0.99 . . . . 2.8 109.695 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.7 t 66.05 -111.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.226 -0.897 . . . . 3.13 110.185 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.65 8.55 4.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 4.56 110.358 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 92.82 39.7 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 3.01 110.46 -175.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.738 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 49.8 Cg_endo -70.58 128.22 14.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.425 2.084 . . . . 1.91 112.029 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.11 137.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 2.46 109.436 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.51 47.35 16.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.712 0.633 . . . . 2.42 110.442 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 69' ' ' PHE . 2.7 p -156.08 175.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.11 109.808 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -53.83 -36.88 63.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.286 0.476 . . . . 2.19 112.286 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.641 ' H ' HG13 ' A' ' 67' ' ' VAL . 86.0 m-85 -84.09 3.21 35.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.46 -0.336 . . . . 1.87 111.66 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.31 73.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.782 0.325 . . . . 1.09 111.459 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.93 141.48 1.21 Allowed Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.134 -0.691 . . . . 3.23 109.134 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HB2' ' H ' ' A' ' 73' ' ' THR . 23.0 Cg_exo -64.62 -86.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.539 2.16 . . . . 1.77 111.867 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.703 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -80.92 136.72 36.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.713 0.292 . . . . 2.46 110.541 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.497 ' CG1' ' HA ' ' A' ' 16' ' ' GLU . 38.0 mm -64.69 -25.05 36.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 2.08 111.097 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.703 ' HD3' ' HB ' ' A' ' 73' ' ' THR . 1.1 pttt -50.48 -34.56 25.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.301 -0.409 . . . . 3.8 111.801 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.556 ' N ' ' HG2' ' A' ' 75' ' ' LYS . . . -70.41 -50.75 35.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.037 0.446 . . . . 1.08 111.005 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 68' ' ' LEU . 1.8 pp -73.06 -15.51 61.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 2.41 110.71 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -75.56 -31.71 60.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 1.57 110.735 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.32 5.94 47.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 2.74 111.45 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.02 -48.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.529 0.566 . . . . 2.85 112.529 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.53 -51.38 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.085 0.402 . . . . 2.13 112.085 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -65.89 -16.15 63.59 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.075 0.398 . . . . 1.9 112.075 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.046 0.451 . . . . 2.65 110.824 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 2.2 mt-10 . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.743 -0.466 . . . . 3.47 109.743 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.33 128.76 33.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.909 0.385 . . . . 3.01 111.055 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.78 -19.46 41.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.236 0.541 . . . . 3.51 110.301 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -91.04 57.61 3.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.925 -0.579 . . . . 2.32 110.111 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.09 67.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 122.193 0.997 . . . . 2.13 110.431 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -143.51 110.38 5.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.196 -0.911 . . . . 2.09 110.288 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 5.5 Cg_exo -78.73 171.05 17.23 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.257 2.638 . . . . 1.88 112.382 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.87 -47.48 4.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.121 0.486 . . . . 2.04 110.666 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 24.0 t-20 -108.08 154.08 22.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 2.24 110.669 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.97 -29.12 69.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 1.42 111.246 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.04 -35.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.21 0.528 . . . . 1.99 110.27 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -73.13 -36.74 66.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.713 -0.676 . . . . 1.93 110.598 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -35.22 74.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 1.48 110.53 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -45.07 78.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.091 -0.504 . . . . 2.96 110.757 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 19' ' ' LEU . 2.0 mt -64.74 -37.29 87.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 1.81 110.129 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.74 -30.8 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 1.08 110.595 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 16.5 tt0 -61.96 -47.17 86.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.981 -0.378 . . . . 2.69 109.981 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.2 mt -69.92 -55.16 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.333 -0.394 . . . . 1.91 111.158 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.535 ' CH2' ' HD2' ' A' ' 47' ' ' LYS . 64.1 m95 -68.56 -49.1 62.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.257 0.465 . . . . 1.33 112.257 -172.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.89 -50.24 24.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.438 0.162 . . . . 2.78 111.438 -174.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 1.1 mmt85 -66.6 -27.38 67.66 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.694 -0.402 . . . . 4.4 111.643 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.17 -55.75 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.219 -0.193 . . . . 2.01 111.288 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.89 -44.32 5.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.404 0.52 . . . . 2.85 112.404 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.57 -59.82 10.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.353 -0.451 . . . . 1.73 113.57 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.1 t 72.12 -56.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 123.329 0.652 . . . . 1.92 111.897 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.467 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 2.4 m -74.35 -41.04 61.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 2.21 111.16 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.1 127.38 3.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.758 -0.734 . . . . 1.58 112.096 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -164.44 161.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.94 -0.393 . . . . 3.56 109.94 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.45 -103.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.038 -1.077 . . . . 2.28 113.552 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mm -81.16 65.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.146 0.498 . . . . 2.67 111.637 -171.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.97 171.63 15.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.112 -0.495 . . . . 2.46 110.139 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.53 112.87 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.095 -0.502 . . . . 4.2 109.751 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -146.95 172.31 13.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.175 0.512 . . . . 4.13 111.682 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -63.45 153.17 36.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.129 -0.941 . . . . 2.27 112.717 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.9 -39.08 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.931 0.892 . . . . 2.01 112.891 171.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -65.32 -36.31 83.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.803 0.335 . . . . 2.39 111.19 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.527 ' H ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -99.03 15.85 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 3.23 111.546 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.23 135.88 2.56 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.664 -0.779 . . . . 2.06 112.129 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.65 70.76 1.02 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.686 -0.768 . . . . 2.17 111.338 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.649 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 24.6 p80 -60.75 150.67 31.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.78 0.324 . . . . 2.26 111.135 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -179.24 4.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 1.31 110.993 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 35.15 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 2.37 111.21 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HD2' ' CH2' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -129.09 171.23 12.59 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.988 -0.285 . . . . 2.27 110.985 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.24 69.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 1.64 112.408 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -37.87 64.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.041 0.448 . . . . 2.58 111.066 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 44' ' ' HIS . . . -76.62 -40.69 48.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 1.06 110.89 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.04 -41.55 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 1.46 110.546 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.11 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.97 111.04 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.41 -36.46 74.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.93 111.022 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 61' ' ' VAL . 3.0 pt20 -76.49 -18.33 58.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 1.86 111.626 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.6 p -115.86 0.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.094 0.405 . . . . 1.82 112.094 -175.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -32.57 72.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.412 . . . . 1.97 112.114 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.29 -76.65 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.891 -0.323 . . . . 3.57 110.751 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.46 55.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 3.64 110.065 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.3 72.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.252 -0.885 . . . . 4.58 111.789 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.51 -14.94 29.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.7 -0.682 . . . . 2.8 110.143 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.559 ' HA ' ' HB2' ' A' ' 54' ' ' GLN . 5.9 t 60.15 -92.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.268 -0.878 . . . . 3.13 112.066 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HG2' HG12 ' A' ' 61' ' ' VAL . 4.2 mm-40 -99.1 15.11 26.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.729 0.3 . . . . 4.56 111.238 -175.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -121.42 79.74 37.35 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.063 0.458 . . . . 3.01 110.463 178.004 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.65 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 85.7 Cg_endo -96.89 16.06 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.008 2.472 . . . . 1.91 112.638 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.76 117.76 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 2.46 111.496 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt 68.52 3.71 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.265 -0.879 . . . . 2.42 112.202 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.13 -53.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.715 -0.476 . . . . 2.11 109.715 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.65 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -171.9 154.56 3.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.461 -0.94 . . . . 2.19 108.461 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 75.0 -56.06 0.64 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.314 0.487 . . . . 1.87 112.314 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . . . -77.22 67.86 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.347 0.499 . . . . 1.09 112.347 -173.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.549 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 3.0 mm-40 -155.46 128.24 4.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.153 -0.684 . . . . 3.23 109.153 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 23.7 Cg_exo -64.29 -11.87 30.11 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.988 2.459 . . . . 1.77 112.98 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 t -132.22 115.31 15.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.412 0.625 . . . . 2.46 110.085 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.471 HD13 HD12 ' A' ' 19' ' ' LEU . 1.1 mt -77.88 -17.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.653 -0.703 . . . . 2.08 110.786 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 4.4 tttt -56.47 -50.38 71.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.278 -0.419 . . . . 3.8 110.49 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -62.95 -41.68 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.675 -0.693 . . . . 1.08 110.967 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 77' ' ' LEU . 6.2 mt -63.09 -46.31 87.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 2.41 111.269 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.94 -29.07 70.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 1.57 112.003 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -101.37 8.65 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.681 -0.408 . . . . 2.74 111.249 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 1.7 m-85 -119.28 -93.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.508 -0.314 . . . . 2.85 110.719 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.02 43.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 2.13 111.321 -175.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.48 -40.65 1.58 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.657 -0.701 . . . . 1.9 109.675 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.587 -0.733 . . . . 2.65 110.907 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.77 0.319 . . . . 3.47 110.912 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.456 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -94.01 179.92 5.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 3.01 110.507 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -112.43 95.88 5.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 3.51 110.522 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.466 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 2.7 t80 -155.23 -103.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 2.32 110.542 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.614 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.5 OUTLIER 71.2 -7.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.595 0.758 . . . . 2.13 112.214 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.18 31.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 2.09 110.737 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.813 ' HA ' HD11 ' A' ' 34' ' ' ILE . 59.5 Cg_endo -94.98 172.15 1.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.285 2.656 . . . . 1.88 113.167 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 -40.21 8.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.083 -0.71 . . . . 2.04 109.083 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -119.6 151.55 38.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.224 -0.898 . . . . 2.24 109.299 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.49 -33.7 70.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.907 0.336 . . . . 1.42 111.907 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.04 -27.34 42.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 1.99 111.56 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.817 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.0 -58.82 6.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.005 0.431 . . . . 1.93 111.166 -175.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -79.46 -12.43 59.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.365 -0.38 . . . . 1.48 111.283 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -51.52 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.57 -0.53 . . . . 2.96 109.57 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -62.7 -41.85 99.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 1.81 110.329 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.39 77.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 1.08 110.857 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.641 ' HG2' ' HG3' ' A' ' 25' ' ' ARG . 2.3 tt0 -63.33 -31.37 72.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.236 -0.438 . . . . 2.69 111.206 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.552 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 20.9 mt -62.13 -42.73 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.109 0.481 . . . . 1.91 110.301 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.807 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 36.7 m95 -79.54 -46.76 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.085 -0.507 . . . . 1.33 111.781 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 pt-20 -76.41 -8.56 57.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.839 0.681 . . . . 2.78 112.839 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 2.1 mtp85 -120.89 -4.98 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.607 -0.437 . . . . 4.4 111.74 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.552 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 6.5 t -108.71 -49.83 7.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.01 110.467 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.954 HD11 ' HG3' ' A' ' 47' ' ' LYS . 80.9 mt -95.73 -85.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.078 0.466 . . . . 2.85 110.568 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.19 89.61 1.48 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.688 -0.767 . . . . 1.73 111.502 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 58.4 t -62.8 105.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.968 0.414 . . . . 1.92 110.206 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.26 -64.92 0.71 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.204 -0.453 . . . . 2.21 111.409 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.3 85.45 1.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.83 -0.7 . . . . 1.58 111.413 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.744 HD11 ' HD2' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -137.47 -58.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.872 0.368 . . . . 3.56 111.654 -174.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . 101.65 -138.09 13.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.711 -0.757 . . . . 2.28 111.476 -172.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.813 HD11 ' HA ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -120.06 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.347 . . . . 2.67 110.98 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.839 ' HG ' ' H ' ' A' ' 36' ' ' ASP . 1.3 pt? -152.73 -66.07 0.16 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.502 -0.317 . . . . 2.46 111.118 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.839 ' H ' ' HG ' ' A' ' 35' ' ' LEU . 5.9 t70 -176.76 173.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 4.2 110.047 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER 65.73 23.51 11.53 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.51 0.724 . . . . 4.13 112.815 173.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.744 ' HD2' HD11 ' A' ' 32' ' ' ILE . 20.9 t80 173.18 138.04 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.509 -0.769 . . . . 2.27 109.108 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 67.15 -72.25 0.09 Allowed 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.034 0.834 . . . . 2.01 110.558 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.35 59.67 2.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 2.39 110.484 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 -48.98 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.654 -0.703 . . . . 3.23 110.181 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.68 116.63 2.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.06 111.641 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.33 -159.24 24.52 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.795 -0.717 . . . . 2.17 112.042 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -125.66 73.86 1.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.874 0.369 . . . . 2.26 110.561 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.45 145.62 49.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.193 -0.458 . . . . 1.31 110.496 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 46' ' ' LEU . 3.1 mt -92.31 66.74 4.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 2.37 111.416 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.954 ' HG3' HD11 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -144.01 155.5 44.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.403 -0.362 . . . . 2.27 110.312 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.79 -43.73 63.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.491 0.552 . . . . 1.64 112.491 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.807 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 6.2 tpt -62.86 -34.76 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.802 0.334 . . . . 2.58 111.179 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB2' ' HH2' ' A' ' 23' ' ' TRP . . . -76.41 -37.58 56.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 1.06 110.488 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.69 -40.24 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.927 -0.579 . . . . 1.46 110.257 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -61.2 -36.83 80.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 0.97 110.983 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.23 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.424 -0.353 . . . . 0.93 110.617 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -65.06 -38.7 91.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 1.86 110.873 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.85 -26.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 1.82 110.502 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -66.21 -38.29 87.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 1.97 109.906 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.44 173.16 11.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.423 -0.584 . . . . 3.57 109.423 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -82.23 48.32 1.25 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.436 -0.347 . . . . 3.64 110.226 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.483 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 79.7 m-85 56.26 78.94 0.19 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.769 0.795 . . . . 4.58 109.692 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 17.4 pm0 -71.44 -11.79 61.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 2.8 113.06 -169.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 t 63.3 -82.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 123.292 0.37 . . . . 3.13 111.113 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -131.53 5.87 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.535 0.198 . . . . 4.56 111.535 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -122.64 78.46 47.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 3.01 111.133 -178.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.53 54.35 4.7 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.355 2.704 . . . . 1.91 112.237 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.78 130.42 42.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.436 -0.802 . . . . 2.46 111.719 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 71' ' ' GLN . 2.2 mptm? 46.15 54.82 7.86 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.187 0.929 . . . . 2.42 113.247 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.96 -33.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.728 0.299 . . . . 2.11 110.775 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.04 -62.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.198 0.523 . . . . 2.19 110.048 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.89 -21.79 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.597 -0.729 . . . . 1.87 111.454 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -116.06 40.67 2.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.458 -0.337 . . . . 1.09 111.04 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -170.09 84.5 0.58 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 3.23 109.621 175.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.88 59.16 3.47 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.739 2.959 . . . . 1.77 112.993 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -148.43 79.89 1.45 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 2.46 109.391 176.217 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 16' ' ' GLU . 80.2 mt -61.87 -41.89 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.689 -0.687 . . . . 2.08 112.541 -169.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -44.58 84.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.435 -0.506 . . . . 3.8 110.42 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -63.86 -34.03 77.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 1.08 110.68 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -61.98 -32.03 72.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 2.41 110.837 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 -22.29 61.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.57 110.991 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.28 5.25 42.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.353 -0.385 . . . . 2.74 110.434 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -119.72 -75.95 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 2.85 111.475 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.95 -46.53 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 2.13 111.315 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.83 67.33 1.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 1.9 110.307 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.92 -0.582 . . . . 2.65 111.168 -175.502 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.96 0.409 . . . . 3.47 110.367 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.95 88.6 3.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 3.01 110.516 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -75.41 71.49 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 3.51 110.281 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.448 ' HB3' HD21 ' A' ' 35' ' ' LEU . 83.2 t80 -162.62 23.43 0.1 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.664 0.745 . . . . 2.32 109.275 -175.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.51 65.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.899 0.857 . . . . 2.13 111.526 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.39 70.34 39.44 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.812 -1.085 . . . . 2.09 108.546 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.841 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 31.3 Cg_exo -61.08 146.69 97.34 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.651 2.901 . . . . 1.88 113.788 -171.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -28.19 37.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 2.04 110.575 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -123.88 146.98 48.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.24 109.936 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -21.63 66.46 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.317 0.386 . . . . 1.42 111.408 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.64 -37.74 80.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.213 -0.449 . . . . 1.99 110.537 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.841 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . 36.3 mt-10 -70.66 -34.77 72.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 1.93 110.271 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.12 79.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.076 0.465 . . . . 1.48 110.627 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 2.2 tptm -72.71 -43.77 62.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 2.96 110.373 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -47.29 77.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.599 -0.728 . . . . 1.81 110.599 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . . . -57.87 -55.1 39.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.5 -0.773 . . . . 1.08 111.275 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.79 -42.86 85.03 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.805 0.298 . . . . 2.69 111.805 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.9 mt -69.43 -55.61 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 1.91 111.266 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.66 -35.57 81.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 1.33 111.492 -175.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 3.3 tp10 -63.62 -46.7 84.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.196 -0.456 . . . . 2.78 110.965 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -5.32 41.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 4.4 111.583 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.18 -60.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.462 -0.335 . . . . 2.01 111.32 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -35.27 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.532 0.567 . . . . 2.85 112.532 -171.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.62 ' HA3' HG12 ' A' ' 32' ' ' ILE . . . -77.32 -69.83 1.36 Allowed Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.578 -0.82 . . . . 1.73 113.505 -172.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t 56.51 54.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.729 . . . . 1.92 110.129 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.41 -32.9 0.04 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.14 -0.936 . . . . 2.21 110.567 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.47 65.34 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.181 -0.767 . . . . 1.58 111.181 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.62 HG12 ' HA3' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -131.1 -178.09 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.564 0.221 . . . . 3.56 111.413 -175.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.798 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . 120.96 31.98 1.13 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.934 -0.651 . . . . 2.28 113.269 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -156.87 -65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 117.343 0.571 . . . . 2.67 111.982 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 35' ' ' LEU . 1.9 pt? -142.37 33.03 1.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.975 0.893 . . . . 2.46 110.052 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.96 1.61 4.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.5 -1.227 . . . . 4.2 112.487 -174.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.451 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 21.2 t-20 74.12 -60.8 0.51 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.111 0.564 . . . . 4.13 112.278 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HE1' HG21 ' A' ' 32' ' ' ILE . 25.9 p90 -64.64 -22.71 67.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.331 0.493 . . . . 2.27 112.331 -172.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.447 ' CE2' ' HE2' ' A' ' 69' ' ' PHE . 15.9 t80 -108.16 -16.9 14.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.947 0.403 . . . . 2.01 110.812 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -110.48 0.93 17.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 2.39 111.751 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 37' ' ' ASN . 5.1 tp -88.93 -23.19 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.136 0.493 . . . . 3.23 110.604 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 55.31 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.87 -0.892 . . . . 2.06 110.87 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.87 128.74 29.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.984 -0.627 . . . . 2.17 112.74 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.83 59.4 1.37 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.374 0.607 . . . . 2.26 110.352 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -179.31 6.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.346 -0.843 . . . . 1.31 110.313 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.2 63.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.075 0.464 . . . . 2.37 110.153 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.9 tptt -130.66 165.8 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.834 -0.621 . . . . 2.27 110.428 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.04 87.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 1.64 111.534 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -62.53 -38.08 88.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.171 -0.468 . . . . 2.58 110.824 177.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -71.04 -45.36 64.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 1.06 111.405 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.3 m -70.72 -22.4 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.58 -0.282 . . . . 1.46 110.979 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.42 88.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 0.97 110.01 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.49 76.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 0.93 110.647 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -60.23 -55.97 27.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 1.86 111.041 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 51' ' ' VAL . 2.2 t -78.38 9.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.108 0.48 . . . . 1.82 111.095 -177.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.429 ' NE2' ' HA ' ' A' ' 82' ' ' ALA . 1.5 t-80 -88.56 -9.93 50.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 1.97 110.744 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 57' ' ' ARG . 3.9 ttm180 -137.18 9.41 2.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.609 . . . . 3.57 109.52 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 72.48 -12.97 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.249 -0.887 . . . . 3.64 112.043 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -169.23 176.08 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.379 . . . . 4.58 110.517 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.99 -52.5 0.19 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 2.8 109.112 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 41.8 57.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.132 0.973 . . . . 3.13 112.921 175.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.27 9.51 6.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.482 -0.781 . . . . 4.56 112.555 172.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 61' ' ' VAL . 0.3 OUTLIER -126.95 73.19 76.36 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.759 0.314 . . . . 3.01 110.73 176.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 6.5 Cg_endo -87.92 117.99 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.075 2.516 . . . . 1.91 112.265 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -143.95 122.16 12.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.204 -0.295 . . . . 2.46 110.204 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 tttt 53.58 55.53 8.46 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.58 0.55 . . . . 2.42 111.123 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.37 -76.1 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.094 -0.503 . . . . 2.11 110.69 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.09 -42.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.302 -0.863 . . . . 2.19 109.049 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 49' ' ' MET . 52.4 m-85 -97.55 18.05 16.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.416 -0.811 . . . . 1.87 109.962 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -144.1 134.86 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.877 -1.056 . . . . 1.09 108.233 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 12.7 mp0 70.55 97.1 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 O-C-N 124.324 1.015 . . . . 3.23 109.198 -169.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.57 70.59 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.728 2.952 . . . . 1.77 113.066 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.26 53.96 1.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 2.46 108.968 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 74' ' ' ILE . 2.0 mm -51.35 -49.8 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.698 -1.137 . . . . 2.08 112.319 -172.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -64.41 -47.4 79.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 3.8 111.066 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 1.08 111.18 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.47 -36.01 81.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.222 -0.444 . . . . 2.41 110.983 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.739 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -72.05 -36.89 69.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 1.57 111.296 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -9.81 59.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.949 0.404 . . . . 2.74 111.062 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -103.95 -76.85 0.58 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 2.85 111.014 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.7 -40.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.681 . . . . 2.13 111.421 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.739 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -79.94 54.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 1.9 111.794 -175.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.998 -0.546 . . . . 2.65 110.466 178.627 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.976 0.417 . . . . 3.47 110.394 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.05 118.23 15.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.022 -0.536 . . . . 3.01 110.113 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -81.13 22.58 0.64 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.418 -0.355 . . . . 3.51 111.464 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.49 ' CD2' HD22 ' A' ' 35' ' ' LEU . 85.0 t80 -66.44 -56.48 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.06 -0.718 . . . . 2.32 109.06 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p 21.95 65.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 124.892 1.37 . . . . 2.13 113.156 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.76 76.39 74.49 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 2.09 110.999 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 23.3 Cg_exo -65.23 115.69 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.304 2.002 . . . . 1.88 110.5 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -34.68 75.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 2.04 111.955 -171.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.94 150.73 27.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.741 0.305 . . . . 2.24 110.971 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.09 70.35 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.576 . . . . 1.42 112.006 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.51 -36.56 75.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.157 0.503 . . . . 1.99 110.696 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 21.0 mt-10 -79.53 -23.34 42.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.658 -0.701 . . . . 1.93 111.102 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -71.07 -45.45 63.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.372 . . . . 1.48 110.411 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -63.7 -38.98 93.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.119 0.485 . . . . 2.96 110.666 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -63.64 -47.1 82.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 1.81 110.079 177.037 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.3 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 1.08 111.083 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -56.23 -53.9 51.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 2.69 110.876 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.501 HG22 HD23 ' A' ' 27' ' ' LEU . 37.7 mm -68.86 -43.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.156 -0.475 . . . . 1.91 111.323 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.916 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 64.4 m95 -71.7 -39.82 69.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.616 0.598 . . . . 1.33 112.616 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 1.6 pt-20 -77.11 -33.48 56.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.904 -0.318 . . . . 2.78 111.413 -177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.554 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 8.4 mmp_? -90.08 -57.48 2.84 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.141 0.423 . . . . 4.4 112.141 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.23 -43.23 12.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.064 0.394 . . . . 2.01 112.064 -171.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.916 ' HB2' ' HA ' ' A' ' 23' ' ' TRP . 1.4 mm? -70.54 -69.79 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.998 0.427 . . . . 2.85 111.962 -174.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.59 -22.27 31.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.9 -0.667 . . . . 1.73 113.401 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t 55.76 52.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.678 0.751 . . . . 1.92 110.076 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.4 141.66 32.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.394 -0.821 . . . . 2.21 110.096 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.7 77.27 2.08 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.588 -0.815 . . . . 1.58 111.36 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.503 ' HB ' ' H ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -118.89 -147.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.022 0.439 . . . . 3.56 111.133 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.503 ' H ' ' HB ' ' A' ' 32' ' ' ILE . . . 174.58 -174.97 46.82 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.285 -0.726 . . . . 2.28 111.285 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 16' ' ' GLU . 5.9 mm -80.56 83.26 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.421 . . . . 2.67 110.295 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.717 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.95 -51.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 2.46 110.671 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.717 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 t0 178.1 -175.06 0.17 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.864 -0.421 . . . . 4.2 109.864 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 74.22 -3.45 2.54 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.003 0.815 . . . . 4.13 111.86 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 t80 178.57 163.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.736 0.648 . . . . 2.27 109.333 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 70.58 -70.23 0.16 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.906 0.754 . . . . 2.01 111.017 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.11 72.34 10.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.851 0.357 . . . . 2.39 110.526 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 172.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.207 -0.451 . . . . 3.23 110.822 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . -76.41 94.61 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.029 -0.605 . . . . 2.06 112.887 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.71 -159.65 32.99 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.952 -0.642 . . . . 2.17 112.001 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -165.57 127.74 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 2.26 110.219 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.19 162.19 22.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.075 -0.512 . . . . 1.31 110.97 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.77 67.2 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.489 -0.323 . . . . 2.37 110.92 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.16 127.42 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.357 -0.383 . . . . 2.27 111.379 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 23.6 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.498 1.519 . . . . 1.64 114.64 171.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.5 ttt -54.05 -42.42 69.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.965 -0.561 . . . . 2.58 112.235 -173.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.41 74.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 1.06 110.838 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.5 t -66.31 -46.28 87.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.765 -0.457 . . . . 1.46 109.765 177.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.82 -24.99 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 0.97 111.206 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.52 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 0.93 110.543 177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -25.51 47.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.19 0.519 . . . . 1.86 110.317 177.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -93.03 13.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.863 -0.608 . . . . 1.82 110.161 177.047 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.99 4.78 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.741 -0.663 . . . . 1.97 109.689 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HD2' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -154.99 -165.38 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.114 -0.948 . . . . 3.57 109.175 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -79.62 38.47 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.417 -0.356 . . . . 3.64 111.542 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 60.6 78.39 0.28 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.647 0.737 . . . . 4.58 109.524 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 19.2 pm0 -77.68 23.3 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.943 -1.026 . . . . 2.8 112.826 -171.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.47 ' HB ' ' H ' ' A' ' 62' ' ' GLU . 2.9 t 55.0 -100.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.446 0.298 . . . . 3.13 110.877 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' H ' ' HB ' ' A' ' 61' ' ' VAL . 2.5 pt-20 -134.23 32.1 3.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 4.56 110.605 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.569 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 12.8 mt -104.4 100.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 3.01 110.114 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.477 ' HG3' ' HA2' ' A' ' 42' ' ' GLY . 87.2 Cg_endo -84.4 3.08 7.75 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.856 2.371 . . . . 1.91 113.184 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.86 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.206 0.941 . . . . 2.46 112.64 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 58.31 23.63 10.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.68 -0.691 . . . . 2.42 112.471 175.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.403 HG22 ' HD2' ' A' ' 57' ' ' ARG . 7.5 t -97.06 -51.74 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.153 0.501 . . . . 2.11 109.991 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -170.64 -54.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.499 -0.773 . . . . 2.19 110.012 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . 19.6 m-85 -84.08 35.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 1.87 111.262 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.14 47.52 0.69 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.989 -0.745 . . . . 1.09 108.989 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.03 104.81 0.49 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.326 -1.306 . . . . 3.23 108.692 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.84 40.46 0.65 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.016 2.478 . . . . 1.77 113.485 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.74 94.6 2.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.628 -0.508 . . . . 2.46 109.628 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 77' ' ' LEU . 2.6 mt -67.14 -35.09 73.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.304 -0.407 . . . . 2.08 110.78 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -36.03 79.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 3.8 110.283 176.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.77 83.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 1.08 110.379 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 74' ' ' ILE . 17.4 mt -66.74 -33.38 75.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 2.41 110.547 177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.8 -17.07 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.57 111.625 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -110.2 12.95 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 2.74 110.299 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -126.79 -88.9 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.945 -0.571 . . . . 2.85 110.865 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.36 -17.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.963 0.357 . . . . 2.13 111.963 -175.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.05 39.28 3.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 1.9 110.787 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 2.65 111.284 -177.412 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.638 0.256 . . . . 3.47 110.384 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.81 39.99 29.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.823 -0.626 . . . . 3.01 111.19 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -70.49 -57.32 4.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.703 -0.681 . . . . 3.51 111.039 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.451 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 1.2 t80 -103.42 -88.27 0.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 2.32 111.406 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' H ' ' HB3' ' A' ' 8' ' ' TYR . 2.1 t 56.0 52.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.287 0.565 . . . . 2.13 110.822 -174.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.6 86.38 53.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.014 -0.539 . . . . 2.09 110.692 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.633 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 96.3 Cg_endo -89.95 -168.78 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.929 2.42 . . . . 1.88 111.945 177.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -77.68 -69.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.122 -0.231 . . . . 2.04 111.15 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -173.43 140.2 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.861 0.319 . . . . 2.24 111.861 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.15 -84.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.743 1.016 . . . . 1.42 113.743 168.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -61.02 -55.85 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 1.99 111.88 -171.454 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.731 ' HA ' HD11 ' A' ' 74' ' ' ILE . 13.2 mt-10 -63.89 -35.88 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.007 -0.542 . . . . 1.93 111.187 -176.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.403 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -64.97 -47.0 79.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.121 -0.49 . . . . 1.48 111.315 -178.42 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -74.09 -37.66 64.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.31 -0.405 . . . . 2.96 110.899 -178.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.63 -49.9 74.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 1.81 110.932 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.67 97.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 1.08 110.679 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.37 -57.14 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.769 -0.65 . . . . 2.69 111.024 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.2 mt -65.0 -52.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.092 -0.504 . . . . 1.91 111.29 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -61.62 -51.29 69.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.402 0.519 . . . . 1.33 112.402 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -74.88 -10.59 59.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.894 0.331 . . . . 2.78 111.894 -173.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.561 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -100.36 -22.3 15.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.741 -0.384 . . . . 4.4 111.608 177.761 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 25' ' ' ARG . 53.6 t -103.52 -50.33 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 2.01 111.437 -176.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -27.52 62.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 2.85 110.318 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.0 -168.76 14.03 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.037 -0.825 . . . . 1.73 111.037 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.01 56.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.481 1.134 . . . . 1.92 109.018 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -113.49 -127.52 0.29 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.029 -0.987 . . . . 2.21 111.28 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.52 50.26 0.3 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.713 -0.955 . . . . 1.58 110.713 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.59 -43.77 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.677 0.275 . . . . 3.56 110.733 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.14 -132.7 13.8 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.75 -0.738 . . . . 2.28 112.729 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -75.32 93.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.852 0.358 . . . . 2.67 111.475 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -173.87 -65.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.059 -0.719 . . . . 2.46 109.059 177.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -133.03 49.24 2.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.383 -0.969 . . . . 4.2 108.383 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.552 ' O ' HG22 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -62.9 96.36 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.371 -1.286 . . . . 4.13 111.969 -174.079 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -66.8 -17.9 65.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 2.27 111.009 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -93.66 -64.27 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.138 -0.483 . . . . 2.01 110.577 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.749 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -84.94 58.98 5.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 2.39 111.726 -173.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.749 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 3.6 tp 156.63 -24.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.934 0.894 . . . . 3.23 110.48 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.27 -25.92 74.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.995 -0.622 . . . . 2.06 112.769 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.88 -104.4 0.25 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.824 -0.703 . . . . 2.17 111.932 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.14 149.28 15.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.56 0.219 . . . . 2.26 110.606 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.69 178.33 8.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.737 -0.468 . . . . 1.31 109.737 174.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -119.15 59.87 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.37 0.605 . . . . 2.37 110.224 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 179.04 6.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.539 -0.755 . . . . 2.27 110.059 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.59 73.77 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.048 0.388 . . . . 1.64 112.048 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -36.43 72.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 2.58 111.057 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -75.06 -38.93 61.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.976 -0.556 . . . . 1.06 110.805 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.4 t -63.8 -41.59 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 1.46 110.236 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -59.93 -39.51 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.577 . . . . 0.97 110.83 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.46 -34.46 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.93 110.673 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -50.83 69.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 1.86 110.716 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 51' ' ' VAL . 4.0 t -70.4 -36.85 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 1.82 111.098 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -49.91 -45.73 51.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.668 -0.696 . . . . 1.97 111.573 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.496 ' HB3' ' H ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -87.08 -103.68 0.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.381 -0.372 . . . . 3.57 111.034 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.496 ' H ' ' HB3' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -140.53 36.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.549 -0.296 . . . . 3.64 111.225 -175.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 53.04 64.58 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.264 0.555 . . . . 4.58 110.363 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -38.1 78.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.629 -0.714 . . . . 2.8 111.79 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t 70.48 -50.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 123.669 0.606 . . . . 3.13 110.963 -175.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.444 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -80.92 -131.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 4.56 111.057 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -71.71 132.17 85.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.159 0.504 . . . . 3.01 110.864 -177.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.1 Cg_exo -78.53 69.82 7.55 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 123.516 2.811 . . . . 1.91 111.917 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -60.09 117.57 5.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 2.46 111.817 -176.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.05 50.63 17.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.501 -0.772 . . . . 2.42 112.213 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 p -126.97 -35.66 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.528 -0.469 . . . . 2.11 110.931 173.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.675 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.0 OUTLIER 177.09 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.443 0.464 . . . . 2.19 110.781 178.343 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.584 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 22.1 m-85 -72.59 -51.89 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.233 0.457 . . . . 1.87 112.233 -173.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.921 0.391 . . . . 1.09 111.546 -176.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -179.51 97.58 0.2 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 3.23 109.63 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HD3' HD13 ' A' ' 41' ' ' ILE . 9.5 Cg_exo -71.84 54.37 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.286 2.657 . . . . 1.77 112.707 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.484 HG22 ' HE2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -150.97 59.67 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.921 -0.77 . . . . 2.46 108.921 176.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.731 HD11 ' HA ' ' A' ' 16' ' ' GLU . 17.9 pt -64.61 -21.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 2.08 112.446 -170.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.484 ' HE2' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -61.61 -39.65 92.01 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.064 0.459 . . . . 3.8 110.493 175.124 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.77 73.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.923 -0.58 . . . . 1.08 110.648 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.675 HD13 ' HA ' ' A' ' 68' ' ' LEU . 25.5 mt -72.82 -25.31 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.264 -0.425 . . . . 2.41 110.441 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.5 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 1.57 111.331 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.427 ' H ' ' HG2' ' A' ' 79' ' ' GLN . 5.4 pt20 -104.53 -39.79 6.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.392 -0.523 . . . . 2.74 111.055 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.14 -65.42 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.995 0.369 . . . . 2.85 111.995 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.92 -25.01 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 2.13 111.57 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.55 33.83 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 1.9 111.477 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.278 0.561 . . . . 2.65 110.707 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.496 0.665 . . . . 3.47 111.127 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.527 ' HB1' ' HG ' ' A' ' 35' ' ' LEU . . . -80.34 125.02 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.422 -0.808 . . . . 3.01 110.939 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -80.32 58.78 3.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.222 0.534 . . . . 3.51 110.332 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.474 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -141.58 -94.14 0.14 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.67 -0.696 . . . . 2.32 109.925 178.405 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.547 HG23 ' HA3' ' A' ' 33' ' ' GLY . 13.0 p 33.09 62.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.295 0.997 . . . . 2.13 112.697 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.09 100.96 53.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.781 -0.645 . . . . 2.09 110.691 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.1 139.16 23.71 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.147 2.564 . . . . 1.88 112.425 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -47.09 8.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 2.04 110.238 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.6 t-20 -102.95 149.64 24.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.374 -0.83 . . . . 2.24 109.821 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.88 81.73 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.266 0.469 . . . . 1.42 112.266 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -29.38 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.52 -0.309 . . . . 1.99 110.516 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 51.9 mt-10 -60.03 -40.18 88.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 1.93 109.808 175.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -37.76 79.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.034 -0.53 . . . . 1.48 110.325 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.17 91.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 2.96 110.374 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -67.05 -53.59 29.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.712 -0.676 . . . . 1.81 110.978 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.24 99.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 1.08 112.092 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -63.25 -53.5 52.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.856 -0.156 . . . . 2.69 111.132 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.602 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 33.5 mm -58.5 -47.95 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 1.91 111.169 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -67.46 -53.53 28.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.786 0.327 . . . . 1.33 111.677 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 32' ' ' ILE . 4.6 tp10 -71.91 -52.15 18.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.548 -0.297 . . . . 2.78 111.743 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -0.69 24.09 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.933 -0.48 . . . . 4.4 111.781 -172.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.602 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 5.1 t -108.59 -43.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.075 -0.25 . . . . 2.01 110.758 173.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.08 -51.99 2.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 2.85 111.852 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -61.07 -45.2 97.06 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.255 -0.498 . . . . 1.73 113.003 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 33.7 t 76.56 -51.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.553 0.741 . . . . 1.92 111.809 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.93 -54.76 42.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.958 0.355 . . . . 2.21 111.958 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.31 57.97 0.66 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.151 -1.023 . . . . 1.58 111.88 -175.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.414 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 22.8 mm -90.64 -52.8 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.639 -0.504 . . . . 3.56 109.639 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . 56.32 -117.06 8.32 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.488 -0.778 . . . . 2.28 113.152 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.509 ' H ' ' HA ' ' A' ' 9' ' ' VAL . 13.3 mm -81.52 87.78 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 2.67 111.078 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.527 ' HG ' ' HB1' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -166.07 26.45 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 2.46 109.327 174.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.876 ' HA ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 p-10 38.47 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.909 -1.041 . . . . 4.2 111.983 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.13 -69.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.23 0.826 . . . . 4.13 113.23 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -56.67 15.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.795 0.331 . . . . 2.27 111.588 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.84 -72.15 0.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.288 -0.415 . . . . 2.01 111.698 -174.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.876 ' HG2' ' HA ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -73.62 81.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 2.39 111.803 -174.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 tp 179.08 -26.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.336 -0.847 . . . . 3.23 110.013 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.01 28.07 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.945 -0.645 . . . . 2.06 112.235 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.94 103.23 1.1 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 2.17 112.467 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -130.24 61.62 1.59 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.448 . . . . 2.26 110.305 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.16 162.47 29.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.79 -0.641 . . . . 1.31 110.735 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.61 61.5 4.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.484 0.659 . . . . 2.37 110.719 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 155.79 49.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.373 -0.83 . . . . 2.27 109.774 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.98 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.565 0.222 . . . . 1.64 111.506 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.86 -42.51 75.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 2.58 111.203 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -76.85 -36.51 56.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 1.06 111.124 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 55' ' ' VAL . 46.5 t -64.15 -42.96 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 1.46 110.4 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.45 84.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 0.97 111.019 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.84 -35.12 79.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.93 111.147 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.67 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 3.5 tt0 -67.64 -40.86 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 1.86 111.017 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 51' ' ' VAL . 22.5 t -79.53 -38.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.845 -0.616 . . . . 1.82 111.483 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -58.57 -30.86 67.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.472 -0.331 . . . . 1.97 111.304 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.587 ' HB3' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -87.15 16.03 5.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.746 -0.206 . . . . 3.57 111.283 -178.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 56.44 65.92 1.31 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.321 -0.4 . . . . 3.64 110.328 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 64.45 76.92 0.33 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.705 -0.68 . . . . 4.58 110.566 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.67 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -84.38 -11.96 55.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 2.8 111.028 -178.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t 53.32 -111.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.027 -0.533 . . . . 3.13 110.385 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 2.1 tp10 -127.26 28.93 5.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.08 0.467 . . . . 4.56 110.121 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.02 87.9 20.3 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 3.01 110.961 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 9.3 Cg_endo -91.82 105.49 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.639 2.893 . . . . 1.91 112.208 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 mt -118.03 -30.11 5.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.026 0.441 . . . . 2.46 110.884 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -153.83 82.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 2.42 110.301 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.441 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -149.26 -169.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.897 -0.592 . . . . 2.11 110.137 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -60.14 -32.3 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 2.19 111.037 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 50' ' ' ALA . 89.1 m-85 -110.17 36.62 2.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 1.87 110.61 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HB3' ' H ' ' A' ' 67' ' ' VAL . . . -158.9 56.54 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.367 . . . . 1.09 110.969 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.532 ' HG3' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -164.52 128.34 1.77 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 3.23 109.954 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 6.5 Cg_exo -75.5 13.82 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.994 2.463 . . . . 1.77 112.363 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -153.85 115.65 4.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.3 -0.63 . . . . 2.46 109.3 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -28.83 5.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.44 . . . . 2.08 111.344 -171.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 13' ' ' ASN . 17.6 pttt -57.92 -36.69 72.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.588 -0.278 . . . . 3.8 111.169 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.16 -39.26 89.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.076 0.465 . . . . 1.08 110.801 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HG3' ' A' ' 71' ' ' GLN . 5.4 mt -72.47 -45.41 59.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 2.41 110.133 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -59.22 -42.5 91.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.57 111.749 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.26 1.25 41.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 2.74 111.566 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -129.78 -90.2 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.726 -0.39 . . . . 2.85 111.69 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.3 m -70.6 -18.6 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.51 0.559 . . . . 2.13 112.51 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.85 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -102.25 15.29 29.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.331 . . . . 1.9 111.77 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 120.839 -0.344 . . . . 2.65 111.219 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.434 -0.58 . . . . 3.47 109.434 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.31 -99.19 0.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.499 -0.319 . . . . 3.01 110.904 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.26 -58.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.68 0.276 . . . . 3.51 110.884 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.468 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . 8.6 t80 -46.97 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.231 -0.895 . . . . 2.32 112.577 -173.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.2 p 42.74 36.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.094 0.949 . . . . 2.13 112.524 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.38 84.32 56.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.89 -0.595 . . . . 2.09 111.531 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 31.3 Cg_exo -59.71 133.96 54.55 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.353 2.036 . . . . 1.88 111.103 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -45.96 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.651 0.612 . . . . 2.04 112.651 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -136.47 107.36 6.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.706 1.002 . . . . 2.24 113.706 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 42.09 -85.88 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.961 1.467 . . . . 1.42 114.961 163.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -53.29 -34.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.072 -0.513 . . . . 1.99 111.204 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.98 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 39.5 mt-10 -61.81 -45.97 91.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.463 -0.789 . . . . 1.93 110.69 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.555 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -63.25 -35.49 80.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 1.48 110.997 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -60.59 -60.07 4.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 2.96 110.976 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.57 -40.01 77.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 1.81 111.427 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.53 -50.72 66.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.362 -0.381 . . . . 1.08 111.454 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 26.2 mt-10 -62.53 -41.03 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.497 0.189 . . . . 2.69 111.428 -175.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.85 -43.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 1.91 110.362 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -72.79 -48.72 35.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.09 -0.504 . . . . 1.33 112.065 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.81 -26.49 25.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.585 0.587 . . . . 2.78 112.585 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -99.22 -48.05 4.97 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 4.4 111.552 -177.263 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.85 -47.68 16.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.688 0.28 . . . . 2.01 111.618 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.54 -65.58 0.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 2.85 111.872 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.09 -41.7 17.38 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.942 -0.647 . . . . 1.73 113.306 -175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t 63.77 83.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.16 0.505 . . . . 1.92 110.214 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.28 -83.49 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 2.21 111.778 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.14 72.31 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.231 -1.147 . . . . 1.58 110.231 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 33' ' ' GLY . 4.8 tp -96.75 173.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.369 0.604 . . . . 3.56 112.415 -167.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.555 ' H ' HG13 ' A' ' 32' ' ' ILE . . . -152.47 173.85 31.46 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.825 -0.625 . . . . 2.28 111.651 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.649 HG23 ' HB2' ' A' ' 72' ' ' PRO . 19.3 mm -85.97 68.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.369 0.604 . . . . 2.67 110.559 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -141.64 -67.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.491 -0.777 . . . . 2.46 109.041 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -131.07 147.39 52.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.47 -0.937 . . . . 4.2 108.47 173.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -144.71 160.96 40.36 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 121.062 -0.255 . . . . 4.13 110.859 -174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -100.96 -17.17 16.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.136 -0.484 . . . . 2.27 110.475 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.449 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.1 OUTLIER -129.66 -45.44 1.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.947 -0.57 . . . . 2.01 110.683 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.449 HE21 ' HE2' ' A' ' 39' ' ' PHE . 26.2 mt-30 -82.65 62.23 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.25 -0.281 . . . . 2.39 110.662 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 tp -169.5 -22.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 111.916 0.339 . . . . 3.23 111.916 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.22 -36.96 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.426 -0.892 . . . . 2.06 112.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.35 131.21 41.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.037 -0.602 . . . . 2.17 111.884 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -113.19 100.71 8.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.043 0.449 . . . . 2.26 110.336 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.0 154.73 25.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.573 -0.74 . . . . 1.31 111.032 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.83 91.46 1.96 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 2.37 110.485 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.32 156.12 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 2.27 110.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -25.6 64.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 1.64 111.064 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 ttt -63.1 -34.75 78.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 2.58 110.601 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HA ' ' HZ ' ' A' ' 69' ' ' PHE . . . -72.29 -38.75 68.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 1.06 110.355 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 55' ' ' VAL . 10.5 t -64.25 -38.58 82.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 1.46 110.315 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.26 93.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 0.97 110.719 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.92 96.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 0.93 110.47 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.479 ' HA ' ' HG3' ' A' ' 60' ' ' GLN . 4.0 mm-40 -58.36 -49.63 76.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.701 . . . . 1.86 110.716 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.7 t -64.63 -31.25 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 1.82 110.769 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -68.79 -18.96 64.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 1.97 111.924 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -120.8 19.18 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.715 0.293 . . . . 3.57 110.642 178.068 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 51.44 60.62 3.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.544 -0.753 . . . . 3.64 111.302 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 68.54 73.29 0.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.315 -0.857 . . . . 4.58 110.879 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -79.68 97.33 6.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.152 -0.931 . . . . 2.8 110.024 178.013 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -70.11 88.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.393 . . . . 3.13 111.115 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.22 43.46 26.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.724 -0.671 . . . . 4.56 111.179 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -154.62 75.0 5.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 3.01 110.584 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.731 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.7 Cg_endo -87.03 47.68 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.517 2.811 . . . . 1.91 112.432 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -56.83 101.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.682 -0.69 . . . . 2.46 112.268 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.766 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 11.4 mtmm 58.3 31.3 20.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.457 -0.792 . . . . 2.42 112.213 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.92 -21.37 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.945 -0.302 . . . . 2.11 110.948 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -175.04 -74.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.101 0.477 . . . . 2.19 109.727 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.731 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 11.0 m-85 -84.49 53.14 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 1.87 111.056 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.766 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -172.09 134.08 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.92 -0.582 . . . . 1.09 109.607 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 65.7 tp60 72.88 88.51 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 124.199 0.937 . . . . 3.23 110.455 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HB2' HG23 ' A' ' 34' ' ' ILE . 7.6 Cg_exo -72.97 63.59 4.07 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.443 2.762 . . . . 1.77 112.429 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.1 93.88 2.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.827 -0.624 . . . . 2.46 109.506 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.98 ' HB ' ' HG2' ' A' ' 16' ' ' GLU . 1.8 mt -64.88 -35.88 76.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 2.08 111.293 -173.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -59.17 -43.6 92.12 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.923 0.392 . . . . 3.8 110.648 175.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -42.92 69.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 1.08 110.68 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.31 -25.95 67.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 2.41 110.809 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.17 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.192 -0.458 . . . . 1.57 111.002 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.36 -13.63 59.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.017 0.437 . . . . 2.74 110.551 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.25 -72.93 0.48 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 2.85 111.226 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.29 -43.52 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 2.13 110.976 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.63 30.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.347 0.594 . . . . 1.9 110.841 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 2.65 110.129 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.111 -0.7 . . . . 3.47 109.111 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.31 -21.05 50.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 3.01 112.426 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 68.48 -58.84 0.46 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.272 0.629 . . . . 3.51 111.153 -175.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.83 72.9 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 2.32 110.893 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.464 ' HA ' HG12 ' A' ' 34' ' ' ILE . 6.5 p -125.99 5.52 4.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.399 0.619 . . . . 2.13 110.464 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -86.59 109.53 24.66 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 2.09 110.658 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.556 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 5.1 Cg_exo -81.43 -172.41 1.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.385 2.723 . . . . 1.88 111.871 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.98 -49.18 2.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 2.04 110.885 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.404 HD21 HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -99.85 159.38 15.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 2.24 110.717 -175.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.8 95.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.48 . . . . 1.42 112.12 -175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 HD21 ' A' ' 13' ' ' ASN . 15.3 t -64.09 -39.82 86.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 1.99 110.667 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.613 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 27.7 mt-10 -57.36 -42.34 81.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.774 -0.648 . . . . 1.93 110.458 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -75.16 -31.28 60.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 1.48 111.428 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -56.03 22.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 2.96 111.043 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.55 -32.64 73.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 1.81 110.612 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.7 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 1.08 110.691 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -56.39 -50.96 70.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.536 . . . . 2.69 111.055 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.21 -52.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.693 -0.685 . . . . 1.91 111.129 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -64.07 -42.83 96.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.444 -0.343 . . . . 1.33 111.417 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.729 ' HB2' HG12 ' A' ' 32' ' ' ILE . 5.5 tp10 -60.21 -44.8 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.584 -0.28 . . . . 2.78 111.169 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -20.75 39.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 4.4 112.295 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -97.07 -52.39 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.842 0.312 . . . . 2.01 111.842 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.73 -31.47 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.948 0.351 . . . . 2.85 111.948 -174.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.81 -73.84 0.42 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.306 -0.473 . . . . 1.73 112.72 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t 69.15 -63.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.049 0.54 . . . . 1.92 111.926 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 m -66.57 -32.76 74.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 2.21 110.616 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.83 127.54 2.76 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.762 -0.733 . . . . 1.58 112.654 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.729 HG12 ' HB2' ' A' ' 24' ' ' GLU . 1.3 pt -104.2 172.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 3.56 110.535 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.65 163.34 33.53 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.044 -0.598 . . . . 2.28 111.78 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -92.49 -7.53 10.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.038 0.446 . . . . 2.67 110.821 -178.325 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.627 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -87.18 -43.16 12.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.509 -0.314 . . . . 2.46 110.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.627 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 20.3 t70 -174.71 161.51 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.141 -0.689 . . . . 4.2 109.141 -177.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.599 ' ND2' ' HA ' ' A' ' 32' ' ' ILE . 6.5 t-20 -169.64 164.11 10.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.207 -0.294 . . . . 4.13 110.207 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -77.51 -24.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 2.27 110.807 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -88.2 -33.69 18.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.083 -0.508 . . . . 2.01 111.042 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.4 mt-30 -84.63 33.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.333 . . . . 2.39 111.779 -172.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.465 ' HB ' ' H ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -151.25 -127.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.693 -0.484 . . . . 3.23 109.693 176.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 41' ' ' ILE . . . -84.89 53.91 4.87 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.914 -0.66 . . . . 2.06 111.949 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -139.73 55.44 0.65 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.617 -0.593 . . . . 2.17 111.617 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -73.61 135.36 43.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.626 0.25 . . . . 2.26 110.799 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.99 171.43 14.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 1.31 110.266 175.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.15 67.95 3.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.219 0.533 . . . . 2.37 109.562 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -126.41 170.8 11.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 2.27 110.6 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.71 71.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 1.64 110.766 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.3 tpp -60.38 -35.34 75.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.903 -0.589 . . . . 2.58 110.674 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -70.13 -44.08 69.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 1.06 110.264 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.01 -44.5 91.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.05 -0.523 . . . . 1.46 110.319 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.91 73.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.97 111.089 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -64.2 -51.09 65.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.93 111.147 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -68.11 -33.1 73.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.042 -0.263 . . . . 1.86 111.178 -178.1 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.15 -44.1 81.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.356 . . . . 1.82 110.421 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -71.46 -28.01 63.66 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.901 0.381 . . . . 1.97 110.698 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -78.93 -32.63 45.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 3.57 110.695 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER 70.1 9.75 7.15 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.742 0.651 . . . . 3.64 110.903 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -172.66 156.63 3.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.033 -1.099 . . . . 4.58 108.033 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -143.67 -36.65 0.35 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.103 -0.639 . . . . 2.8 112.096 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.1 t 69.01 -73.89 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 123.579 0.549 . . . . 3.13 109.733 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.78 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.483 0.713 . . . . 4.56 109.422 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -105.66 107.74 60.02 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.821 -0.627 . . . . 3.01 110.33 178.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 18.6 Cg_endo -92.38 99.27 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.466 2.778 . . . . 1.91 111.915 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.97 -19.65 47.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.717 0.265 . . . . 2.46 111.717 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.78 115.94 3.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.645 -0.252 . . . . 2.42 110.364 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.416 HG13 ' H ' ' A' ' 68' ' ' LEU . 2.1 p -171.25 -55.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.46 -0.336 . . . . 2.11 110.781 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.541 ' HA ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -167.02 -37.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.009 0.433 . . . . 2.19 110.225 -176.162 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -83.0 -67.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 1.87 111.106 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 40' ' ' GLN . . . -76.58 88.96 3.3 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.041 0.448 . . . . 1.09 111.625 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.513 ' HB3' HD23 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -175.45 85.08 0.3 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.166 -0.925 . . . . 3.23 109.455 175.038 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.12 70.74 0.55 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.433 2.755 . . . . 1.77 112.034 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.52 -24.57 0.09 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.246 -0.888 . . . . 2.46 109.555 177.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.514 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 mt 71.35 -68.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.501 -0.772 . . . . 2.08 111.955 174.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HB2' ' HG3' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -72.28 -15.68 61.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.698 0.259 . . . . 3.8 111.698 -174.361 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.52 13.77 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.024 0.44 . . . . 1.08 110.8 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -63.44 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 2.41 109.96 178.237 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -75.15 0.42 16.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 1.57 111.529 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -32.41 11.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 2.74 110.454 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.49 -64.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.276 -0.569 . . . . 2.85 112.381 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.45 -40.28 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 2.13 110.96 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -105.91 159.12 16.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.809 -0.632 . . . . 1.9 109.482 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 123.038 0.535 . . . . 2.65 111.551 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 121.186 0.517 . . . . 3.47 110.389 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.63 125.61 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.462 -0.79 . . . . 3.01 111.42 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.61 63.09 4.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 3.51 111.131 -177.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.633 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t80 -121.89 -86.37 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.938 -0.764 . . . . 2.32 108.938 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' H ' ' HB3' ' A' ' 8' ' ' TYR . 94.7 t 73.13 -55.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.759 0.662 . . . . 2.13 111.872 173.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -82.32 108.69 12.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.58 0.229 . . . . 2.09 111.033 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.779 ' HG2' ' HB3' ' A' ' 16' ' ' GLU . 20.4 Cg_endo -95.64 -99.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.593 2.862 . . . . 1.88 111.559 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 p -98.87 -80.4 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.866 0.365 . . . . 2.04 110.239 174.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -134.24 -174.86 3.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 2.24 110.873 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.92 -33.4 56.54 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.63 0.974 . . . . 1.42 113.63 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.82 -34.33 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.955 0.407 . . . . 1.99 110.701 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.779 ' HB3' ' HG2' ' A' ' 11' ' ' PRO . 4.6 tt0 -79.95 -38.01 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.253 -0.43 . . . . 1.93 110.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -63.62 -39.01 93.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.403 . . . . 1.48 110.884 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HE3' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -69.59 -31.66 69.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.448 -0.342 . . . . 2.96 110.803 178.477 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.496 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 tp -64.92 -46.13 82.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.605 -0.517 . . . . 1.81 109.605 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 24' ' ' GLU . . . -60.19 -33.87 72.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.484 -0.78 . . . . 1.08 110.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 17' ' ' SER . 85.5 mt-10 -57.79 -47.23 83.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 2.69 111.092 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.549 HD11 ' HE3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -71.83 -48.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.042 0.449 . . . . 1.91 111.066 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -68.57 -47.08 67.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.551 . . . . 1.33 112.035 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -69.79 -45.55 67.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.623 -0.262 . . . . 2.78 111.17 -175.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.468 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 2.1 mmt180 -71.89 -37.85 70.08 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.005 0.372 . . . . 4.4 112.005 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.29 -59.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.096 0.406 . . . . 2.01 112.096 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 40.3 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.1 0.476 . . . . 2.85 111.349 -173.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -172.83 -46.41 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.645 -0.788 . . . . 1.73 112.207 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 7.2 t 78.4 -37.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.352 0.661 . . . . 1.92 110.572 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.7 144.77 43.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.128 -0.487 . . . . 2.21 110.406 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.58 71.74 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.722 . . . . 1.58 113.08 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 36.1 mm -101.96 91.34 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.453 0.644 . . . . 3.56 110.359 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 34' ' ' ILE . . . -79.7 79.98 1.62 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.648 -0.787 . . . . 2.28 112.246 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 33' ' ' GLY . 38.8 mm 78.05 -43.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.399 0.68 . . . . 2.67 112.504 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.633 ' HG ' ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -35.86 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 2.46 113.527 -174.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.72 110.71 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 4.2 111.089 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.05 95.7 6.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.068 -0.515 . . . . 4.13 109.88 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -96.59 -24.58 15.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 2.27 112.637 -174.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -131.79 -9.21 3.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.632 -0.427 . . . . 2.01 111.637 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 8.1 mp0 -72.0 -57.71 4.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.337 -0.392 . . . . 2.39 111.329 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.549 HG23 ' HB1' ' A' ' 70' ' ' ALA . 1.6 mt -105.62 74.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.998 0.428 . . . . 3.23 111.281 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.95 -82.55 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.369 -0.92 . . . . 2.06 113.257 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.45 80.81 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.133 -0.556 . . . . 2.17 112.733 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.427 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 2.9 p-80 -65.21 141.7 58.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.01 0.433 . . . . 2.26 110.483 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.74 29.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 1.31 111.206 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 mt -87.24 -10.96 51.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.104 -0.702 . . . . 2.37 109.104 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -56.21 150.53 14.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.595 -1.184 . . . . 2.27 110.989 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -17.83 51.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.197 -0.456 . . . . 1.64 111.964 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -63.1 -48.23 79.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 2.58 110.786 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.71 -28.39 50.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 1.06 110.431 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.18 -40.13 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 1.46 110.272 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.82 92.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.97 110.533 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.519 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -64.52 -42.24 95.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 0.93 110.415 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.699 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 tt0 -59.84 -46.92 87.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.587 -0.733 . . . . 1.86 110.777 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -65.95 -39.24 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 1.82 110.903 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -72.71 5.3 3.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 1.97 111.897 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -137.29 24.66 2.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.977 0.418 . . . . 3.57 110.362 175.316 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.08 49.73 11.1 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.438 -0.801 . . . . 3.64 111.965 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.699 ' HA ' ' HG3' ' A' ' 54' ' ' GLN . 21.7 m-30 66.8 87.97 0.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.692 -0.685 . . . . 4.58 112.147 171.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -77.76 -17.79 57.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.607 -0.724 . . . . 2.8 110.988 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 53.6 t 77.03 -57.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 123.388 0.675 . . . . 3.13 112.264 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 -70.45 0.79 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.823 0.305 . . . . 4.56 111.823 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.51 140.9 28.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.569 -0.287 . . . . 3.01 110.899 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' OE1' ' A' ' 60' ' ' GLN . 74.5 Cg_endo -75.84 62.39 6.51 Favored 'Trans proline' 0 C--O 1.237 0.466 0 C-N-CA 122.933 2.422 . . . . 1.91 111.731 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.834 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 22.3 tp -77.08 126.55 31.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 2.46 111.679 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt 64.48 14.9 9.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.416 -0.811 . . . . 2.42 112.487 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.519 HG11 ' HB1' ' A' ' 53' ' ' ALA . 7.2 p -98.35 -35.15 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.759 -0.376 . . . . 2.11 110.188 174.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER 175.43 -58.8 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.164 0 O-C-N 123.612 0.57 . . . . 2.19 110.585 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.4 m-85 -66.74 -50.9 61.27 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.964 0.727 . . . . 1.87 112.964 -171.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . -77.95 70.55 4.33 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.184 0.438 . . . . 1.09 112.184 -173.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.71 130.22 1.52 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.58 -0.736 . . . . 3.23 109.509 174.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.665 ' O ' ' HB ' ' A' ' 73' ' ' THR . 39.5 Cg_exo -61.27 105.15 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.499 2.132 . . . . 1.77 111.282 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.665 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER 81.94 113.54 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.18 0.925 . . . . 2.46 109.35 -171.349 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 68' ' ' LEU . 4.2 mm -83.12 -22.69 8.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.044 -0.98 . . . . 2.08 110.322 -174.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -54.08 -37.12 63.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.633 -0.712 . . . . 3.8 111.681 -178.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.06 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.08 110.968 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.66 -27.74 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 2.41 110.646 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.876 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -60.83 -49.71 76.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 1.57 111.865 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.82 -0.29 57.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.742 -0.383 . . . . 2.74 111.412 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -101.43 -69.08 0.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.94 -0.304 . . . . 2.85 111.283 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -13.43 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 111.854 0.316 . . . . 2.13 111.854 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.876 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -99.05 21.9 11.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 1.9 111.124 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.501 0.667 . . . . 2.65 110.692 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.678 0.275 . . . . 8.54 110.87 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 54.81 21.95 24.72 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.461 -0.876 . . . . 5.41 111.733 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.3 m -52.8 -17.62 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 120.957 0.408 . . . . 6.05 110.911 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p -42.47 149.06 0.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.429 -0.805 . . . . 3.59 111.316 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 5' ' ' GLU . 11.6 mp0 -44.54 118.32 1.53 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.89 -0.595 . . . . 3.47 111.068 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . . . -82.91 130.07 35.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.044 -0.526 . . . . 3.01 111.05 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -85.15 20.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 3.51 110.519 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -125.05 46.01 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 2.32 111.126 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.55 2.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 2.13 111.058 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.07 110.25 3.98 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 2.09 111.45 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -91.03 158.93 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.592 2.195 . . . . 1.88 111.975 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.23 -44.24 8.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 2.04 111.082 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.04 156.36 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 2.24 110.976 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.49 64.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 1.42 111.296 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -64.89 -41.95 93.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 1.99 111.168 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.22 -38.45 78.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 1.93 111.027 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -64.52 -42.02 96.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.48 110.986 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -68.18 -48.79 64.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 2.96 111.258 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -47.2 85.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 1.81 110.957 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.18 80.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.511 . . . . 1.08 111.367 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 17' ' ' SER . 10.2 tt0 -66.05 -51.7 55.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 2.69 111.501 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.81 -34.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.09 0.404 . . . . 1.91 112.09 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -76.38 -44.2 37.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.666 0.617 . . . . 1.33 112.666 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.47 9.65 12.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.908 0.336 . . . . 2.78 111.908 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.48 ' HB2' HH11 ' A' ' 25' ' ' ARG . 5.6 ttm105 -118.46 -21.74 7.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 4.4 110.853 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.41 -24.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 2.01 111.133 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.74 -61.37 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 2.85 111.517 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -59.61 9.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 1.73 113.319 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t 59.09 12.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.03 0.443 . . . . 1.92 110.85 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.7 m -98.46 -68.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 2.21 111.01 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.54 33.97 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.754 -0.736 . . . . 1.58 111.932 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.452 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 1.1 pt -88.44 -173.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 3.56 111.308 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.55 -109.23 0.23 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.868 -0.682 . . . . 2.28 112.413 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.28 49.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.724 0.297 . . . . 2.67 111.189 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.98 9.85 6.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.497 -0.32 . . . . 2.46 111.318 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.13 150.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 4.2 110.443 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.428 ' ND2' ' HB ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -177.76 -96.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 4.13 111.117 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -119.95 -28.11 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.357 -0.383 . . . . 2.27 111.264 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -78.67 -83.89 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.294 -0.412 . . . . 2.01 111.676 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.86 82.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 2.39 111.247 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 tp -172.03 -36.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.849 0.315 . . . . 3.23 111.849 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.96 -30.46 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.252 -0.975 . . . . 2.06 112.98 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.12 120.43 18.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.613 -0.803 . . . . 2.17 112.297 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -98.76 26.56 5.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.751 0.275 . . . . 2.26 111.387 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 31.16 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.99 0.737 . . . . 1.31 112.99 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.92 31.57 0.94 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.214 -0.448 . . . . 2.37 110.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -105.3 169.6 8.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 2.27 111.205 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.2 79.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.013 -0.54 . . . . 1.64 111.229 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.6 ttt -58.9 -32.11 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.414 . . . . 2.58 110.606 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.47 -47.17 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 1.06 110.652 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 55' ' ' VAL . 19.8 t -57.52 -34.48 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 1.46 110.089 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -65.48 -43.28 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.639 . . . . 0.97 110.275 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -26.42 67.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.02 -0.536 . . . . 0.93 110.483 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -44.6 61.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.805 -0.634 . . . . 1.86 110.801 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 51' ' ' VAL . 13.0 t -76.55 -26.49 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 1.82 111.282 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -77.61 2.68 15.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 1.97 111.154 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -133.58 8.27 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.37 . . . . 3.57 111.537 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 68.39 53.8 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 3.64 111.31 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 57.74 88.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 4.58 111.8 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.782 ' NE2' HG11 ' A' ' 67' ' ' VAL . 5.7 mt-30 -67.68 -30.1 69.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.649 -0.501 . . . . 2.8 109.649 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.2 t 65.86 -72.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 115.322 -0.854 . . . . 3.13 111.861 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -92.81 -84.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.506 0.558 . . . . 4.56 112.506 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.06 135.14 20.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.206 0.447 . . . . 3.01 112.206 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 67' ' ' VAL . 84.4 Cg_endo -88.24 58.36 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.769 2.313 . . . . 1.91 111.125 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.95 119.08 5.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.587 -0.733 . . . . 2.46 112.241 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mttp 47.15 83.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 2.42 112.123 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.782 HG11 ' NE2' ' A' ' 60' ' ' GLN . 13.7 p -155.62 -44.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.288 -0.414 . . . . 2.11 111.051 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.432 ' N ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -178.27 -39.53 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.549 -0.296 . . . . 2.19 111.499 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -91.97 -52.72 4.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.066 0.395 . . . . 1.87 112.066 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.9 71.56 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.954 0.353 . . . . 1.09 111.954 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.623 ' HB2' HD11 ' A' ' 77' ' ' LEU . 0.0 OUTLIER 176.42 115.27 0.13 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.148 -0.478 . . . . 3.23 110.582 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.99 41.35 0.83 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.434 2.09 . . . . 1.77 112.879 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.91 74.54 0.73 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.146 0.498 . . . . 2.46 110.23 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.08 -40.79 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.648 -0.705 . . . . 2.08 112.296 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -30.83 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 3.8 111.146 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.09 68.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 1.08 110.734 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 71' ' ' GLN . 30.7 mt -72.82 -27.33 61.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.049 -0.523 . . . . 2.41 110.602 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.814 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -60.61 -34.28 74.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 1.57 111.106 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -103.31 21.61 15.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 2.74 111.041 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 1.0 OUTLIER -129.91 -69.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 2.85 111.094 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 t -94.1 -39.26 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 2.13 111.332 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -72.64 -16.86 61.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 1.9 111.348 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 85' ' ' SER . 0.2 OUTLIER -55.82 -27.53 51.84 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.971 -0.381 . . . . 2.65 109.971 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.439 ' NH2' ' HA ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 58.4 -83.89 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.268 -0.878 . . . . 7.09 110.305 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.439 ' HA ' ' NH2' ' A' ' 84' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.141 -0.933 . . . . 5.98 110.507 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.818 -0.438 . . . . 8.54 109.818 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.56 -118.51 15.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.005 -0.617 . . . . 5.41 111.97 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.53 -28.76 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.875 -0.417 . . . . 6.05 109.875 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER 60.2 -124.86 1.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.547 -0.752 . . . . 3.59 110.106 -176.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 1.018 ' HA ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER 66.39 165.25 0.2 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.62 0.724 . . . . 3.47 112.174 177.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . . . -163.81 146.65 9.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.455 -0.793 . . . . 3.01 110.148 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -122.69 33.79 5.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.514 0.674 . . . . 3.51 109.196 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 34' ' ' ILE . 5.1 t80 -116.12 17.23 15.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.371 -0.831 . . . . 2.32 111.334 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.43 67.03 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.403 1.096 . . . . 2.13 110.122 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -106.41 105.29 53.88 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.106 -0.952 . . . . 2.09 110.515 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 1.1 Cg_endo -83.52 156.61 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.121 2.547 . . . . 1.88 111.974 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.56 -44.92 3.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.237 0.541 . . . . 2.04 109.645 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -114.59 177.49 4.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.511 -0.768 . . . . 2.24 109.832 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.42 -15.57 54.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.896 0.379 . . . . 1.42 110.768 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.78 -57.52 10.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.922 -0.581 . . . . 1.99 111.039 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.899 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 12.6 pm0 -72.75 -22.71 60.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.23 -0.441 . . . . 1.93 110.699 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.66 -48.5 79.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 1.48 110.097 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -61.08 -45.18 95.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 2.96 110.856 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.38 -56.07 16.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 1.81 111.395 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -67.12 -43.8 81.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.669 -0.696 . . . . 1.08 112.092 -173.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.05 -37.21 83.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.604 0.24 . . . . 2.69 111.314 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -46.99 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.045 -0.262 . . . . 1.91 110.595 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -69.28 -27.36 65.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.33 110.563 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.1 tm-20 -58.83 -52.03 67.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 2.78 110.471 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -19.35 60.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.726 0.298 . . . . 4.4 111.364 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.63 -49.27 15.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.497 -0.319 . . . . 2.01 111.409 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.45 -31.69 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.686 0.624 . . . . 2.85 112.686 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 -82.1 0.47 Allowed Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.656 -0.783 . . . . 1.73 113.723 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 74.56 4.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.011 0.924 . . . . 1.92 110.92 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.018 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 15.2 m -112.5 -17.0 12.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.703 -0.68 . . . . 2.21 111.965 -172.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 34.78 8.34 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.651 -0.98 . . . . 1.58 110.651 -174.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 30' ' ' SER . 1.3 pt -78.94 170.52 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.273 0.559 . . . . 3.56 112.085 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.77 158.19 7.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.52 -0.764 . . . . 2.28 111.619 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.453 HG21 ' HE2' ' A' ' 8' ' ' TYR . 36.4 mm 66.27 -79.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.011 0.525 . . . . 2.67 111.272 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.966 -0.383 . . . . 2.46 109.966 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 17.7 t0 41.75 -92.73 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.362 1.039 . . . . 4.2 112.906 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 92.74 -7.39 0.17 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.711 1.257 . . . . 4.13 111.761 175.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.627 ' HE2' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -109.67 -55.53 2.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.537 -0.542 . . . . 2.27 109.537 173.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.503 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 29.7 t80 -91.75 -73.13 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.378 -0.828 . . . . 2.01 109.909 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.536 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.8 mt-30 -70.43 96.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 2.39 109.963 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.5 tp 168.69 -18.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 3.23 110.029 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.55 35.55 3.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.666 -0.778 . . . . 2.06 111.418 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.13 124.75 7.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.679 -0.772 . . . . 2.17 111.746 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -84.7 74.75 10.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 2.26 110.556 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.53 161.45 30.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.868 -0.605 . . . . 1.31 110.835 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 67.43 6.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 2.37 110.596 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -139.33 160.16 40.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.726 -0.67 . . . . 2.27 109.761 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.09 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.445 0.466 . . . . 1.64 112.159 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tpt -60.85 -31.55 71.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.329 . . . . 2.58 111.305 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.521 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -71.74 -37.01 70.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.438 -0.346 . . . . 1.06 111.196 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 1.46 110.057 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -65.91 -35.17 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.09 -0.505 . . . . 0.97 110.151 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.432 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -69.78 -26.67 64.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.91 -0.586 . . . . 0.93 110.672 176.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -79.71 -22.56 43.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 1.86 110.897 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -94.91 -15.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 1.82 111.607 -176.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.68 40.89 1.05 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.295 0.569 . . . . 1.97 110.873 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 177.81 -150.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.672 -1.233 . . . . 3.57 107.672 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.06 164.62 14.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.579 -0.897 . . . . 3.64 108.579 168.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.37 82.96 2.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.278 0.561 . . . . 4.58 109.974 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.7 2.02 7.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.934 -1.03 . . . . 2.8 112.871 -173.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.436 ' HB ' ' H ' ' A' ' 62' ' ' GLU . 3.1 t 58.82 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 122.834 0.454 . . . . 3.13 111.442 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.441 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 55.0 mm-40 -121.71 23.78 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.552 -0.295 . . . . 4.56 110.983 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -125.45 68.98 60.88 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.403 . . . . 3.01 110.857 177.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 62' ' ' GLU . 5.6 Cg_endo -87.38 73.03 2.9 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.196 2.597 . . . . 1.91 111.991 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.0 tp -82.46 129.46 34.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.12 -0.491 . . . . 2.46 110.847 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 58.13 34.19 23.92 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.766 0.666 . . . . 2.42 111.127 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.603 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -94.99 -174.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.525 -0.761 . . . . 2.11 110.433 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.592 ' H ' HG22 ' A' ' 67' ' ' VAL . 5.4 mt -53.84 -21.29 7.27 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.247 0.832 . . . . 2.19 113.247 -174.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.521 ' HE2' ' HA ' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -138.93 44.51 2.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.106 0.479 . . . . 1.87 111.287 175.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.603 ' HB3' ' H ' ' A' ' 67' ' ' VAL . . . -120.98 47.7 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.899 0.381 . . . . 1.09 110.66 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.607 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -162.16 144.99 8.82 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.206 -0.906 . . . . 3.23 108.792 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.49 1.19 3.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.927 2.418 . . . . 1.77 113.119 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.595 HG22 ' HG3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -128.94 89.43 2.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.741 0.305 . . . . 2.46 110.577 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.506 ' HA ' HD12 ' A' ' 77' ' ' LEU . 2.7 tp -58.43 -32.61 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.059 -0.519 . . . . 2.08 112.255 -176.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.899 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -62.59 -38.86 91.79 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.228 -0.295 . . . . 3.8 110.79 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.26 -31.97 73.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 1.08 110.676 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.607 HD21 ' HB2' ' A' ' 71' ' ' GLN . 12.7 mt -78.42 -36.82 45.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.986 -0.552 . . . . 2.41 110.61 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.2 66.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 1.57 110.633 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -91.55 -0.05 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.621 . . . . 2.74 110.614 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -114.04 -88.89 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 2.85 111.121 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 m -82.29 21.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 2.13 112.044 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 68' ' ' LEU . . . -130.1 -4.24 4.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 1.9 110.867 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.69 -55.95 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 2.65 111.153 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -118.24 85.16 2.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 7.09 110.964 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.105 -0.95 . . . . 5.98 110.036 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HB3' ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.325 -0.25 . . . . 8.54 110.325 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' A' ' 1' ' ' MET . . . -86.24 139.88 17.13 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.755 -0.736 . . . . 5.41 112.305 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.37 103.62 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.948 0.404 . . . . 6.05 110.593 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.72 125.77 44.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.008 -0.542 . . . . 3.59 110.598 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' HG3' ' HB3' ' A' ' 30' ' ' SER . 2.0 mp0 -71.77 139.76 49.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.125 -0.488 . . . . 3.47 110.91 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 32' ' ' ILE . . . -148.39 144.65 27.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.021 -0.536 . . . . 3.01 110.082 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -105.16 91.37 3.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.896 0.379 . . . . 3.51 110.887 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.434 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 7.0 t80 -146.43 2.57 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.003 -0.544 . . . . 2.32 111.18 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 2.8 p -79.15 93.44 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 2.13 111.327 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.06 74.98 1.69 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.511 -0.768 . . . . 2.09 110.424 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HB2' ' H ' ' A' ' 12' ' ' THR . 2.1 Cg_endo -81.61 -133.69 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.088 2.525 . . . . 1.88 112.226 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -123.63 -48.11 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.118 0.485 . . . . 2.04 111.798 -177.485 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.788 HD21 ' HB ' ' A' ' 15' ' ' VAL . 1.8 t30 -98.27 132.4 43.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.872 -0.604 . . . . 2.24 110.503 -172.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.28 68.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.671 -0.695 . . . . 1.42 112.0 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.788 ' HB ' HD21 ' A' ' 13' ' ' ASN . 48.1 t -70.17 -48.42 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 1.99 110.958 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.505 ' OE1' ' HB3' ' A' ' 13' ' ' ASN . 1.7 pt-20 -67.8 -32.31 72.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.947 0.404 . . . . 1.93 110.32 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.42 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.3 m -69.48 -35.84 75.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.894 -0.594 . . . . 1.48 110.205 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -64.95 -41.78 95.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 2.96 110.737 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -46.4 90.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 1.81 110.652 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.02 92.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 1.08 111.282 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -40.43 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 2.69 111.696 -176.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -38.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 120.97 -0.292 . . . . 1.91 110.973 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -66.7 -45.25 79.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.089 0.471 . . . . 1.33 110.166 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -83.45 19.42 1.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.392 0.615 . . . . 2.78 111.301 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.471 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -120.17 -0.87 10.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.771 -0.649 . . . . 4.4 109.317 170.225 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.2 -25.13 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.862 -0.608 . . . . 2.01 111.852 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 tp -93.04 -81.13 0.36 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.501 0.191 . . . . 2.85 111.364 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.4 -39.87 6.64 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.66 -0.781 . . . . 1.73 111.644 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t 70.18 53.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.774 0.797 . . . . 1.92 110.648 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HB3' ' HG3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -118.64 -35.85 3.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 2.21 109.775 173.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' CA ' HH21 ' A' ' 25' ' ' ARG . . . 98.22 42.77 2.93 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.732 -0.667 . . . . 1.58 112.383 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -87.69 -80.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.803 0.335 . . . . 3.56 111.156 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.25 -69.71 3.08 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.932 -0.651 . . . . 2.28 111.589 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' HB ' ' HD2' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -107.31 152.09 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.172 -1.048 . . . . 2.67 108.172 174.154 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 44.3 1.53 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.359 -0.978 . . . . 2.46 108.359 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -70.46 174.52 5.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.23 -1.35 . . . . 4.2 111.957 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -140.85 -8.12 1.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 4.13 111.08 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.41 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 26.7 p90 -148.34 -33.81 0.23 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.002 0.742 . . . . 2.27 113.002 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -96.53 -83.09 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.047 -0.408 . . . . 2.01 111.66 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -59.12 -29.42 67.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.39 112.018 -173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 tp -115.1 -2.0 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.417 . . . . 3.23 111.52 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 38' ' ' PHE . . . -92.51 -95.95 1.4 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.437 -0.887 . . . . 2.06 112.71 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.12 -138.29 2.65 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.667 -0.778 . . . . 2.17 112.397 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -97.01 122.96 40.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.241 0.543 . . . . 2.26 111.366 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.33 -178.11 6.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 1.31 109.986 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -89.15 45.68 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.049 0.452 . . . . 2.37 110.947 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.58 163.74 22.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.393 -0.367 . . . . 2.27 111.418 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.96 94.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 1.64 111.534 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ttt -60.33 -34.58 74.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.402 . . . . 2.58 110.456 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . . . -69.95 -40.58 75.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 1.06 110.846 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -71.69 -34.88 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 1.46 110.616 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.35 -29.94 62.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.97 110.807 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -38.68 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.93 111.271 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' A' ' 51' ' ' VAL . 5.2 pt20 -68.73 -38.42 80.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.011 -0.276 . . . . 1.86 110.936 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 51' ' ' VAL . 35.7 m -92.83 19.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 1.82 110.973 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -88.13 -18.13 29.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.07 -0.513 . . . . 1.97 110.456 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.59 ' HG3' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -106.25 -63.9 1.22 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.041 0.448 . . . . 3.57 110.682 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.3 -151.97 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.632 -0.713 . . . . 3.64 109.298 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -75.82 64.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.414 0.626 . . . . 4.58 110.194 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.543 HE22 HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -119.18 91.99 3.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 2.8 109.177 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.29 -55.75 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.7 -0.682 . . . . 3.13 112.185 -170.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -63.72 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 4.56 111.652 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.72 111.66 54.11 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 3.01 110.672 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.9 127.54 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.557 2.171 . . . . 1.91 111.226 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tp -123.73 96.22 4.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 2.46 110.506 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 0.5 OUTLIER 54.67 62.62 2.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.908 -0.587 . . . . 2.42 111.377 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' A' ' 57' ' ' ARG . 11.3 p -132.04 -29.66 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.171 -0.468 . . . . 2.11 111.178 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.61 -51.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.92 -0.77 . . . . 2.19 108.92 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 50' ' ' ALA . 1.1 m-85 -104.67 172.31 6.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.217 -0.901 . . . . 1.87 109.172 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 71' ' ' GLN . . . 60.35 43.67 13.22 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.91 0.756 . . . . 1.09 111.266 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 167.06 123.57 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 O-C-N 124.215 0.947 . . . . 3.23 109.752 176.406 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.44 28.95 0.54 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.813 2.342 . . . . 1.77 113.061 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.47 39.75 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.06 0.457 . . . . 2.46 110.629 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -57.51 -39.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 2.08 111.846 -175.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.513 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -64.86 -43.07 94.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.788 0.328 . . . . 3.8 110.814 -178.314 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.05 74.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 1.08 110.992 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.23 -43.2 95.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.345 -0.389 . . . . 2.41 111.36 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.46 -4.62 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 1.57 111.493 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.29 -57.67 2.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.966 0.412 . . . . 2.74 110.781 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -74.11 -42.35 60.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 2.85 111.836 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.78 30.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.84 0.353 . . . . 2.13 111.425 -174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.96 30.32 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.091 0.472 . . . . 1.9 110.443 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -34.11 61.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 2.65 111.244 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.33 32.9 16.79 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 123.721 0.638 . . . . 7.09 110.529 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.291 -0.862 . . . . 5.98 110.131 -177.113 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 110.106 -0.331 . . . . 8.54 110.106 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.9 -127.78 1.19 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.872 -0.68 . . . . 5.41 111.839 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.448 HG12 ' HG3' ' A' ' 5' ' ' GLU . 1.7 t -86.15 81.06 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.807 0.337 . . . . 6.05 111.067 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -20.19 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.421 . . . . 3.59 110.25 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.448 ' HG3' HG12 ' A' ' 3' ' ' VAL . 3.9 mt-10 56.42 -146.33 0.57 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.079 -0.964 . . . . 3.47 111.894 174.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HA ' HD13 ' A' ' 35' ' ' LEU . . . -152.91 83.96 1.22 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.931 0.396 . . . . 3.01 111.051 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -92.59 -9.64 40.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 3.51 110.097 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -91.55 -54.86 3.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 2.32 110.052 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.53 HG12 ' HD3' ' A' ' 11' ' ' PRO . 2.2 t 56.73 -100.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.944 -0.571 . . . . 2.13 111.415 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.513 ' H ' ' HB ' ' A' ' 9' ' ' VAL . . . 57.02 65.63 3.65 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.596 0.591 . . . . 2.09 112.596 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.53 ' HD3' HG12 ' A' ' 9' ' ' VAL . 73.9 Cg_endo -88.97 143.44 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.55 2.166 . . . . 1.88 111.518 176.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.442 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -107.75 -34.64 6.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.858 0.361 . . . . 2.04 111.313 -177.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.35 151.07 49.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.32 -0.4 . . . . 2.24 110.764 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.35 68.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 1.42 111.297 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.17 -44.95 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 1.99 110.738 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -43.09 89.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 1.93 110.849 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -69.69 -43.95 71.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.541 . . . . 1.48 111.207 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.79 -40.51 83.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.682 -0.235 . . . . 2.96 111.213 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -45.0 96.57 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.761 0.315 . . . . 1.81 110.219 177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.41 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 1.08 110.903 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.76 -47.52 84.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 2.69 110.873 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.3 mt -71.89 -49.46 44.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.327 -0.397 . . . . 1.91 110.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.618 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 4.0 m95 -56.94 -52.5 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 1.33 111.609 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -63.0 -44.48 95.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.101 -0.5 . . . . 2.78 111.022 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 1.7 mmp_? -73.06 -2.84 22.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.958 0.355 . . . . 4.4 111.958 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.26 -45.07 8.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.6 -0.273 . . . . 2.01 111.246 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.1 -4.59 13.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.918 0.71 . . . . 2.85 112.918 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.3 -78.74 0.3 Allowed Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 120.088 -1.053 . . . . 1.73 112.917 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 80.96 -6.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.935 0.894 . . . . 1.92 110.627 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -44.78 78.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.516 -0.765 . . . . 2.21 111.479 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 5' ' ' GLU . . . 110.97 25.29 5.16 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.057 -0.592 . . . . 1.58 112.391 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.3 129.01 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.688 -0.301 . . . . 3.56 110.621 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.44 -80.56 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.299 -0.953 . . . . 2.28 112.608 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.461 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -96.08 85.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 2.67 110.699 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -166.33 -135.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.16 -0.927 . . . . 2.46 108.91 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.9 106.53 1.25 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.207 -1.035 . . . . 4.2 108.207 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.87 135.27 36.97 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.991 0.737 . . . . 4.13 112.991 -164.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -121.67 7.83 10.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.989 -1.005 . . . . 2.27 109.043 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.407 ' CD2' ' HG3' ' A' ' 40' ' ' GLN . 31.4 t80 -125.91 -62.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.226 -0.897 . . . . 2.01 110.651 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.63 ' NE2' ' HA ' ' A' ' 72' ' ' PRO . 5.1 mt-30 -85.02 53.63 2.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.487 . . . . 2.39 110.655 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.81 38.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 3.23 109.971 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.88 -71.21 0.3 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.195 -0.762 . . . . 2.06 111.195 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 -95.35 0.57 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.878 -0.677 . . . . 2.17 112.711 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER 56.34 33.89 23.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.002 1.382 . . . . 2.26 109.929 -174.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 171.7 13.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.253 -1.34 . . . . 1.31 111.732 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.03 65.83 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 2.37 110.518 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -133.72 152.82 51.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 2.27 110.261 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.29 85.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 1.64 111.574 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.618 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -60.09 -35.06 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 2.58 110.825 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.6 -36.86 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 1.06 110.296 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 91.3 t -62.16 -40.23 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.837 -0.62 . . . . 1.46 110.431 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -63.62 -39.07 93.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 0.97 110.842 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.05 83.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.354 -0.384 . . . . 0.93 110.786 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.654 ' HA ' ' NE2' ' A' ' 60' ' ' GLN . 3.0 pt20 -88.94 12.35 15.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 1.86 111.342 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 52' ' ' ALA . 1.4 p -123.46 -13.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.167 0.508 . . . . 1.82 110.432 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -94.22 -8.83 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.625 0.726 . . . . 1.97 109.368 173.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.538 ' HG2' ' N ' ' A' ' 58' ' ' GLU . 18.6 ttt-85 -145.35 163.72 33.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.262 -1.384 . . . . 3.57 107.262 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.538 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -49.98 144.31 6.87 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 117.776 0.262 . . . . 3.64 110.983 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -48.7 117.91 2.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.722 0.639 . . . . 4.58 111.674 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.837 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 1.5 mt-30 -92.15 73.81 5.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.46 -0.791 . . . . 2.8 110.994 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -80.76 -22.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 3.13 109.758 176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.76 -78.41 0.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.241 -0.89 . . . . 4.56 110.719 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.34 112.2 8.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.744 0.307 . . . . 3.01 111.64 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.837 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 14.7 Cg_exo -71.62 68.2 2.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.458 2.772 . . . . 1.91 111.473 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 3.7 tp -81.82 133.63 35.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 2.46 112.489 -172.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.71 19.48 11.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.533 0.938 . . . . 2.42 113.533 169.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -54.75 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.811 -0.356 . . . . 2.11 110.365 174.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.858 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.6 mt -169.08 -40.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 2.19 110.462 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -82.24 2.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 1.87 112.429 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . -133.65 52.62 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.732 0.301 . . . . 1.09 111.399 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.6 ' HB3' HD11 ' A' ' 77' ' ' LEU . 36.1 tp60 -177.39 113.14 0.24 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.592 -0.731 . . . . 3.23 109.734 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.63 ' HA ' ' NE2' ' A' ' 40' ' ' GLN . 13.3 Cg_exo -71.15 48.01 0.85 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.335 2.69 . . . . 1.77 112.166 177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.4 m -156.95 83.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.785 -0.643 . . . . 2.46 109.468 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.4 mm -65.05 -37.09 79.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.536 -0.756 . . . . 2.08 111.259 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HD3' ' HB ' ' A' ' 12' ' ' THR . 2.3 ttpt -56.34 -39.11 72.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 3.8 111.36 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' ' HG3' ' A' ' 79' ' ' GLN . . . -66.92 -46.33 75.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.331 . . . . 1.08 111.052 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.858 HD13 ' HA ' ' A' ' 68' ' ' LEU . 3.4 mt -70.09 -27.07 64.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.874 0.369 . . . . 2.41 110.908 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -65.28 -32.32 73.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.57 111.019 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 1.1 pt20 -97.37 15.06 24.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 2.74 110.551 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -119.8 -80.29 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.113 0.482 . . . . 2.85 110.662 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.46 -35.52 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.783 -0.644 . . . . 2.13 111.417 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -69.13 -28.25 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 1.9 111.495 -176.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.14 -21.58 22.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.446 -0.343 . . . . 2.65 110.83 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.81 -73.37 0.1 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.53 -0.759 . . . . 7.09 111.42 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.414 -0.803 . . . . 5.98 110.839 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.908 0.385 . . . . 8.54 110.38 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.79 166.37 34.41 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.713 -0.756 . . . . 5.41 112.013 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -68.63 104.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.321 0.581 . . . . 6.05 110.384 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.479 ' N ' ' HB3' ' A' ' 30' ' ' SER . 5.3 m -99.52 81.32 2.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.813 -0.63 . . . . 3.59 111.431 -177.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 2.1 mt-10 -83.63 144.27 29.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.776 -0.824 . . . . 3.47 108.776 171.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 8' ' ' TYR . . . -127.76 146.55 50.55 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.736 -0.386 . . . . 3.01 111.434 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.65 37.22 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 3.51 110.107 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 6' ' ' ALA . 5.4 t80 -152.86 43.05 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.384 -0.825 . . . . 2.32 109.13 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.686 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 10.0 p -102.4 35.05 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.086 0.946 . . . . 2.13 110.096 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.18 112.44 38.69 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.314 -0.857 . . . . 2.09 109.84 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.52 131.33 27.57 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.683 2.256 . . . . 1.88 112.094 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.7 0.85 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.726 -0.67 . . . . 2.04 109.997 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.604 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -158.03 148.23 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.158 -0.928 . . . . 2.24 109.572 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.32 72.76 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.173 0.434 . . . . 1.42 112.173 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 43.0 t -68.33 -26.28 33.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.479 -0.328 . . . . 1.99 110.482 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -64.0 -49.12 73.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 1.93 110.395 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -64.56 -40.48 95.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.76 -0.654 . . . . 1.48 111.286 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -46.89 64.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 2.96 111.098 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 23' ' ' TRP . 3.0 tp -63.67 -54.58 33.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.964 -0.562 . . . . 1.81 111.087 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -61.11 -29.1 69.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.446 . . . . 1.08 111.453 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -68.93 -67.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 2.69 110.65 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.704 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 37.5 mm -59.23 -47.71 89.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.436 -0.347 . . . . 1.91 111.37 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.678 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 3.8 m95 -57.67 -46.33 84.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 1.33 110.716 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.712 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 3.2 mm-40 -89.6 28.14 1.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 2.78 111.757 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.704 ' HD2' ' HA ' ' A' ' 22' ' ' ILE . 9.4 mtt180 -114.68 -14.26 12.04 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.109 -1.071 . . . . 4.4 108.109 161.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.04 -37.96 3.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.003 -0.998 . . . . 2.01 111.778 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HB3' ' H ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -95.98 -97.33 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.109 0.411 . . . . 2.85 112.109 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 27' ' ' LEU . . . -87.96 -28.0 24.64 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.762 -0.732 . . . . 1.73 112.304 -173.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 2.9 t 63.84 41.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.537 0.684 . . . . 1.92 110.789 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -98.11 -98.02 0.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 2.21 111.115 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 30' ' ' SER . . . 140.96 76.72 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.908 -0.663 . . . . 1.58 111.689 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -117.81 132.09 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.012 0.435 . . . . 3.56 111.37 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . -100.18 -123.43 5.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 2.28 111.844 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mt -79.68 68.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.506 0.67 . . . . 2.67 110.322 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.752 ' HB3' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -148.64 4.17 0.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.387 -0.824 . . . . 2.46 110.504 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.741 ' HA ' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m-20 54.0 -109.9 0.51 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.102 -0.499 . . . . 4.2 111.1 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.8 -73.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.432 0.693 . . . . 4.13 112.705 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.02 -51.39 3.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.308 -0.405 . . . . 2.27 111.024 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -98.99 -70.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 2.01 112.153 -170.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.741 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 29.9 mp0 -60.31 -21.45 62.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.722 -0.672 . . . . 2.39 112.602 -170.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 3.9 tp -63.93 -21.87 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 3.23 111.366 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.783 ' HA2' ' HB3' ' A' ' 69' ' ' PHE . . . 108.0 45.68 1.08 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.579 -0.82 . . . . 2.06 112.26 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.76 107.19 2.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.702 -0.761 . . . . 2.17 112.134 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -72.81 86.39 1.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 2.26 110.294 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.93 178.25 8.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.81 -0.632 . . . . 1.31 111.178 -178.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.422 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -96.51 29.33 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 2.37 110.387 177.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -107.37 163.51 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.854 -0.612 . . . . 2.27 110.842 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.88 86.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.59 . . . . 1.64 112.227 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.678 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 11.2 ttt -61.27 -34.78 75.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 2.58 111.036 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.21 -0.45 . . . . 1.06 110.538 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.478 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 18.0 t -72.67 -42.29 62.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 1.46 109.923 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -63.35 -23.58 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.876 -0.602 . . . . 0.97 110.88 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.06 -43.61 57.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.909 -0.587 . . . . 0.93 110.928 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 51' ' ' VAL . 2.1 pt20 -75.64 -24.39 56.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.901 0.382 . . . . 1.86 110.808 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -87.65 -14.95 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.112 0.482 . . . . 1.82 110.4 177.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.817 ' HB3' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -64.62 -32.75 74.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 1.97 110.807 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.729 ' HD2' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.18 -0.76 13.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 3.57 109.807 175.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER 50.23 84.99 0.04 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.847 -1.069 . . . . 3.64 111.717 -177.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 11.6 m-30 69.95 76.22 0.21 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.237 -0.892 . . . . 4.58 111.433 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.68 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 6.0 pm0 -97.37 -37.5 10.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.107 -0.331 . . . . 2.8 110.107 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.68 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 2.4 p 159.46 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.806 -1.183 . . . . 3.13 107.806 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.614 ' H ' HG22 ' A' ' 61' ' ' VAL . 18.2 mp0 -58.35 -49.08 78.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.089 0.404 . . . . 4.56 111.265 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.505 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 47.7 mt -89.37 134.14 33.39 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.03 0.443 . . . . 3.01 111.174 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.3 Cg_exo -81.06 59.72 7.56 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.219 2.613 . . . . 1.91 112.496 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.599 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -69.56 116.31 9.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 2.46 111.793 -176.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.16 19.13 10.42 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.615 -0.72 . . . . 2.42 111.608 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 56' ' ' HIS . 1.7 t -106.78 -20.95 5.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.326 0.584 . . . . 2.11 109.978 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 mt 180.0 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.589 -1.187 . . . . 2.19 108.579 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.783 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 95.2 m-85 -112.94 -177.23 3.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 1.87 109.81 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . 60.87 55.32 3.21 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.338 0.59 . . . . 1.09 110.849 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -149.99 100.15 3.25 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.37 -0.832 . . . . 3.23 110.208 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.513 ' O ' ' HB ' ' A' ' 73' ' ' THR . 47.5 Cg_exo -56.53 105.95 0.19 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.766 2.311 . . . . 1.77 110.949 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 77.2 m 72.33 103.5 0.07 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.318 -0.623 . . . . 2.46 109.318 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -84.44 12.81 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 2.08 111.071 -172.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.604 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -58.27 -50.37 73.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 3.8 110.807 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.21 93.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 1.08 110.947 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -67.17 -36.11 81.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.122 -0.49 . . . . 2.41 110.65 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.877 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -62.89 -33.29 74.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.083 -0.508 . . . . 1.57 111.576 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -99.39 16.81 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.816 0.341 . . . . 2.74 110.711 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -126.47 -86.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.275 -0.42 . . . . 2.85 110.942 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.1 -25.87 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.416 -0.356 . . . . 2.13 111.436 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -71.04 -28.14 64.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.67 -0.241 . . . . 1.9 111.305 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.06 56.56 2.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.296 0.57 . . . . 2.65 110.853 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -137.49 23.96 2.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 7.09 110.054 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.438 -0.791 . . . . 5.98 110.592 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.693 0.282 . . . . 8.54 110.659 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.86 3.65 2.54 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.495 -0.86 . . . . 5.41 113.563 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 36' ' ' ASP . 6.9 p -83.77 80.09 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 122.147 0.975 . . . . 6.05 110.732 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -69.85 0.73 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.443 -0.799 . . . . 3.59 110.703 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -170.74 76.89 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.728 . . . . 3.47 109.246 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.32 122.4 41.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.146 0.498 . . . . 3.01 112.115 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.65 70.47 2.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 3.51 110.021 174.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -134.92 -47.5 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.873 -0.603 . . . . 2.32 110.853 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG12 ' HB1' ' A' ' 20' ' ' ALA . 0.3 OUTLIER 49.35 -134.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.671 -0.695 . . . . 2.13 110.903 -177.414 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB2' HG12 ' A' ' 34' ' ' ILE . . . -178.63 94.04 0.22 Allowed Pre-proline 0 N--CA 1.463 0.199 0 O-C-N 123.128 0.268 . . . . 2.09 111.126 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -92.25 46.47 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.775 2.316 . . . . 1.88 111.875 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -86.73 106.44 17.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.768 0.655 . . . . 2.04 112.768 -173.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t30 40.53 54.88 2.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.043 1.127 . . . . 2.24 114.043 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 70.64 -52.29 0.67 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.743 1.016 . . . . 1.42 113.743 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.25 -60.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 1.99 111.314 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.471 ' HA ' HD12 ' A' ' 19' ' ' LEU . 3.2 mp0 -62.22 -31.08 71.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.21 -0.45 . . . . 1.93 110.997 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -40.07 90.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.938 0.399 . . . . 1.48 110.814 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -41.77 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.834 -0.621 . . . . 2.96 110.519 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 16' ' ' GLU . 28.1 mt -61.87 -43.75 98.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.064 -0.517 . . . . 1.81 110.01 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB1' HG12 ' A' ' 9' ' ' VAL . . . -56.44 -55.03 38.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.647 -0.706 . . . . 1.08 111.507 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.644 ' HG3' HD12 ' A' ' 22' ' ' ILE . 10.9 pt-20 -64.6 -46.75 81.32 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 111.706 0.261 . . . . 2.69 111.706 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.644 HD12 ' HG3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -68.0 -47.95 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.62 -0.264 . . . . 1.91 111.219 -175.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -76.8 -14.16 59.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 1.33 111.001 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.6 mm-40 -69.04 -50.1 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.089 -0.338 . . . . 2.78 110.089 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.498 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -75.28 -24.51 57.55 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.833 -0.347 . . . . 4.4 111.935 -174.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.45 33.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.687 -0.405 . . . . 2.01 111.894 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tp -171.99 -73.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.847 0.314 . . . . 2.85 111.847 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.78 -62.62 2.62 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.984 -0.627 . . . . 1.73 113.88 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 t 53.77 32.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.031 0.532 . . . . 1.92 110.804 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -143.08 11.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 2.21 111.523 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.41 60.49 3.02 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.892 -0.883 . . . . 1.58 110.892 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.56 81.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 3.56 111.519 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.41 155.73 50.46 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.701 -0.682 . . . . 2.28 112.151 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 10' ' ' ALA . 7.0 mm -80.05 56.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.764 0.792 . . . . 2.67 111.483 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.89 -42.07 2.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.184 -0.916 . . . . 2.46 108.614 171.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.458 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 12.0 t70 -156.54 128.02 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.02 -0.991 . . . . 4.2 108.562 174.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' O ' HG12 ' A' ' 41' ' ' ILE . 43.7 t30 -173.22 149.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.885 -0.413 . . . . 4.13 109.885 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 29.25 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.974 0.416 . . . . 2.27 111.295 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -117.07 -66.98 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.296 -0.411 . . . . 2.01 110.15 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.656 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.4 pm0 -79.84 13.11 2.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.936 -0.575 . . . . 2.39 112.003 -176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 37' ' ' ASN . 14.5 pt -106.97 7.49 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 3.23 110.181 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 33.03 10.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.821 -0.704 . . . . 2.06 112.025 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.32 151.0 35.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 2.17 111.996 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 73.51 10.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.072 0.463 . . . . 2.26 111.014 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.04 125.3 28.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.915 -0.584 . . . . 1.31 110.35 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 46' ' ' LEU . 8.5 tp -73.72 71.74 1.46 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.002 0.43 . . . . 2.37 111.992 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -145.44 152.4 39.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.915 -0.584 . . . . 2.27 109.489 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -32.72 73.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 1.64 111.523 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.3 ttt -61.81 -35.49 78.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 2.58 110.991 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.94 -36.57 67.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 1.06 110.546 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 t -66.58 -42.53 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.568 . . . . 1.46 110.361 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.8 94.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.97 110.845 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.68 84.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.93 110.825 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -10.93 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 1.86 111.162 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.9 t -104.0 -22.9 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.286 -0.415 . . . . 1.82 110.865 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -74.72 55.14 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.925 0.713 . . . . 1.97 112.925 -172.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.472 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -176.85 -70.6 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.158 -0.682 . . . . 3.57 109.158 175.26 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -170.87 40.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 3.64 110.624 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 59.26 78.7 0.25 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.99 -0.55 . . . . 4.58 110.631 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.472 ' OE1' ' HB3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -77.95 76.88 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.522 -0.763 . . . . 2.8 110.874 -176.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -76.18 -18.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.792 -0.64 . . . . 3.13 111.009 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -97.84 43.97 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 4.56 110.024 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.19 129.43 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.171 -0.922 . . . . 3.01 111.047 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.2 73.65 4.36 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.696 2.264 . . . . 1.91 112.461 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 67' ' ' VAL . 2.1 tp -59.53 113.69 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 2.46 110.363 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.791 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 19.2 mttt 58.42 -110.1 0.49 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.886 -0.597 . . . . 2.42 110.383 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 65' ' ' LEU . 46.3 t 59.64 -85.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.223 0.609 . . . . 2.11 111.843 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 78' ' ' ALA . 5.5 tp -148.2 10.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 2.19 110.879 -176.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 -56.15 0.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.251 0.463 . . . . 1.87 112.251 -173.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.791 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -80.71 66.43 6.23 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.121 0.415 . . . . 1.09 112.121 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -166.74 126.85 1.18 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.23 109.837 176.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 14.0 Cg_exo -71.73 42.39 0.49 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.505 2.804 . . . . 1.77 113.408 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.02 72.12 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.756 -0.831 . . . . 2.46 108.756 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.79 -34.36 46.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.339 -0.846 . . . . 2.08 111.236 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -60.28 -32.2 70.96 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.939 0.399 . . . . 3.8 110.589 178.107 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.56 -44.14 35.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 1.08 110.805 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.29 -43.37 98.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 2.41 110.737 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.561 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.81 -18.42 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.619 . . . . 1.57 111.49 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.76 -7.42 58.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 2.74 110.245 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.78 -70.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 2.85 111.399 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.44 51.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.828 0.347 . . . . 2.13 111.378 -173.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -157.58 -33.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.247 -0.433 . . . . 1.9 111.501 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -40.44 95.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.416 . . . . 2.65 111.708 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 58.91 27.07 15.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.436 0.636 . . . . 7.09 110.608 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.327 -0.844 . . . . 5.98 109.936 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.963 -0.384 . . . . 8.54 109.963 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.06 -64.67 0.16 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.817 -0.706 . . . . 5.41 111.769 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -145.76 108.72 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.28 0.562 . . . . 6.05 110.866 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -86.0 60.18 6.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.288 0.566 . . . . 3.59 110.787 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.66 110.29 0.74 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.552 -0.749 . . . . 3.47 109.585 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -146.48 116.66 7.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.092 -0.504 . . . . 3.01 111.006 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -83.27 49.02 1.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 3.51 109.682 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.61 -89.75 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.724 . . . . 2.32 111.273 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t 63.64 -86.33 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.012 -0.54 . . . . 2.13 110.687 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 49.74 69.9 2.38 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 123.02 0.528 . . . . 2.09 111.948 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -88.5 155.0 6.48 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.766 2.311 . . . . 1.88 112.653 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.14 -67.32 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.54 -0.3 . . . . 2.04 111.18 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -153.91 118.19 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.46 0.541 . . . . 2.24 112.46 -176.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.77 -79.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.879 1.066 . . . . 1.42 113.879 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -63.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.694 0.627 . . . . 1.99 112.694 -169.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' HA ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -62.79 -37.58 87.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.93 111.473 -176.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -45.98 83.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.095 -0.502 . . . . 1.48 111.269 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -38.14 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.028 -0.533 . . . . 2.96 111.367 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -47.72 79.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 1.81 110.854 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.92 82.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 1.08 110.494 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.55 -48.74 79.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 2.69 111.478 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.495 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 2.5 tt -67.93 -36.32 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.929 -0.308 . . . . 1.91 111.765 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -81.75 -53.38 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 1.33 111.838 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -78.02 -7.74 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.092 0.404 . . . . 2.78 112.092 -172.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.643 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 1.4 mmm180 -115.56 -0.25 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.255 -0.578 . . . . 4.4 111.658 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -115.63 -23.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 2.01 111.177 175.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 tp -122.86 -76.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 2.85 110.77 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.471 ' HA3' ' HZ ' ' A' ' 38' ' ' PHE . . . -85.93 62.35 4.39 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.774 -0.727 . . . . 1.73 112.92 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 1.6 p -67.68 105.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.564 0.697 . . . . 1.92 110.645 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.16 -32.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.217 -0.901 . . . . 2.21 110.141 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.61 96.08 2.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.897 -0.668 . . . . 1.58 111.646 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.63 HD13 ' HB3' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -131.64 -40.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.97 0.414 . . . . 3.56 110.691 -178.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.545 ' C ' HG12 ' A' ' 34' ' ' ILE . . . 65.0 -99.62 0.38 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.937 -0.574 . . . . 2.28 112.729 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' C ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -142.31 52.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.092 0.472 . . . . 2.67 110.932 -177.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 35' ' ' LEU . 5.2 mt -129.72 -111.49 0.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.244 -0.285 . . . . 2.46 111.033 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.466 ' H ' ' HB3' ' A' ' 35' ' ' LEU . 26.5 t0 -88.91 71.64 8.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 4.2 110.288 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.63 ' HB3' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -114.18 164.45 13.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.643 -0.708 . . . . 4.13 110.994 -176.385 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HZ ' ' HA3' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -82.32 -14.96 54.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.008 -0.542 . . . . 2.27 110.634 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.477 ' HB3' ' OE1' ' A' ' 40' ' ' GLN . 18.7 t80 -81.97 -90.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.088 -0.506 . . . . 2.01 110.277 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 39' ' ' PHE . 3.6 mp0 -68.09 125.42 26.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.574 -0.528 . . . . 2.39 109.574 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 78.52 -9.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 123.978 0.799 . . . . 3.23 110.972 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.46 -58.29 3.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.975 -0.631 . . . . 2.06 112.256 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.738 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . 147.67 -76.13 0.26 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.385 -0.912 . . . . 2.17 112.613 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -165.81 119.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.039 0.447 . . . . 2.26 110.992 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.03 144.34 26.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 1.31 110.176 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.11 92.57 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.995 0.426 . . . . 2.37 111.243 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -171.48 164.64 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 2.27 110.285 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.75 65.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 1.64 111.854 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -39.16 83.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.362 . . . . 2.58 110.742 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.02 -37.59 61.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 1.06 110.472 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.81 -42.96 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 1.46 110.677 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.48 96.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.97 110.903 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.453 . . . . 0.93 110.32 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -49.3 73.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.604 -0.726 . . . . 1.86 111.098 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 m -75.15 -33.0 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.929 -0.308 . . . . 1.82 111.73 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -31.13 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.881 -0.328 . . . . 1.97 111.224 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 -9.81 53.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.893 -0.41 . . . . 3.57 109.893 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER 67.33 62.4 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.216 -0.902 . . . . 3.64 110.882 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 1.2 m-85 78.91 109.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 4.58 111.65 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.07 -20.04 18.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.021 -0.99 . . . . 2.8 109.695 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.7 t 66.05 -111.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.226 -0.897 . . . . 3.13 110.185 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.65 8.55 4.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 4.56 110.358 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 92.82 39.7 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 3.01 110.46 -175.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.738 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 49.8 Cg_endo -70.58 128.22 14.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.425 2.084 . . . . 1.91 112.029 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.11 137.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 2.46 109.436 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.51 47.35 16.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.712 0.633 . . . . 2.42 110.442 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 69' ' ' PHE . 2.7 p -156.08 175.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.11 109.808 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -53.83 -36.88 63.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.286 0.476 . . . . 2.19 112.286 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.641 ' H ' HG13 ' A' ' 67' ' ' VAL . 86.0 m-85 -84.09 3.21 35.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.46 -0.336 . . . . 1.87 111.66 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.31 73.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.782 0.325 . . . . 1.09 111.459 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.93 141.48 1.21 Allowed Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.134 -0.691 . . . . 3.23 109.134 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HB2' ' H ' ' A' ' 73' ' ' THR . 23.0 Cg_exo -64.62 -86.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.539 2.16 . . . . 1.77 111.867 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.703 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -80.92 136.72 36.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.713 0.292 . . . . 2.46 110.541 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.497 ' CG1' ' HA ' ' A' ' 16' ' ' GLU . 38.0 mm -64.69 -25.05 36.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 2.08 111.097 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.703 ' HD3' ' HB ' ' A' ' 73' ' ' THR . 1.1 pttt -50.48 -34.56 25.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.301 -0.409 . . . . 3.8 111.801 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.556 ' N ' ' HG2' ' A' ' 75' ' ' LYS . . . -70.41 -50.75 35.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.037 0.446 . . . . 1.08 111.005 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 68' ' ' LEU . 1.8 pp -73.06 -15.51 61.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 2.41 110.71 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -75.56 -31.71 60.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 1.57 110.735 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.32 5.94 47.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 2.74 111.45 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.02 -48.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.529 0.566 . . . . 2.85 112.529 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.53 -51.38 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.085 0.402 . . . . 2.13 112.085 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -65.89 -16.15 63.59 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.075 0.398 . . . . 1.9 112.075 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -17.6 59.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.046 0.451 . . . . 2.65 110.824 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -88.8 80.13 7.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.926 -0.579 . . . . 7.09 110.292 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.875 -1.059 . . . . 5.98 109.491 177.363 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.849 0.357 . . . . 8.54 110.705 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.497 ' HA2' ' CD1' ' A' ' 38' ' ' PHE . . . -129.11 27.7 4.23 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.955 -0.64 . . . . 5.41 112.229 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.24 48.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.151 -0.685 . . . . 6.05 109.151 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.08 143.6 30.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.553 -0.749 . . . . 3.59 111.59 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 2.2 mt-10 -92.65 101.65 14.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.094 -0.503 . . . . 3.47 109.743 175.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.33 128.76 33.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.909 0.385 . . . . 3.01 111.055 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.78 -19.46 41.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.236 0.541 . . . . 3.51 110.301 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -91.04 57.61 3.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.925 -0.579 . . . . 2.32 110.111 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.09 67.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 122.193 0.997 . . . . 2.13 110.431 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -143.51 110.38 5.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.196 -0.911 . . . . 2.09 110.288 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 5.5 Cg_exo -78.73 171.05 17.23 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.257 2.638 . . . . 1.88 112.382 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.87 -47.48 4.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.121 0.486 . . . . 2.04 110.666 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 24.0 t-20 -108.08 154.08 22.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 2.24 110.669 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.97 -29.12 69.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 1.42 111.246 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.04 -35.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.21 0.528 . . . . 1.99 110.27 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -73.13 -36.74 66.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.713 -0.676 . . . . 1.93 110.598 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -35.22 74.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 1.48 110.53 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -45.07 78.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.091 -0.504 . . . . 2.96 110.757 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 19' ' ' LEU . 2.0 mt -64.74 -37.29 87.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 1.81 110.129 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.74 -30.8 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 1.08 110.595 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 16.5 tt0 -61.96 -47.17 86.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.981 -0.378 . . . . 2.69 109.981 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.2 mt -69.92 -55.16 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.333 -0.394 . . . . 1.91 111.158 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.535 ' CH2' ' HD2' ' A' ' 47' ' ' LYS . 64.1 m95 -68.56 -49.1 62.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.257 0.465 . . . . 1.33 112.257 -172.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.89 -50.24 24.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.438 0.162 . . . . 2.78 111.438 -174.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 1.1 mmt85 -66.6 -27.38 67.66 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.694 -0.402 . . . . 4.4 111.643 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.17 -55.75 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.219 -0.193 . . . . 2.01 111.288 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.89 -44.32 5.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.404 0.52 . . . . 2.85 112.404 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.57 -59.82 10.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.353 -0.451 . . . . 1.73 113.57 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.1 t 72.12 -56.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 123.329 0.652 . . . . 1.92 111.897 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.467 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 2.4 m -74.35 -41.04 61.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 2.21 111.16 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.1 127.38 3.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.758 -0.734 . . . . 1.58 112.096 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -164.44 161.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.94 -0.393 . . . . 3.56 109.94 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.45 -103.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.038 -1.077 . . . . 2.28 113.552 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mm -81.16 65.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.146 0.498 . . . . 2.67 111.637 -171.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.97 171.63 15.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.112 -0.495 . . . . 2.46 110.139 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.53 112.87 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.095 -0.502 . . . . 4.2 109.751 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -146.95 172.31 13.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.175 0.512 . . . . 4.13 111.682 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CD1' ' HA2' ' A' ' 2' ' ' GLY . 19.8 p90 -63.45 153.17 36.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.129 -0.941 . . . . 2.27 112.717 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.9 -39.08 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.931 0.892 . . . . 2.01 112.891 171.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -65.32 -36.31 83.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.803 0.335 . . . . 2.39 111.19 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.527 ' H ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -99.03 15.85 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 3.23 111.546 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.23 135.88 2.56 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.664 -0.779 . . . . 2.06 112.129 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.65 70.76 1.02 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.686 -0.768 . . . . 2.17 111.338 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.649 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 24.6 p80 -60.75 150.67 31.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.78 0.324 . . . . 2.26 111.135 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -179.24 4.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 1.31 110.993 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 35.15 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 2.37 111.21 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HD2' ' CH2' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -129.09 171.23 12.59 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.988 -0.285 . . . . 2.27 110.985 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.24 69.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 1.64 112.408 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -37.87 64.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.041 0.448 . . . . 2.58 111.066 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 44' ' ' HIS . . . -76.62 -40.69 48.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 1.06 110.89 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.04 -41.55 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 1.46 110.546 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.11 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.97 111.04 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.41 -36.46 74.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.93 111.022 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 61' ' ' VAL . 3.0 pt20 -76.49 -18.33 58.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 1.86 111.626 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.6 p -115.86 0.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.094 0.405 . . . . 1.82 112.094 -175.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -32.57 72.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.412 . . . . 1.97 112.114 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.29 -76.65 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.891 -0.323 . . . . 3.57 110.751 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.46 55.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 3.64 110.065 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.3 72.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.252 -0.885 . . . . 4.58 111.789 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.51 -14.94 29.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.7 -0.682 . . . . 2.8 110.143 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.559 ' HA ' ' HB2' ' A' ' 54' ' ' GLN . 5.9 t 60.15 -92.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.268 -0.878 . . . . 3.13 112.066 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HG2' HG12 ' A' ' 61' ' ' VAL . 4.2 mm-40 -99.1 15.11 26.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.729 0.3 . . . . 4.56 111.238 -175.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -121.42 79.74 37.35 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.063 0.458 . . . . 3.01 110.463 178.004 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.65 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 85.7 Cg_endo -96.89 16.06 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.008 2.472 . . . . 1.91 112.638 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.76 117.76 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 2.46 111.496 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt 68.52 3.71 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.265 -0.879 . . . . 2.42 112.202 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.13 -53.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.715 -0.476 . . . . 2.11 109.715 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.65 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -171.9 154.56 3.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.461 -0.94 . . . . 2.19 108.461 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 75.0 -56.06 0.64 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.314 0.487 . . . . 1.87 112.314 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . . . -77.22 67.86 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.347 0.499 . . . . 1.09 112.347 -173.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.549 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 3.0 mm-40 -155.46 128.24 4.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.153 -0.684 . . . . 3.23 109.153 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 23.7 Cg_exo -64.29 -11.87 30.11 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.988 2.459 . . . . 1.77 112.98 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 t -132.22 115.31 15.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.412 0.625 . . . . 2.46 110.085 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.471 HD13 HD12 ' A' ' 19' ' ' LEU . 1.1 mt -77.88 -17.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.653 -0.703 . . . . 2.08 110.786 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 4.4 tttt -56.47 -50.38 71.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.278 -0.419 . . . . 3.8 110.49 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -62.95 -41.68 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.675 -0.693 . . . . 1.08 110.967 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 77' ' ' LEU . 6.2 mt -63.09 -46.31 87.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 2.41 111.269 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.94 -29.07 70.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 1.57 112.003 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -101.37 8.65 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.681 -0.408 . . . . 2.74 111.249 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 1.7 m-85 -119.28 -93.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.508 -0.314 . . . . 2.85 110.719 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.02 43.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 2.13 111.321 -175.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.48 -40.65 1.58 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.657 -0.701 . . . . 1.9 109.675 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 133.28 50.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.587 -0.733 . . . . 2.65 110.907 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -82.25 83.87 7.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.032 0.444 . . . . 7.09 110.231 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.231 -0.89 . . . . 5.98 110.231 179.694 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.373 -0.232 . . . . 8.54 110.373 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.75 64.99 2.32 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.112 -0.566 . . . . 5.41 112.478 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -144.1 90.1 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.372 . . . . 6.05 110.867 179.542 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.33 138.05 32.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 3.59 110.761 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.96 106.82 3.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.462 -0.336 . . . . 3.47 110.912 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.456 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -94.01 179.92 5.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 3.01 110.507 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -112.43 95.88 5.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 3.51 110.522 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.466 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 2.7 t80 -155.23 -103.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 2.32 110.542 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.614 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.5 OUTLIER 71.2 -7.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.595 0.758 . . . . 2.13 112.214 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.18 31.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 2.09 110.737 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.813 ' HA ' HD11 ' A' ' 34' ' ' ILE . 59.5 Cg_endo -94.98 172.15 1.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.285 2.656 . . . . 1.88 113.167 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 -40.21 8.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.083 -0.71 . . . . 2.04 109.083 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -119.6 151.55 38.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.224 -0.898 . . . . 2.24 109.299 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.49 -33.7 70.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.907 0.336 . . . . 1.42 111.907 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.04 -27.34 42.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 1.99 111.56 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.817 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.0 -58.82 6.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.005 0.431 . . . . 1.93 111.166 -175.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -79.46 -12.43 59.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.365 -0.38 . . . . 1.48 111.283 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -51.52 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.57 -0.53 . . . . 2.96 109.57 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -62.7 -41.85 99.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 1.81 110.329 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.39 77.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 1.08 110.857 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.641 ' HG2' ' HG3' ' A' ' 25' ' ' ARG . 2.3 tt0 -63.33 -31.37 72.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.236 -0.438 . . . . 2.69 111.206 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.552 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 20.9 mt -62.13 -42.73 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.109 0.481 . . . . 1.91 110.301 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.807 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 36.7 m95 -79.54 -46.76 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.085 -0.507 . . . . 1.33 111.781 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 pt-20 -76.41 -8.56 57.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.839 0.681 . . . . 2.78 112.839 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 2.1 mtp85 -120.89 -4.98 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.607 -0.437 . . . . 4.4 111.74 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.552 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 6.5 t -108.71 -49.83 7.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.01 110.467 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.954 HD11 ' HG3' ' A' ' 47' ' ' LYS . 80.9 mt -95.73 -85.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.078 0.466 . . . . 2.85 110.568 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.19 89.61 1.48 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.688 -0.767 . . . . 1.73 111.502 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 58.4 t -62.8 105.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.968 0.414 . . . . 1.92 110.206 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.26 -64.92 0.71 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.204 -0.453 . . . . 2.21 111.409 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.3 85.45 1.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.83 -0.7 . . . . 1.58 111.413 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.744 HD11 ' HD2' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -137.47 -58.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.872 0.368 . . . . 3.56 111.654 -174.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . 101.65 -138.09 13.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.711 -0.757 . . . . 2.28 111.476 -172.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.813 HD11 ' HA ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -120.06 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.347 . . . . 2.67 110.98 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.839 ' HG ' ' H ' ' A' ' 36' ' ' ASP . 1.3 pt? -152.73 -66.07 0.16 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.502 -0.317 . . . . 2.46 111.118 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.839 ' H ' ' HG ' ' A' ' 35' ' ' LEU . 5.9 t70 -176.76 173.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 4.2 110.047 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 0.7 OUTLIER 65.73 23.51 11.53 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.51 0.724 . . . . 4.13 112.815 173.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.744 ' HD2' HD11 ' A' ' 32' ' ' ILE . 20.9 t80 173.18 138.04 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.509 -0.769 . . . . 2.27 109.108 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 67.15 -72.25 0.09 Allowed 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.034 0.834 . . . . 2.01 110.558 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.35 59.67 2.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 2.39 110.484 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 -48.98 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.654 -0.703 . . . . 3.23 110.181 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.68 116.63 2.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.06 111.641 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.33 -159.24 24.52 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.795 -0.717 . . . . 2.17 112.042 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -125.66 73.86 1.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.874 0.369 . . . . 2.26 110.561 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.45 145.62 49.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.193 -0.458 . . . . 1.31 110.496 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 46' ' ' LEU . 3.1 mt -92.31 66.74 4.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 2.37 111.416 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.954 ' HG3' HD11 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -144.01 155.5 44.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.403 -0.362 . . . . 2.27 110.312 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.79 -43.73 63.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.491 0.552 . . . . 1.64 112.491 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.807 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 6.2 tpt -62.86 -34.76 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.802 0.334 . . . . 2.58 111.179 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB2' ' HH2' ' A' ' 23' ' ' TRP . . . -76.41 -37.58 56.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 1.06 110.488 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.69 -40.24 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.927 -0.579 . . . . 1.46 110.257 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -61.2 -36.83 80.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 0.97 110.983 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.23 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.424 -0.353 . . . . 0.93 110.617 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -65.06 -38.7 91.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 1.86 110.873 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.85 -26.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 1.82 110.502 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -66.21 -38.29 87.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 1.97 109.906 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.44 173.16 11.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.423 -0.584 . . . . 3.57 109.423 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -82.23 48.32 1.25 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.436 -0.347 . . . . 3.64 110.226 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.483 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 79.7 m-85 56.26 78.94 0.19 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.769 0.795 . . . . 4.58 109.692 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 17.4 pm0 -71.44 -11.79 61.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 2.8 113.06 -169.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 t 63.3 -82.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 123.292 0.37 . . . . 3.13 111.113 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -131.53 5.87 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.535 0.198 . . . . 4.56 111.535 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -122.64 78.46 47.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 3.01 111.133 -178.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.53 54.35 4.7 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.355 2.704 . . . . 1.91 112.237 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.78 130.42 42.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.436 -0.802 . . . . 2.46 111.719 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 71' ' ' GLN . 2.2 mptm? 46.15 54.82 7.86 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.187 0.929 . . . . 2.42 113.247 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.96 -33.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.728 0.299 . . . . 2.11 110.775 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.04 -62.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.198 0.523 . . . . 2.19 110.048 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.89 -21.79 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.597 -0.729 . . . . 1.87 111.454 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -116.06 40.67 2.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.458 -0.337 . . . . 1.09 111.04 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -170.09 84.5 0.58 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 3.23 109.621 175.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.88 59.16 3.47 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.739 2.959 . . . . 1.77 112.993 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -148.43 79.89 1.45 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 2.46 109.391 176.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 16' ' ' GLU . 80.2 mt -61.87 -41.89 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.689 -0.687 . . . . 2.08 112.541 -169.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -44.58 84.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.435 -0.506 . . . . 3.8 110.42 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -63.86 -34.03 77.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 1.08 110.68 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -61.98 -32.03 72.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 2.41 110.837 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 -22.29 61.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.57 110.991 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.28 5.25 42.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.353 -0.385 . . . . 2.74 110.434 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -119.72 -75.95 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 2.85 111.475 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.95 -46.53 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 2.13 111.315 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.83 67.33 1.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 1.9 110.307 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t -109.38 -18.94 13.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.92 -0.582 . . . . 2.65 111.168 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 68.1 -68.15 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.58 0.55 . . . . 7.09 110.697 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.0 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.799 -0.619 . . . . 5.98 109.481 177.776 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.132 -0.321 . . . . 8.54 110.132 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.71 -40.08 3.03 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.004 -0.617 . . . . 5.41 113.585 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.65 99.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 6.05 111.341 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.32 80.78 8.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.158 -0.474 . . . . 3.59 110.819 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -177.49 115.18 0.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.96 -0.563 . . . . 3.47 110.367 175.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.95 88.6 3.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 3.01 110.516 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -75.41 71.49 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 3.51 110.281 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.448 ' HB3' HD21 ' A' ' 35' ' ' LEU . 83.2 t80 -162.62 23.43 0.1 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.664 0.745 . . . . 2.32 109.275 -175.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.51 65.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.899 0.857 . . . . 2.13 111.526 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.39 70.34 39.44 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.812 -1.085 . . . . 2.09 108.546 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.841 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 31.3 Cg_exo -61.08 146.69 97.34 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.651 2.901 . . . . 1.88 113.788 -171.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -28.19 37.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 2.04 110.575 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -123.88 146.98 48.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.24 109.936 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -21.63 66.46 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.317 0.386 . . . . 1.42 111.408 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.64 -37.74 80.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.213 -0.449 . . . . 1.99 110.537 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.841 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . 36.3 mt-10 -70.66 -34.77 72.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 1.93 110.271 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.12 79.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.076 0.465 . . . . 1.48 110.627 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 2.2 tptm -72.71 -43.77 62.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 2.96 110.373 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -47.29 77.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.599 -0.728 . . . . 1.81 110.599 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . . . -57.87 -55.1 39.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.5 -0.773 . . . . 1.08 111.275 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.79 -42.86 85.03 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.805 0.298 . . . . 2.69 111.805 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.9 mt -69.43 -55.61 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 1.91 111.266 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.66 -35.57 81.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 1.33 111.492 -175.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 3.3 tp10 -63.62 -46.7 84.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.196 -0.456 . . . . 2.78 110.965 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -5.32 41.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 4.4 111.583 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.18 -60.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.462 -0.335 . . . . 2.01 111.32 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -35.27 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.532 0.567 . . . . 2.85 112.532 -171.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.62 ' HA3' HG12 ' A' ' 32' ' ' ILE . . . -77.32 -69.83 1.36 Allowed Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.578 -0.82 . . . . 1.73 113.505 -172.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t 56.51 54.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.729 . . . . 1.92 110.129 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.41 -32.9 0.04 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.14 -0.936 . . . . 2.21 110.567 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.47 65.34 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.181 -0.767 . . . . 1.58 111.181 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.62 HG12 ' HA3' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -131.1 -178.09 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.564 0.221 . . . . 3.56 111.413 -175.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.798 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . 120.96 31.98 1.13 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.934 -0.651 . . . . 2.28 113.269 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -156.87 -65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 117.343 0.571 . . . . 2.67 111.982 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 35' ' ' LEU . 1.9 pt? -142.37 33.03 1.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.975 0.893 . . . . 2.46 110.052 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.96 1.61 4.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.5 -1.227 . . . . 4.2 112.487 -174.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.451 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 21.2 t-20 74.12 -60.8 0.51 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.111 0.564 . . . . 4.13 112.278 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HE1' HG21 ' A' ' 32' ' ' ILE . 25.9 p90 -64.64 -22.71 67.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.331 0.493 . . . . 2.27 112.331 -172.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.447 ' CE2' ' HE2' ' A' ' 69' ' ' PHE . 15.9 t80 -108.16 -16.9 14.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.947 0.403 . . . . 2.01 110.812 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -110.48 0.93 17.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 2.39 111.751 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 37' ' ' ASN . 5.1 tp -88.93 -23.19 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.136 0.493 . . . . 3.23 110.604 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 55.31 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.87 -0.892 . . . . 2.06 110.87 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.87 128.74 29.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.984 -0.627 . . . . 2.17 112.74 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.83 59.4 1.37 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.374 0.607 . . . . 2.26 110.352 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -179.31 6.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.346 -0.843 . . . . 1.31 110.313 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.2 63.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.075 0.464 . . . . 2.37 110.153 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.9 tptt -130.66 165.8 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.834 -0.621 . . . . 2.27 110.428 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.04 87.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 1.64 111.534 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -62.53 -38.08 88.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.171 -0.468 . . . . 2.58 110.824 177.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -71.04 -45.36 64.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 1.06 111.405 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.3 m -70.72 -22.4 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.58 -0.282 . . . . 1.46 110.979 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.42 88.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 0.97 110.01 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.49 76.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 0.93 110.647 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -60.23 -55.97 27.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 1.86 111.041 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 51' ' ' VAL . 2.2 t -78.38 9.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.108 0.48 . . . . 1.82 111.095 -177.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.429 ' NE2' ' HA ' ' A' ' 82' ' ' ALA . 1.5 t-80 -88.56 -9.93 50.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 1.97 110.744 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 57' ' ' ARG . 3.9 ttm180 -137.18 9.41 2.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.609 . . . . 3.57 109.52 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 72.48 -12.97 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.249 -0.887 . . . . 3.64 112.043 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -169.23 176.08 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.379 . . . . 4.58 110.517 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.99 -52.5 0.19 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 2.8 109.112 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 41.8 57.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.132 0.973 . . . . 3.13 112.921 175.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.27 9.51 6.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.482 -0.781 . . . . 4.56 112.555 172.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 61' ' ' VAL . 0.3 OUTLIER -126.95 73.19 76.36 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.759 0.314 . . . . 3.01 110.73 176.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 6.5 Cg_endo -87.92 117.99 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.075 2.516 . . . . 1.91 112.265 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -143.95 122.16 12.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.204 -0.295 . . . . 2.46 110.204 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 tttt 53.58 55.53 8.46 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.58 0.55 . . . . 2.42 111.123 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.37 -76.1 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.094 -0.503 . . . . 2.11 110.69 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.09 -42.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.302 -0.863 . . . . 2.19 109.049 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 49' ' ' MET . 52.4 m-85 -97.55 18.05 16.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.416 -0.811 . . . . 1.87 109.962 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -144.1 134.86 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.877 -1.056 . . . . 1.09 108.233 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 12.7 mp0 70.55 97.1 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 O-C-N 124.324 1.015 . . . . 3.23 109.198 -169.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.57 70.59 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.728 2.952 . . . . 1.77 113.066 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.26 53.96 1.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 2.46 108.968 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 74' ' ' ILE . 2.0 mm -51.35 -49.8 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.698 -1.137 . . . . 2.08 112.319 -172.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -64.41 -47.4 79.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 3.8 111.066 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 1.08 111.18 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.47 -36.01 81.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.222 -0.444 . . . . 2.41 110.983 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.739 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -72.05 -36.89 69.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 1.57 111.296 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -9.81 59.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.949 0.404 . . . . 2.74 111.062 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -103.95 -76.85 0.58 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 2.85 111.014 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.7 -40.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.681 . . . . 2.13 111.421 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.739 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -79.94 54.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 1.9 111.794 -175.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 85' ' ' SER . 4.8 t -168.63 -28.01 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.998 -0.546 . . . . 2.65 110.466 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.89 48.54 7.07 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.185 0.594 . . . . 7.09 111.509 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.413 ' H ' HG23 ' A' ' 83' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.848 -0.596 . . . . 5.98 109.763 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HG3' ' N ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.67 0.272 . . . . 8.54 110.82 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 37' ' ' ASN . . . -174.46 38.65 0.12 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.139 -1.029 . . . . 5.41 112.399 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.41 38.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.936 0.398 . . . . 6.05 110.624 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 m -143.56 131.55 21.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.096 -0.502 . . . . 3.59 110.539 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.06 138.99 30.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.976 0.417 . . . . 3.47 110.394 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.05 118.23 15.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.022 -0.536 . . . . 3.01 110.113 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -81.13 22.58 0.64 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.418 -0.355 . . . . 3.51 111.464 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.49 ' CD2' HD22 ' A' ' 35' ' ' LEU . 85.0 t80 -66.44 -56.48 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.06 -0.718 . . . . 2.32 109.06 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p 21.95 65.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 124.892 1.37 . . . . 2.13 113.156 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.76 76.39 74.49 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 2.09 110.999 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 23.3 Cg_exo -65.23 115.69 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.304 2.002 . . . . 1.88 110.5 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -34.68 75.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 2.04 111.955 -171.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.94 150.73 27.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.741 0.305 . . . . 2.24 110.971 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.09 70.35 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.576 . . . . 1.42 112.006 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.51 -36.56 75.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.157 0.503 . . . . 1.99 110.696 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 21.0 mt-10 -79.53 -23.34 42.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.658 -0.701 . . . . 1.93 111.102 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -71.07 -45.45 63.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.372 . . . . 1.48 110.411 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -63.7 -38.98 93.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.119 0.485 . . . . 2.96 110.666 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -63.64 -47.1 82.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 1.81 110.079 177.037 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.3 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 1.08 111.083 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -56.23 -53.9 51.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 2.69 110.876 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.501 HG22 HD23 ' A' ' 27' ' ' LEU . 37.7 mm -68.86 -43.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.156 -0.475 . . . . 1.91 111.323 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.916 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 64.4 m95 -71.7 -39.82 69.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.616 0.598 . . . . 1.33 112.616 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 1.6 pt-20 -77.11 -33.48 56.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.904 -0.318 . . . . 2.78 111.413 -177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.554 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 8.4 mmp_? -90.08 -57.48 2.84 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.141 0.423 . . . . 4.4 112.141 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.23 -43.23 12.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.064 0.394 . . . . 2.01 112.064 -171.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.916 ' HB2' ' HA ' ' A' ' 23' ' ' TRP . 1.4 mm? -70.54 -69.79 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.998 0.427 . . . . 2.85 111.962 -174.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.59 -22.27 31.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.9 -0.667 . . . . 1.73 113.401 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t 55.76 52.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.678 0.751 . . . . 1.92 110.076 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.4 141.66 32.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.394 -0.821 . . . . 2.21 110.096 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.7 77.27 2.08 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.588 -0.815 . . . . 1.58 111.36 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.503 ' HB ' ' H ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -118.89 -147.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.022 0.439 . . . . 3.56 111.133 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.503 ' H ' ' HB ' ' A' ' 32' ' ' ILE . . . 174.58 -174.97 46.82 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.285 -0.726 . . . . 2.28 111.285 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 16' ' ' GLU . 5.9 mm -80.56 83.26 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.421 . . . . 2.67 110.295 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.717 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.95 -51.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 2.46 110.671 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.717 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 t0 178.1 -175.06 0.17 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.864 -0.421 . . . . 4.2 109.864 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.53 ' O ' ' HA2' ' A' ' 2' ' ' GLY . 35.0 m-20 74.22 -3.45 2.54 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.003 0.815 . . . . 4.13 111.86 174.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 t80 178.57 163.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.736 0.648 . . . . 2.27 109.333 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 70.58 -70.23 0.16 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.906 0.754 . . . . 2.01 111.017 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.11 72.34 10.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.851 0.357 . . . . 2.39 110.526 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 172.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.207 -0.451 . . . . 3.23 110.822 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . -76.41 94.61 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.029 -0.605 . . . . 2.06 112.887 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.71 -159.65 32.99 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.952 -0.642 . . . . 2.17 112.001 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -165.57 127.74 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 2.26 110.219 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.19 162.19 22.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.075 -0.512 . . . . 1.31 110.97 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.77 67.2 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.489 -0.323 . . . . 2.37 110.92 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.16 127.42 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.357 -0.383 . . . . 2.27 111.379 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 23.6 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.498 1.519 . . . . 1.64 114.64 171.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.5 ttt -54.05 -42.42 69.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.965 -0.561 . . . . 2.58 112.235 -173.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.41 74.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 1.06 110.838 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.5 t -66.31 -46.28 87.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.765 -0.457 . . . . 1.46 109.765 177.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.82 -24.99 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 0.97 111.206 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.52 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 0.93 110.543 177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -25.51 47.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.19 0.519 . . . . 1.86 110.317 177.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -93.03 13.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.863 -0.608 . . . . 1.82 110.161 177.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.99 4.78 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.741 -0.663 . . . . 1.97 109.689 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HD2' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -154.99 -165.38 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.114 -0.948 . . . . 3.57 109.175 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -79.62 38.47 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.417 -0.356 . . . . 3.64 111.542 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 60.6 78.39 0.28 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.647 0.737 . . . . 4.58 109.524 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 19.2 pm0 -77.68 23.3 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.943 -1.026 . . . . 2.8 112.826 -171.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.47 ' HB ' ' H ' ' A' ' 62' ' ' GLU . 2.9 t 55.0 -100.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.446 0.298 . . . . 3.13 110.877 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' H ' ' HB ' ' A' ' 61' ' ' VAL . 2.5 pt-20 -134.23 32.1 3.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 4.56 110.605 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.569 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 12.8 mt -104.4 100.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 3.01 110.114 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.477 ' HG3' ' HA2' ' A' ' 42' ' ' GLY . 87.2 Cg_endo -84.4 3.08 7.75 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.856 2.371 . . . . 1.91 113.184 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.86 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.206 0.941 . . . . 2.46 112.64 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 58.31 23.63 10.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.68 -0.691 . . . . 2.42 112.471 175.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.403 HG22 ' HD2' ' A' ' 57' ' ' ARG . 7.5 t -97.06 -51.74 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.153 0.501 . . . . 2.11 109.991 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -170.64 -54.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.499 -0.773 . . . . 2.19 110.012 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . 19.6 m-85 -84.08 35.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 1.87 111.262 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.14 47.52 0.69 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.989 -0.745 . . . . 1.09 108.989 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.03 104.81 0.49 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.326 -1.306 . . . . 3.23 108.692 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.84 40.46 0.65 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.016 2.478 . . . . 1.77 113.485 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.74 94.6 2.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.628 -0.508 . . . . 2.46 109.628 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 77' ' ' LEU . 2.6 mt -67.14 -35.09 73.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.304 -0.407 . . . . 2.08 110.78 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -36.03 79.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 3.8 110.283 176.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.77 83.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 1.08 110.379 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 74' ' ' ILE . 17.4 mt -66.74 -33.38 75.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 2.41 110.547 177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.8 -17.07 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.57 111.625 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -110.2 12.95 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 2.74 110.299 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -126.79 -88.9 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.945 -0.571 . . . . 2.85 110.865 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.36 -17.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.963 0.357 . . . . 2.13 111.963 -175.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.05 39.28 3.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 1.9 110.787 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 14.0 t -80.21 -26.9 38.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 2.65 111.284 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 83' ' ' THR . 48.8 mtm-85 73.23 -49.62 0.69 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.4 0.68 . . . . 7.09 110.925 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.247 0.933 0 N-CA-C 109.314 -0.624 . . . . 5.98 109.314 175.891 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 110.279 -0.267 . . . . 8.54 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.37 89.36 0.16 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.644 -0.789 . . . . 5.41 112.305 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.74 48.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.422 0.629 . . . . 6.05 110.376 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.35 23.1 0.42 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.481 -0.782 . . . . 3.59 109.861 177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -122.48 109.24 14.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 3.47 110.384 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.81 39.99 29.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.823 -0.626 . . . . 3.01 111.19 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -70.49 -57.32 4.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.703 -0.681 . . . . 3.51 111.039 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.451 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 1.2 t80 -103.42 -88.27 0.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 2.32 111.406 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' H ' ' HB3' ' A' ' 8' ' ' TYR . 2.1 t 56.0 52.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.287 0.565 . . . . 2.13 110.822 -174.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.6 86.38 53.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.014 -0.539 . . . . 2.09 110.692 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.633 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 96.3 Cg_endo -89.95 -168.78 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.929 2.42 . . . . 1.88 111.945 177.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -77.68 -69.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.122 -0.231 . . . . 2.04 111.15 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -173.43 140.2 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.861 0.319 . . . . 2.24 111.861 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.15 -84.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.743 1.016 . . . . 1.42 113.743 168.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -61.02 -55.85 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 1.99 111.88 -171.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.731 ' HA ' HD11 ' A' ' 74' ' ' ILE . 13.2 mt-10 -63.89 -35.88 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.007 -0.542 . . . . 1.93 111.187 -176.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.403 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -64.97 -47.0 79.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.121 -0.49 . . . . 1.48 111.315 -178.42 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -74.09 -37.66 64.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.31 -0.405 . . . . 2.96 110.899 -178.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.63 -49.9 74.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 1.81 110.932 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.67 97.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 1.08 110.679 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.37 -57.14 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.769 -0.65 . . . . 2.69 111.024 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.2 mt -65.0 -52.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.092 -0.504 . . . . 1.91 111.29 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -61.62 -51.29 69.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.402 0.519 . . . . 1.33 112.402 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -74.88 -10.59 59.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.894 0.331 . . . . 2.78 111.894 -173.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.561 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -100.36 -22.3 15.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.741 -0.384 . . . . 4.4 111.608 177.761 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 25' ' ' ARG . 53.6 t -103.52 -50.33 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 2.01 111.437 -176.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -27.52 62.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 2.85 110.318 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.0 -168.76 14.03 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.037 -0.825 . . . . 1.73 111.037 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.01 56.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.481 1.134 . . . . 1.92 109.018 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -113.49 -127.52 0.29 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.029 -0.987 . . . . 2.21 111.28 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.52 50.26 0.3 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.713 -0.955 . . . . 1.58 110.713 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.59 -43.77 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.677 0.275 . . . . 3.56 110.733 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.14 -132.7 13.8 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.75 -0.738 . . . . 2.28 112.729 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -75.32 93.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.852 0.358 . . . . 2.67 111.475 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -173.87 -65.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.059 -0.719 . . . . 2.46 109.059 177.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -133.03 49.24 2.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.383 -0.969 . . . . 4.2 108.383 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.552 ' O ' HG22 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -62.9 96.36 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.371 -1.286 . . . . 4.13 111.969 -174.079 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -66.8 -17.9 65.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 2.27 111.009 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -93.66 -64.27 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.138 -0.483 . . . . 2.01 110.577 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.749 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -84.94 58.98 5.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 2.39 111.726 -173.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.749 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 3.6 tp 156.63 -24.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.934 0.894 . . . . 3.23 110.48 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.27 -25.92 74.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.995 -0.622 . . . . 2.06 112.769 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.88 -104.4 0.25 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.824 -0.703 . . . . 2.17 111.932 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.14 149.28 15.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.56 0.219 . . . . 2.26 110.606 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.69 178.33 8.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.737 -0.468 . . . . 1.31 109.737 174.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -119.15 59.87 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.37 0.605 . . . . 2.37 110.224 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 179.04 6.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.539 -0.755 . . . . 2.27 110.059 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.59 73.77 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.048 0.388 . . . . 1.64 112.048 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -36.43 72.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 2.58 111.057 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -75.06 -38.93 61.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.976 -0.556 . . . . 1.06 110.805 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.4 t -63.8 -41.59 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 1.46 110.236 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -59.93 -39.51 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.577 . . . . 0.97 110.83 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.46 -34.46 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.93 110.673 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -50.83 69.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 1.86 110.716 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 51' ' ' VAL . 4.0 t -70.4 -36.85 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 1.82 111.098 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -49.91 -45.73 51.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.668 -0.696 . . . . 1.97 111.573 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.496 ' HB3' ' H ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -87.08 -103.68 0.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.381 -0.372 . . . . 3.57 111.034 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.496 ' H ' ' HB3' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -140.53 36.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.549 -0.296 . . . . 3.64 111.225 -175.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 53.04 64.58 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.264 0.555 . . . . 4.58 110.363 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -38.1 78.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.629 -0.714 . . . . 2.8 111.79 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t 70.48 -50.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 123.669 0.606 . . . . 3.13 110.963 -175.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.444 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -80.92 -131.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 4.56 111.057 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -71.71 132.17 85.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.159 0.504 . . . . 3.01 110.864 -177.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.1 Cg_exo -78.53 69.82 7.55 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 123.516 2.811 . . . . 1.91 111.917 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -60.09 117.57 5.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 2.46 111.817 -176.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.05 50.63 17.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.501 -0.772 . . . . 2.42 112.213 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 p -126.97 -35.66 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.528 -0.469 . . . . 2.11 110.931 173.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.675 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.0 OUTLIER 177.09 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.443 0.464 . . . . 2.19 110.781 178.343 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.584 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 22.1 m-85 -72.59 -51.89 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.233 0.457 . . . . 1.87 112.233 -173.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.921 0.391 . . . . 1.09 111.546 -176.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -179.51 97.58 0.2 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 3.23 109.63 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HD3' HD13 ' A' ' 41' ' ' ILE . 9.5 Cg_exo -71.84 54.37 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.286 2.657 . . . . 1.77 112.707 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.484 HG22 ' HE2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -150.97 59.67 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.921 -0.77 . . . . 2.46 108.921 176.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.731 HD11 ' HA ' ' A' ' 16' ' ' GLU . 17.9 pt -64.61 -21.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 2.08 112.446 -170.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.484 ' HE2' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -61.61 -39.65 92.01 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.064 0.459 . . . . 3.8 110.493 175.124 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.77 73.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.923 -0.58 . . . . 1.08 110.648 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.675 HD13 ' HA ' ' A' ' 68' ' ' LEU . 25.5 mt -72.82 -25.31 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.264 -0.425 . . . . 2.41 110.441 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.5 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 1.57 111.331 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' H ' ' HG2' ' A' ' 79' ' ' GLN . 5.4 pt20 -104.53 -39.79 6.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.392 -0.523 . . . . 2.74 111.055 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.14 -65.42 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.995 0.369 . . . . 2.85 111.995 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.92 -25.01 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 2.13 111.57 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.55 33.83 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 1.9 111.477 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -27.95 68.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.278 0.561 . . . . 2.65 110.707 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 84' ' ' ARG . 8.9 mmm180 -117.6 69.03 0.76 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 7.09 109.156 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.573 -0.727 . . . . 5.98 111.002 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ttp . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.056 0.455 . . . . 8.54 110.182 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.4 159.19 14.67 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.07 -0.586 . . . . 5.41 111.771 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.88 -15.17 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.969 0.414 . . . . 6.05 110.762 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 t -126.93 126.23 42.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.071 -0.513 . . . . 3.59 110.067 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.92 93.36 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.68 -0.691 . . . . 3.47 111.127 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.527 ' HB1' ' HG ' ' A' ' 35' ' ' LEU . . . -80.34 125.02 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.422 -0.808 . . . . 3.01 110.939 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -80.32 58.78 3.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.222 0.534 . . . . 3.51 110.332 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.474 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -141.58 -94.14 0.14 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.67 -0.696 . . . . 2.32 109.925 178.405 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.547 HG23 ' HA3' ' A' ' 33' ' ' GLY . 13.0 p 33.09 62.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.295 0.997 . . . . 2.13 112.697 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.09 100.96 53.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.781 -0.645 . . . . 2.09 110.691 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.1 139.16 23.71 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.147 2.564 . . . . 1.88 112.425 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -47.09 8.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 2.04 110.238 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.6 t-20 -102.95 149.64 24.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.374 -0.83 . . . . 2.24 109.821 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.88 81.73 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.266 0.469 . . . . 1.42 112.266 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -29.38 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.52 -0.309 . . . . 1.99 110.516 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 51.9 mt-10 -60.03 -40.18 88.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 1.93 109.808 175.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -37.76 79.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.034 -0.53 . . . . 1.48 110.325 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.17 91.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 2.96 110.374 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -67.05 -53.59 29.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.712 -0.676 . . . . 1.81 110.978 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.24 99.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 1.08 112.092 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -63.25 -53.5 52.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.856 -0.156 . . . . 2.69 111.132 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.602 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 33.5 mm -58.5 -47.95 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 1.91 111.169 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -67.46 -53.53 28.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.786 0.327 . . . . 1.33 111.677 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 32' ' ' ILE . 4.6 tp10 -71.91 -52.15 18.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.548 -0.297 . . . . 2.78 111.743 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -0.69 24.09 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.933 -0.48 . . . . 4.4 111.781 -172.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.602 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 5.1 t -108.59 -43.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.075 -0.25 . . . . 2.01 110.758 173.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.08 -51.99 2.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 2.85 111.852 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -61.07 -45.2 97.06 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.255 -0.498 . . . . 1.73 113.003 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 33.7 t 76.56 -51.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.553 0.741 . . . . 1.92 111.809 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.93 -54.76 42.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.958 0.355 . . . . 2.21 111.958 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.31 57.97 0.66 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.151 -1.023 . . . . 1.58 111.88 -175.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.414 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 22.8 mm -90.64 -52.8 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.639 -0.504 . . . . 3.56 109.639 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . 56.32 -117.06 8.32 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.488 -0.778 . . . . 2.28 113.152 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.509 ' H ' ' HA ' ' A' ' 9' ' ' VAL . 13.3 mm -81.52 87.78 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 2.67 111.078 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.527 ' HG ' ' HB1' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -166.07 26.45 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 2.46 109.327 174.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.876 ' HA ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 p-10 38.47 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.909 -1.041 . . . . 4.2 111.983 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.13 -69.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.23 0.826 . . . . 4.13 113.23 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -56.67 15.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.795 0.331 . . . . 2.27 111.588 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.84 -72.15 0.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.288 -0.415 . . . . 2.01 111.698 -174.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.876 ' HG2' ' HA ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -73.62 81.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 2.39 111.803 -174.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 tp 179.08 -26.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.336 -0.847 . . . . 3.23 110.013 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.01 28.07 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.945 -0.645 . . . . 2.06 112.235 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.94 103.23 1.1 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 2.17 112.467 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -130.24 61.62 1.59 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.448 . . . . 2.26 110.305 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.16 162.47 29.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.79 -0.641 . . . . 1.31 110.735 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.61 61.5 4.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.484 0.659 . . . . 2.37 110.719 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 155.79 49.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.373 -0.83 . . . . 2.27 109.774 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.98 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.565 0.222 . . . . 1.64 111.506 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.86 -42.51 75.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 2.58 111.203 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -76.85 -36.51 56.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 1.06 111.124 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 55' ' ' VAL . 46.5 t -64.15 -42.96 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 1.46 110.4 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.45 84.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 0.97 111.019 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.84 -35.12 79.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.93 111.147 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.67 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 3.5 tt0 -67.64 -40.86 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 1.86 111.017 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 51' ' ' VAL . 22.5 t -79.53 -38.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.845 -0.616 . . . . 1.82 111.483 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -58.57 -30.86 67.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.472 -0.331 . . . . 1.97 111.304 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.587 ' HB3' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -87.15 16.03 5.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.746 -0.206 . . . . 3.57 111.283 -178.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 56.44 65.92 1.31 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.321 -0.4 . . . . 3.64 110.328 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 64.45 76.92 0.33 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.705 -0.68 . . . . 4.58 110.566 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.67 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -84.38 -11.96 55.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 2.8 111.028 -178.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t 53.32 -111.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.027 -0.533 . . . . 3.13 110.385 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 2.1 tp10 -127.26 28.93 5.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.08 0.467 . . . . 4.56 110.121 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.02 87.9 20.3 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 3.01 110.961 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 9.3 Cg_endo -91.82 105.49 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.639 2.893 . . . . 1.91 112.208 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 mt -118.03 -30.11 5.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.026 0.441 . . . . 2.46 110.884 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -153.83 82.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 2.42 110.301 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.441 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -149.26 -169.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.897 -0.592 . . . . 2.11 110.137 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -60.14 -32.3 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 2.19 111.037 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 50' ' ' ALA . 89.1 m-85 -110.17 36.62 2.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 1.87 110.61 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HB3' ' H ' ' A' ' 67' ' ' VAL . . . -158.9 56.54 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.367 . . . . 1.09 110.969 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.532 ' HG3' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -164.52 128.34 1.77 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 3.23 109.954 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 6.5 Cg_exo -75.5 13.82 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.994 2.463 . . . . 1.77 112.363 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -153.85 115.65 4.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.3 -0.63 . . . . 2.46 109.3 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -28.83 5.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.44 . . . . 2.08 111.344 -171.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 13' ' ' ASN . 17.6 pttt -57.92 -36.69 72.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.588 -0.278 . . . . 3.8 111.169 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.16 -39.26 89.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.076 0.465 . . . . 1.08 110.801 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HG3' ' A' ' 71' ' ' GLN . 5.4 mt -72.47 -45.41 59.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 2.41 110.133 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -59.22 -42.5 91.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.57 111.749 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.26 1.25 41.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 2.74 111.566 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -129.78 -90.2 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.726 -0.39 . . . . 2.85 111.69 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.3 m -70.6 -18.6 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.51 0.559 . . . . 2.13 112.51 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.85 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -102.25 15.29 29.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.331 . . . . 1.9 111.77 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.79 9.0 42.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.839 -0.344 . . . . 2.65 111.219 176.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 64.53 9.84 5.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.762 -0.653 . . . . 7.09 112.516 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.963 0 CA-C-O 117.876 -1.059 . . . . 5.98 109.821 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttp . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.722 0.296 . . . . 8.54 110.34 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.72 23.61 27.8 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.947 -0.645 . . . . 5.41 111.667 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -81.9 52.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.326 0.584 . . . . 6.05 111.926 -174.435 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 m -116.6 -37.97 3.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.522 -0.763 . . . . 3.59 109.776 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -154.35 118.82 4.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.717 -0.674 . . . . 3.47 109.434 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.31 -99.19 0.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.499 -0.319 . . . . 3.01 110.904 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.26 -58.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.68 0.276 . . . . 3.51 110.884 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.468 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . 8.6 t80 -46.97 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.231 -0.895 . . . . 2.32 112.577 -173.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.2 p 42.74 36.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.094 0.949 . . . . 2.13 112.524 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.38 84.32 56.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.89 -0.595 . . . . 2.09 111.531 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 31.3 Cg_exo -59.71 133.96 54.55 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.353 2.036 . . . . 1.88 111.103 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -45.96 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.651 0.612 . . . . 2.04 112.651 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -136.47 107.36 6.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.706 1.002 . . . . 2.24 113.706 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 42.09 -85.88 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.961 1.467 . . . . 1.42 114.961 163.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -53.29 -34.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.072 -0.513 . . . . 1.99 111.204 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.98 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 39.5 mt-10 -61.81 -45.97 91.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.463 -0.789 . . . . 1.93 110.69 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.555 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -63.25 -35.49 80.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 1.48 110.997 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -60.59 -60.07 4.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 2.96 110.976 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.57 -40.01 77.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 1.81 111.427 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.53 -50.72 66.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.362 -0.381 . . . . 1.08 111.454 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 26.2 mt-10 -62.53 -41.03 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.497 0.189 . . . . 2.69 111.428 -175.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.85 -43.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 1.91 110.362 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -72.79 -48.72 35.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.09 -0.504 . . . . 1.33 112.065 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.81 -26.49 25.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.585 0.587 . . . . 2.78 112.585 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -99.22 -48.05 4.97 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 4.4 111.552 -177.263 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.85 -47.68 16.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.688 0.28 . . . . 2.01 111.618 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.54 -65.58 0.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 2.85 111.872 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.09 -41.7 17.38 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.942 -0.647 . . . . 1.73 113.306 -175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t 63.77 83.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.16 0.505 . . . . 1.92 110.214 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.28 -83.49 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 2.21 111.778 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.14 72.31 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.231 -1.147 . . . . 1.58 110.231 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 33' ' ' GLY . 4.8 tp -96.75 173.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.369 0.604 . . . . 3.56 112.415 -167.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.555 ' H ' HG13 ' A' ' 32' ' ' ILE . . . -152.47 173.85 31.46 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.825 -0.625 . . . . 2.28 111.651 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.649 HG23 ' HB2' ' A' ' 72' ' ' PRO . 19.3 mm -85.97 68.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.369 0.604 . . . . 2.67 110.559 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -141.64 -67.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.491 -0.777 . . . . 2.46 109.041 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -131.07 147.39 52.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.47 -0.937 . . . . 4.2 108.47 173.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -144.71 160.96 40.36 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 121.062 -0.255 . . . . 4.13 110.859 -174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -100.96 -17.17 16.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.136 -0.484 . . . . 2.27 110.475 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.449 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.1 OUTLIER -129.66 -45.44 1.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.947 -0.57 . . . . 2.01 110.683 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.449 HE21 ' HE2' ' A' ' 39' ' ' PHE . 26.2 mt-30 -82.65 62.23 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.25 -0.281 . . . . 2.39 110.662 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 tp -169.5 -22.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 111.916 0.339 . . . . 3.23 111.916 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.22 -36.96 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.426 -0.892 . . . . 2.06 112.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.35 131.21 41.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.037 -0.602 . . . . 2.17 111.884 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -113.19 100.71 8.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.043 0.449 . . . . 2.26 110.336 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.0 154.73 25.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.573 -0.74 . . . . 1.31 111.032 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.83 91.46 1.96 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 2.37 110.485 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.32 156.12 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 2.27 110.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -25.6 64.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 1.64 111.064 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 ttt -63.1 -34.75 78.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 2.58 110.601 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HA ' ' HZ ' ' A' ' 69' ' ' PHE . . . -72.29 -38.75 68.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 1.06 110.355 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 55' ' ' VAL . 10.5 t -64.25 -38.58 82.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 1.46 110.315 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.26 93.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 0.97 110.719 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.92 96.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 0.93 110.47 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.479 ' HA ' ' HG3' ' A' ' 60' ' ' GLN . 4.0 mm-40 -58.36 -49.63 76.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.701 . . . . 1.86 110.716 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.7 t -64.63 -31.25 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 1.82 110.769 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -68.79 -18.96 64.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 1.97 111.924 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -120.8 19.18 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.715 0.293 . . . . 3.57 110.642 178.068 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 51.44 60.62 3.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.544 -0.753 . . . . 3.64 111.302 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 68.54 73.29 0.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.315 -0.857 . . . . 4.58 110.879 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -79.68 97.33 6.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.152 -0.931 . . . . 2.8 110.024 178.013 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -70.11 88.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.393 . . . . 3.13 111.115 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.22 43.46 26.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.724 -0.671 . . . . 4.56 111.179 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -154.62 75.0 5.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 3.01 110.584 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.731 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.7 Cg_endo -87.03 47.68 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.517 2.811 . . . . 1.91 112.432 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -56.83 101.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.682 -0.69 . . . . 2.46 112.268 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.766 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 11.4 mtmm 58.3 31.3 20.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.457 -0.792 . . . . 2.42 112.213 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.92 -21.37 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.945 -0.302 . . . . 2.11 110.948 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -175.04 -74.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.101 0.477 . . . . 2.19 109.727 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.731 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 11.0 m-85 -84.49 53.14 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 1.87 111.056 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.766 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -172.09 134.08 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.92 -0.582 . . . . 1.09 109.607 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 65.7 tp60 72.88 88.51 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 124.199 0.937 . . . . 3.23 110.455 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HB2' HG23 ' A' ' 34' ' ' ILE . 7.6 Cg_exo -72.97 63.59 4.07 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.443 2.762 . . . . 1.77 112.429 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.1 93.88 2.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.827 -0.624 . . . . 2.46 109.506 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.98 ' HB ' ' HG2' ' A' ' 16' ' ' GLU . 1.8 mt -64.88 -35.88 76.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 2.08 111.293 -173.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -59.17 -43.6 92.12 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.923 0.392 . . . . 3.8 110.648 175.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -42.92 69.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 1.08 110.68 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.31 -25.95 67.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 2.41 110.809 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.17 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.192 -0.458 . . . . 1.57 111.002 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.36 -13.63 59.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.017 0.437 . . . . 2.74 110.551 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.25 -72.93 0.48 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 2.85 111.226 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.29 -43.52 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 2.13 110.976 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.63 30.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.347 0.594 . . . . 1.9 110.841 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.56 -14.16 59.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 2.65 110.129 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.482 ' HB2' ' H ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -97.89 -145.49 0.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.655 -0.702 . . . . 7.09 109.56 177.075 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.482 ' H ' ' HB2' ' A' ' 84' ' ' ARG . 3.3 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.615 -0.707 . . . . 5.98 110.198 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.899 0.38 . . . . 8.54 110.165 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.15 128.3 6.33 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.748 -0.739 . . . . 5.41 112.036 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.98 133.43 64.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.648 0.261 . . . . 6.05 110.411 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.07 -78.84 0.27 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.198 -0.456 . . . . 3.59 110.273 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.49 98.17 9.95 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.111 -0.7 . . . . 3.47 109.111 176.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.31 -21.05 50.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 3.01 112.426 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 68.48 -58.84 0.46 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.272 0.629 . . . . 3.51 111.153 -175.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.83 72.9 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 2.32 110.893 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.464 ' HA ' HG12 ' A' ' 34' ' ' ILE . 6.5 p -125.99 5.52 4.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.399 0.619 . . . . 2.13 110.464 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -86.59 109.53 24.66 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 2.09 110.658 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.556 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 5.1 Cg_exo -81.43 -172.41 1.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.385 2.723 . . . . 1.88 111.871 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.98 -49.18 2.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 2.04 110.885 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.404 HD21 HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -99.85 159.38 15.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 2.24 110.717 -175.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.8 95.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.48 . . . . 1.42 112.12 -175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 HD21 ' A' ' 13' ' ' ASN . 15.3 t -64.09 -39.82 86.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 1.99 110.667 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.613 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 27.7 mt-10 -57.36 -42.34 81.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.774 -0.648 . . . . 1.93 110.458 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -75.16 -31.28 60.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 1.48 111.428 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -56.03 22.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 2.96 111.043 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.55 -32.64 73.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 1.81 110.612 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.7 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 1.08 110.691 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -56.39 -50.96 70.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.536 . . . . 2.69 111.055 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.21 -52.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.693 -0.685 . . . . 1.91 111.129 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -64.07 -42.83 96.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.444 -0.343 . . . . 1.33 111.417 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.729 ' HB2' HG12 ' A' ' 32' ' ' ILE . 5.5 tp10 -60.21 -44.8 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.584 -0.28 . . . . 2.78 111.169 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -20.75 39.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 4.4 112.295 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -97.07 -52.39 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.842 0.312 . . . . 2.01 111.842 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.73 -31.47 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.948 0.351 . . . . 2.85 111.948 -174.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.81 -73.84 0.42 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.306 -0.473 . . . . 1.73 112.72 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t 69.15 -63.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.049 0.54 . . . . 1.92 111.926 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 m -66.57 -32.76 74.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 2.21 110.616 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.83 127.54 2.76 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.762 -0.733 . . . . 1.58 112.654 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.729 HG12 ' HB2' ' A' ' 24' ' ' GLU . 1.3 pt -104.2 172.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 3.56 110.535 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.65 163.34 33.53 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.044 -0.598 . . . . 2.28 111.78 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -92.49 -7.53 10.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.038 0.446 . . . . 2.67 110.821 -178.325 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.627 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -87.18 -43.16 12.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.509 -0.314 . . . . 2.46 110.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.627 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 20.3 t70 -174.71 161.51 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.141 -0.689 . . . . 4.2 109.141 -177.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.599 ' ND2' ' HA ' ' A' ' 32' ' ' ILE . 6.5 t-20 -169.64 164.11 10.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.207 -0.294 . . . . 4.13 110.207 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -77.51 -24.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 2.27 110.807 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -88.2 -33.69 18.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.083 -0.508 . . . . 2.01 111.042 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.4 mt-30 -84.63 33.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.333 . . . . 2.39 111.779 -172.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.465 ' HB ' ' H ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -151.25 -127.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.693 -0.484 . . . . 3.23 109.693 176.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 41' ' ' ILE . . . -84.89 53.91 4.87 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.914 -0.66 . . . . 2.06 111.949 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -139.73 55.44 0.65 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.617 -0.593 . . . . 2.17 111.617 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -73.61 135.36 43.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.626 0.25 . . . . 2.26 110.799 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.99 171.43 14.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 1.31 110.266 175.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.15 67.95 3.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.219 0.533 . . . . 2.37 109.562 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -126.41 170.8 11.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 2.27 110.6 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.71 71.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 1.64 110.766 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.3 tpp -60.38 -35.34 75.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.903 -0.589 . . . . 2.58 110.674 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -70.13 -44.08 69.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 1.06 110.264 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.01 -44.5 91.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.05 -0.523 . . . . 1.46 110.319 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.91 73.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.97 111.089 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -64.2 -51.09 65.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.93 111.147 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -68.11 -33.1 73.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.042 -0.263 . . . . 1.86 111.178 -178.1 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.15 -44.1 81.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.356 . . . . 1.82 110.421 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -71.46 -28.01 63.66 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.901 0.381 . . . . 1.97 110.698 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -78.93 -32.63 45.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 3.57 110.695 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER 70.1 9.75 7.15 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.742 0.651 . . . . 3.64 110.903 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -172.66 156.63 3.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.033 -1.099 . . . . 4.58 108.033 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -143.67 -36.65 0.35 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.103 -0.639 . . . . 2.8 112.096 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.1 t 69.01 -73.89 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 123.579 0.549 . . . . 3.13 109.733 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.78 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.483 0.713 . . . . 4.56 109.422 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -105.66 107.74 60.02 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.821 -0.627 . . . . 3.01 110.33 178.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 18.6 Cg_endo -92.38 99.27 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.466 2.778 . . . . 1.91 111.915 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.97 -19.65 47.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.717 0.265 . . . . 2.46 111.717 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.78 115.94 3.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.645 -0.252 . . . . 2.42 110.364 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.416 HG13 ' H ' ' A' ' 68' ' ' LEU . 2.1 p -171.25 -55.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.46 -0.336 . . . . 2.11 110.781 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.541 ' HA ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -167.02 -37.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.009 0.433 . . . . 2.19 110.225 -176.162 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -83.0 -67.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 1.87 111.106 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 40' ' ' GLN . . . -76.58 88.96 3.3 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.041 0.448 . . . . 1.09 111.625 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.513 ' HB3' HD23 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -175.45 85.08 0.3 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.166 -0.925 . . . . 3.23 109.455 175.038 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.12 70.74 0.55 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.433 2.755 . . . . 1.77 112.034 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.52 -24.57 0.09 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.246 -0.888 . . . . 2.46 109.555 177.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.514 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 mt 71.35 -68.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.501 -0.772 . . . . 2.08 111.955 174.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HB2' ' HG3' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -72.28 -15.68 61.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.698 0.259 . . . . 3.8 111.698 -174.361 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.52 13.77 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.024 0.44 . . . . 1.08 110.8 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -63.44 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 2.41 109.96 178.237 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -75.15 0.42 16.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 1.57 111.529 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -32.41 11.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 2.74 110.454 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.49 -64.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.276 -0.569 . . . . 2.85 112.381 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.45 -40.28 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 2.13 110.96 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -105.91 159.12 16.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.809 -0.632 . . . . 1.9 109.482 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.68 -61.47 0.41 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.038 0.535 . . . . 2.65 111.551 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -22.6 54.25 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.952 -0.388 . . . . 7.09 109.952 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.022 -0.99 . . . . 5.98 112.159 174.086 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 mmm . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.865 -0.42 . . . . 8.54 109.865 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.27 76.47 0.31 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.693 -0.765 . . . . 5.41 112.642 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.723 ' HA ' ' HB3' ' A' ' 30' ' ' SER . 0.2 OUTLIER -84.67 37.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.218 0.532 . . . . 6.05 110.523 -179.41 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.6 -3.24 20.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.835 -0.621 . . . . 3.59 111.38 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 57.59 77.71 0.27 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.186 0.517 . . . . 3.47 110.389 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.63 125.61 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.462 -0.79 . . . . 3.01 111.42 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.61 63.09 4.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 3.51 111.131 -177.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.633 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t80 -121.89 -86.37 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.938 -0.764 . . . . 2.32 108.938 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' H ' ' HB3' ' A' ' 8' ' ' TYR . 94.7 t 73.13 -55.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.759 0.662 . . . . 2.13 111.872 173.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -82.32 108.69 12.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.58 0.229 . . . . 2.09 111.033 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.779 ' HG2' ' HB3' ' A' ' 16' ' ' GLU . 20.4 Cg_endo -95.64 -99.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.593 2.862 . . . . 1.88 111.559 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 p -98.87 -80.4 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.866 0.365 . . . . 2.04 110.239 174.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -134.24 -174.86 3.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 2.24 110.873 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.92 -33.4 56.54 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.63 0.974 . . . . 1.42 113.63 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.82 -34.33 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.955 0.407 . . . . 1.99 110.701 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.779 ' HB3' ' HG2' ' A' ' 11' ' ' PRO . 4.6 tt0 -79.95 -38.01 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.253 -0.43 . . . . 1.93 110.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -63.62 -39.01 93.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.403 . . . . 1.48 110.884 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HE3' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -69.59 -31.66 69.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.448 -0.342 . . . . 2.96 110.803 178.477 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.496 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 tp -64.92 -46.13 82.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.605 -0.517 . . . . 1.81 109.605 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 24' ' ' GLU . . . -60.19 -33.87 72.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.484 -0.78 . . . . 1.08 110.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 17' ' ' SER . 85.5 mt-10 -57.79 -47.23 83.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 2.69 111.092 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.549 HD11 ' HE3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -71.83 -48.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.042 0.449 . . . . 1.91 111.066 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -68.57 -47.08 67.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.551 . . . . 1.33 112.035 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -69.79 -45.55 67.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.623 -0.262 . . . . 2.78 111.17 -175.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.468 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 2.1 mmt180 -71.89 -37.85 70.08 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.005 0.372 . . . . 4.4 112.005 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.29 -59.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.096 0.406 . . . . 2.01 112.096 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 40.3 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.1 0.476 . . . . 2.85 111.349 -173.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -172.83 -46.41 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.645 -0.788 . . . . 1.73 112.207 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 7.2 t 78.4 -37.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.352 0.661 . . . . 1.92 110.572 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.723 ' HB3' ' HA ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -74.7 144.77 43.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.128 -0.487 . . . . 2.21 110.406 177.182 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.58 71.74 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.722 . . . . 1.58 113.08 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 36.1 mm -101.96 91.34 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.453 0.644 . . . . 3.56 110.359 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 34' ' ' ILE . . . -79.7 79.98 1.62 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.648 -0.787 . . . . 2.28 112.246 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 33' ' ' GLY . 38.8 mm 78.05 -43.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.399 0.68 . . . . 2.67 112.504 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.633 ' HG ' ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -35.86 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 2.46 113.527 -174.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.72 110.71 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 4.2 111.089 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.05 95.7 6.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.068 -0.515 . . . . 4.13 109.88 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -96.59 -24.58 15.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 2.27 112.637 -174.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -131.79 -9.21 3.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.632 -0.427 . . . . 2.01 111.637 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 8.1 mp0 -72.0 -57.71 4.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.337 -0.392 . . . . 2.39 111.329 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.549 HG23 ' HB1' ' A' ' 70' ' ' ALA . 1.6 mt -105.62 74.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.998 0.428 . . . . 3.23 111.281 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.95 -82.55 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.369 -0.92 . . . . 2.06 113.257 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.45 80.81 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.133 -0.556 . . . . 2.17 112.733 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.427 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 2.9 p-80 -65.21 141.7 58.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.01 0.433 . . . . 2.26 110.483 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.74 29.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 1.31 111.206 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 mt -87.24 -10.96 51.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.104 -0.702 . . . . 2.37 109.104 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -56.21 150.53 14.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.595 -1.184 . . . . 2.27 110.989 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -17.83 51.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.197 -0.456 . . . . 1.64 111.964 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -63.1 -48.23 79.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 2.58 110.786 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.71 -28.39 50.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 1.06 110.431 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.18 -40.13 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 1.46 110.272 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.82 92.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.97 110.533 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.519 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -64.52 -42.24 95.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 0.93 110.415 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.699 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 tt0 -59.84 -46.92 87.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.587 -0.733 . . . . 1.86 110.777 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -65.95 -39.24 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 1.82 110.903 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -72.71 5.3 3.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 1.97 111.897 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -137.29 24.66 2.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.977 0.418 . . . . 3.57 110.362 175.316 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.08 49.73 11.1 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.438 -0.801 . . . . 3.64 111.965 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.699 ' HA ' ' HG3' ' A' ' 54' ' ' GLN . 21.7 m-30 66.8 87.97 0.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.692 -0.685 . . . . 4.58 112.147 171.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -77.76 -17.79 57.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.607 -0.724 . . . . 2.8 110.988 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 53.6 t 77.03 -57.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 123.388 0.675 . . . . 3.13 112.264 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 -70.45 0.79 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.823 0.305 . . . . 4.56 111.823 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.51 140.9 28.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.569 -0.287 . . . . 3.01 110.899 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' OE1' ' A' ' 60' ' ' GLN . 74.5 Cg_endo -75.84 62.39 6.51 Favored 'Trans proline' 0 C--O 1.237 0.466 0 C-N-CA 122.933 2.422 . . . . 1.91 111.731 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.834 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 22.3 tp -77.08 126.55 31.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 2.46 111.679 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt 64.48 14.9 9.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.416 -0.811 . . . . 2.42 112.487 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.519 HG11 ' HB1' ' A' ' 53' ' ' ALA . 7.2 p -98.35 -35.15 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.759 -0.376 . . . . 2.11 110.188 174.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER 175.43 -58.8 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.164 0 O-C-N 123.612 0.57 . . . . 2.19 110.585 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.4 m-85 -66.74 -50.9 61.27 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.964 0.727 . . . . 1.87 112.964 -171.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . -77.95 70.55 4.33 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.184 0.438 . . . . 1.09 112.184 -173.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.71 130.22 1.52 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.58 -0.736 . . . . 3.23 109.509 174.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.665 ' O ' ' HB ' ' A' ' 73' ' ' THR . 39.5 Cg_exo -61.27 105.15 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.499 2.132 . . . . 1.77 111.282 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.665 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER 81.94 113.54 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.18 0.925 . . . . 2.46 109.35 -171.349 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 68' ' ' LEU . 4.2 mm -83.12 -22.69 8.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.044 -0.98 . . . . 2.08 110.322 -174.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -54.08 -37.12 63.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.633 -0.712 . . . . 3.8 111.681 -178.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.06 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.08 110.968 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.66 -27.74 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 2.41 110.646 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.876 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -60.83 -49.71 76.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 1.57 111.865 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.82 -0.29 57.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.742 -0.383 . . . . 2.74 111.412 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -101.43 -69.08 0.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.94 -0.304 . . . . 2.85 111.283 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -13.43 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 111.854 0.316 . . . . 2.13 111.854 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.876 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -99.05 21.9 11.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 1.9 111.124 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -8.35 54.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.501 0.667 . . . . 2.65 110.692 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -95.73 -3.09 46.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.236 -0.893 . . . . 7.09 109.924 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.46 -0.781 . . . . 5.98 110.641 -176.02 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 120.782 0.325 . . . . 3.47 111.068 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . . . -82.91 130.07 35.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.044 -0.526 . . . . 3.01 111.05 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -85.15 20.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 3.51 110.519 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -125.05 46.01 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 2.32 111.126 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.55 2.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 2.13 111.058 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.07 110.25 3.98 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 2.09 111.45 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -91.03 158.93 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.592 2.195 . . . . 1.88 111.975 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.23 -44.24 8.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 2.04 111.082 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.04 156.36 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 2.24 110.976 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.49 64.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 1.42 111.296 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -64.89 -41.95 93.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 1.99 111.168 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.22 -38.45 78.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 1.93 111.027 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -64.52 -42.02 96.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.48 110.986 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -68.18 -48.79 64.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 2.96 111.258 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -47.2 85.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 1.81 110.957 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.18 80.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.511 . . . . 1.08 111.367 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 17' ' ' SER . 10.2 tt0 -66.05 -51.7 55.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 2.69 111.501 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.81 -34.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.09 0.404 . . . . 1.91 112.09 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -76.38 -44.2 37.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.666 0.617 . . . . 1.33 112.666 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.47 9.65 12.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.908 0.336 . . . . 2.78 111.908 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.48 ' HB2' HH11 ' A' ' 25' ' ' ARG . 5.6 ttm105 -118.46 -21.74 7.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 4.4 110.853 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.41 -24.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 2.01 111.133 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.74 -61.37 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 2.85 111.517 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -59.61 9.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 1.73 113.319 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t 59.09 12.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.03 0.443 . . . . 1.92 110.85 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.7 m -98.46 -68.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 2.21 111.01 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.54 33.97 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.754 -0.736 . . . . 1.58 111.932 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.452 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 1.1 pt -88.44 -173.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 3.56 111.308 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.55 -109.23 0.23 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.868 -0.682 . . . . 2.28 112.413 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.28 49.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.724 0.297 . . . . 2.67 111.189 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.98 9.85 6.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.497 -0.32 . . . . 2.46 111.318 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.13 150.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 4.2 110.443 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.558 HD22 ' H ' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -177.76 -96.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 4.13 111.117 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.558 ' H ' HD22 ' A' ' 37' ' ' ASN . 9.7 p90 -119.95 -28.11 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.357 -0.383 . . . . 2.27 111.264 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.455 ' HB3' HE21 ' A' ' 40' ' ' GLN . 14.0 t80 -78.67 -83.89 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.294 -0.412 . . . . 2.01 111.676 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -73.86 82.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 2.39 111.247 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 tp -172.03 -36.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.849 0.315 . . . . 3.23 111.849 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.96 -30.46 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.252 -0.975 . . . . 2.06 112.98 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.12 120.43 18.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.613 -0.803 . . . . 2.17 112.297 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -98.76 26.56 5.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.751 0.275 . . . . 2.26 111.387 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 31.16 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.99 0.737 . . . . 1.31 112.99 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.92 31.57 0.94 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.214 -0.448 . . . . 2.37 110.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -105.3 169.6 8.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 2.27 111.205 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.2 79.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.013 -0.54 . . . . 1.64 111.229 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.6 ttt -58.9 -32.11 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.414 . . . . 2.58 110.606 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.47 -47.17 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 1.06 110.652 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 55' ' ' VAL . 19.8 t -57.52 -34.48 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 1.46 110.089 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -65.48 -43.28 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.639 . . . . 0.97 110.275 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -26.42 67.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.02 -0.536 . . . . 0.93 110.483 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.414 ' HG2' ' NE2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -72.73 -44.6 61.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.805 -0.634 . . . . 1.86 110.801 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 51' ' ' VAL . 13.0 t -76.55 -26.49 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 1.82 111.282 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -77.61 2.68 15.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 1.97 111.154 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -133.58 8.27 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.37 . . . . 3.57 111.537 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 68.39 53.8 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 3.64 111.31 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 57.74 88.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 4.58 111.8 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.63 ' OE1' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -67.68 -30.1 69.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.649 -0.501 . . . . 2.8 109.649 178.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.2 t 65.86 -72.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 115.322 -0.854 . . . . 3.13 111.861 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -92.81 -84.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.506 0.558 . . . . 4.56 112.506 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.06 135.14 20.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.206 0.447 . . . . 3.01 112.206 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 67' ' ' VAL . 84.4 Cg_endo -88.24 58.36 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.769 2.313 . . . . 1.91 111.125 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.95 119.08 5.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.587 -0.733 . . . . 2.46 112.241 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mttp 47.15 83.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 2.42 112.123 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.63 HG11 ' OE1' ' A' ' 60' ' ' GLN . 13.7 p -155.62 -44.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.288 -0.414 . . . . 2.11 111.051 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.432 ' N ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -178.27 -39.53 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.549 -0.296 . . . . 2.19 111.499 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -91.97 -52.72 4.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.066 0.395 . . . . 1.87 112.066 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.9 71.56 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.954 0.353 . . . . 1.09 111.954 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.672 HE21 ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 176.42 115.27 0.13 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.148 -0.478 . . . . 3.23 110.582 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.672 ' HD2' HE21 ' A' ' 71' ' ' GLN . 73.4 Cg_endo -75.99 41.35 0.83 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.434 2.09 . . . . 1.77 112.879 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.91 74.54 0.73 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.146 0.498 . . . . 2.46 110.23 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.08 -40.79 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.648 -0.705 . . . . 2.08 112.296 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -30.83 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 3.8 111.146 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.09 68.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 1.08 110.734 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 71' ' ' GLN . 30.7 mt -72.82 -27.33 61.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.049 -0.523 . . . . 2.41 110.602 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.814 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -60.61 -34.28 74.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 1.57 111.106 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -103.31 21.61 15.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 2.74 111.041 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 1.0 OUTLIER -129.91 -69.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 2.85 111.094 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 t -94.1 -39.26 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 2.13 111.332 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -72.64 -16.86 61.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 1.9 111.348 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 109.971 -0.381 . . . . 2.65 109.971 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 1.018 ' HA ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.62 0.724 . . . . 3.47 112.174 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . . . -163.81 146.65 9.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.455 -0.793 . . . . 3.01 110.148 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -122.69 33.79 5.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.514 0.674 . . . . 3.51 109.196 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 34' ' ' ILE . 5.1 t80 -116.12 17.23 15.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.371 -0.831 . . . . 2.32 111.334 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.43 67.03 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.403 1.096 . . . . 2.13 110.122 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -106.41 105.29 53.88 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.106 -0.952 . . . . 2.09 110.515 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 1.1 Cg_endo -83.52 156.61 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.121 2.547 . . . . 1.88 111.974 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.56 -44.92 3.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.237 0.541 . . . . 2.04 109.645 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -114.59 177.49 4.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.511 -0.768 . . . . 2.24 109.832 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.42 -15.57 54.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.896 0.379 . . . . 1.42 110.768 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.78 -57.52 10.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.922 -0.581 . . . . 1.99 111.039 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.899 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 12.6 pm0 -72.75 -22.71 60.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.23 -0.441 . . . . 1.93 110.699 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.66 -48.5 79.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 1.48 110.097 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -61.08 -45.18 95.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 2.96 110.856 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.38 -56.07 16.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 1.81 111.395 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -67.12 -43.8 81.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.669 -0.696 . . . . 1.08 112.092 -173.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.05 -37.21 83.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.604 0.24 . . . . 2.69 111.314 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -46.99 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.045 -0.262 . . . . 1.91 110.595 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -69.28 -27.36 65.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.33 110.563 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.1 tm-20 -58.83 -52.03 67.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 2.78 110.471 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -19.35 60.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.726 0.298 . . . . 4.4 111.364 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.63 -49.27 15.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.497 -0.319 . . . . 2.01 111.409 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.45 -31.69 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.686 0.624 . . . . 2.85 112.686 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 -82.1 0.47 Allowed Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.656 -0.783 . . . . 1.73 113.723 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 74.56 4.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.011 0.924 . . . . 1.92 110.92 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.018 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 15.2 m -112.5 -17.0 12.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.703 -0.68 . . . . 2.21 111.965 -172.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 34.78 8.34 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.651 -0.98 . . . . 1.58 110.651 -174.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 30' ' ' SER . 1.3 pt -78.94 170.52 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.273 0.559 . . . . 3.56 112.085 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.77 158.19 7.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.52 -0.764 . . . . 2.28 111.619 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.453 HG21 ' HE2' ' A' ' 8' ' ' TYR . 36.4 mm 66.27 -79.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.011 0.525 . . . . 2.67 111.272 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.966 -0.383 . . . . 2.46 109.966 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 17.7 t0 41.75 -92.73 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.362 1.039 . . . . 4.2 112.906 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 92.74 -7.39 0.17 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.711 1.257 . . . . 4.13 111.761 175.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.627 ' HE2' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -109.67 -55.53 2.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.537 -0.542 . . . . 2.27 109.537 173.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.503 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 29.7 t80 -91.75 -73.13 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.378 -0.828 . . . . 2.01 109.909 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.536 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.8 mt-30 -70.43 96.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 2.39 109.963 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.5 tp 168.69 -18.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 3.23 110.029 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.55 35.55 3.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.666 -0.778 . . . . 2.06 111.418 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.13 124.75 7.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.679 -0.772 . . . . 2.17 111.746 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -84.7 74.75 10.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 2.26 110.556 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.53 161.45 30.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.868 -0.605 . . . . 1.31 110.835 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 67.43 6.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 2.37 110.596 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -139.33 160.16 40.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.726 -0.67 . . . . 2.27 109.761 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.09 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.445 0.466 . . . . 1.64 112.159 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tpt -60.85 -31.55 71.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.329 . . . . 2.58 111.305 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.521 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -71.74 -37.01 70.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.438 -0.346 . . . . 1.06 111.196 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 1.46 110.057 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -65.91 -35.17 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.09 -0.505 . . . . 0.97 110.151 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.432 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -69.78 -26.67 64.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.91 -0.586 . . . . 0.93 110.672 176.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -79.71 -22.56 43.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 1.86 110.897 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -94.91 -15.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 1.82 111.607 -176.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.68 40.89 1.05 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.295 0.569 . . . . 1.97 110.873 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 177.81 -150.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.672 -1.233 . . . . 3.57 107.672 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.06 164.62 14.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.579 -0.897 . . . . 3.64 108.579 168.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.37 82.96 2.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.278 0.561 . . . . 4.58 109.974 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.7 2.02 7.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.934 -1.03 . . . . 2.8 112.871 -173.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.436 ' HB ' ' H ' ' A' ' 62' ' ' GLU . 3.1 t 58.82 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 122.834 0.454 . . . . 3.13 111.442 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.441 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 55.0 mm-40 -121.71 23.78 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.552 -0.295 . . . . 4.56 110.983 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -125.45 68.98 60.88 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.403 . . . . 3.01 110.857 177.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 62' ' ' GLU . 5.6 Cg_endo -87.38 73.03 2.9 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.196 2.597 . . . . 1.91 111.991 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.0 tp -82.46 129.46 34.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.12 -0.491 . . . . 2.46 110.847 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 58.13 34.19 23.92 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.766 0.666 . . . . 2.42 111.127 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.603 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -94.99 -174.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.525 -0.761 . . . . 2.11 110.433 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.592 ' H ' HG22 ' A' ' 67' ' ' VAL . 5.4 mt -53.84 -21.29 7.27 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.247 0.832 . . . . 2.19 113.247 -174.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.521 ' HE2' ' HA ' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -138.93 44.51 2.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.106 0.479 . . . . 1.87 111.287 175.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.603 ' HB3' ' H ' ' A' ' 67' ' ' VAL . . . -120.98 47.7 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.899 0.381 . . . . 1.09 110.66 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.607 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -162.16 144.99 8.82 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.206 -0.906 . . . . 3.23 108.792 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.49 1.19 3.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.927 2.418 . . . . 1.77 113.119 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.595 HG22 ' HG3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -128.94 89.43 2.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.741 0.305 . . . . 2.46 110.577 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.506 ' HA ' HD12 ' A' ' 77' ' ' LEU . 2.7 tp -58.43 -32.61 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.059 -0.519 . . . . 2.08 112.255 -176.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.899 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -62.59 -38.86 91.79 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.228 -0.295 . . . . 3.8 110.79 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.26 -31.97 73.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 1.08 110.676 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.607 HD21 ' HB2' ' A' ' 71' ' ' GLN . 12.7 mt -78.42 -36.82 45.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.986 -0.552 . . . . 2.41 110.61 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.2 66.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 1.57 110.633 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -91.55 -0.05 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.621 . . . . 2.74 110.614 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -114.04 -88.89 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 2.85 111.121 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 m -82.29 21.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 2.13 112.044 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 68' ' ' LEU . . . -130.1 -4.24 4.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 1.9 110.867 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 2.65 111.153 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' HG3' ' HB3' ' A' ' 30' ' ' SER . 2.0 mp0 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 120.825 0.345 . . . . 3.47 110.91 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 32' ' ' ILE . . . -148.39 144.65 27.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.021 -0.536 . . . . 3.01 110.082 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.16 91.37 3.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.896 0.379 . . . . 3.51 110.887 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.434 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 7.0 t80 -146.43 2.57 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.003 -0.544 . . . . 2.32 111.18 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 2.8 p -79.15 93.44 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 2.13 111.327 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.06 74.98 1.69 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.511 -0.768 . . . . 2.09 110.424 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HB2' ' H ' ' A' ' 12' ' ' THR . 2.1 Cg_endo -81.61 -133.69 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.088 2.525 . . . . 1.88 112.226 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -123.63 -48.11 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.118 0.485 . . . . 2.04 111.798 -177.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.788 HD21 ' HB ' ' A' ' 15' ' ' VAL . 1.8 t30 -98.27 132.4 43.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.872 -0.604 . . . . 2.24 110.503 -172.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.28 68.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.671 -0.695 . . . . 1.42 112.0 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.788 ' HB ' HD21 ' A' ' 13' ' ' ASN . 48.1 t -70.17 -48.42 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 1.99 110.958 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.505 ' OE1' ' HB3' ' A' ' 13' ' ' ASN . 1.7 pt-20 -67.8 -32.31 72.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.947 0.404 . . . . 1.93 110.32 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.42 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.3 m -69.48 -35.84 75.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.894 -0.594 . . . . 1.48 110.205 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -64.95 -41.78 95.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 2.96 110.737 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -46.4 90.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 1.81 110.652 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.02 92.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 1.08 111.282 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -40.43 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 2.69 111.696 -176.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -38.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 120.97 -0.292 . . . . 1.91 110.973 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -66.7 -45.25 79.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.089 0.471 . . . . 1.33 110.166 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -83.45 19.42 1.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.392 0.615 . . . . 2.78 111.301 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.471 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -120.17 -0.87 10.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.771 -0.649 . . . . 4.4 109.317 170.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.2 -25.13 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.862 -0.608 . . . . 2.01 111.852 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 tp -93.04 -81.13 0.36 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.501 0.191 . . . . 2.85 111.364 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.4 -39.87 6.64 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.66 -0.781 . . . . 1.73 111.644 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t 70.18 53.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.774 0.797 . . . . 1.92 110.648 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HB3' ' HG3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -118.64 -35.85 3.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 2.21 109.775 173.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' CA ' HH21 ' A' ' 25' ' ' ARG . . . 98.22 42.77 2.93 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.732 -0.667 . . . . 1.58 112.383 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -87.69 -80.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.803 0.335 . . . . 3.56 111.156 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.25 -69.71 3.08 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.932 -0.651 . . . . 2.28 111.589 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' HB ' ' HD2' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -107.31 152.09 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.172 -1.048 . . . . 2.67 108.172 174.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 44.3 1.53 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.359 -0.978 . . . . 2.46 108.359 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -70.46 174.52 5.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.23 -1.35 . . . . 4.2 111.957 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -140.85 -8.12 1.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 4.13 111.08 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.41 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 26.7 p90 -148.34 -33.81 0.23 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.002 0.742 . . . . 2.27 113.002 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -96.53 -83.09 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.047 -0.408 . . . . 2.01 111.66 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -29.42 67.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.39 112.018 -173.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 tp -115.1 -2.0 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.417 . . . . 3.23 111.52 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 38' ' ' PHE . . . -92.51 -95.95 1.4 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.437 -0.887 . . . . 2.06 112.71 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.12 -138.29 2.65 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.667 -0.778 . . . . 2.17 112.397 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -97.01 122.96 40.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.241 0.543 . . . . 2.26 111.366 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.33 -178.11 6.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 1.31 109.986 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -89.15 45.68 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.049 0.452 . . . . 2.37 110.947 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.58 163.74 22.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.393 -0.367 . . . . 2.27 111.418 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.96 94.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 1.64 111.534 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ttt -60.33 -34.58 74.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.402 . . . . 2.58 110.456 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . . . -69.95 -40.58 75.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 1.06 110.846 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.634 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -71.69 -34.88 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 1.46 110.616 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.35 -29.94 62.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.97 110.807 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -38.68 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.93 111.271 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.634 ' NE2' ' HA ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -68.73 -38.42 80.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.011 -0.276 . . . . 1.86 110.936 -177.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 51' ' ' VAL . 35.7 m -92.83 19.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 1.82 110.973 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.436 ' HE1' ' O ' ' A' ' 81' ' ' VAL . 15.5 t-160 -88.13 -18.13 29.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.07 -0.513 . . . . 1.97 110.456 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.59 ' HG3' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -106.25 -63.9 1.22 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.041 0.448 . . . . 3.57 110.682 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.3 -151.97 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.632 -0.713 . . . . 3.64 109.298 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -75.82 64.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.414 0.626 . . . . 4.58 110.194 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.543 HE22 HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -119.18 91.99 3.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 2.8 109.177 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.29 -55.75 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.7 -0.682 . . . . 3.13 112.185 -170.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -63.72 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 4.56 111.652 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.72 111.66 54.11 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 3.01 110.672 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.9 127.54 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.557 2.171 . . . . 1.91 111.226 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tp -123.73 96.22 4.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 2.46 110.506 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 0.5 OUTLIER 54.67 62.62 2.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.908 -0.587 . . . . 2.42 111.377 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' A' ' 57' ' ' ARG . 11.3 p -132.04 -29.66 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.171 -0.468 . . . . 2.11 111.178 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.61 -51.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.92 -0.77 . . . . 2.19 108.92 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 50' ' ' ALA . 1.1 m-85 -104.67 172.31 6.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.217 -0.901 . . . . 1.87 109.172 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 71' ' ' GLN . . . 60.35 43.67 13.22 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.91 0.756 . . . . 1.09 111.266 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 167.06 123.57 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 O-C-N 124.215 0.947 . . . . 3.23 109.752 176.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.44 28.95 0.54 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.813 2.342 . . . . 1.77 113.061 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.47 39.75 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.06 0.457 . . . . 2.46 110.629 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.535 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -57.51 -39.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 2.08 111.846 -175.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.513 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -64.86 -43.07 94.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.788 0.328 . . . . 3.8 110.814 -178.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.05 74.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 1.08 110.992 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.23 -43.2 95.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.345 -0.389 . . . . 2.41 111.36 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.46 -4.62 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 1.57 111.493 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.29 -57.67 2.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.966 0.412 . . . . 2.74 110.781 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -74.11 -42.35 60.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 2.85 111.836 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.436 ' O ' ' HE1' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -108.78 30.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.84 0.353 . . . . 2.13 111.425 -174.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.96 30.32 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.091 0.472 . . . . 1.9 110.443 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 2.65 111.244 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.9 mt-10 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 111.894 0.331 . . . . 3.47 111.894 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HA ' HD13 ' A' ' 35' ' ' LEU . . . -152.91 83.96 1.22 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.931 0.396 . . . . 3.01 111.051 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -92.59 -9.64 40.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 3.51 110.097 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -91.55 -54.86 3.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 2.32 110.052 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.53 HG12 ' HD3' ' A' ' 11' ' ' PRO . 2.2 t 56.73 -100.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.944 -0.571 . . . . 2.13 111.415 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.513 ' H ' ' HB ' ' A' ' 9' ' ' VAL . . . 57.02 65.63 3.65 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.596 0.591 . . . . 2.09 112.596 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.53 ' HD3' HG12 ' A' ' 9' ' ' VAL . 73.9 Cg_endo -88.97 143.44 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.55 2.166 . . . . 1.88 111.518 176.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.442 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -107.75 -34.64 6.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.858 0.361 . . . . 2.04 111.313 -177.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.35 151.07 49.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.32 -0.4 . . . . 2.24 110.764 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.35 68.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 1.42 111.297 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.17 -44.95 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 1.99 110.738 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -43.09 89.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 1.93 110.849 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -69.69 -43.95 71.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.541 . . . . 1.48 111.207 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.79 -40.51 83.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.682 -0.235 . . . . 2.96 111.213 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -45.0 96.57 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.761 0.315 . . . . 1.81 110.219 177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.41 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 1.08 110.903 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.76 -47.52 84.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 2.69 110.873 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.3 mt -71.89 -49.46 44.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.327 -0.397 . . . . 1.91 110.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.618 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 4.0 m95 -56.94 -52.5 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 1.33 111.609 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -63.0 -44.48 95.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.101 -0.5 . . . . 2.78 111.022 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 1.7 mmp_? -73.06 -2.84 22.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.958 0.355 . . . . 4.4 111.958 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.26 -45.07 8.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.6 -0.273 . . . . 2.01 111.246 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.1 -4.59 13.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.918 0.71 . . . . 2.85 112.918 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.3 -78.74 0.3 Allowed Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 120.088 -1.053 . . . . 1.73 112.917 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 80.96 -6.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.935 0.894 . . . . 1.92 110.627 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -44.78 78.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.516 -0.765 . . . . 2.21 111.479 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 5' ' ' GLU . . . 110.97 25.29 5.16 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.057 -0.592 . . . . 1.58 112.391 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.3 129.01 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.688 -0.301 . . . . 3.56 110.621 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.44 -80.56 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.299 -0.953 . . . . 2.28 112.608 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.461 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -96.08 85.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 2.67 110.699 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -166.33 -135.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.16 -0.927 . . . . 2.46 108.91 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.9 106.53 1.25 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.207 -1.035 . . . . 4.2 108.207 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.87 135.27 36.97 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.991 0.737 . . . . 4.13 112.991 -164.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -121.67 7.83 10.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.989 -1.005 . . . . 2.27 109.043 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.407 ' CD2' ' HG3' ' A' ' 40' ' ' GLN . 31.4 t80 -125.91 -62.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.226 -0.897 . . . . 2.01 110.651 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 72' ' ' PRO . 7.7 mt-30 -85.02 53.63 2.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.487 . . . . 2.39 110.655 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.81 38.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 3.23 109.971 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.88 -71.21 0.3 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.195 -0.762 . . . . 2.06 111.195 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 -95.35 0.57 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.878 -0.677 . . . . 2.17 112.711 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER 56.34 33.89 23.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.002 1.382 . . . . 2.26 109.929 -174.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 171.7 13.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.253 -1.34 . . . . 1.31 111.732 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.03 65.83 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 2.37 110.518 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -133.72 152.82 51.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 2.27 110.261 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.29 85.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 1.64 111.574 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.618 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -60.09 -35.06 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 2.58 110.825 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.6 -36.86 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 1.06 110.296 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 91.3 t -62.16 -40.23 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.837 -0.62 . . . . 1.46 110.431 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -63.62 -39.07 93.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 0.97 110.842 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.05 83.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.354 -0.384 . . . . 0.93 110.786 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.654 ' HA ' ' NE2' ' A' ' 60' ' ' GLN . 3.0 pt20 -88.94 12.35 15.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 1.86 111.342 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 52' ' ' ALA . 1.4 p -123.46 -13.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.167 0.508 . . . . 1.82 110.432 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -94.22 -8.83 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.625 0.726 . . . . 1.97 109.368 173.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.538 ' HG2' ' N ' ' A' ' 58' ' ' GLU . 18.6 ttt-85 -145.35 163.72 33.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.262 -1.384 . . . . 3.57 107.262 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.538 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -49.98 144.31 6.87 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 117.776 0.262 . . . . 3.64 110.983 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -48.7 117.91 2.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.722 0.639 . . . . 4.58 111.674 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.837 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 1.5 mt-30 -92.15 73.81 5.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.46 -0.791 . . . . 2.8 110.994 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -80.76 -22.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 3.13 109.758 176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.76 -78.41 0.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.241 -0.89 . . . . 4.56 110.719 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.34 112.2 8.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.744 0.307 . . . . 3.01 111.64 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.837 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 14.7 Cg_exo -71.62 68.2 2.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.458 2.772 . . . . 1.91 111.473 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 3.7 tp -81.82 133.63 35.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 2.46 112.489 -172.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.71 19.48 11.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.533 0.938 . . . . 2.42 113.533 169.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -54.75 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.811 -0.356 . . . . 2.11 110.365 174.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.858 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.6 mt -169.08 -40.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 2.19 110.462 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -82.24 2.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 1.87 112.429 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . -133.65 52.62 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.732 0.301 . . . . 1.09 111.399 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.6 ' HB3' HD11 ' A' ' 77' ' ' LEU . 36.1 tp60 -177.39 113.14 0.24 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.592 -0.731 . . . . 3.23 109.734 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HA ' ' OE1' ' A' ' 40' ' ' GLN . 13.3 Cg_exo -71.15 48.01 0.85 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.335 2.69 . . . . 1.77 112.166 177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.4 m -156.95 83.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.785 -0.643 . . . . 2.46 109.468 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.4 mm -65.05 -37.09 79.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.536 -0.756 . . . . 2.08 111.259 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HD3' ' HB ' ' A' ' 12' ' ' THR . 2.3 ttpt -56.34 -39.11 72.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 3.8 111.36 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' ' HG3' ' A' ' 79' ' ' GLN . . . -66.92 -46.33 75.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.331 . . . . 1.08 111.052 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.858 HD13 ' HA ' ' A' ' 68' ' ' LEU . 3.4 mt -70.09 -27.07 64.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.874 0.369 . . . . 2.41 110.908 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -65.28 -32.32 73.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.57 111.019 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 1.1 pt20 -97.37 15.06 24.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 2.74 110.551 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -119.8 -80.29 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.113 0.482 . . . . 2.85 110.662 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.46 -35.52 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.783 -0.644 . . . . 2.13 111.417 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -69.13 -28.25 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 1.9 111.495 -176.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.446 -0.343 . . . . 2.65 110.83 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 108.776 -0.824 . . . . 3.47 108.776 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 8' ' ' TYR . . . -127.76 146.55 50.55 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.736 -0.386 . . . . 3.01 111.434 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.65 37.22 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 3.51 110.107 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 6' ' ' ALA . 5.4 t80 -152.86 43.05 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.384 -0.825 . . . . 2.32 109.13 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.686 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 10.0 p -102.4 35.05 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.086 0.946 . . . . 2.13 110.096 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.18 112.44 38.69 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.314 -0.857 . . . . 2.09 109.84 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.52 131.33 27.57 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.683 2.256 . . . . 1.88 112.094 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.7 0.85 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.726 -0.67 . . . . 2.04 109.997 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.604 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -158.03 148.23 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.158 -0.928 . . . . 2.24 109.572 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.32 72.76 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.173 0.434 . . . . 1.42 112.173 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 43.0 t -68.33 -26.28 33.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.479 -0.328 . . . . 1.99 110.482 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -64.0 -49.12 73.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 1.93 110.395 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -64.56 -40.48 95.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.76 -0.654 . . . . 1.48 111.286 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -46.89 64.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 2.96 111.098 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 23' ' ' TRP . 3.0 tp -63.67 -54.58 33.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.964 -0.562 . . . . 1.81 111.087 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -61.11 -29.1 69.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.446 . . . . 1.08 111.453 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -68.93 -67.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 2.69 110.65 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.704 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 37.5 mm -59.23 -47.71 89.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.436 -0.347 . . . . 1.91 111.37 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.678 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 3.8 m95 -57.67 -46.33 84.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 1.33 110.716 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.712 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 3.2 mm-40 -89.6 28.14 1.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 2.78 111.757 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.704 ' HD2' ' HA ' ' A' ' 22' ' ' ILE . 9.4 mtt180 -114.68 -14.26 12.04 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.109 -1.071 . . . . 4.4 108.109 161.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.04 -37.96 3.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.003 -0.998 . . . . 2.01 111.778 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HB3' ' H ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -95.98 -97.33 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.109 0.411 . . . . 2.85 112.109 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 27' ' ' LEU . . . -87.96 -28.0 24.64 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.762 -0.732 . . . . 1.73 112.304 -173.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 2.9 t 63.84 41.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.537 0.684 . . . . 1.92 110.789 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -98.11 -98.02 0.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 2.21 111.115 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 30' ' ' SER . . . 140.96 76.72 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.908 -0.663 . . . . 1.58 111.689 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -117.81 132.09 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.012 0.435 . . . . 3.56 111.37 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . -100.18 -123.43 5.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 2.28 111.844 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mt -79.68 68.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.506 0.67 . . . . 2.67 110.322 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.752 ' HB3' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -148.64 4.17 0.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.387 -0.824 . . . . 2.46 110.504 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.741 ' HA ' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m-20 54.0 -109.9 0.51 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.102 -0.499 . . . . 4.2 111.1 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.8 -73.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.432 0.693 . . . . 4.13 112.705 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.02 -51.39 3.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.308 -0.405 . . . . 2.27 111.024 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -98.99 -70.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 2.01 112.153 -170.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.741 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 29.9 mp0 -60.31 -21.45 62.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.722 -0.672 . . . . 2.39 112.602 -170.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 3.9 tp -63.93 -21.87 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 3.23 111.366 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.783 ' HA2' ' HB3' ' A' ' 69' ' ' PHE . . . 108.0 45.68 1.08 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.579 -0.82 . . . . 2.06 112.26 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.76 107.19 2.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.702 -0.761 . . . . 2.17 112.134 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -72.81 86.39 1.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 2.26 110.294 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.93 178.25 8.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.81 -0.632 . . . . 1.31 111.178 -178.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.422 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -96.51 29.33 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 2.37 110.387 177.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -107.37 163.51 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.854 -0.612 . . . . 2.27 110.842 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.88 86.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.59 . . . . 1.64 112.227 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.678 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 11.2 ttt -61.27 -34.78 75.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 2.58 111.036 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.21 -0.45 . . . . 1.06 110.538 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.478 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 18.0 t -72.67 -42.29 62.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 1.46 109.923 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -63.35 -23.58 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.876 -0.602 . . . . 0.97 110.88 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.06 -43.61 57.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.909 -0.587 . . . . 0.93 110.928 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 51' ' ' VAL . 2.1 pt20 -75.64 -24.39 56.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.901 0.382 . . . . 1.86 110.808 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -87.65 -14.95 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.112 0.482 . . . . 1.82 110.4 177.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.817 ' HB3' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -64.62 -32.75 74.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 1.97 110.807 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.729 ' HD2' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.18 -0.76 13.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 3.57 109.807 175.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER 50.23 84.99 0.04 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.847 -1.069 . . . . 3.64 111.717 -177.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 11.6 m-30 69.95 76.22 0.21 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.237 -0.892 . . . . 4.58 111.433 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.68 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 6.0 pm0 -97.37 -37.5 10.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.107 -0.331 . . . . 2.8 110.107 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.68 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 2.4 p 159.46 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.806 -1.183 . . . . 3.13 107.806 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.614 ' H ' HG22 ' A' ' 61' ' ' VAL . 18.2 mp0 -58.35 -49.08 78.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.089 0.404 . . . . 4.56 111.265 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.505 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 47.7 mt -89.37 134.14 33.39 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.03 0.443 . . . . 3.01 111.174 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.3 Cg_exo -81.06 59.72 7.56 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.219 2.613 . . . . 1.91 112.496 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.599 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -69.56 116.31 9.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 2.46 111.793 -176.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.16 19.13 10.42 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.615 -0.72 . . . . 2.42 111.608 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 56' ' ' HIS . 1.7 t -106.78 -20.95 5.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.326 0.584 . . . . 2.11 109.978 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 mt 180.0 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.589 -1.187 . . . . 2.19 108.579 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.783 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 95.2 m-85 -112.94 -177.23 3.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 1.87 109.81 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . 60.87 55.32 3.21 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.338 0.59 . . . . 1.09 110.849 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -149.99 100.15 3.25 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.37 -0.832 . . . . 3.23 110.208 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.513 ' O ' ' HB ' ' A' ' 73' ' ' THR . 47.5 Cg_exo -56.53 105.95 0.19 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.766 2.311 . . . . 1.77 110.949 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 77.2 m 72.33 103.5 0.07 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.318 -0.623 . . . . 2.46 109.318 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -84.44 12.81 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 2.08 111.071 -172.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.604 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -58.27 -50.37 73.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 3.8 110.807 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.21 93.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 1.08 110.947 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -67.17 -36.11 81.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.122 -0.49 . . . . 2.41 110.65 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.877 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -62.89 -33.29 74.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.083 -0.508 . . . . 1.57 111.576 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -99.39 16.81 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.816 0.341 . . . . 2.74 110.711 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -126.47 -86.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.275 -0.42 . . . . 2.85 110.942 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.1 -25.87 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.416 -0.356 . . . . 2.13 111.436 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -71.04 -28.14 64.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.67 -0.241 . . . . 1.9 111.305 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.296 0.57 . . . . 2.65 110.853 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 N-CA-C 109.246 -0.649 . . . . 3.47 109.246 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.32 122.4 41.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.146 0.498 . . . . 3.01 112.115 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.65 70.47 2.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 3.51 110.021 174.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -134.92 -47.5 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.873 -0.603 . . . . 2.32 110.853 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG12 ' HB1' ' A' ' 20' ' ' ALA . 0.3 OUTLIER 49.35 -134.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.671 -0.695 . . . . 2.13 110.903 -177.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB2' HG12 ' A' ' 34' ' ' ILE . . . -178.63 94.04 0.22 Allowed Pre-proline 0 N--CA 1.463 0.199 0 O-C-N 123.128 0.268 . . . . 2.09 111.126 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -92.25 46.47 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.775 2.316 . . . . 1.88 111.875 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -86.73 106.44 17.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.768 0.655 . . . . 2.04 112.768 -173.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t30 40.53 54.88 2.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.043 1.127 . . . . 2.24 114.043 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 70.64 -52.29 0.67 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.743 1.016 . . . . 1.42 113.743 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.25 -60.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 1.99 111.314 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.471 ' HA ' HD12 ' A' ' 19' ' ' LEU . 3.2 mp0 -62.22 -31.08 71.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.21 -0.45 . . . . 1.93 110.997 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -40.07 90.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.938 0.399 . . . . 1.48 110.814 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -41.77 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.834 -0.621 . . . . 2.96 110.519 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 16' ' ' GLU . 28.1 mt -61.87 -43.75 98.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.064 -0.517 . . . . 1.81 110.01 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB1' HG12 ' A' ' 9' ' ' VAL . . . -56.44 -55.03 38.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.647 -0.706 . . . . 1.08 111.507 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.644 ' HG3' HD12 ' A' ' 22' ' ' ILE . 10.9 pt-20 -64.6 -46.75 81.32 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 111.706 0.261 . . . . 2.69 111.706 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.644 HD12 ' HG3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -68.0 -47.95 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.62 -0.264 . . . . 1.91 111.219 -175.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -76.8 -14.16 59.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 1.33 111.001 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.6 mm-40 -69.04 -50.1 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.089 -0.338 . . . . 2.78 110.089 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.498 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -75.28 -24.51 57.55 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.833 -0.347 . . . . 4.4 111.935 -174.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.45 33.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.687 -0.405 . . . . 2.01 111.894 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tp -171.99 -73.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.847 0.314 . . . . 2.85 111.847 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.78 -62.62 2.62 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.984 -0.627 . . . . 1.73 113.88 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 t 53.77 32.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.031 0.532 . . . . 1.92 110.804 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -143.08 11.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 2.21 111.523 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.41 60.49 3.02 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.892 -0.883 . . . . 1.58 110.892 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.56 81.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 3.56 111.519 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.41 155.73 50.46 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.701 -0.682 . . . . 2.28 112.151 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 10' ' ' ALA . 7.0 mm -80.05 56.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.764 0.792 . . . . 2.67 111.483 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.89 -42.07 2.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.184 -0.916 . . . . 2.46 108.614 171.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -156.54 128.02 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.02 -0.991 . . . . 4.2 108.562 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.505 ' O ' HG12 ' A' ' 41' ' ' ILE . 43.7 t30 -173.22 149.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.885 -0.413 . . . . 4.13 109.885 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 29.25 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.974 0.416 . . . . 2.27 111.295 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -117.07 -66.98 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.296 -0.411 . . . . 2.01 110.15 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.656 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.4 pm0 -79.84 13.11 2.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.936 -0.575 . . . . 2.39 112.003 -176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 37' ' ' ASN . 14.5 pt -106.97 7.49 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 3.23 110.181 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 33.03 10.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.821 -0.704 . . . . 2.06 112.025 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.32 151.0 35.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 2.17 111.996 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 73.51 10.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.072 0.463 . . . . 2.26 111.014 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.04 125.3 28.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.915 -0.584 . . . . 1.31 110.35 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 46' ' ' LEU . 8.5 tp -73.72 71.74 1.46 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.002 0.43 . . . . 2.37 111.992 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -145.44 152.4 39.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.915 -0.584 . . . . 2.27 109.489 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -32.72 73.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 1.64 111.523 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.3 ttt -61.81 -35.49 78.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 2.58 110.991 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.94 -36.57 67.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 1.06 110.546 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 t -66.58 -42.53 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.568 . . . . 1.46 110.361 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.8 94.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.97 110.845 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.68 84.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.93 110.825 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -10.93 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 1.86 111.162 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.9 t -104.0 -22.9 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.286 -0.415 . . . . 1.82 110.865 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.797 ' HE1' ' HA ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -74.72 55.14 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.925 0.713 . . . . 1.97 112.925 -172.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.472 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -176.85 -70.6 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.158 -0.682 . . . . 3.57 109.158 175.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -170.87 40.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 3.64 110.624 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 59.26 78.7 0.25 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.99 -0.55 . . . . 4.58 110.631 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.472 ' OE1' ' HB3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -77.95 76.88 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.522 -0.763 . . . . 2.8 110.874 -176.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -76.18 -18.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.792 -0.64 . . . . 3.13 111.009 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -97.84 43.97 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 4.56 110.024 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.19 129.43 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.171 -0.922 . . . . 3.01 111.047 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.2 73.65 4.36 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.696 2.264 . . . . 1.91 112.461 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 67' ' ' VAL . 2.1 tp -59.53 113.69 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 2.46 110.363 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.791 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 19.2 mttt 58.42 -110.1 0.49 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.886 -0.597 . . . . 2.42 110.383 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 65' ' ' LEU . 46.3 t 59.64 -85.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.223 0.609 . . . . 2.11 111.843 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 78' ' ' ALA . 5.5 tp -148.2 10.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 2.19 110.879 -176.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 -56.15 0.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.251 0.463 . . . . 1.87 112.251 -173.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.791 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -80.71 66.43 6.23 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.121 0.415 . . . . 1.09 112.121 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -166.74 126.85 1.18 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.23 109.837 176.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 14.0 Cg_exo -71.73 42.39 0.49 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.505 2.804 . . . . 1.77 113.408 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.02 72.12 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.756 -0.831 . . . . 2.46 108.756 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.79 -34.36 46.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.339 -0.846 . . . . 2.08 111.236 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -60.28 -32.2 70.96 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.939 0.399 . . . . 3.8 110.589 178.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.56 -44.14 35.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 1.08 110.805 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.29 -43.37 98.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 2.41 110.737 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.561 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.81 -18.42 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.619 . . . . 1.57 111.49 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.76 -7.42 58.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 2.74 110.245 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.78 -70.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 2.85 111.399 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.44 51.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.828 0.347 . . . . 2.13 111.378 -173.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.797 ' HA ' ' HE1' ' A' ' 56' ' ' HIS . . . -157.58 -33.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.247 -0.433 . . . . 1.9 111.501 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.416 . . . . 2.65 111.708 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.585 -0.524 . . . . 3.47 109.585 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -146.48 116.66 7.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.092 -0.504 . . . . 3.01 111.006 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -83.27 49.02 1.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 3.51 109.682 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.61 -89.75 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.724 . . . . 2.32 111.273 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t 63.64 -86.33 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.012 -0.54 . . . . 2.13 110.687 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 49.74 69.9 2.38 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 123.02 0.528 . . . . 2.09 111.948 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -88.5 155.0 6.48 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.766 2.311 . . . . 1.88 112.653 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.14 -67.32 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.54 -0.3 . . . . 2.04 111.18 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -153.91 118.19 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.46 0.541 . . . . 2.24 112.46 -176.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.77 -79.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.879 1.066 . . . . 1.42 113.879 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -63.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.694 0.627 . . . . 1.99 112.694 -169.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' HA ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -62.79 -37.58 87.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.93 111.473 -176.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -45.98 83.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.095 -0.502 . . . . 1.48 111.269 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -38.14 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.028 -0.533 . . . . 2.96 111.367 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -47.72 79.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 1.81 110.854 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.92 82.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 1.08 110.494 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.55 -48.74 79.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 2.69 111.478 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.495 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 2.5 tt -67.93 -36.32 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.929 -0.308 . . . . 1.91 111.765 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -81.75 -53.38 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 1.33 111.838 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -78.02 -7.74 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.092 0.404 . . . . 2.78 112.092 -172.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.643 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 1.4 mmm180 -115.56 -0.25 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.255 -0.578 . . . . 4.4 111.658 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -115.63 -23.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 2.01 111.177 175.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 tp -122.86 -76.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 2.85 110.77 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.471 ' HA3' ' HZ ' ' A' ' 38' ' ' PHE . . . -85.93 62.35 4.39 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.774 -0.727 . . . . 1.73 112.92 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 1.6 p -67.68 105.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.564 0.697 . . . . 1.92 110.645 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.16 -32.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.217 -0.901 . . . . 2.21 110.141 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.61 96.08 2.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.897 -0.668 . . . . 1.58 111.646 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.63 HD13 ' HB3' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -131.64 -40.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.97 0.414 . . . . 3.56 110.691 -178.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.545 ' C ' HG12 ' A' ' 34' ' ' ILE . . . 65.0 -99.62 0.38 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.937 -0.574 . . . . 2.28 112.729 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' C ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -142.31 52.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.092 0.472 . . . . 2.67 110.932 -177.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 35' ' ' LEU . 5.2 mt -129.72 -111.49 0.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.244 -0.285 . . . . 2.46 111.033 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.466 ' H ' ' HB3' ' A' ' 35' ' ' LEU . 26.5 t0 -88.91 71.64 8.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 4.2 110.288 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.63 ' HB3' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -114.18 164.45 13.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.643 -0.708 . . . . 4.13 110.994 -176.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HZ ' ' HA3' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -82.32 -14.96 54.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.008 -0.542 . . . . 2.27 110.634 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.477 ' HB3' ' OE1' ' A' ' 40' ' ' GLN . 18.7 t80 -81.97 -90.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.088 -0.506 . . . . 2.01 110.277 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 39' ' ' PHE . 3.6 mp0 -68.09 125.42 26.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.574 -0.528 . . . . 2.39 109.574 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 78.52 -9.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 123.978 0.799 . . . . 3.23 110.972 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.46 -58.29 3.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.975 -0.631 . . . . 2.06 112.256 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.738 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . 147.67 -76.13 0.26 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.385 -0.912 . . . . 2.17 112.613 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -165.81 119.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.039 0.447 . . . . 2.26 110.992 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.03 144.34 26.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 1.31 110.176 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.11 92.57 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.995 0.426 . . . . 2.37 111.243 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -171.48 164.64 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 2.27 110.285 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.75 65.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 1.64 111.854 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -39.16 83.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.362 . . . . 2.58 110.742 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.02 -37.59 61.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 1.06 110.472 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.81 -42.96 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 1.46 110.677 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.48 96.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.97 110.903 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.453 . . . . 0.93 110.32 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -49.3 73.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.604 -0.726 . . . . 1.86 111.098 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 m -75.15 -33.0 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.929 -0.308 . . . . 1.82 111.73 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -31.13 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.881 -0.328 . . . . 1.97 111.224 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 -9.81 53.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.893 -0.41 . . . . 3.57 109.893 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER 67.33 62.4 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.216 -0.902 . . . . 3.64 110.882 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 1.2 m-85 78.91 109.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 4.58 111.65 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.07 -20.04 18.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.021 -0.99 . . . . 2.8 109.695 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.7 t 66.05 -111.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.226 -0.897 . . . . 3.13 110.185 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.65 8.55 4.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 4.56 110.358 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 92.82 39.7 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 3.01 110.46 -175.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.738 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 49.8 Cg_endo -70.58 128.22 14.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.425 2.084 . . . . 1.91 112.029 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.11 137.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 2.46 109.436 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.51 47.35 16.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.712 0.633 . . . . 2.42 110.442 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 69' ' ' PHE . 2.7 p -156.08 175.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.11 109.808 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -53.83 -36.88 63.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.286 0.476 . . . . 2.19 112.286 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.641 ' H ' HG13 ' A' ' 67' ' ' VAL . 86.0 m-85 -84.09 3.21 35.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.46 -0.336 . . . . 1.87 111.66 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.31 73.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.782 0.325 . . . . 1.09 111.459 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.93 141.48 1.21 Allowed Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.134 -0.691 . . . . 3.23 109.134 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HB2' ' H ' ' A' ' 73' ' ' THR . 23.0 Cg_exo -64.62 -86.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.539 2.16 . . . . 1.77 111.867 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.703 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -80.92 136.72 36.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.713 0.292 . . . . 2.46 110.541 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.497 ' CG1' ' HA ' ' A' ' 16' ' ' GLU . 38.0 mm -64.69 -25.05 36.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 2.08 111.097 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.703 ' HD3' ' HB ' ' A' ' 73' ' ' THR . 1.1 pttt -50.48 -34.56 25.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.301 -0.409 . . . . 3.8 111.801 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.556 ' N ' ' HG2' ' A' ' 75' ' ' LYS . . . -70.41 -50.75 35.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.037 0.446 . . . . 1.08 111.005 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 68' ' ' LEU . 1.8 pp -73.06 -15.51 61.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 2.41 110.71 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -75.56 -31.71 60.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 1.57 110.735 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.32 5.94 47.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 2.74 111.45 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.02 -48.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.529 0.566 . . . . 2.85 112.529 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.53 -51.38 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.085 0.402 . . . . 2.13 112.085 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -65.89 -16.15 63.59 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.075 0.398 . . . . 1.9 112.075 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.046 0.451 . . . . 2.65 110.824 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 2.2 mt-10 . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.743 -0.466 . . . . 3.47 109.743 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.33 128.76 33.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.909 0.385 . . . . 3.01 111.055 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.78 -19.46 41.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.236 0.541 . . . . 3.51 110.301 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -91.04 57.61 3.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.925 -0.579 . . . . 2.32 110.111 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.09 67.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 122.193 0.997 . . . . 2.13 110.431 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -143.51 110.38 5.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.196 -0.911 . . . . 2.09 110.288 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 5.5 Cg_exo -78.73 171.05 17.23 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.257 2.638 . . . . 1.88 112.382 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.87 -47.48 4.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.121 0.486 . . . . 2.04 110.666 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 24.0 t-20 -108.08 154.08 22.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 2.24 110.669 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.97 -29.12 69.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 1.42 111.246 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.04 -35.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.21 0.528 . . . . 1.99 110.27 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -73.13 -36.74 66.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.713 -0.676 . . . . 1.93 110.598 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -35.22 74.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 1.48 110.53 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -45.07 78.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.091 -0.504 . . . . 2.96 110.757 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 19' ' ' LEU . 2.0 mt -64.74 -37.29 87.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 1.81 110.129 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.74 -30.8 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 1.08 110.595 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 16.5 tt0 -61.96 -47.17 86.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.981 -0.378 . . . . 2.69 109.981 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.2 mt -69.92 -55.16 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.333 -0.394 . . . . 1.91 111.158 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.535 ' CH2' ' HD2' ' A' ' 47' ' ' LYS . 64.1 m95 -68.56 -49.1 62.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.257 0.465 . . . . 1.33 112.257 -172.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.89 -50.24 24.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.438 0.162 . . . . 2.78 111.438 -174.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 1.1 mmt85 -66.6 -27.38 67.66 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.694 -0.402 . . . . 4.4 111.643 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.17 -55.75 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.219 -0.193 . . . . 2.01 111.288 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.89 -44.32 5.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.404 0.52 . . . . 2.85 112.404 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.57 -59.82 10.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.353 -0.451 . . . . 1.73 113.57 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.1 t 72.12 -56.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 123.329 0.652 . . . . 1.92 111.897 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.467 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 2.4 m -74.35 -41.04 61.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 2.21 111.16 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.1 127.38 3.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.758 -0.734 . . . . 1.58 112.096 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -164.44 161.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.94 -0.393 . . . . 3.56 109.94 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.45 -103.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.038 -1.077 . . . . 2.28 113.552 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mm -81.16 65.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.146 0.498 . . . . 2.67 111.637 -171.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.97 171.63 15.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.112 -0.495 . . . . 2.46 110.139 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.53 112.87 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.095 -0.502 . . . . 4.2 109.751 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.511 HD21 ' NE2' ' A' ' 40' ' ' GLN . 3.4 p30 -146.95 172.31 13.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.175 0.512 . . . . 4.13 111.682 -174.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -63.45 153.17 36.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.129 -0.941 . . . . 2.27 112.717 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.9 -39.08 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.931 0.892 . . . . 2.01 112.891 171.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.511 ' NE2' HD21 ' A' ' 37' ' ' ASN . 38.4 mt-30 -65.32 -36.31 83.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.803 0.335 . . . . 2.39 111.19 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.527 ' H ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -99.03 15.85 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 3.23 111.546 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.23 135.88 2.56 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.664 -0.779 . . . . 2.06 112.129 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.65 70.76 1.02 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.686 -0.768 . . . . 2.17 111.338 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.649 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 24.6 p80 -60.75 150.67 31.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.78 0.324 . . . . 2.26 111.135 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -179.24 4.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 1.31 110.993 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 35.15 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 2.37 111.21 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HD2' ' CH2' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -129.09 171.23 12.59 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.988 -0.285 . . . . 2.27 110.985 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.24 69.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 1.64 112.408 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -37.87 64.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.041 0.448 . . . . 2.58 111.066 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 44' ' ' HIS . . . -76.62 -40.69 48.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 1.06 110.89 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.04 -41.55 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 1.46 110.546 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.11 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.97 111.04 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.41 -36.46 74.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.93 111.022 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 61' ' ' VAL . 3.0 pt20 -76.49 -18.33 58.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 1.86 111.626 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.6 p -115.86 0.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.094 0.405 . . . . 1.82 112.094 -175.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -32.57 72.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.412 . . . . 1.97 112.114 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.29 -76.65 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.891 -0.323 . . . . 3.57 110.751 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.46 55.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 3.64 110.065 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.3 72.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.252 -0.885 . . . . 4.58 111.789 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.51 -14.94 29.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.7 -0.682 . . . . 2.8 110.143 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.559 ' HA ' ' HB2' ' A' ' 54' ' ' GLN . 5.9 t 60.15 -92.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.268 -0.878 . . . . 3.13 112.066 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HG2' HG12 ' A' ' 61' ' ' VAL . 4.2 mm-40 -99.1 15.11 26.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.729 0.3 . . . . 4.56 111.238 -175.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -121.42 79.74 37.35 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.063 0.458 . . . . 3.01 110.463 178.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.65 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 85.7 Cg_endo -96.89 16.06 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.008 2.472 . . . . 1.91 112.638 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.76 117.76 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 2.46 111.496 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt 68.52 3.71 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.265 -0.879 . . . . 2.42 112.202 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.13 -53.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.715 -0.476 . . . . 2.11 109.715 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.65 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -171.9 154.56 3.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.461 -0.94 . . . . 2.19 108.461 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 75.0 -56.06 0.64 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.314 0.487 . . . . 1.87 112.314 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . . . -77.22 67.86 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.347 0.499 . . . . 1.09 112.347 -173.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.549 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 3.0 mm-40 -155.46 128.24 4.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.153 -0.684 . . . . 3.23 109.153 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 23.7 Cg_exo -64.29 -11.87 30.11 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.988 2.459 . . . . 1.77 112.98 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 t -132.22 115.31 15.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.412 0.625 . . . . 2.46 110.085 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.471 HD13 HD12 ' A' ' 19' ' ' LEU . 1.1 mt -77.88 -17.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.653 -0.703 . . . . 2.08 110.786 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 4.4 tttt -56.47 -50.38 71.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.278 -0.419 . . . . 3.8 110.49 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -62.95 -41.68 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.675 -0.693 . . . . 1.08 110.967 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 77' ' ' LEU . 6.2 mt -63.09 -46.31 87.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 2.41 111.269 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.94 -29.07 70.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 1.57 112.003 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -101.37 8.65 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.681 -0.408 . . . . 2.74 111.249 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 1.7 m-85 -119.28 -93.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.508 -0.314 . . . . 2.85 110.719 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.02 43.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 2.13 111.321 -175.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.48 -40.65 1.58 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.657 -0.701 . . . . 1.9 109.675 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.587 -0.733 . . . . 2.65 110.907 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.77 0.319 . . . . 3.47 110.912 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.456 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -94.01 179.92 5.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 3.01 110.507 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -112.43 95.88 5.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 3.51 110.522 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.466 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 2.7 t80 -155.23 -103.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 2.32 110.542 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.614 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.5 OUTLIER 71.2 -7.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.595 0.758 . . . . 2.13 112.214 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.18 31.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 2.09 110.737 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.813 ' HA ' HD11 ' A' ' 34' ' ' ILE . 59.5 Cg_endo -94.98 172.15 1.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.285 2.656 . . . . 1.88 113.167 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 -40.21 8.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.083 -0.71 . . . . 2.04 109.083 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -119.6 151.55 38.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.224 -0.898 . . . . 2.24 109.299 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.49 -33.7 70.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.907 0.336 . . . . 1.42 111.907 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.04 -27.34 42.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 1.99 111.56 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.817 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.0 -58.82 6.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.005 0.431 . . . . 1.93 111.166 -175.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -79.46 -12.43 59.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.365 -0.38 . . . . 1.48 111.283 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -51.52 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.57 -0.53 . . . . 2.96 109.57 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -62.7 -41.85 99.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 1.81 110.329 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.39 77.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 1.08 110.857 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.641 ' HG2' ' HG3' ' A' ' 25' ' ' ARG . 2.3 tt0 -63.33 -31.37 72.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.236 -0.438 . . . . 2.69 111.206 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.552 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 20.9 mt -62.13 -42.73 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.109 0.481 . . . . 1.91 110.301 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.807 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 36.7 m95 -79.54 -46.76 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.085 -0.507 . . . . 1.33 111.781 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 pt-20 -76.41 -8.56 57.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.839 0.681 . . . . 2.78 112.839 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 2.1 mtp85 -120.89 -4.98 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.607 -0.437 . . . . 4.4 111.74 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.552 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 6.5 t -108.71 -49.83 7.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.01 110.467 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.954 HD11 ' HG3' ' A' ' 47' ' ' LYS . 80.9 mt -95.73 -85.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.078 0.466 . . . . 2.85 110.568 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.19 89.61 1.48 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.688 -0.767 . . . . 1.73 111.502 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 58.4 t -62.8 105.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.968 0.414 . . . . 1.92 110.206 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.26 -64.92 0.71 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.204 -0.453 . . . . 2.21 111.409 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.3 85.45 1.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.83 -0.7 . . . . 1.58 111.413 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.744 HD11 ' HD2' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -137.47 -58.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.872 0.368 . . . . 3.56 111.654 -174.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . 101.65 -138.09 13.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.711 -0.757 . . . . 2.28 111.476 -172.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.813 HD11 ' HA ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -120.06 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.347 . . . . 2.67 110.98 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.839 ' HG ' ' H ' ' A' ' 36' ' ' ASP . 1.3 pt? -152.73 -66.07 0.16 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.502 -0.317 . . . . 2.46 111.118 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.839 ' H ' ' HG ' ' A' ' 35' ' ' LEU . 5.9 t70 -176.76 173.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 4.2 110.047 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER 65.73 23.51 11.53 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.51 0.724 . . . . 4.13 112.815 173.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.744 ' HD2' HD11 ' A' ' 32' ' ' ILE . 20.9 t80 173.18 138.04 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.509 -0.769 . . . . 2.27 109.108 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 67.15 -72.25 0.09 Allowed 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.034 0.834 . . . . 2.01 110.558 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.35 59.67 2.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 2.39 110.484 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 -48.98 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.654 -0.703 . . . . 3.23 110.181 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.68 116.63 2.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.06 111.641 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.33 -159.24 24.52 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.795 -0.717 . . . . 2.17 112.042 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -125.66 73.86 1.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.874 0.369 . . . . 2.26 110.561 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.45 145.62 49.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.193 -0.458 . . . . 1.31 110.496 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 46' ' ' LEU . 3.1 mt -92.31 66.74 4.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 2.37 111.416 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.954 ' HG3' HD11 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -144.01 155.5 44.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.403 -0.362 . . . . 2.27 110.312 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.79 -43.73 63.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.491 0.552 . . . . 1.64 112.491 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.807 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 6.2 tpt -62.86 -34.76 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.802 0.334 . . . . 2.58 111.179 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB2' ' HH2' ' A' ' 23' ' ' TRP . . . -76.41 -37.58 56.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 1.06 110.488 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.69 -40.24 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.927 -0.579 . . . . 1.46 110.257 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -61.2 -36.83 80.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 0.97 110.983 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.23 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.424 -0.353 . . . . 0.93 110.617 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -65.06 -38.7 91.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 1.86 110.873 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.85 -26.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 1.82 110.502 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -66.21 -38.29 87.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 1.97 109.906 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.44 173.16 11.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.423 -0.584 . . . . 3.57 109.423 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -82.23 48.32 1.25 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.436 -0.347 . . . . 3.64 110.226 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.483 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 79.7 m-85 56.26 78.94 0.19 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.769 0.795 . . . . 4.58 109.692 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 17.4 pm0 -71.44 -11.79 61.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 2.8 113.06 -169.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 t 63.3 -82.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 123.292 0.37 . . . . 3.13 111.113 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -131.53 5.87 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.535 0.198 . . . . 4.56 111.535 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -122.64 78.46 47.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 3.01 111.133 -178.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.53 54.35 4.7 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.355 2.704 . . . . 1.91 112.237 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.78 130.42 42.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.436 -0.802 . . . . 2.46 111.719 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 71' ' ' GLN . 2.2 mptm? 46.15 54.82 7.86 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.187 0.929 . . . . 2.42 113.247 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.96 -33.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.728 0.299 . . . . 2.11 110.775 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.04 -62.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.198 0.523 . . . . 2.19 110.048 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.89 -21.79 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.597 -0.729 . . . . 1.87 111.454 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -116.06 40.67 2.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.458 -0.337 . . . . 1.09 111.04 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -170.09 84.5 0.58 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 3.23 109.621 175.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.88 59.16 3.47 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.739 2.959 . . . . 1.77 112.993 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -148.43 79.89 1.45 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 2.46 109.391 176.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 16' ' ' GLU . 80.2 mt -61.87 -41.89 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.689 -0.687 . . . . 2.08 112.541 -169.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -44.58 84.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.435 -0.506 . . . . 3.8 110.42 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -63.86 -34.03 77.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 1.08 110.68 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -61.98 -32.03 72.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 2.41 110.837 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 -22.29 61.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.57 110.991 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.28 5.25 42.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.353 -0.385 . . . . 2.74 110.434 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -119.72 -75.95 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 2.85 111.475 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.95 -46.53 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 2.13 111.315 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.83 67.33 1.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 1.9 110.307 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.92 -0.582 . . . . 2.65 111.168 -175.502 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.96 0.409 . . . . 3.47 110.367 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.95 88.6 3.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 3.01 110.516 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -75.41 71.49 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 3.51 110.281 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.448 ' HB3' HD21 ' A' ' 35' ' ' LEU . 83.2 t80 -162.62 23.43 0.1 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.664 0.745 . . . . 2.32 109.275 -175.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.51 65.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.899 0.857 . . . . 2.13 111.526 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.39 70.34 39.44 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.812 -1.085 . . . . 2.09 108.546 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.841 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 31.3 Cg_exo -61.08 146.69 97.34 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.651 2.901 . . . . 1.88 113.788 -171.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -28.19 37.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 2.04 110.575 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -123.88 146.98 48.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.24 109.936 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -21.63 66.46 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.317 0.386 . . . . 1.42 111.408 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.64 -37.74 80.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.213 -0.449 . . . . 1.99 110.537 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.841 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . 36.3 mt-10 -70.66 -34.77 72.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 1.93 110.271 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.12 79.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.076 0.465 . . . . 1.48 110.627 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 2.2 tptm -72.71 -43.77 62.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 2.96 110.373 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -47.29 77.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.599 -0.728 . . . . 1.81 110.599 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . . . -57.87 -55.1 39.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.5 -0.773 . . . . 1.08 111.275 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.79 -42.86 85.03 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.805 0.298 . . . . 2.69 111.805 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.9 mt -69.43 -55.61 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 1.91 111.266 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.66 -35.57 81.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 1.33 111.492 -175.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 3.3 tp10 -63.62 -46.7 84.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.196 -0.456 . . . . 2.78 110.965 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -5.32 41.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 4.4 111.583 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.18 -60.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.462 -0.335 . . . . 2.01 111.32 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -35.27 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.532 0.567 . . . . 2.85 112.532 -171.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.62 ' HA3' HG12 ' A' ' 32' ' ' ILE . . . -77.32 -69.83 1.36 Allowed Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.578 -0.82 . . . . 1.73 113.505 -172.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t 56.51 54.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.729 . . . . 1.92 110.129 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.41 -32.9 0.04 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.14 -0.936 . . . . 2.21 110.567 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.47 65.34 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.181 -0.767 . . . . 1.58 111.181 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.62 HG12 ' HA3' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -131.1 -178.09 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.564 0.221 . . . . 3.56 111.413 -175.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.798 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . 120.96 31.98 1.13 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.934 -0.651 . . . . 2.28 113.269 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -156.87 -65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 117.343 0.571 . . . . 2.67 111.982 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 35' ' ' LEU . 1.9 pt? -142.37 33.03 1.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.975 0.893 . . . . 2.46 110.052 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.96 1.61 4.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.5 -1.227 . . . . 4.2 112.487 -174.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.451 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 21.2 t-20 74.12 -60.8 0.51 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.111 0.564 . . . . 4.13 112.278 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HE1' HG21 ' A' ' 32' ' ' ILE . 25.9 p90 -64.64 -22.71 67.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.331 0.493 . . . . 2.27 112.331 -172.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.447 ' CE2' ' HE2' ' A' ' 69' ' ' PHE . 15.9 t80 -108.16 -16.9 14.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.947 0.403 . . . . 2.01 110.812 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -110.48 0.93 17.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 2.39 111.751 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 37' ' ' ASN . 5.1 tp -88.93 -23.19 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.136 0.493 . . . . 3.23 110.604 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 55.31 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.87 -0.892 . . . . 2.06 110.87 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.87 128.74 29.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.984 -0.627 . . . . 2.17 112.74 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.83 59.4 1.37 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.374 0.607 . . . . 2.26 110.352 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -179.31 6.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.346 -0.843 . . . . 1.31 110.313 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.2 63.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.075 0.464 . . . . 2.37 110.153 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.9 tptt -130.66 165.8 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.834 -0.621 . . . . 2.27 110.428 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.04 87.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 1.64 111.534 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -62.53 -38.08 88.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.171 -0.468 . . . . 2.58 110.824 177.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -71.04 -45.36 64.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 1.06 111.405 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.3 m -70.72 -22.4 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.58 -0.282 . . . . 1.46 110.979 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.42 88.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 0.97 110.01 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.49 76.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 0.93 110.647 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -60.23 -55.97 27.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 1.86 111.041 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 51' ' ' VAL . 2.2 t -78.38 9.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.108 0.48 . . . . 1.82 111.095 -177.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.429 ' NE2' ' HA ' ' A' ' 82' ' ' ALA . 1.5 t-80 -88.56 -9.93 50.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 1.97 110.744 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 57' ' ' ARG . 3.9 ttm180 -137.18 9.41 2.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.609 . . . . 3.57 109.52 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 72.48 -12.97 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.249 -0.887 . . . . 3.64 112.043 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -169.23 176.08 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.379 . . . . 4.58 110.517 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.99 -52.5 0.19 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 2.8 109.112 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 41.8 57.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.132 0.973 . . . . 3.13 112.921 175.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.27 9.51 6.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.482 -0.781 . . . . 4.56 112.555 172.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 61' ' ' VAL . 0.3 OUTLIER -126.95 73.19 76.36 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.759 0.314 . . . . 3.01 110.73 176.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 6.5 Cg_endo -87.92 117.99 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.075 2.516 . . . . 1.91 112.265 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -143.95 122.16 12.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.204 -0.295 . . . . 2.46 110.204 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 tttt 53.58 55.53 8.46 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.58 0.55 . . . . 2.42 111.123 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.37 -76.1 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.094 -0.503 . . . . 2.11 110.69 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.09 -42.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.302 -0.863 . . . . 2.19 109.049 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 49' ' ' MET . 52.4 m-85 -97.55 18.05 16.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.416 -0.811 . . . . 1.87 109.962 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -144.1 134.86 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.877 -1.056 . . . . 1.09 108.233 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 12.7 mp0 70.55 97.1 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 O-C-N 124.324 1.015 . . . . 3.23 109.198 -169.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.57 70.59 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.728 2.952 . . . . 1.77 113.066 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.26 53.96 1.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 2.46 108.968 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 74' ' ' ILE . 2.0 mm -51.35 -49.8 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.698 -1.137 . . . . 2.08 112.319 -172.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -64.41 -47.4 79.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 3.8 111.066 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 1.08 111.18 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.47 -36.01 81.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.222 -0.444 . . . . 2.41 110.983 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.739 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -72.05 -36.89 69.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 1.57 111.296 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -9.81 59.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.949 0.404 . . . . 2.74 111.062 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -103.95 -76.85 0.58 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 2.85 111.014 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.7 -40.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.681 . . . . 2.13 111.421 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.739 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -79.94 54.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 1.9 111.794 -175.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.998 -0.546 . . . . 2.65 110.466 178.627 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.976 0.417 . . . . 3.47 110.394 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.05 118.23 15.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.022 -0.536 . . . . 3.01 110.113 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -81.13 22.58 0.64 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.418 -0.355 . . . . 3.51 111.464 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.49 ' CD2' HD22 ' A' ' 35' ' ' LEU . 85.0 t80 -66.44 -56.48 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.06 -0.718 . . . . 2.32 109.06 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p 21.95 65.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 124.892 1.37 . . . . 2.13 113.156 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.76 76.39 74.49 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 2.09 110.999 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 23.3 Cg_exo -65.23 115.69 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.304 2.002 . . . . 1.88 110.5 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -34.68 75.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 2.04 111.955 -171.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.94 150.73 27.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.741 0.305 . . . . 2.24 110.971 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.09 70.35 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.576 . . . . 1.42 112.006 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.51 -36.56 75.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.157 0.503 . . . . 1.99 110.696 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 21.0 mt-10 -79.53 -23.34 42.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.658 -0.701 . . . . 1.93 111.102 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -71.07 -45.45 63.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.372 . . . . 1.48 110.411 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -63.7 -38.98 93.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.119 0.485 . . . . 2.96 110.666 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -63.64 -47.1 82.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 1.81 110.079 177.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.3 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 1.08 111.083 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -56.23 -53.9 51.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 2.69 110.876 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.501 HG22 HD23 ' A' ' 27' ' ' LEU . 37.7 mm -68.86 -43.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.156 -0.475 . . . . 1.91 111.323 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.916 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 64.4 m95 -71.7 -39.82 69.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.616 0.598 . . . . 1.33 112.616 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 1.6 pt-20 -77.11 -33.48 56.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.904 -0.318 . . . . 2.78 111.413 -177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.554 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 8.4 mmp_? -90.08 -57.48 2.84 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.141 0.423 . . . . 4.4 112.141 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.23 -43.23 12.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.064 0.394 . . . . 2.01 112.064 -171.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.916 ' HB2' ' HA ' ' A' ' 23' ' ' TRP . 1.4 mm? -70.54 -69.79 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.998 0.427 . . . . 2.85 111.962 -174.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.59 -22.27 31.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.9 -0.667 . . . . 1.73 113.401 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t 55.76 52.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.678 0.751 . . . . 1.92 110.076 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.4 141.66 32.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.394 -0.821 . . . . 2.21 110.096 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.7 77.27 2.08 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.588 -0.815 . . . . 1.58 111.36 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.503 ' HB ' ' H ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -118.89 -147.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.022 0.439 . . . . 3.56 111.133 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.503 ' H ' ' HB ' ' A' ' 32' ' ' ILE . . . 174.58 -174.97 46.82 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.285 -0.726 . . . . 2.28 111.285 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 16' ' ' GLU . 5.9 mm -80.56 83.26 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.421 . . . . 2.67 110.295 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.717 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.95 -51.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 2.46 110.671 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.717 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 t0 178.1 -175.06 0.17 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.864 -0.421 . . . . 4.2 109.864 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 74.22 -3.45 2.54 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.003 0.815 . . . . 4.13 111.86 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 t80 178.57 163.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.736 0.648 . . . . 2.27 109.333 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 70.58 -70.23 0.16 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.906 0.754 . . . . 2.01 111.017 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.11 72.34 10.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.851 0.357 . . . . 2.39 110.526 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 172.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.207 -0.451 . . . . 3.23 110.822 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . -76.41 94.61 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.029 -0.605 . . . . 2.06 112.887 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.71 -159.65 32.99 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.952 -0.642 . . . . 2.17 112.001 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -165.57 127.74 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 2.26 110.219 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.19 162.19 22.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.075 -0.512 . . . . 1.31 110.97 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.77 67.2 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.489 -0.323 . . . . 2.37 110.92 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.16 127.42 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.357 -0.383 . . . . 2.27 111.379 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 23.6 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.498 1.519 . . . . 1.64 114.64 171.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.5 ttt -54.05 -42.42 69.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.965 -0.561 . . . . 2.58 112.235 -173.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.41 74.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 1.06 110.838 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.5 t -66.31 -46.28 87.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.765 -0.457 . . . . 1.46 109.765 177.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.82 -24.99 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 0.97 111.206 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.52 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 0.93 110.543 177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -25.51 47.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.19 0.519 . . . . 1.86 110.317 177.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -93.03 13.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.863 -0.608 . . . . 1.82 110.161 177.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.99 4.78 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.741 -0.663 . . . . 1.97 109.689 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HD2' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -154.99 -165.38 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.114 -0.948 . . . . 3.57 109.175 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -79.62 38.47 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.417 -0.356 . . . . 3.64 111.542 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 60.6 78.39 0.28 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.647 0.737 . . . . 4.58 109.524 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 19.2 pm0 -77.68 23.3 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.943 -1.026 . . . . 2.8 112.826 -171.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.47 ' HB ' ' H ' ' A' ' 62' ' ' GLU . 2.9 t 55.0 -100.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.446 0.298 . . . . 3.13 110.877 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' H ' ' HB ' ' A' ' 61' ' ' VAL . 2.5 pt-20 -134.23 32.1 3.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 4.56 110.605 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.569 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 12.8 mt -104.4 100.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 3.01 110.114 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.477 ' HG3' ' HA2' ' A' ' 42' ' ' GLY . 87.2 Cg_endo -84.4 3.08 7.75 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.856 2.371 . . . . 1.91 113.184 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.86 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.206 0.941 . . . . 2.46 112.64 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 58.31 23.63 10.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.68 -0.691 . . . . 2.42 112.471 175.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.403 HG22 ' HD2' ' A' ' 57' ' ' ARG . 7.5 t -97.06 -51.74 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.153 0.501 . . . . 2.11 109.991 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -170.64 -54.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.499 -0.773 . . . . 2.19 110.012 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . 19.6 m-85 -84.08 35.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 1.87 111.262 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.14 47.52 0.69 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.989 -0.745 . . . . 1.09 108.989 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.03 104.81 0.49 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.326 -1.306 . . . . 3.23 108.692 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.84 40.46 0.65 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.016 2.478 . . . . 1.77 113.485 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.74 94.6 2.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.628 -0.508 . . . . 2.46 109.628 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 77' ' ' LEU . 2.6 mt -67.14 -35.09 73.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.304 -0.407 . . . . 2.08 110.78 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -36.03 79.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 3.8 110.283 176.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.77 83.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 1.08 110.379 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 74' ' ' ILE . 17.4 mt -66.74 -33.38 75.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 2.41 110.547 177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.8 -17.07 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.57 111.625 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -110.2 12.95 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 2.74 110.299 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -126.79 -88.9 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.945 -0.571 . . . . 2.85 110.865 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.36 -17.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.963 0.357 . . . . 2.13 111.963 -175.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.05 39.28 3.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 1.9 110.787 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 2.65 111.284 -177.412 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.638 0.256 . . . . 3.47 110.384 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.81 39.99 29.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.823 -0.626 . . . . 3.01 111.19 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -70.49 -57.32 4.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.703 -0.681 . . . . 3.51 111.039 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.451 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 1.2 t80 -103.42 -88.27 0.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 2.32 111.406 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' H ' ' HB3' ' A' ' 8' ' ' TYR . 2.1 t 56.0 52.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.287 0.565 . . . . 2.13 110.822 -174.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.6 86.38 53.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.014 -0.539 . . . . 2.09 110.692 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.633 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 96.3 Cg_endo -89.95 -168.78 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.929 2.42 . . . . 1.88 111.945 177.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -77.68 -69.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.122 -0.231 . . . . 2.04 111.15 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -173.43 140.2 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.861 0.319 . . . . 2.24 111.861 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.15 -84.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.743 1.016 . . . . 1.42 113.743 168.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -61.02 -55.85 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 1.99 111.88 -171.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.731 ' HA ' HD11 ' A' ' 74' ' ' ILE . 13.2 mt-10 -63.89 -35.88 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.007 -0.542 . . . . 1.93 111.187 -176.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.403 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -64.97 -47.0 79.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.121 -0.49 . . . . 1.48 111.315 -178.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -74.09 -37.66 64.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.31 -0.405 . . . . 2.96 110.899 -178.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.63 -49.9 74.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 1.81 110.932 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.67 97.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 1.08 110.679 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.37 -57.14 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.769 -0.65 . . . . 2.69 111.024 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.2 mt -65.0 -52.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.092 -0.504 . . . . 1.91 111.29 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -61.62 -51.29 69.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.402 0.519 . . . . 1.33 112.402 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -74.88 -10.59 59.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.894 0.331 . . . . 2.78 111.894 -173.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.561 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -100.36 -22.3 15.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.741 -0.384 . . . . 4.4 111.608 177.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 25' ' ' ARG . 53.6 t -103.52 -50.33 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 2.01 111.437 -176.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -27.52 62.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 2.85 110.318 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.0 -168.76 14.03 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.037 -0.825 . . . . 1.73 111.037 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.01 56.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.481 1.134 . . . . 1.92 109.018 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -113.49 -127.52 0.29 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.029 -0.987 . . . . 2.21 111.28 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.52 50.26 0.3 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.713 -0.955 . . . . 1.58 110.713 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.59 -43.77 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.677 0.275 . . . . 3.56 110.733 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.14 -132.7 13.8 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.75 -0.738 . . . . 2.28 112.729 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -75.32 93.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.852 0.358 . . . . 2.67 111.475 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -173.87 -65.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.059 -0.719 . . . . 2.46 109.059 177.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -133.03 49.24 2.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.383 -0.969 . . . . 4.2 108.383 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.552 ' O ' HG22 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -62.9 96.36 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.371 -1.286 . . . . 4.13 111.969 -174.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -66.8 -17.9 65.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 2.27 111.009 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -93.66 -64.27 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.138 -0.483 . . . . 2.01 110.577 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.749 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -84.94 58.98 5.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 2.39 111.726 -173.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.749 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 3.6 tp 156.63 -24.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.934 0.894 . . . . 3.23 110.48 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.27 -25.92 74.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.995 -0.622 . . . . 2.06 112.769 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.88 -104.4 0.25 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.824 -0.703 . . . . 2.17 111.932 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.14 149.28 15.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.56 0.219 . . . . 2.26 110.606 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.69 178.33 8.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.737 -0.468 . . . . 1.31 109.737 174.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -119.15 59.87 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.37 0.605 . . . . 2.37 110.224 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 179.04 6.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.539 -0.755 . . . . 2.27 110.059 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.59 73.77 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.048 0.388 . . . . 1.64 112.048 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -36.43 72.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 2.58 111.057 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -75.06 -38.93 61.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.976 -0.556 . . . . 1.06 110.805 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.4 t -63.8 -41.59 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 1.46 110.236 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -59.93 -39.51 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.577 . . . . 0.97 110.83 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.46 -34.46 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.93 110.673 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -50.83 69.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 1.86 110.716 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 51' ' ' VAL . 4.0 t -70.4 -36.85 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 1.82 111.098 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -49.91 -45.73 51.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.668 -0.696 . . . . 1.97 111.573 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.496 ' HB3' ' H ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -87.08 -103.68 0.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.381 -0.372 . . . . 3.57 111.034 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.496 ' H ' ' HB3' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -140.53 36.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.549 -0.296 . . . . 3.64 111.225 -175.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 53.04 64.58 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.264 0.555 . . . . 4.58 110.363 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -38.1 78.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.629 -0.714 . . . . 2.8 111.79 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t 70.48 -50.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 123.669 0.606 . . . . 3.13 110.963 -175.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.444 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -80.92 -131.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 4.56 111.057 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -71.71 132.17 85.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.159 0.504 . . . . 3.01 110.864 -177.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.1 Cg_exo -78.53 69.82 7.55 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 123.516 2.811 . . . . 1.91 111.917 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -60.09 117.57 5.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 2.46 111.817 -176.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.05 50.63 17.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.501 -0.772 . . . . 2.42 112.213 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 p -126.97 -35.66 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.528 -0.469 . . . . 2.11 110.931 173.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.675 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.0 OUTLIER 177.09 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.443 0.464 . . . . 2.19 110.781 178.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.584 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 22.1 m-85 -72.59 -51.89 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.233 0.457 . . . . 1.87 112.233 -173.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.921 0.391 . . . . 1.09 111.546 -176.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -179.51 97.58 0.2 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 3.23 109.63 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HD3' HD13 ' A' ' 41' ' ' ILE . 9.5 Cg_exo -71.84 54.37 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.286 2.657 . . . . 1.77 112.707 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.484 HG22 ' HE2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -150.97 59.67 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.921 -0.77 . . . . 2.46 108.921 176.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.731 HD11 ' HA ' ' A' ' 16' ' ' GLU . 17.9 pt -64.61 -21.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 2.08 112.446 -170.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.484 ' HE2' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -61.61 -39.65 92.01 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.064 0.459 . . . . 3.8 110.493 175.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.77 73.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.923 -0.58 . . . . 1.08 110.648 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.675 HD13 ' HA ' ' A' ' 68' ' ' LEU . 25.5 mt -72.82 -25.31 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.264 -0.425 . . . . 2.41 110.441 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.5 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 1.57 111.331 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.427 ' H ' ' HG2' ' A' ' 79' ' ' GLN . 5.4 pt20 -104.53 -39.79 6.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.392 -0.523 . . . . 2.74 111.055 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.14 -65.42 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.995 0.369 . . . . 2.85 111.995 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.92 -25.01 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 2.13 111.57 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.55 33.83 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 1.9 111.477 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.278 0.561 . . . . 2.65 110.707 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.496 0.665 . . . . 3.47 111.127 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.527 ' HB1' ' HG ' ' A' ' 35' ' ' LEU . . . -80.34 125.02 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.422 -0.808 . . . . 3.01 110.939 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -80.32 58.78 3.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.222 0.534 . . . . 3.51 110.332 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.474 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -141.58 -94.14 0.14 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.67 -0.696 . . . . 2.32 109.925 178.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.547 HG23 ' HA3' ' A' ' 33' ' ' GLY . 13.0 p 33.09 62.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.295 0.997 . . . . 2.13 112.697 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.09 100.96 53.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.781 -0.645 . . . . 2.09 110.691 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.1 139.16 23.71 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.147 2.564 . . . . 1.88 112.425 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -47.09 8.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 2.04 110.238 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.6 t-20 -102.95 149.64 24.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.374 -0.83 . . . . 2.24 109.821 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.88 81.73 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.266 0.469 . . . . 1.42 112.266 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -29.38 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.52 -0.309 . . . . 1.99 110.516 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 51.9 mt-10 -60.03 -40.18 88.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 1.93 109.808 175.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -37.76 79.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.034 -0.53 . . . . 1.48 110.325 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.17 91.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 2.96 110.374 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -67.05 -53.59 29.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.712 -0.676 . . . . 1.81 110.978 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.24 99.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 1.08 112.092 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -63.25 -53.5 52.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.856 -0.156 . . . . 2.69 111.132 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.602 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 33.5 mm -58.5 -47.95 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 1.91 111.169 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -67.46 -53.53 28.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.786 0.327 . . . . 1.33 111.677 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 32' ' ' ILE . 4.6 tp10 -71.91 -52.15 18.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.548 -0.297 . . . . 2.78 111.743 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -0.69 24.09 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.933 -0.48 . . . . 4.4 111.781 -172.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.602 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 5.1 t -108.59 -43.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.075 -0.25 . . . . 2.01 110.758 173.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.08 -51.99 2.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 2.85 111.852 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -61.07 -45.2 97.06 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.255 -0.498 . . . . 1.73 113.003 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 33.7 t 76.56 -51.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.553 0.741 . . . . 1.92 111.809 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.93 -54.76 42.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.958 0.355 . . . . 2.21 111.958 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.31 57.97 0.66 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.151 -1.023 . . . . 1.58 111.88 -175.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.414 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 22.8 mm -90.64 -52.8 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.639 -0.504 . . . . 3.56 109.639 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . 56.32 -117.06 8.32 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.488 -0.778 . . . . 2.28 113.152 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.509 ' H ' ' HA ' ' A' ' 9' ' ' VAL . 13.3 mm -81.52 87.78 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 2.67 111.078 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.527 ' HG ' ' HB1' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -166.07 26.45 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 2.46 109.327 174.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.876 ' HA ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 p-10 38.47 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.909 -1.041 . . . . 4.2 111.983 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.13 -69.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.23 0.826 . . . . 4.13 113.23 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -56.67 15.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.795 0.331 . . . . 2.27 111.588 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.84 -72.15 0.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.288 -0.415 . . . . 2.01 111.698 -174.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.876 ' HG2' ' HA ' ' A' ' 36' ' ' ASP . 1.9 pm0 -73.62 81.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 2.39 111.803 -174.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 tp 179.08 -26.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.336 -0.847 . . . . 3.23 110.013 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.01 28.07 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.945 -0.645 . . . . 2.06 112.235 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.94 103.23 1.1 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 2.17 112.467 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -130.24 61.62 1.59 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.448 . . . . 2.26 110.305 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.16 162.47 29.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.79 -0.641 . . . . 1.31 110.735 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.61 61.5 4.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.484 0.659 . . . . 2.37 110.719 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 155.79 49.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.373 -0.83 . . . . 2.27 109.774 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.98 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.565 0.222 . . . . 1.64 111.506 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.86 -42.51 75.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 2.58 111.203 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -76.85 -36.51 56.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 1.06 111.124 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 55' ' ' VAL . 46.5 t -64.15 -42.96 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 1.46 110.4 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.45 84.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 0.97 111.019 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.84 -35.12 79.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.93 111.147 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.67 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 3.5 tt0 -67.64 -40.86 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 1.86 111.017 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 51' ' ' VAL . 22.5 t -79.53 -38.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.845 -0.616 . . . . 1.82 111.483 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -58.57 -30.86 67.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.472 -0.331 . . . . 1.97 111.304 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.587 ' HB3' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -87.15 16.03 5.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.746 -0.206 . . . . 3.57 111.283 -178.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 56.44 65.92 1.31 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.321 -0.4 . . . . 3.64 110.328 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 64.45 76.92 0.33 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.705 -0.68 . . . . 4.58 110.566 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.67 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -84.38 -11.96 55.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 2.8 111.028 -178.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t 53.32 -111.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.027 -0.533 . . . . 3.13 110.385 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 2.1 tp10 -127.26 28.93 5.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.08 0.467 . . . . 4.56 110.121 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.02 87.9 20.3 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 3.01 110.961 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 9.3 Cg_endo -91.82 105.49 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.639 2.893 . . . . 1.91 112.208 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 mt -118.03 -30.11 5.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.026 0.441 . . . . 2.46 110.884 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -153.83 82.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 2.42 110.301 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.441 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -149.26 -169.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.897 -0.592 . . . . 2.11 110.137 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -60.14 -32.3 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 2.19 111.037 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 50' ' ' ALA . 89.1 m-85 -110.17 36.62 2.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 1.87 110.61 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HB3' ' H ' ' A' ' 67' ' ' VAL . . . -158.9 56.54 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.367 . . . . 1.09 110.969 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.532 ' HG3' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -164.52 128.34 1.77 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 3.23 109.954 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 6.5 Cg_exo -75.5 13.82 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.994 2.463 . . . . 1.77 112.363 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -153.85 115.65 4.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.3 -0.63 . . . . 2.46 109.3 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -28.83 5.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.44 . . . . 2.08 111.344 -171.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 13' ' ' ASN . 17.6 pttt -57.92 -36.69 72.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.588 -0.278 . . . . 3.8 111.169 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.16 -39.26 89.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.076 0.465 . . . . 1.08 110.801 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HG3' ' A' ' 71' ' ' GLN . 5.4 mt -72.47 -45.41 59.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 2.41 110.133 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -59.22 -42.5 91.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.57 111.749 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.26 1.25 41.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 2.74 111.566 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -129.78 -90.2 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.726 -0.39 . . . . 2.85 111.69 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.3 m -70.6 -18.6 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.51 0.559 . . . . 2.13 112.51 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.85 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -102.25 15.29 29.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.331 . . . . 1.9 111.77 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 120.839 -0.344 . . . . 2.65 111.219 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.434 -0.58 . . . . 3.47 109.434 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.31 -99.19 0.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.499 -0.319 . . . . 3.01 110.904 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.26 -58.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.68 0.276 . . . . 3.51 110.884 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.468 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . 8.6 t80 -46.97 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.231 -0.895 . . . . 2.32 112.577 -173.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.2 p 42.74 36.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.094 0.949 . . . . 2.13 112.524 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.38 84.32 56.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.89 -0.595 . . . . 2.09 111.531 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 31.3 Cg_exo -59.71 133.96 54.55 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.353 2.036 . . . . 1.88 111.103 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -45.96 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.651 0.612 . . . . 2.04 112.651 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -136.47 107.36 6.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.706 1.002 . . . . 2.24 113.706 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 42.09 -85.88 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.961 1.467 . . . . 1.42 114.961 163.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -53.29 -34.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.072 -0.513 . . . . 1.99 111.204 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.98 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 39.5 mt-10 -61.81 -45.97 91.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.463 -0.789 . . . . 1.93 110.69 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.555 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -63.25 -35.49 80.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 1.48 110.997 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -60.59 -60.07 4.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 2.96 110.976 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.57 -40.01 77.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 1.81 111.427 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.53 -50.72 66.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.362 -0.381 . . . . 1.08 111.454 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 26.2 mt-10 -62.53 -41.03 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.497 0.189 . . . . 2.69 111.428 -175.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.85 -43.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 1.91 110.362 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -72.79 -48.72 35.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.09 -0.504 . . . . 1.33 112.065 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.81 -26.49 25.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.585 0.587 . . . . 2.78 112.585 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -99.22 -48.05 4.97 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 4.4 111.552 -177.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.85 -47.68 16.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.688 0.28 . . . . 2.01 111.618 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.54 -65.58 0.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 2.85 111.872 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.09 -41.7 17.38 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.942 -0.647 . . . . 1.73 113.306 -175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t 63.77 83.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.16 0.505 . . . . 1.92 110.214 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.28 -83.49 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 2.21 111.778 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.14 72.31 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.231 -1.147 . . . . 1.58 110.231 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 33' ' ' GLY . 4.8 tp -96.75 173.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.369 0.604 . . . . 3.56 112.415 -167.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.555 ' H ' HG13 ' A' ' 32' ' ' ILE . . . -152.47 173.85 31.46 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.825 -0.625 . . . . 2.28 111.651 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.649 HG23 ' HB2' ' A' ' 72' ' ' PRO . 19.3 mm -85.97 68.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.369 0.604 . . . . 2.67 110.559 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -141.64 -67.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.491 -0.777 . . . . 2.46 109.041 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -131.07 147.39 52.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.47 -0.937 . . . . 4.2 108.47 173.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -144.71 160.96 40.36 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 121.062 -0.255 . . . . 4.13 110.859 -174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -100.96 -17.17 16.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.136 -0.484 . . . . 2.27 110.475 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.449 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.1 OUTLIER -129.66 -45.44 1.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.947 -0.57 . . . . 2.01 110.683 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.449 HE21 ' HE2' ' A' ' 39' ' ' PHE . 26.2 mt-30 -82.65 62.23 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.25 -0.281 . . . . 2.39 110.662 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 tp -169.5 -22.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 111.916 0.339 . . . . 3.23 111.916 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.22 -36.96 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.426 -0.892 . . . . 2.06 112.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.35 131.21 41.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.037 -0.602 . . . . 2.17 111.884 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -113.19 100.71 8.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.043 0.449 . . . . 2.26 110.336 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.0 154.73 25.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.573 -0.74 . . . . 1.31 111.032 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.83 91.46 1.96 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 2.37 110.485 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.32 156.12 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 2.27 110.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -25.6 64.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 1.64 111.064 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 ttt -63.1 -34.75 78.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 2.58 110.601 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HA ' ' HZ ' ' A' ' 69' ' ' PHE . . . -72.29 -38.75 68.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 1.06 110.355 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 55' ' ' VAL . 10.5 t -64.25 -38.58 82.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 1.46 110.315 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.26 93.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 0.97 110.719 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.92 96.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 0.93 110.47 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.479 ' HA ' ' HG3' ' A' ' 60' ' ' GLN . 4.0 mm-40 -58.36 -49.63 76.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.701 . . . . 1.86 110.716 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.7 t -64.63 -31.25 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 1.82 110.769 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -68.79 -18.96 64.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 1.97 111.924 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -120.8 19.18 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.715 0.293 . . . . 3.57 110.642 178.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 51.44 60.62 3.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.544 -0.753 . . . . 3.64 111.302 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 68.54 73.29 0.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.315 -0.857 . . . . 4.58 110.879 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -79.68 97.33 6.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.152 -0.931 . . . . 2.8 110.024 178.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -70.11 88.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.393 . . . . 3.13 111.115 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.22 43.46 26.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.724 -0.671 . . . . 4.56 111.179 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -154.62 75.0 5.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 3.01 110.584 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.731 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.7 Cg_endo -87.03 47.68 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.517 2.811 . . . . 1.91 112.432 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -56.83 101.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.682 -0.69 . . . . 2.46 112.268 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.766 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 11.4 mtmm 58.3 31.3 20.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.457 -0.792 . . . . 2.42 112.213 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.92 -21.37 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.945 -0.302 . . . . 2.11 110.948 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -175.04 -74.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.101 0.477 . . . . 2.19 109.727 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.731 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 11.0 m-85 -84.49 53.14 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 1.87 111.056 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.766 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -172.09 134.08 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.92 -0.582 . . . . 1.09 109.607 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 65.7 tp60 72.88 88.51 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 124.199 0.937 . . . . 3.23 110.455 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HB2' HG23 ' A' ' 34' ' ' ILE . 7.6 Cg_exo -72.97 63.59 4.07 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.443 2.762 . . . . 1.77 112.429 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.1 93.88 2.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.827 -0.624 . . . . 2.46 109.506 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.98 ' HB ' ' HG2' ' A' ' 16' ' ' GLU . 1.8 mt -64.88 -35.88 76.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 2.08 111.293 -173.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -59.17 -43.6 92.12 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.923 0.392 . . . . 3.8 110.648 175.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -42.92 69.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 1.08 110.68 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.31 -25.95 67.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 2.41 110.809 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.17 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.192 -0.458 . . . . 1.57 111.002 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.36 -13.63 59.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.017 0.437 . . . . 2.74 110.551 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.25 -72.93 0.48 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 2.85 111.226 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.29 -43.52 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 2.13 110.976 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.63 30.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.347 0.594 . . . . 1.9 110.841 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 2.65 110.129 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.111 -0.7 . . . . 3.47 109.111 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.31 -21.05 50.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 3.01 112.426 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 68.48 -58.84 0.46 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.272 0.629 . . . . 3.51 111.153 -175.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.83 72.9 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 2.32 110.893 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.464 ' HA ' HG12 ' A' ' 34' ' ' ILE . 6.5 p -125.99 5.52 4.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.399 0.619 . . . . 2.13 110.464 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -86.59 109.53 24.66 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 2.09 110.658 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.556 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 5.1 Cg_exo -81.43 -172.41 1.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.385 2.723 . . . . 1.88 111.871 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.98 -49.18 2.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 2.04 110.885 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.404 HD21 HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -99.85 159.38 15.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 2.24 110.717 -175.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.8 95.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.48 . . . . 1.42 112.12 -175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 HD21 ' A' ' 13' ' ' ASN . 15.3 t -64.09 -39.82 86.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 1.99 110.667 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.613 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 27.7 mt-10 -57.36 -42.34 81.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.774 -0.648 . . . . 1.93 110.458 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -75.16 -31.28 60.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 1.48 111.428 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -56.03 22.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 2.96 111.043 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.55 -32.64 73.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 1.81 110.612 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.7 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 1.08 110.691 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -56.39 -50.96 70.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.536 . . . . 2.69 111.055 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.21 -52.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.693 -0.685 . . . . 1.91 111.129 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -64.07 -42.83 96.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.444 -0.343 . . . . 1.33 111.417 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.729 ' HB2' HG12 ' A' ' 32' ' ' ILE . 5.5 tp10 -60.21 -44.8 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.584 -0.28 . . . . 2.78 111.169 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -20.75 39.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 4.4 112.295 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -97.07 -52.39 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.842 0.312 . . . . 2.01 111.842 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.73 -31.47 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.948 0.351 . . . . 2.85 111.948 -174.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.81 -73.84 0.42 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.306 -0.473 . . . . 1.73 112.72 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t 69.15 -63.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.049 0.54 . . . . 1.92 111.926 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 m -66.57 -32.76 74.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 2.21 110.616 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.83 127.54 2.76 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.762 -0.733 . . . . 1.58 112.654 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.729 HG12 ' HB2' ' A' ' 24' ' ' GLU . 1.3 pt -104.2 172.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 3.56 110.535 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.65 163.34 33.53 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.044 -0.598 . . . . 2.28 111.78 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -92.49 -7.53 10.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.038 0.446 . . . . 2.67 110.821 -178.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.627 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -87.18 -43.16 12.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.509 -0.314 . . . . 2.46 110.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.627 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 20.3 t70 -174.71 161.51 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.141 -0.689 . . . . 4.2 109.141 -177.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.599 ' ND2' ' HA ' ' A' ' 32' ' ' ILE . 6.5 t-20 -169.64 164.11 10.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.207 -0.294 . . . . 4.13 110.207 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -77.51 -24.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 2.27 110.807 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -88.2 -33.69 18.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.083 -0.508 . . . . 2.01 111.042 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.4 mt-30 -84.63 33.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.333 . . . . 2.39 111.779 -172.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.465 ' HB ' ' H ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -151.25 -127.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.693 -0.484 . . . . 3.23 109.693 176.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 41' ' ' ILE . . . -84.89 53.91 4.87 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.914 -0.66 . . . . 2.06 111.949 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -139.73 55.44 0.65 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.617 -0.593 . . . . 2.17 111.617 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -73.61 135.36 43.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.626 0.25 . . . . 2.26 110.799 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.99 171.43 14.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 1.31 110.266 175.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.15 67.95 3.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.219 0.533 . . . . 2.37 109.562 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -126.41 170.8 11.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 2.27 110.6 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.71 71.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 1.64 110.766 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.3 tpp -60.38 -35.34 75.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.903 -0.589 . . . . 2.58 110.674 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -70.13 -44.08 69.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 1.06 110.264 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.01 -44.5 91.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.05 -0.523 . . . . 1.46 110.319 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.91 73.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.97 111.089 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -64.2 -51.09 65.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.93 111.147 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -68.11 -33.1 73.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.042 -0.263 . . . . 1.86 111.178 -178.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.15 -44.1 81.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.356 . . . . 1.82 110.421 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -71.46 -28.01 63.66 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.901 0.381 . . . . 1.97 110.698 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -78.93 -32.63 45.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 3.57 110.695 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER 70.1 9.75 7.15 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.742 0.651 . . . . 3.64 110.903 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -172.66 156.63 3.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.033 -1.099 . . . . 4.58 108.033 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.511 ' HA ' ' NE2' ' A' ' 60' ' ' GLN . 3.1 tp60 -143.67 -36.65 0.35 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.103 -0.639 . . . . 2.8 112.096 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.1 t 69.01 -73.89 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 123.579 0.549 . . . . 3.13 109.733 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.78 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.483 0.713 . . . . 4.56 109.422 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -105.66 107.74 60.02 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.821 -0.627 . . . . 3.01 110.33 178.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 18.6 Cg_endo -92.38 99.27 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.466 2.778 . . . . 1.91 111.915 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.97 -19.65 47.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.717 0.265 . . . . 2.46 111.717 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.78 115.94 3.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.645 -0.252 . . . . 2.42 110.364 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.416 HG13 ' H ' ' A' ' 68' ' ' LEU . 2.1 p -171.25 -55.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.46 -0.336 . . . . 2.11 110.781 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.541 ' HA ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -167.02 -37.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.009 0.433 . . . . 2.19 110.225 -176.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -83.0 -67.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 1.87 111.106 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 40' ' ' GLN . . . -76.58 88.96 3.3 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.041 0.448 . . . . 1.09 111.625 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.513 ' HB3' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -175.45 85.08 0.3 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.166 -0.925 . . . . 3.23 109.455 175.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.12 70.74 0.55 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.433 2.755 . . . . 1.77 112.034 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.52 -24.57 0.09 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.246 -0.888 . . . . 2.46 109.555 177.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.514 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 mt 71.35 -68.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.501 -0.772 . . . . 2.08 111.955 174.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HB2' ' HG3' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -72.28 -15.68 61.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.698 0.259 . . . . 3.8 111.698 -174.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.52 13.77 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.024 0.44 . . . . 1.08 110.8 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -63.44 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 2.41 109.96 178.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -75.15 0.42 16.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 1.57 111.529 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -32.41 11.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 2.74 110.454 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.49 -64.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.276 -0.569 . . . . 2.85 112.381 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.45 -40.28 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 2.13 110.96 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -105.91 159.12 16.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.809 -0.632 . . . . 1.9 109.482 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 123.038 0.535 . . . . 2.65 111.551 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 121.186 0.517 . . . . 3.47 110.389 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.63 125.61 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.462 -0.79 . . . . 3.01 111.42 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.61 63.09 4.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 3.51 111.131 -177.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.633 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t80 -121.89 -86.37 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.938 -0.764 . . . . 2.32 108.938 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' H ' ' HB3' ' A' ' 8' ' ' TYR . 94.7 t 73.13 -55.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.759 0.662 . . . . 2.13 111.872 173.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -82.32 108.69 12.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.58 0.229 . . . . 2.09 111.033 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.779 ' HG2' ' HB3' ' A' ' 16' ' ' GLU . 20.4 Cg_endo -95.64 -99.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.593 2.862 . . . . 1.88 111.559 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 p -98.87 -80.4 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.866 0.365 . . . . 2.04 110.239 174.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -134.24 -174.86 3.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 2.24 110.873 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.92 -33.4 56.54 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.63 0.974 . . . . 1.42 113.63 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.82 -34.33 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.955 0.407 . . . . 1.99 110.701 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.779 ' HB3' ' HG2' ' A' ' 11' ' ' PRO . 4.6 tt0 -79.95 -38.01 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.253 -0.43 . . . . 1.93 110.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -63.62 -39.01 93.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.403 . . . . 1.48 110.884 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HE3' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -69.59 -31.66 69.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.448 -0.342 . . . . 2.96 110.803 178.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.496 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 tp -64.92 -46.13 82.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.605 -0.517 . . . . 1.81 109.605 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 24' ' ' GLU . . . -60.19 -33.87 72.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.484 -0.78 . . . . 1.08 110.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 17' ' ' SER . 85.5 mt-10 -57.79 -47.23 83.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 2.69 111.092 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.549 HD11 ' HE3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -71.83 -48.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.042 0.449 . . . . 1.91 111.066 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -68.57 -47.08 67.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.551 . . . . 1.33 112.035 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -69.79 -45.55 67.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.623 -0.262 . . . . 2.78 111.17 -175.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.468 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 2.1 mmt180 -71.89 -37.85 70.08 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.005 0.372 . . . . 4.4 112.005 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.29 -59.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.096 0.406 . . . . 2.01 112.096 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 40.3 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.1 0.476 . . . . 2.85 111.349 -173.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -172.83 -46.41 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.645 -0.788 . . . . 1.73 112.207 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 7.2 t 78.4 -37.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.352 0.661 . . . . 1.92 110.572 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.7 144.77 43.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.128 -0.487 . . . . 2.21 110.406 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.58 71.74 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.722 . . . . 1.58 113.08 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 36.1 mm -101.96 91.34 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.453 0.644 . . . . 3.56 110.359 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 34' ' ' ILE . . . -79.7 79.98 1.62 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.648 -0.787 . . . . 2.28 112.246 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 33' ' ' GLY . 38.8 mm 78.05 -43.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.399 0.68 . . . . 2.67 112.504 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.633 ' HG ' ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -35.86 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 2.46 113.527 -174.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.72 110.71 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 4.2 111.089 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.05 95.7 6.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.068 -0.515 . . . . 4.13 109.88 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -96.59 -24.58 15.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 2.27 112.637 -174.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -131.79 -9.21 3.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.632 -0.427 . . . . 2.01 111.637 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 8.1 mp0 -72.0 -57.71 4.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.337 -0.392 . . . . 2.39 111.329 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.549 HG23 ' HB1' ' A' ' 70' ' ' ALA . 1.6 mt -105.62 74.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.998 0.428 . . . . 3.23 111.281 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.95 -82.55 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.369 -0.92 . . . . 2.06 113.257 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.45 80.81 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.133 -0.556 . . . . 2.17 112.733 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.427 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 2.9 p-80 -65.21 141.7 58.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.01 0.433 . . . . 2.26 110.483 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.74 29.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 1.31 111.206 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 mt -87.24 -10.96 51.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.104 -0.702 . . . . 2.37 109.104 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -56.21 150.53 14.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.595 -1.184 . . . . 2.27 110.989 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -17.83 51.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.197 -0.456 . . . . 1.64 111.964 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -63.1 -48.23 79.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 2.58 110.786 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.71 -28.39 50.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 1.06 110.431 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.18 -40.13 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 1.46 110.272 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.82 92.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.97 110.533 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.519 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -64.52 -42.24 95.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 0.93 110.415 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.699 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 tt0 -59.84 -46.92 87.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.587 -0.733 . . . . 1.86 110.777 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -65.95 -39.24 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 1.82 110.903 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -72.71 5.3 3.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 1.97 111.897 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -137.29 24.66 2.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.977 0.418 . . . . 3.57 110.362 175.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.08 49.73 11.1 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.438 -0.801 . . . . 3.64 111.965 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.699 ' HA ' ' HG3' ' A' ' 54' ' ' GLN . 21.7 m-30 66.8 87.97 0.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.692 -0.685 . . . . 4.58 112.147 171.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -77.76 -17.79 57.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.607 -0.724 . . . . 2.8 110.988 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 53.6 t 77.03 -57.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 123.388 0.675 . . . . 3.13 112.264 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 -70.45 0.79 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.823 0.305 . . . . 4.56 111.823 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.51 140.9 28.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.569 -0.287 . . . . 3.01 110.899 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' OE1' ' A' ' 60' ' ' GLN . 74.5 Cg_endo -75.84 62.39 6.51 Favored 'Trans proline' 0 C--O 1.237 0.466 0 C-N-CA 122.933 2.422 . . . . 1.91 111.731 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.834 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 22.3 tp -77.08 126.55 31.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 2.46 111.679 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt 64.48 14.9 9.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.416 -0.811 . . . . 2.42 112.487 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.519 HG11 ' HB1' ' A' ' 53' ' ' ALA . 7.2 p -98.35 -35.15 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.759 -0.376 . . . . 2.11 110.188 174.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER 175.43 -58.8 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.164 0 O-C-N 123.612 0.57 . . . . 2.19 110.585 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.4 m-85 -66.74 -50.9 61.27 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.964 0.727 . . . . 1.87 112.964 -171.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . -77.95 70.55 4.33 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.184 0.438 . . . . 1.09 112.184 -173.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.71 130.22 1.52 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.58 -0.736 . . . . 3.23 109.509 174.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.665 ' O ' ' HB ' ' A' ' 73' ' ' THR . 39.5 Cg_exo -61.27 105.15 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.499 2.132 . . . . 1.77 111.282 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.665 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER 81.94 113.54 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.18 0.925 . . . . 2.46 109.35 -171.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 68' ' ' LEU . 4.2 mm -83.12 -22.69 8.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.044 -0.98 . . . . 2.08 110.322 -174.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -54.08 -37.12 63.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.633 -0.712 . . . . 3.8 111.681 -178.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.06 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.08 110.968 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.66 -27.74 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 2.41 110.646 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.876 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -60.83 -49.71 76.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 1.57 111.865 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.82 -0.29 57.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.742 -0.383 . . . . 2.74 111.412 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -101.43 -69.08 0.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.94 -0.304 . . . . 2.85 111.283 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -13.43 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 111.854 0.316 . . . . 2.13 111.854 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.876 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -99.05 21.9 11.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 1.9 111.124 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.501 0.667 . . . . 2.65 110.692 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.678 0.275 . . . . 8.54 110.87 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 54.81 21.95 24.72 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.461 -0.876 . . . . 5.41 111.733 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.3 m -52.8 -17.62 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 120.957 0.408 . . . . 6.05 110.911 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p -42.47 149.06 0.18 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.429 -0.805 . . . . 3.59 111.316 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 5' ' ' GLU . 11.6 mp0 -44.54 118.32 1.53 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.89 -0.595 . . . . 3.47 111.068 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . . . -82.91 130.07 35.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.044 -0.526 . . . . 3.01 111.05 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -85.15 20.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 3.51 110.519 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -125.05 46.01 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 2.32 111.126 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 p -84.55 2.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 2.13 111.058 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.07 110.25 3.98 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 2.09 111.45 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -91.03 158.93 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.592 2.195 . . . . 1.88 111.975 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.23 -44.24 8.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 2.04 111.082 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.04 156.36 29.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 2.24 110.976 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.39 -29.49 64.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.054 -0.521 . . . . 1.42 111.296 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -64.89 -41.95 93.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 1.99 111.168 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.22 -38.45 78.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 1.93 111.027 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -64.52 -42.02 96.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.48 110.986 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -68.18 -48.79 64.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 2.96 111.258 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -47.2 85.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 1.81 110.957 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.87 -35.18 80.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.511 . . . . 1.08 111.367 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 17' ' ' SER . 10.2 tt0 -66.05 -51.7 55.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.425 -0.352 . . . . 2.69 111.501 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.81 -34.6 71.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.09 0.404 . . . . 1.91 112.09 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -76.38 -44.2 37.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.666 0.617 . . . . 1.33 112.666 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.47 9.65 12.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.908 0.336 . . . . 2.78 111.908 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.48 HH11 ' HB2' ' A' ' 25' ' ' ARG . 5.6 ttm105 -118.46 -21.74 7.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 4.4 110.853 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.41 -24.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 2.01 111.133 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.74 -61.37 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 2.85 111.517 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -59.61 9.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 1.73 113.319 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t 59.09 12.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.03 0.443 . . . . 1.92 110.85 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.7 m -98.46 -68.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 2.21 111.01 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 143.54 33.97 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.754 -0.736 . . . . 1.58 111.932 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.452 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 1.1 pt -88.44 -173.08 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.9 0.381 . . . . 3.56 111.308 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.55 -109.23 0.23 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.868 -0.682 . . . . 2.28 112.413 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 mm -103.28 49.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.724 0.297 . . . . 2.67 111.189 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.98 9.85 6.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.497 -0.32 . . . . 2.46 111.318 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.13 150.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 4.2 110.443 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.558 HD22 ' H ' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -177.76 -96.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 4.13 111.117 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.558 ' H ' HD22 ' A' ' 37' ' ' ASN . 9.7 p90 -119.95 -28.11 5.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.357 -0.383 . . . . 2.27 111.264 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' HB3' HE21 ' A' ' 40' ' ' GLN . 14.0 t80 -78.67 -83.89 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.294 -0.412 . . . . 2.01 111.676 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -73.86 82.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.416 -0.356 . . . . 2.39 111.247 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 tp -172.03 -36.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.849 0.315 . . . . 3.23 111.849 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.96 -30.46 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.252 -0.975 . . . . 2.06 112.98 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.12 120.43 18.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.613 -0.803 . . . . 2.17 112.297 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -98.76 26.56 5.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.751 0.275 . . . . 2.26 111.387 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 31.16 -145.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.99 0.737 . . . . 1.31 112.99 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.92 31.57 0.94 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.214 -0.448 . . . . 2.37 110.689 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -105.3 169.6 8.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 2.27 111.205 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.2 79.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.013 -0.54 . . . . 1.64 111.229 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.6 ttt -58.9 -32.11 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.968 0.414 . . . . 2.58 110.606 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.47 -47.17 34.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.918 -0.583 . . . . 1.06 110.652 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 55' ' ' VAL . 19.8 t -57.52 -34.48 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 1.46 110.089 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -65.48 -43.28 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.793 -0.639 . . . . 0.97 110.275 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -26.42 67.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.02 -0.536 . . . . 0.93 110.483 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.414 ' HG2' ' NE2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -72.73 -44.6 61.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.805 -0.634 . . . . 1.86 110.801 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 51' ' ' VAL . 13.0 t -76.55 -26.49 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 1.82 111.282 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -77.61 2.68 15.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 1.97 111.154 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -133.58 8.27 3.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.37 . . . . 3.57 111.537 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 68.39 53.8 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 3.64 111.31 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 57.74 88.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 4.58 111.8 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.63 ' OE1' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -67.68 -30.1 69.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.649 -0.501 . . . . 2.8 109.649 178.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.2 t 65.86 -72.71 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 115.322 -0.854 . . . . 3.13 111.861 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -92.81 -84.44 0.29 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.506 0.558 . . . . 4.56 112.506 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.06 135.14 20.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.206 0.447 . . . . 3.01 112.206 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 67' ' ' VAL . 84.4 Cg_endo -88.24 58.36 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.769 2.313 . . . . 1.91 111.125 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.95 119.08 5.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.587 -0.733 . . . . 2.46 112.241 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mttp 47.15 83.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.775 -0.648 . . . . 2.42 112.123 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.63 HG11 ' OE1' ' A' ' 60' ' ' GLN . 13.7 p -155.62 -44.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.288 -0.414 . . . . 2.11 111.051 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.432 ' N ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -178.27 -39.53 0.01 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.549 -0.296 . . . . 2.19 111.499 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -91.97 -52.72 4.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.066 0.395 . . . . 1.87 112.066 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.9 71.56 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.954 0.353 . . . . 1.09 111.954 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.672 HE21 ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER 176.42 115.27 0.13 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.148 -0.478 . . . . 3.23 110.582 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.672 ' HD2' HE21 ' A' ' 71' ' ' GLN . 73.4 Cg_endo -75.99 41.35 0.83 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.434 2.09 . . . . 1.77 112.879 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.91 74.54 0.73 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.146 0.498 . . . . 2.46 110.23 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.08 -40.79 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.648 -0.705 . . . . 2.08 112.296 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -30.83 71.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 3.8 111.146 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.09 68.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 1.08 110.734 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 71' ' ' GLN . 30.7 mt -72.82 -27.33 61.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.049 -0.523 . . . . 2.41 110.602 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.814 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -60.61 -34.28 74.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.895 -0.593 . . . . 1.57 111.106 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -103.31 21.61 15.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 2.74 111.041 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 1.0 OUTLIER -129.91 -69.95 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 2.85 111.094 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 t -94.1 -39.26 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 2.13 111.332 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -72.64 -16.86 61.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 1.9 111.348 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 85' ' ' SER . 0.2 OUTLIER -55.82 -27.53 51.84 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.971 -0.381 . . . . 2.65 109.971 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.439 ' NH2' ' HA ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 58.4 -83.89 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.268 -0.878 . . . . 7.09 110.305 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.439 ' HA ' ' NH2' ' A' ' 84' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.141 -0.933 . . . . 5.98 110.507 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.818 -0.438 . . . . 8.54 109.818 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.56 -118.51 15.1 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.005 -0.617 . . . . 5.41 111.97 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.53 -28.76 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.875 -0.417 . . . . 6.05 109.875 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER 60.2 -124.86 1.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.547 -0.752 . . . . 3.59 110.106 -176.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 1.018 ' HA ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER 66.39 165.25 0.2 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.62 0.724 . . . . 3.47 112.174 177.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . . . -163.81 146.65 9.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.455 -0.793 . . . . 3.01 110.148 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -122.69 33.79 5.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.514 0.674 . . . . 3.51 109.196 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 34' ' ' ILE . 5.1 t80 -116.12 17.23 15.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.371 -0.831 . . . . 2.32 111.334 -173.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.43 67.03 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.403 1.096 . . . . 2.13 110.122 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -106.41 105.29 53.88 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.106 -0.952 . . . . 2.09 110.515 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 1.1 Cg_endo -83.52 156.61 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.121 2.547 . . . . 1.88 111.974 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.56 -44.92 3.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.237 0.541 . . . . 2.04 109.645 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -114.59 177.49 4.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.511 -0.768 . . . . 2.24 109.832 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.42 -15.57 54.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.896 0.379 . . . . 1.42 110.768 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -64.78 -57.52 10.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.922 -0.581 . . . . 1.99 111.039 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.899 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 12.6 pm0 -72.75 -22.71 60.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.23 -0.441 . . . . 1.93 110.699 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.66 -48.5 79.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 1.48 110.097 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -61.08 -45.18 95.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 2.96 110.856 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.38 -56.07 16.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 1.81 111.395 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -67.12 -43.8 81.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.669 -0.696 . . . . 1.08 112.092 -173.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.05 -37.21 83.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.604 0.24 . . . . 2.69 111.314 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.13 -46.99 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.045 -0.262 . . . . 1.91 110.595 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -69.28 -27.36 65.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.33 110.563 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.1 tm-20 -58.83 -52.03 67.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.761 -0.654 . . . . 2.78 110.471 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -19.35 60.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.726 0.298 . . . . 4.4 111.364 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.63 -49.27 15.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.497 -0.319 . . . . 2.01 111.409 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.45 -31.69 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.686 0.624 . . . . 2.85 112.686 -173.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 -82.1 0.47 Allowed Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.656 -0.783 . . . . 1.73 113.723 -173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 74.56 4.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.011 0.924 . . . . 1.92 110.92 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.018 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 15.2 m -112.5 -17.0 12.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.703 -0.68 . . . . 2.21 111.965 -172.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.46 34.78 8.34 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.651 -0.98 . . . . 1.58 110.651 -174.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 30' ' ' SER . 1.3 pt -78.94 170.52 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.273 0.559 . . . . 3.56 112.085 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.77 158.19 7.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.52 -0.764 . . . . 2.28 111.619 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.453 HG21 ' HE2' ' A' ' 8' ' ' TYR . 36.4 mm 66.27 -79.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.011 0.525 . . . . 2.67 111.272 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.55 -31.73 65.5 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.966 -0.383 . . . . 2.46 109.966 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 17.7 t0 41.75 -92.73 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.362 1.039 . . . . 4.2 112.906 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 92.74 -7.39 0.17 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.711 1.257 . . . . 4.13 111.761 175.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.627 ' HE2' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -109.67 -55.53 2.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.537 -0.542 . . . . 2.27 109.537 173.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.503 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 29.7 t80 -91.75 -73.13 0.55 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.378 -0.828 . . . . 2.01 109.909 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.536 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.8 mt-30 -70.43 96.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 2.39 109.963 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.5 tp 168.69 -18.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 3.23 110.029 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.55 35.55 3.53 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.666 -0.778 . . . . 2.06 111.418 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.13 124.75 7.8 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.679 -0.772 . . . . 2.17 111.746 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -84.7 74.75 10.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 2.26 110.556 -177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.53 161.45 30.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.868 -0.605 . . . . 1.31 110.835 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.25 67.43 6.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 2.37 110.596 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -139.33 160.16 40.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.726 -0.67 . . . . 2.27 109.761 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.23 -42.09 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.445 0.466 . . . . 1.64 112.159 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tpt -60.85 -31.55 71.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.329 . . . . 2.58 111.305 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.521 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -71.74 -37.01 70.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.438 -0.346 . . . . 1.06 111.196 -178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -28.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.918 0.389 . . . . 1.46 110.057 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -65.91 -35.17 79.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.09 -0.505 . . . . 0.97 110.151 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.432 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -69.78 -26.67 64.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.91 -0.586 . . . . 0.93 110.672 176.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -79.71 -22.56 43.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 1.86 110.897 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -94.91 -15.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.3 -0.409 . . . . 1.82 111.607 -176.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.68 40.89 1.05 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.295 0.569 . . . . 1.97 110.873 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 177.81 -150.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.672 -1.233 . . . . 3.57 107.672 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.06 164.62 14.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.579 -0.897 . . . . 3.64 108.579 168.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.37 82.96 2.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.278 0.561 . . . . 4.58 109.974 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.7 2.02 7.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.934 -1.03 . . . . 2.8 112.871 -173.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.436 ' HB ' ' H ' ' A' ' 62' ' ' GLU . 3.1 t 58.82 -96.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 122.834 0.454 . . . . 3.13 111.442 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.441 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 55.0 mm-40 -121.71 23.78 10.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.552 -0.295 . . . . 4.56 110.983 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -125.45 68.98 60.88 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.403 . . . . 3.01 110.857 177.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 62' ' ' GLU . 5.6 Cg_endo -87.38 73.03 2.9 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.196 2.597 . . . . 1.91 111.991 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.0 tp -82.46 129.46 34.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.12 -0.491 . . . . 2.46 110.847 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mttp 58.13 34.19 23.92 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.766 0.666 . . . . 2.42 111.127 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.603 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -94.99 -174.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.525 -0.761 . . . . 2.11 110.433 -178.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.592 ' H ' HG22 ' A' ' 67' ' ' VAL . 5.4 mt -53.84 -21.29 7.27 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.247 0.832 . . . . 2.19 113.247 -174.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.521 ' HE2' ' HA ' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -138.93 44.51 2.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.106 0.479 . . . . 1.87 111.287 175.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.603 ' HB3' ' H ' ' A' ' 67' ' ' VAL . . . -120.98 47.7 1.77 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.899 0.381 . . . . 1.09 110.66 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.607 ' HB2' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -162.16 144.99 8.82 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.206 -0.906 . . . . 3.23 108.792 177.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.49 1.19 3.85 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.927 2.418 . . . . 1.77 113.119 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.595 HG22 ' HG3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -128.94 89.43 2.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.741 0.305 . . . . 2.46 110.577 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.506 ' HA ' HD12 ' A' ' 77' ' ' LEU . 2.7 tp -58.43 -32.61 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.059 -0.519 . . . . 2.08 112.255 -176.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.899 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -62.59 -38.86 91.79 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.228 -0.295 . . . . 3.8 110.79 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.26 -31.97 73.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.953 0.406 . . . . 1.08 110.676 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.607 HD21 ' HB2' ' A' ' 71' ' ' GLN . 12.7 mt -78.42 -36.82 45.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.986 -0.552 . . . . 2.41 110.61 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.1 -25.2 66.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 1.57 110.633 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -91.55 -0.05 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.621 . . . . 2.74 110.614 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -114.04 -88.89 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 2.85 111.121 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 m -82.29 21.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.075 -0.511 . . . . 2.13 112.044 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 68' ' ' LEU . . . -130.1 -4.24 4.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 1.9 110.867 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.69 -55.95 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 2.65 111.153 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -118.24 85.16 2.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 7.09 110.964 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.105 -0.95 . . . . 5.98 110.036 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HB3' ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.325 -0.25 . . . . 8.54 110.325 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' A' ' 1' ' ' MET . . . -86.24 139.88 17.13 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.755 -0.736 . . . . 5.41 112.305 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.37 103.62 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.948 0.404 . . . . 6.05 110.593 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.72 125.77 44.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.008 -0.542 . . . . 3.59 110.598 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' HG3' ' HB3' ' A' ' 30' ' ' SER . 2.0 mp0 -71.77 139.76 49.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.125 -0.488 . . . . 3.47 110.91 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 32' ' ' ILE . . . -148.39 144.65 27.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.021 -0.536 . . . . 3.01 110.082 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.16 91.37 3.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.896 0.379 . . . . 3.51 110.887 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.434 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 7.0 t80 -146.43 2.57 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.003 -0.544 . . . . 2.32 111.18 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 2.8 p -79.15 93.44 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 2.13 111.327 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.06 74.98 1.69 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.511 -0.768 . . . . 2.09 110.424 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HB2' ' H ' ' A' ' 12' ' ' THR . 2.1 Cg_endo -81.61 -133.69 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.088 2.525 . . . . 1.88 112.226 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -123.63 -48.11 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.118 0.485 . . . . 2.04 111.798 -177.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.788 HD21 ' HB ' ' A' ' 15' ' ' VAL . 1.8 t30 -98.27 132.4 43.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.872 -0.604 . . . . 2.24 110.503 -172.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.28 68.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.671 -0.695 . . . . 1.42 112.0 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.788 ' HB ' HD21 ' A' ' 13' ' ' ASN . 48.1 t -70.17 -48.42 61.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 1.99 110.958 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.505 ' OE1' ' HB3' ' A' ' 13' ' ' ASN . 1.7 pt-20 -67.8 -32.31 72.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.947 0.404 . . . . 1.93 110.32 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.42 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.3 m -69.48 -35.84 75.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.894 -0.594 . . . . 1.48 110.205 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -64.95 -41.78 95.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 2.96 110.737 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -46.4 90.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 1.81 110.652 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.02 92.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 1.08 111.282 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -40.43 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.389 -0.369 . . . . 2.69 111.696 -176.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -38.44 46.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 120.97 -0.292 . . . . 1.91 110.973 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -66.7 -45.25 79.41 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.089 0.471 . . . . 1.33 110.166 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -83.45 19.42 1.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.392 0.615 . . . . 2.78 111.301 -178.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.471 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -120.17 -0.87 10.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.771 -0.649 . . . . 4.4 109.317 170.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.2 -25.13 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.862 -0.608 . . . . 2.01 111.852 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 tp -93.04 -81.13 0.36 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.501 0.191 . . . . 2.85 111.364 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.4 -39.87 6.64 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.66 -0.781 . . . . 1.73 111.644 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t 70.18 53.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.774 0.797 . . . . 1.92 110.648 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HB3' ' HG3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -118.64 -35.85 3.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.414 -0.812 . . . . 2.21 109.775 173.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' CA ' HH21 ' A' ' 25' ' ' ARG . . . 98.22 42.77 2.93 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.732 -0.667 . . . . 1.58 112.383 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 6' ' ' ALA . 0.8 OUTLIER -87.69 -80.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.803 0.335 . . . . 3.56 111.156 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.25 -69.71 3.08 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.932 -0.651 . . . . 2.28 111.589 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' HB ' ' HD2' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -107.31 152.09 9.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.172 -1.048 . . . . 2.67 108.172 174.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 44.3 1.53 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.359 -0.978 . . . . 2.46 108.359 -169.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -70.46 174.52 5.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.23 -1.35 . . . . 4.2 111.957 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -140.85 -8.12 1.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.63 -0.714 . . . . 4.13 111.08 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.41 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 26.7 p90 -148.34 -33.81 0.23 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.002 0.742 . . . . 2.27 113.002 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -96.53 -83.09 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.047 -0.408 . . . . 2.01 111.66 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -29.42 67.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.39 112.018 -173.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 tp -115.1 -2.0 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.417 . . . . 3.23 111.52 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 38' ' ' PHE . . . -92.51 -95.95 1.4 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.437 -0.887 . . . . 2.06 112.71 -175.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.12 -138.29 2.65 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.667 -0.778 . . . . 2.17 112.397 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -97.01 122.96 40.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.241 0.543 . . . . 2.26 111.366 -175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.33 -178.11 6.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 1.31 109.986 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.456 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -89.15 45.68 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.049 0.452 . . . . 2.37 110.947 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.58 163.74 22.07 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.393 -0.367 . . . . 2.27 111.418 -174.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.96 94.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 1.64 111.534 -176.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ttt -60.33 -34.58 74.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.402 . . . . 2.58 110.456 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . . . -69.95 -40.58 75.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 1.06 110.846 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.634 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -71.69 -34.88 53.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.041 0.448 . . . . 1.46 110.616 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.35 -29.94 62.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.97 110.807 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -38.68 64.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.93 111.271 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.634 ' NE2' ' HA ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -68.73 -38.42 80.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.011 -0.276 . . . . 1.86 110.936 -177.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 51' ' ' VAL . 35.7 m -92.83 19.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.076 0.465 . . . . 1.82 110.973 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.436 ' HE1' ' O ' ' A' ' 81' ' ' VAL . 15.5 t-160 -88.13 -18.13 29.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.07 -0.513 . . . . 1.97 110.456 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.59 ' HG3' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -106.25 -63.9 1.22 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.041 0.448 . . . . 3.57 110.682 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.3 -151.97 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.632 -0.713 . . . . 3.64 109.298 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -75.82 64.51 1.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.414 0.626 . . . . 4.58 110.194 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.543 HE22 HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -119.18 91.99 3.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 2.8 109.177 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.29 -55.75 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.7 -0.682 . . . . 3.13 112.185 -170.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -63.72 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.839 0.352 . . . . 4.56 111.652 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.72 111.66 54.11 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.408 -0.36 . . . . 3.01 110.672 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.9 127.54 15.44 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.557 2.171 . . . . 1.91 111.226 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tp -123.73 96.22 4.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.35 -0.386 . . . . 2.46 110.506 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.451 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 0.5 OUTLIER 54.67 62.62 2.46 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.908 -0.587 . . . . 2.42 111.377 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' A' ' 57' ' ' ARG . 11.3 p -132.04 -29.66 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.171 -0.468 . . . . 2.11 111.178 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.61 -51.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.92 -0.77 . . . . 2.19 108.92 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 50' ' ' ALA . 1.1 m-85 -104.67 172.31 6.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.217 -0.901 . . . . 1.87 109.172 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 71' ' ' GLN . . . 60.35 43.67 13.22 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 123.91 0.756 . . . . 1.09 111.266 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 167.06 123.57 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.468 0 O-C-N 124.215 0.947 . . . . 3.23 109.752 176.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.44 28.95 0.54 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.813 2.342 . . . . 1.77 113.061 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.47 39.75 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.06 0.457 . . . . 2.46 110.629 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -57.51 -39.22 67.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.687 -0.688 . . . . 2.08 111.846 -175.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.513 ' H ' ' HG2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -64.86 -43.07 94.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.788 0.328 . . . . 3.8 110.814 -178.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.76 -44.05 74.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.325 -0.398 . . . . 1.08 110.992 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.23 -43.2 95.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.345 -0.389 . . . . 2.41 111.36 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.46 -4.62 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 1.57 111.493 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.29 -57.67 2.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.966 0.412 . . . . 2.74 110.781 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -74.11 -42.35 60.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.003 -0.544 . . . . 2.85 111.836 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.436 ' O ' ' HE1' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -108.78 30.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.84 0.353 . . . . 2.13 111.425 -174.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.96 30.32 0.64 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.091 0.472 . . . . 1.9 110.443 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.28 -34.11 61.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 2.65 111.244 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.33 32.9 16.79 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 123.721 0.638 . . . . 7.09 110.529 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.291 -0.862 . . . . 5.98 110.131 -177.113 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 110.106 -0.331 . . . . 8.54 110.106 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.9 -127.78 1.19 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.872 -0.68 . . . . 5.41 111.839 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.448 HG12 ' HG3' ' A' ' 5' ' ' GLU . 1.7 t -86.15 81.06 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.807 0.337 . . . . 6.05 111.067 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -20.19 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.421 . . . . 3.59 110.25 174.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.448 ' HG3' HG12 ' A' ' 3' ' ' VAL . 3.9 mt-10 56.42 -146.33 0.57 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.079 -0.964 . . . . 3.47 111.894 174.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HA ' HD13 ' A' ' 35' ' ' LEU . . . -152.91 83.96 1.22 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.931 0.396 . . . . 3.01 111.051 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -92.59 -9.64 40.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.034 0.445 . . . . 3.51 110.097 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -91.55 -54.86 3.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.841 -0.618 . . . . 2.32 110.052 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.53 HG12 ' HD3' ' A' ' 11' ' ' PRO . 2.2 t 56.73 -100.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.944 -0.571 . . . . 2.13 111.415 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.513 ' H ' ' HB ' ' A' ' 9' ' ' VAL . . . 57.02 65.63 3.65 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.596 0.591 . . . . 2.09 112.596 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.53 ' HD3' HG12 ' A' ' 9' ' ' VAL . 73.9 Cg_endo -88.97 143.44 4.9 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.55 2.166 . . . . 1.88 111.518 176.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.442 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -107.75 -34.64 6.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.858 0.361 . . . . 2.04 111.313 -177.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.35 151.07 49.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.32 -0.4 . . . . 2.24 110.764 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.35 68.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 1.42 111.297 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.3 t -57.17 -44.95 84.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.853 0.359 . . . . 1.99 110.738 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.89 -43.09 89.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 1.93 110.849 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -69.69 -43.95 71.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.009 -0.541 . . . . 1.48 111.207 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.79 -40.51 83.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.682 -0.235 . . . . 2.96 111.213 -178.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -45.0 96.57 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.761 0.315 . . . . 1.81 110.219 177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.41 86.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 1.08 110.903 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.76 -47.52 84.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 2.69 110.873 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.3 mt -71.89 -49.46 44.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.327 -0.397 . . . . 1.91 110.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.618 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 4.0 m95 -56.94 -52.5 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.916 -0.584 . . . . 1.33 111.609 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -63.0 -44.48 95.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.101 -0.5 . . . . 2.78 111.022 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 1.7 mmp_? -73.06 -2.84 22.9 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.958 0.355 . . . . 4.4 111.958 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 t -106.26 -45.07 8.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.6 -0.273 . . . . 2.01 111.246 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.1 -4.59 13.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.918 0.71 . . . . 2.85 112.918 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.3 -78.74 0.3 Allowed Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 120.088 -1.053 . . . . 1.73 112.917 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 80.96 -6.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 123.935 0.894 . . . . 1.92 110.627 -178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -44.78 78.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.516 -0.765 . . . . 2.21 111.479 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 5' ' ' GLU . . . 110.97 25.29 5.16 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.057 -0.592 . . . . 1.58 112.391 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.3 129.01 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.688 -0.301 . . . . 3.56 110.621 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.44 -80.56 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.299 -0.953 . . . . 2.28 112.608 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.461 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -96.08 85.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.324 0.583 . . . . 2.67 110.699 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -166.33 -135.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.16 -0.927 . . . . 2.46 108.91 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -64.9 106.53 1.25 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.207 -1.035 . . . . 4.2 108.207 169.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.87 135.27 36.97 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.991 0.737 . . . . 4.13 112.991 -164.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -121.67 7.83 10.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.989 -1.005 . . . . 2.27 109.043 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.407 ' CD2' ' HG3' ' A' ' 40' ' ' GLN . 31.4 t80 -125.91 -62.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.226 -0.897 . . . . 2.01 110.651 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 72' ' ' PRO . 7.7 mt-30 -85.02 53.63 2.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.487 . . . . 2.39 110.655 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.81 38.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.732 -0.667 . . . . 3.23 109.971 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.88 -71.21 0.3 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.195 -0.762 . . . . 2.06 111.195 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.16 -95.35 0.57 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.878 -0.677 . . . . 2.17 112.711 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' HIS . 0.0 OUTLIER 56.34 33.89 23.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.002 1.382 . . . . 2.26 109.929 -174.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.15 171.7 13.69 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.253 -1.34 . . . . 1.31 111.732 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.03 65.83 9.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 2.37 110.518 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -133.72 152.82 51.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.107 -0.497 . . . . 2.27 110.261 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.29 85.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 1.64 111.574 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.618 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -60.09 -35.06 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 2.58 110.825 177.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.6 -36.86 60.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 1.06 110.296 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 91.3 t -62.16 -40.23 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.837 -0.62 . . . . 1.46 110.431 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -63.62 -39.07 93.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 0.97 110.842 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.05 83.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.354 -0.384 . . . . 0.93 110.786 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.654 ' HA ' ' NE2' ' A' ' 60' ' ' GLN . 3.0 pt20 -88.94 12.35 15.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.847 0.356 . . . . 1.86 111.342 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 52' ' ' ALA . 1.4 p -123.46 -13.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.167 0.508 . . . . 1.82 110.432 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -94.22 -8.83 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.625 0.726 . . . . 1.97 109.368 173.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.538 ' HG2' ' N ' ' A' ' 58' ' ' GLU . 18.6 ttt-85 -145.35 163.72 33.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.262 -1.384 . . . . 3.57 107.262 176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.538 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -49.98 144.31 6.87 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 117.776 0.262 . . . . 3.64 110.983 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -48.7 117.91 2.28 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.722 0.639 . . . . 4.58 111.674 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.837 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 1.5 mt-30 -92.15 73.81 5.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.46 -0.791 . . . . 2.8 110.994 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -80.76 -22.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 3.13 109.758 176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.76 -78.41 0.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.241 -0.89 . . . . 4.56 110.719 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.34 112.2 8.57 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.744 0.307 . . . . 3.01 111.64 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.837 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 14.7 Cg_exo -71.62 68.2 2.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.458 2.772 . . . . 1.91 111.473 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 3.7 tp -81.82 133.63 35.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.84 -0.618 . . . . 2.46 112.489 -172.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.71 19.48 11.74 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.533 0.938 . . . . 2.42 113.533 169.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -54.75 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.811 -0.356 . . . . 2.11 110.365 174.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.858 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.6 mt -169.08 -40.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 2.19 110.462 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -82.24 2.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 1.87 112.429 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . -133.65 52.62 2.06 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.732 0.301 . . . . 1.09 111.399 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.6 ' HB3' HD11 ' A' ' 77' ' ' LEU . 36.1 tp60 -177.39 113.14 0.24 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.592 -0.731 . . . . 3.23 109.734 174.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HA ' ' OE1' ' A' ' 40' ' ' GLN . 13.3 Cg_exo -71.15 48.01 0.85 Allowed 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.335 2.69 . . . . 1.77 112.166 177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.4 m -156.95 83.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.785 -0.643 . . . . 2.46 109.468 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.4 mm -65.05 -37.09 79.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.536 -0.756 . . . . 2.08 111.259 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HD3' ' HB ' ' A' ' 12' ' ' THR . 2.3 ttpt -56.34 -39.11 72.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 3.8 111.36 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' ' HG3' ' A' ' 79' ' ' GLN . . . -66.92 -46.33 75.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.794 0.331 . . . . 1.08 111.052 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.858 HD13 ' HA ' ' A' ' 68' ' ' LEU . 3.4 mt -70.09 -27.07 64.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.874 0.369 . . . . 2.41 110.908 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -65.28 -32.32 73.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 1.57 111.019 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 1.1 pt20 -97.37 15.06 24.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.371 . . . . 2.74 110.551 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -119.8 -80.29 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.113 0.482 . . . . 2.85 110.662 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.46 -35.52 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.783 -0.644 . . . . 2.13 111.417 -174.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -69.13 -28.25 66.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 1.9 111.495 -176.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.14 -21.58 22.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.446 -0.343 . . . . 2.65 110.83 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.81 -73.37 0.1 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.53 -0.759 . . . . 7.09 111.42 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.414 -0.803 . . . . 5.98 110.839 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.908 0.385 . . . . 8.54 110.38 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.79 166.37 34.41 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.713 -0.756 . . . . 5.41 112.013 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -68.63 104.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.321 0.581 . . . . 6.05 110.384 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.479 ' N ' ' HB3' ' A' ' 30' ' ' SER . 5.3 m -99.52 81.32 2.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.813 -0.63 . . . . 3.59 111.431 -177.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 2.1 mt-10 -83.63 144.27 29.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.776 -0.824 . . . . 3.47 108.776 171.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 8' ' ' TYR . . . -127.76 146.55 50.55 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.736 -0.386 . . . . 3.01 111.434 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.65 37.22 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.391 0.615 . . . . 3.51 110.107 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 6' ' ' ALA . 5.4 t80 -152.86 43.05 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.384 -0.825 . . . . 2.32 109.13 -177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.686 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 10.0 p -102.4 35.05 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 122.086 0.946 . . . . 2.13 110.096 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.18 112.44 38.69 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.314 -0.857 . . . . 2.09 109.84 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.52 131.33 27.57 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.683 2.256 . . . . 1.88 112.094 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.7 0.85 45.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.726 -0.67 . . . . 2.04 109.997 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.604 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -158.03 148.23 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.158 -0.928 . . . . 2.24 109.572 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.32 72.76 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.173 0.434 . . . . 1.42 112.173 -174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 43.0 t -68.33 -26.28 33.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.479 -0.328 . . . . 1.99 110.482 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -64.0 -49.12 73.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.33 -0.395 . . . . 1.93 110.395 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -64.56 -40.48 95.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.76 -0.654 . . . . 1.48 111.286 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.8 -46.89 64.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 2.96 111.098 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 23' ' ' TRP . 3.0 tp -63.67 -54.58 33.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.964 -0.562 . . . . 1.81 111.087 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 24' ' ' GLU . . . -61.11 -29.1 69.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.446 . . . . 1.08 111.453 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -68.93 -67.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.604 -0.271 . . . . 2.69 110.65 178.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.704 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 37.5 mm -59.23 -47.71 89.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.436 -0.347 . . . . 1.91 111.37 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.678 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 3.8 m95 -57.67 -46.33 84.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 1.33 110.716 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.712 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 3.2 mm-40 -89.6 28.14 1.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.182 0.515 . . . . 2.78 111.757 -176.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.704 ' HD2' ' HA ' ' A' ' 22' ' ' ILE . 9.4 mtt180 -114.68 -14.26 12.04 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.109 -1.071 . . . . 4.4 108.109 161.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.04 -37.96 3.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.003 -0.998 . . . . 2.01 111.778 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HB3' ' H ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -95.98 -97.33 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.109 0.411 . . . . 2.85 112.109 -175.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 27' ' ' LEU . . . -87.96 -28.0 24.64 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.762 -0.732 . . . . 1.73 112.304 -173.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 2.9 t 63.84 41.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.537 0.684 . . . . 1.92 110.789 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -98.11 -98.02 0.21 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 2.21 111.115 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' A' ' 30' ' ' SER . . . 140.96 76.72 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.908 -0.663 . . . . 1.58 111.689 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -117.81 132.09 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.012 0.435 . . . . 3.56 111.37 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . -100.18 -123.43 5.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.851 -0.69 . . . . 2.28 111.844 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 mt -79.68 68.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.506 0.67 . . . . 2.67 110.322 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.752 ' HB3' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -148.64 4.17 0.66 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.387 -0.824 . . . . 2.46 110.504 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.741 ' HA ' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m-20 54.0 -109.9 0.51 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.102 -0.499 . . . . 4.2 111.1 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.8 -73.31 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.432 0.693 . . . . 4.13 112.705 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.02 -51.39 3.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.308 -0.405 . . . . 2.27 111.024 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -98.99 -70.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 2.01 112.153 -170.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.741 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . 29.9 mp0 -60.31 -21.45 62.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.722 -0.672 . . . . 2.39 112.602 -170.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' A' ' 36' ' ' ASP . 3.9 tp -63.93 -21.87 29.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.874 0.369 . . . . 3.23 111.366 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.783 ' HA2' ' HB3' ' A' ' 69' ' ' PHE . . . 108.0 45.68 1.08 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.579 -0.82 . . . . 2.06 112.26 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.76 107.19 2.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.702 -0.761 . . . . 2.17 112.134 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -72.81 86.39 1.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.965 0.412 . . . . 2.26 110.294 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.93 178.25 8.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.81 -0.632 . . . . 1.31 111.178 -178.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.422 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -96.51 29.33 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 2.37 110.387 177.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -107.37 163.51 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.854 -0.612 . . . . 2.27 110.842 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.88 86.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.903 -0.59 . . . . 1.64 112.227 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.678 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 11.2 ttt -61.27 -34.78 75.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 2.58 111.036 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.21 -0.45 . . . . 1.06 110.538 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.478 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 18.0 t -72.67 -42.29 62.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 1.46 109.923 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -63.35 -23.58 67.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.876 -0.602 . . . . 0.97 110.88 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.06 -43.61 57.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.909 -0.587 . . . . 0.93 110.928 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 51' ' ' VAL . 2.1 pt20 -75.64 -24.39 56.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.901 0.382 . . . . 1.86 110.808 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 52' ' ' ALA . 0.9 OUTLIER -87.65 -14.95 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.112 0.482 . . . . 1.82 110.4 177.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.817 ' HB3' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -64.62 -32.75 74.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.842 -0.617 . . . . 1.97 110.807 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.729 ' HD2' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.18 -0.76 13.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.09 -0.504 . . . . 3.57 109.807 175.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER 50.23 84.99 0.04 OUTLIER 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.847 -1.069 . . . . 3.64 111.717 -177.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 11.6 m-30 69.95 76.22 0.21 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.237 -0.892 . . . . 4.58 111.433 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.68 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 6.0 pm0 -97.37 -37.5 10.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.107 -0.331 . . . . 2.8 110.107 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.68 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 2.4 p 159.46 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.806 -1.183 . . . . 3.13 107.806 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.614 ' H ' HG22 ' A' ' 61' ' ' VAL . 18.2 mp0 -58.35 -49.08 78.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.089 0.404 . . . . 4.56 111.265 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.505 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 47.7 mt -89.37 134.14 33.39 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.03 0.443 . . . . 3.01 111.174 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.3 Cg_exo -81.06 59.72 7.56 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.219 2.613 . . . . 1.91 112.496 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.599 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -69.56 116.31 9.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 2.46 111.793 -176.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.16 19.13 10.42 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.615 -0.72 . . . . 2.42 111.608 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 56' ' ' HIS . 1.7 t -106.78 -20.95 5.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.326 0.584 . . . . 2.11 109.978 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 mt 180.0 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.589 -1.187 . . . . 2.19 108.579 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.783 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 95.2 m-85 -112.94 -177.23 3.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.876 . . . . 1.87 109.81 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . 60.87 55.32 3.21 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.338 0.59 . . . . 1.09 110.849 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -149.99 100.15 3.25 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.37 -0.832 . . . . 3.23 110.208 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.513 ' O ' ' HB ' ' A' ' 73' ' ' THR . 47.5 Cg_exo -56.53 105.95 0.19 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.766 2.311 . . . . 1.77 110.949 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 77.2 m 72.33 103.5 0.07 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.318 -0.623 . . . . 2.46 109.318 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -84.44 12.81 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.952 -0.567 . . . . 2.08 111.071 -172.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.604 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -58.27 -50.37 73.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.301 -0.409 . . . . 3.8 110.807 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.21 93.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 1.08 110.947 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -67.17 -36.11 81.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.122 -0.49 . . . . 2.41 110.65 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.877 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -62.89 -33.29 74.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.083 -0.508 . . . . 1.57 111.576 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -99.39 16.81 21.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.816 0.341 . . . . 2.74 110.711 178.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -126.47 -86.16 0.61 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.275 -0.42 . . . . 2.85 110.942 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.1 -25.87 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.416 -0.356 . . . . 2.13 111.436 -175.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -71.04 -28.14 64.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.67 -0.241 . . . . 1.9 111.305 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.06 56.56 2.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.296 0.57 . . . . 2.65 110.853 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -137.49 23.96 2.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 7.09 110.054 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.438 -0.791 . . . . 5.98 110.592 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.693 0.282 . . . . 8.54 110.659 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.86 3.65 2.54 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.495 -0.86 . . . . 5.41 113.563 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 36' ' ' ASP . 6.9 p -83.77 80.09 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 122.147 0.975 . . . . 6.05 110.732 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -69.85 0.73 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.443 -0.799 . . . . 3.59 110.703 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -170.74 76.89 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.728 . . . . 3.47 109.246 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.32 122.4 41.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.146 0.498 . . . . 3.01 112.115 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.65 70.47 2.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 3.51 110.021 174.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -134.92 -47.5 0.73 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.873 -0.603 . . . . 2.32 110.853 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG12 ' HB1' ' A' ' 20' ' ' ALA . 0.3 OUTLIER 49.35 -134.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.671 -0.695 . . . . 2.13 110.903 -177.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB2' HG12 ' A' ' 34' ' ' ILE . . . -178.63 94.04 0.22 Allowed Pre-proline 0 N--CA 1.463 0.199 0 O-C-N 123.128 0.268 . . . . 2.09 111.126 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -92.25 46.47 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.775 2.316 . . . . 1.88 111.875 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -86.73 106.44 17.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.768 0.655 . . . . 2.04 112.768 -173.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t30 40.53 54.88 2.95 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.043 1.127 . . . . 2.24 114.043 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 70.64 -52.29 0.67 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.743 1.016 . . . . 1.42 113.743 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.25 -60.53 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.723 0.297 . . . . 1.99 111.314 -175.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.471 ' HA ' HD12 ' A' ' 19' ' ' LEU . 3.2 mp0 -62.22 -31.08 71.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.21 -0.45 . . . . 1.93 110.997 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -40.07 90.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.938 0.399 . . . . 1.48 110.814 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -41.77 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.834 -0.621 . . . . 2.96 110.519 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 16' ' ' GLU . 28.1 mt -61.87 -43.75 98.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.064 -0.517 . . . . 1.81 110.01 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB1' HG12 ' A' ' 9' ' ' VAL . . . -56.44 -55.03 38.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.647 -0.706 . . . . 1.08 111.507 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.644 ' HG3' HD12 ' A' ' 22' ' ' ILE . 10.9 pt-20 -64.6 -46.75 81.32 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 111.706 0.261 . . . . 2.69 111.706 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.644 HD12 ' HG3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -68.0 -47.95 76.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.62 -0.264 . . . . 1.91 111.219 -175.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -76.8 -14.16 59.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 1.33 111.001 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 1.6 mm-40 -69.04 -50.1 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.089 -0.338 . . . . 2.78 110.089 174.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.498 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -75.28 -24.51 57.55 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.833 -0.347 . . . . 4.4 111.935 -174.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.45 33.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.687 -0.405 . . . . 2.01 111.894 -177.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tp -171.99 -73.65 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 111.847 0.314 . . . . 2.85 111.847 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.78 -62.62 2.62 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.984 -0.627 . . . . 1.73 113.88 -171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 t 53.77 32.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.031 0.532 . . . . 1.92 110.804 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -143.08 11.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 2.21 111.523 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.41 60.49 3.02 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.892 -0.883 . . . . 1.58 110.892 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 pt -80.56 81.32 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 3.56 111.519 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.41 155.73 50.46 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.701 -0.682 . . . . 2.28 112.151 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.476 HG12 ' HB2' ' A' ' 10' ' ' ALA . 7.0 mm -80.05 56.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.764 0.792 . . . . 2.67 111.483 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.89 -42.07 2.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.184 -0.916 . . . . 2.46 108.614 171.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.458 ' O ' ' HB ' ' A' ' 3' ' ' VAL . 12.0 t70 -156.54 128.02 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.02 -0.991 . . . . 4.2 108.562 174.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' O ' HG12 ' A' ' 41' ' ' ILE . 43.7 t30 -173.22 149.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.885 -0.413 . . . . 4.13 109.885 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.35 29.25 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.974 0.416 . . . . 2.27 111.295 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -117.07 -66.98 1.03 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.296 -0.411 . . . . 2.01 110.15 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.656 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.4 pm0 -79.84 13.11 2.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.936 -0.575 . . . . 2.39 112.003 -176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 37' ' ' ASN . 14.5 pt -106.97 7.49 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.477 . . . . 3.23 110.181 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.99 33.03 10.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.821 -0.704 . . . . 2.06 112.025 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.32 151.0 35.93 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.761 -0.733 . . . . 2.17 111.996 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.96 73.51 10.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.072 0.463 . . . . 2.26 111.014 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.04 125.3 28.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.915 -0.584 . . . . 1.31 110.35 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 46' ' ' LEU . 8.5 tp -73.72 71.74 1.46 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.002 0.43 . . . . 2.37 111.992 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -145.44 152.4 39.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.915 -0.584 . . . . 2.27 109.489 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -32.72 73.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 1.64 111.523 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.3 ttt -61.81 -35.49 78.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 2.58 110.991 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.94 -36.57 67.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 1.06 110.546 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 t -66.58 -42.53 90.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.949 -0.568 . . . . 1.46 110.361 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.8 94.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 0.97 110.845 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.68 84.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.93 110.825 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -10.93 60.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 1.86 111.162 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.9 t -104.0 -22.9 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.286 -0.415 . . . . 1.82 110.865 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.797 ' HE1' ' HA ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -74.72 55.14 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.925 0.713 . . . . 1.97 112.925 -172.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.472 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -176.85 -70.6 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.158 -0.682 . . . . 3.57 109.158 175.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -170.87 40.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.995 -0.548 . . . . 3.64 110.624 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 59.26 78.7 0.25 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.99 -0.55 . . . . 4.58 110.631 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.472 ' OE1' ' HB3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -77.95 76.88 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.522 -0.763 . . . . 2.8 110.874 -176.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -76.18 -18.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.792 -0.64 . . . . 3.13 111.009 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -97.84 43.97 1.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 4.56 110.024 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 71.19 129.43 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 115.171 -0.922 . . . . 3.01 111.047 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.2 73.65 4.36 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.696 2.264 . . . . 1.91 112.461 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 67' ' ' VAL . 2.1 tp -59.53 113.69 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.97 -0.559 . . . . 2.46 110.363 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.791 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 19.2 mttt 58.42 -110.1 0.49 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.886 -0.597 . . . . 2.42 110.383 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 65' ' ' LEU . 46.3 t 59.64 -85.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.223 0.609 . . . . 2.11 111.843 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 78' ' ' ALA . 5.5 tp -148.2 10.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 2.19 110.879 -176.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 -56.15 0.76 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.251 0.463 . . . . 1.87 112.251 -173.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.791 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -80.71 66.43 6.23 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.121 0.415 . . . . 1.09 112.121 -173.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -166.74 126.85 1.18 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.23 109.837 176.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 14.0 Cg_exo -71.73 42.39 0.49 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.505 2.804 . . . . 1.77 113.408 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.02 72.12 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.756 -0.831 . . . . 2.46 108.756 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.79 -34.36 46.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.339 -0.846 . . . . 2.08 111.236 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -60.28 -32.2 70.96 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.939 0.399 . . . . 3.8 110.589 178.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . -76.56 -44.14 35.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.053 0.454 . . . . 1.08 110.805 178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.29 -43.37 98.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 2.41 110.737 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.561 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.81 -18.42 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.619 . . . . 1.57 111.49 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.76 -7.42 58.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.971 0.415 . . . . 2.74 110.245 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.78 -70.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 2.85 111.399 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.44 51.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.828 0.347 . . . . 2.13 111.378 -173.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.797 ' HA ' ' HE1' ' A' ' 56' ' ' HIS . . . -157.58 -33.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.247 -0.433 . . . . 1.9 111.501 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -40.44 95.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.416 . . . . 2.65 111.708 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.0 ttm105 58.91 27.07 15.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.436 0.636 . . . . 7.09 110.608 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.327 -0.844 . . . . 5.98 109.936 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.963 -0.384 . . . . 8.54 109.963 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.06 -64.67 0.16 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.817 -0.706 . . . . 5.41 111.769 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -145.76 108.72 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.28 0.562 . . . . 6.05 110.866 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -86.0 60.18 6.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.288 0.566 . . . . 3.59 110.787 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.66 110.29 0.74 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.552 -0.749 . . . . 3.47 109.585 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -146.48 116.66 7.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.092 -0.504 . . . . 3.01 111.006 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -83.27 49.02 1.47 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.949 -0.569 . . . . 3.51 109.682 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.61 -89.75 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.608 -0.724 . . . . 2.32 111.273 -173.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 t 63.64 -86.33 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.012 -0.54 . . . . 2.13 110.687 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 49.74 69.9 2.38 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 123.02 0.528 . . . . 2.09 111.948 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -88.5 155.0 6.48 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.766 2.311 . . . . 1.88 112.653 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.14 -67.32 0.86 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.54 -0.3 . . . . 2.04 111.18 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -153.91 118.19 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.46 0.541 . . . . 2.24 112.46 -176.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 66.77 -79.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.879 1.066 . . . . 1.42 113.879 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -63.37 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.694 0.627 . . . . 1.99 112.694 -169.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' HA ' ' CG1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -62.79 -37.58 87.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.791 0.329 . . . . 1.93 111.473 -176.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -45.98 83.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.095 -0.502 . . . . 1.48 111.269 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.43 -38.14 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.028 -0.533 . . . . 2.96 111.367 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -47.72 79.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 1.81 110.854 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.92 82.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.307 -0.406 . . . . 1.08 110.494 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.55 -48.74 79.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.77 -0.65 . . . . 2.69 111.478 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.495 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 2.5 tt -67.93 -36.32 75.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.929 -0.308 . . . . 1.91 111.765 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -81.75 -53.38 6.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.828 0.347 . . . . 1.33 111.838 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.643 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -78.02 -7.74 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.092 0.404 . . . . 2.78 112.092 -172.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.643 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 1.4 mmm180 -115.56 -0.25 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.255 -0.578 . . . . 4.4 111.658 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -115.63 -23.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 2.01 111.177 175.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 tp -122.86 -76.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 2.85 110.77 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.471 ' HA3' ' HZ ' ' A' ' 38' ' ' PHE . . . -85.93 62.35 4.39 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.774 -0.727 . . . . 1.73 112.92 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 1.6 p -67.68 105.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.564 0.697 . . . . 1.92 110.645 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.16 -32.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.217 -0.901 . . . . 2.21 110.141 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.61 96.08 2.04 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.897 -0.668 . . . . 1.58 111.646 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.63 HD13 ' HB3' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -131.64 -40.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.97 0.414 . . . . 3.56 110.691 -178.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.545 ' C ' HG12 ' A' ' 34' ' ' ILE . . . 65.0 -99.62 0.38 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.937 -0.574 . . . . 2.28 112.729 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.545 HG12 ' C ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -142.31 52.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.092 0.472 . . . . 2.67 110.932 -177.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 35' ' ' LEU . 5.2 mt -129.72 -111.49 0.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.244 -0.285 . . . . 2.46 111.033 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.466 ' H ' ' HB3' ' A' ' 35' ' ' LEU . 26.5 t0 -88.91 71.64 8.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.334 0.588 . . . . 4.2 110.288 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.63 ' HB3' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -114.18 164.45 13.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.643 -0.708 . . . . 4.13 110.994 -176.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HZ ' ' HA3' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -82.32 -14.96 54.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.008 -0.542 . . . . 2.27 110.634 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.477 ' HB3' ' OE1' ' A' ' 40' ' ' GLN . 18.7 t80 -81.97 -90.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.088 -0.506 . . . . 2.01 110.277 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 39' ' ' PHE . 3.6 mp0 -68.09 125.42 26.3 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.574 -0.528 . . . . 2.39 109.574 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 78.52 -9.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 123.978 0.799 . . . . 3.23 110.972 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.46 -58.29 3.37 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.975 -0.631 . . . . 2.06 112.256 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.738 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . 147.67 -76.13 0.26 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.385 -0.912 . . . . 2.17 112.613 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -165.81 119.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.039 0.447 . . . . 2.26 110.992 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.03 144.34 26.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.202 -0.454 . . . . 1.31 110.176 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.11 92.57 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.995 0.426 . . . . 2.37 111.243 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -171.48 164.64 6.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 2.27 110.285 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.64 -26.75 65.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 1.64 111.854 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -39.16 83.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.362 . . . . 2.58 110.742 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.02 -37.59 61.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 1.06 110.472 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.81 -42.96 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 1.46 110.677 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.48 96.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.97 110.903 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -34.26 77.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.453 . . . . 0.93 110.32 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -49.3 73.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.604 -0.726 . . . . 1.86 111.098 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 m -75.15 -33.0 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.929 -0.308 . . . . 1.82 111.73 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -31.13 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.881 -0.328 . . . . 1.97 111.224 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 -9.81 53.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.893 -0.41 . . . . 3.57 109.893 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 1.0 OUTLIER 67.33 62.4 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.216 -0.902 . . . . 3.64 110.882 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 1.2 m-85 78.91 109.15 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.818 -1.083 . . . . 4.58 111.65 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.07 -20.04 18.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.021 -0.99 . . . . 2.8 109.695 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.7 t 66.05 -111.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.226 -0.897 . . . . 3.13 110.185 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -131.65 8.55 4.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 4.56 110.358 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.53 92.82 39.7 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.249 -0.432 . . . . 3.01 110.46 -175.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.738 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 49.8 Cg_endo -70.58 128.22 14.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.425 2.084 . . . . 1.91 112.029 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.11 137.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.436 -0.579 . . . . 2.46 109.436 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.51 47.35 16.35 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.712 0.633 . . . . 2.42 110.442 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 69' ' ' PHE . 2.7 p -156.08 175.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 2.11 109.808 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -53.83 -36.88 63.01 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.286 0.476 . . . . 2.19 112.286 -177.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.641 ' H ' HG13 ' A' ' 67' ' ' VAL . 86.0 m-85 -84.09 3.21 35.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.46 -0.336 . . . . 1.87 111.66 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.31 73.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.782 0.325 . . . . 1.09 111.459 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.93 141.48 1.21 Allowed Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.134 -0.691 . . . . 3.23 109.134 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HB2' ' H ' ' A' ' 73' ' ' THR . 23.0 Cg_exo -64.62 -86.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.539 2.16 . . . . 1.77 111.867 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.703 ' HB ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -80.92 136.72 36.09 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.713 0.292 . . . . 2.46 110.541 178.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.497 ' CG1' ' HA ' ' A' ' 16' ' ' GLU . 38.0 mm -64.69 -25.05 36.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.132 -0.486 . . . . 2.08 111.097 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.703 ' HD3' ' HB ' ' A' ' 73' ' ' THR . 1.1 pttt -50.48 -34.56 25.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.301 -0.409 . . . . 3.8 111.801 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.556 ' N ' ' HG2' ' A' ' 75' ' ' LYS . . . -70.41 -50.75 35.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.037 0.446 . . . . 1.08 111.005 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 68' ' ' LEU . 1.8 pp -73.06 -15.51 61.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 2.41 110.71 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -75.56 -31.71 60.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.865 0.364 . . . . 1.57 110.735 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.32 5.94 47.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 2.74 111.45 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.02 -48.37 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.529 0.566 . . . . 2.85 112.529 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.53 -51.38 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.085 0.402 . . . . 2.13 112.085 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -65.89 -16.15 63.59 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.075 0.398 . . . . 1.9 112.075 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -17.6 59.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.046 0.451 . . . . 2.65 110.824 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -88.8 80.13 7.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.926 -0.579 . . . . 7.09 110.292 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.875 -1.059 . . . . 5.98 109.491 177.363 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.849 0.357 . . . . 8.54 110.705 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.497 ' HA2' ' CD1' ' A' ' 38' ' ' PHE . . . -129.11 27.7 4.23 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.955 -0.64 . . . . 5.41 112.229 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.24 48.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.151 -0.685 . . . . 6.05 109.151 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.08 143.6 30.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.553 -0.749 . . . . 3.59 111.59 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 2.2 mt-10 -92.65 101.65 14.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.094 -0.503 . . . . 3.47 109.743 175.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.33 128.76 33.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.909 0.385 . . . . 3.01 111.055 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.78 -19.46 41.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.236 0.541 . . . . 3.51 110.301 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -91.04 57.61 3.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.925 -0.579 . . . . 2.32 110.111 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.09 67.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 122.193 0.997 . . . . 2.13 110.431 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -143.51 110.38 5.33 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.196 -0.911 . . . . 2.09 110.288 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 5.5 Cg_exo -78.73 171.05 17.23 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.257 2.638 . . . . 1.88 112.382 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.87 -47.48 4.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.121 0.486 . . . . 2.04 110.666 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 24.0 t-20 -108.08 154.08 22.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 2.24 110.669 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.97 -29.12 69.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.072 -0.513 . . . . 1.42 111.246 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.04 -35.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.21 0.528 . . . . 1.99 110.27 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -73.13 -36.74 66.76 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.713 -0.676 . . . . 1.93 110.598 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -35.22 74.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 1.48 110.53 176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.17 -45.07 78.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.091 -0.504 . . . . 2.96 110.757 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 19' ' ' LEU . 2.0 mt -64.74 -37.29 87.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.274 -0.421 . . . . 1.81 110.129 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.74 -30.8 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 1.08 110.595 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.632 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 16.5 tt0 -61.96 -47.17 86.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.981 -0.378 . . . . 2.69 109.981 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.2 mt -69.92 -55.16 15.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.333 -0.394 . . . . 1.91 111.158 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.535 ' CH2' ' HD2' ' A' ' 47' ' ' LYS . 64.1 m95 -68.56 -49.1 62.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.257 0.465 . . . . 1.33 112.257 -172.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.89 -50.24 24.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.438 0.162 . . . . 2.78 111.438 -174.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 1.1 mmt85 -66.6 -27.38 67.66 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.694 -0.402 . . . . 4.4 111.643 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.3 t -91.17 -55.75 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 121.219 -0.193 . . . . 2.01 111.288 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.89 -44.32 5.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.404 0.52 . . . . 2.85 112.404 -173.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.57 -59.82 10.08 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.353 -0.451 . . . . 1.73 113.57 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.1 t 72.12 -56.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 123.329 0.652 . . . . 1.92 111.897 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.467 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 2.4 m -74.35 -41.04 61.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 2.21 111.16 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.1 127.38 3.18 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.758 -0.734 . . . . 1.58 112.096 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -164.44 161.88 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.94 -0.393 . . . . 3.56 109.94 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.45 -103.84 0.18 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.038 -1.077 . . . . 2.28 113.552 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mm -81.16 65.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.146 0.498 . . . . 2.67 111.637 -171.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.97 171.63 15.02 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.112 -0.495 . . . . 2.46 110.139 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.53 112.87 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.095 -0.502 . . . . 4.2 109.751 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.511 HD21 ' NE2' ' A' ' 40' ' ' GLN . 3.4 p30 -146.95 172.31 13.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.175 0.512 . . . . 4.13 111.682 -174.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CD1' ' HA2' ' A' ' 2' ' ' GLY . 19.8 p90 -63.45 153.17 36.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.129 -0.941 . . . . 2.27 112.717 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 72.9 -39.08 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.931 0.892 . . . . 2.01 112.891 171.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.511 ' NE2' HD21 ' A' ' 37' ' ' ASN . 38.4 mt-30 -65.32 -36.31 83.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.803 0.335 . . . . 2.39 111.19 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.527 ' H ' HG13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -99.03 15.85 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 3.23 111.546 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.23 135.88 2.56 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.664 -0.779 . . . . 2.06 112.129 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.65 70.76 1.02 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.686 -0.768 . . . . 2.17 111.338 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.649 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 24.6 p80 -60.75 150.67 31.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.78 0.324 . . . . 2.26 111.135 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -179.24 4.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.957 -0.565 . . . . 1.31 110.993 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.49 35.15 2.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 2.37 111.21 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HD2' ' CH2' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -129.09 171.23 12.59 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.988 -0.285 . . . . 2.27 110.985 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.16 -35.24 69.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.81 -0.632 . . . . 1.64 112.408 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -37.87 64.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.041 0.448 . . . . 2.58 111.066 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 44' ' ' HIS . . . -76.62 -40.69 48.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 1.06 110.89 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.04 -41.55 93.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 1.46 110.546 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.11 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.97 111.04 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.41 -36.46 74.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.93 111.022 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 61' ' ' VAL . 3.0 pt20 -76.49 -18.33 58.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 1.86 111.626 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.6 p -115.86 0.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.094 0.405 . . . . 1.82 112.094 -175.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -32.57 72.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.114 0.412 . . . . 1.97 112.114 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.29 -76.65 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.891 -0.323 . . . . 3.57 110.751 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.46 55.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 3.64 110.065 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.3 72.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.252 -0.885 . . . . 4.58 111.789 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.51 -14.94 29.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.7 -0.682 . . . . 2.8 110.143 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.559 ' HA ' ' HB2' ' A' ' 54' ' ' GLN . 5.9 t 60.15 -92.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.268 -0.878 . . . . 3.13 112.066 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HG2' HG12 ' A' ' 61' ' ' VAL . 4.2 mm-40 -99.1 15.11 26.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.729 0.3 . . . . 4.56 111.238 -175.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.46 ' HA ' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -121.42 79.74 37.35 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.063 0.458 . . . . 3.01 110.463 178.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.65 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 85.7 Cg_endo -96.89 16.06 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.008 2.472 . . . . 1.91 112.638 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.76 117.76 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.981 -0.554 . . . . 2.46 111.496 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt 68.52 3.71 3.95 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.265 -0.879 . . . . 2.42 112.202 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.13 -53.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.715 -0.476 . . . . 2.11 109.715 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.65 ' O ' ' HB2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -171.9 154.56 3.57 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.461 -0.94 . . . . 2.19 108.461 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 75.0 -56.06 0.64 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.314 0.487 . . . . 1.87 112.314 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . . . -77.22 67.86 3.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.347 0.499 . . . . 1.09 112.347 -173.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.549 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 3.0 mm-40 -155.46 128.24 4.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.153 -0.684 . . . . 3.23 109.153 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 23.7 Cg_exo -64.29 -11.87 30.11 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.988 2.459 . . . . 1.77 112.98 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 t -132.22 115.31 15.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.412 0.625 . . . . 2.46 110.085 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.471 HD13 HD12 ' A' ' 19' ' ' LEU . 1.1 mt -77.88 -17.96 13.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.653 -0.703 . . . . 2.08 110.786 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' A' ' 13' ' ' ASN . 4.4 tttt -56.47 -50.38 71.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.278 -0.419 . . . . 3.8 110.49 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -62.95 -41.68 99.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.675 -0.693 . . . . 1.08 110.967 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 77' ' ' LEU . 6.2 mt -63.09 -46.31 87.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 2.41 111.269 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.94 -29.07 70.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 1.57 112.003 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -101.37 8.65 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.681 -0.408 . . . . 2.74 111.249 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 1.7 m-85 -119.28 -93.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.508 -0.314 . . . . 2.85 110.719 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.02 43.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.316 0.579 . . . . 2.13 111.321 -175.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.48 -40.65 1.58 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.657 -0.701 . . . . 1.9 109.675 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 133.28 50.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.587 -0.733 . . . . 2.65 110.907 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -82.25 83.87 7.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.032 0.444 . . . . 7.09 110.231 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.231 -0.89 . . . . 5.98 110.231 179.694 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.373 -0.232 . . . . 8.54 110.373 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.75 64.99 2.32 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.112 -0.566 . . . . 5.41 112.478 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -144.1 90.1 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.372 . . . . 6.05 110.867 179.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.33 138.05 32.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.248 -0.433 . . . . 3.59 110.761 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.96 106.82 3.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.462 -0.336 . . . . 3.47 110.912 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.456 ' H ' HG22 ' A' ' 32' ' ' ILE . . . -94.01 179.92 5.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 3.01 110.507 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -112.43 95.88 5.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.9 0.381 . . . . 3.51 110.522 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.466 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 2.7 t80 -155.23 -103.1 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 2.32 110.542 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.614 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.5 OUTLIER 71.2 -7.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.595 0.758 . . . . 2.13 112.214 179.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.18 31.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.765 0.317 . . . . 2.09 110.737 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.813 ' HA ' HD11 ' A' ' 34' ' ' ILE . 59.5 Cg_endo -94.98 172.15 1.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.285 2.656 . . . . 1.88 113.167 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 -40.21 8.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.083 -0.71 . . . . 2.04 109.083 172.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -119.6 151.55 38.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.224 -0.898 . . . . 2.24 109.299 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.49 -33.7 70.1 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.907 0.336 . . . . 1.42 111.907 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.04 -27.34 42.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 1.99 111.56 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.817 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -62.0 -58.82 6.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.005 0.431 . . . . 1.93 111.166 -175.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 m -79.46 -12.43 59.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.365 -0.38 . . . . 1.48 111.283 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -51.52 35.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.57 -0.53 . . . . 2.96 109.57 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -62.7 -41.85 99.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 1.81 110.329 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -49.39 77.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 1.08 110.857 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.641 ' HG2' ' HG3' ' A' ' 25' ' ' ARG . 2.3 tt0 -63.33 -31.37 72.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.236 -0.438 . . . . 2.69 111.206 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.552 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 20.9 mt -62.13 -42.73 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.109 0.481 . . . . 1.91 110.301 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.807 ' HZ2' ' HB3' ' A' ' 49' ' ' MET . 36.7 m95 -79.54 -46.76 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.085 -0.507 . . . . 1.33 111.781 -176.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.3 pt-20 -76.41 -8.56 57.4 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.839 0.681 . . . . 2.78 112.839 -172.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.641 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 2.1 mtp85 -120.89 -4.98 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.607 -0.437 . . . . 4.4 111.74 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.552 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 6.5 t -108.71 -49.83 7.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.01 110.467 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.954 HD11 ' HG3' ' A' ' 47' ' ' LYS . 80.9 mt -95.73 -85.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.078 0.466 . . . . 2.85 110.568 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.19 89.61 1.48 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.688 -0.767 . . . . 1.73 111.502 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 58.4 t -62.8 105.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.968 0.414 . . . . 1.92 110.206 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.26 -64.92 0.71 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.204 -0.453 . . . . 2.21 111.409 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.3 85.45 1.87 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.83 -0.7 . . . . 1.58 111.413 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.744 HD11 ' HD2' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -137.47 -58.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.872 0.368 . . . . 3.56 111.654 -174.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 9' ' ' VAL . . . 101.65 -138.09 13.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.711 -0.757 . . . . 2.28 111.476 -172.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.813 HD11 ' HA ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -120.06 91.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.347 . . . . 2.67 110.98 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.839 ' HG ' ' H ' ' A' ' 36' ' ' ASP . 1.3 pt? -152.73 -66.07 0.16 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.502 -0.317 . . . . 2.46 111.118 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.839 ' H ' ' HG ' ' A' ' 35' ' ' LEU . 5.9 t70 -176.76 173.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 4.2 110.047 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 0.7 OUTLIER 65.73 23.51 11.53 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.51 0.724 . . . . 4.13 112.815 173.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.744 ' HD2' HD11 ' A' ' 32' ' ' ILE . 20.9 t80 173.18 138.04 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.509 -0.769 . . . . 2.27 109.108 170.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 t80 67.15 -72.25 0.09 Allowed 'General case' 0 N--CA 1.464 0.231 0 O-C-N 124.034 0.834 . . . . 2.01 110.558 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.35 59.67 2.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 2.39 110.484 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 -48.98 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.654 -0.703 . . . . 3.23 110.181 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.68 116.63 2.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.06 111.641 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.33 -159.24 24.52 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.795 -0.717 . . . . 2.17 112.042 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -125.66 73.86 1.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.874 0.369 . . . . 2.26 110.561 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.45 145.62 49.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.193 -0.458 . . . . 1.31 110.496 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 46' ' ' LEU . 3.1 mt -92.31 66.74 4.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.783 0.325 . . . . 2.37 111.416 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.954 ' HG3' HD11 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -144.01 155.5 44.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.403 -0.362 . . . . 2.27 110.312 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.79 -43.73 63.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.491 0.552 . . . . 1.64 112.491 -176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.807 ' HB3' ' HZ2' ' A' ' 23' ' ' TRP . 6.2 tpt -62.86 -34.76 78.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.802 0.334 . . . . 2.58 111.179 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HB2' ' HH2' ' A' ' 23' ' ' TRP . . . -76.41 -37.58 56.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 1.06 110.488 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.69 -40.24 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.927 -0.579 . . . . 1.46 110.257 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -61.2 -36.83 80.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 0.97 110.983 178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.23 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.424 -0.353 . . . . 0.93 110.617 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -65.06 -38.7 91.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 1.86 110.873 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -82.85 -26.12 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 1.82 110.502 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -66.21 -38.29 87.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 1.97 109.906 176.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.44 173.16 11.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.423 -0.584 . . . . 3.57 109.423 174.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -82.23 48.32 1.25 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.436 -0.347 . . . . 3.64 110.226 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.483 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 79.7 m-85 56.26 78.94 0.19 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.769 0.795 . . . . 4.58 109.692 -174.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 17.4 pm0 -71.44 -11.79 61.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 2.8 113.06 -169.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 t 63.3 -82.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 123.292 0.37 . . . . 3.13 111.113 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -131.53 5.87 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.535 0.198 . . . . 4.56 111.535 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 0.2 OUTLIER -122.64 78.46 47.6 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 3.01 111.133 -178.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.53 54.35 4.7 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.355 2.704 . . . . 1.91 112.237 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.78 130.42 42.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.436 -0.802 . . . . 2.46 111.719 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 71' ' ' GLN . 2.2 mptm? 46.15 54.82 7.86 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 124.187 0.929 . . . . 2.42 113.247 171.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.96 -33.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.728 0.299 . . . . 2.11 110.775 176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.04 -62.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.198 0.523 . . . . 2.19 110.048 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -68.89 -21.79 64.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.597 -0.729 . . . . 1.87 111.454 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -116.06 40.67 2.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.458 -0.337 . . . . 1.09 111.04 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HG3' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -170.09 84.5 0.58 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.689 -0.687 . . . . 3.23 109.621 175.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.88 59.16 3.47 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.739 2.959 . . . . 1.77 112.993 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -148.43 79.89 1.45 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 2.46 109.391 176.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.817 HD12 ' HA ' ' A' ' 16' ' ' GLU . 80.2 mt -61.87 -41.89 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.689 -0.687 . . . . 2.08 112.541 -169.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -44.58 84.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.435 -0.506 . . . . 3.8 110.42 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -63.86 -34.03 77.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 1.08 110.68 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -61.98 -32.03 72.44 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 2.41 110.837 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 -22.29 61.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.57 110.991 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.28 5.25 42.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.353 -0.385 . . . . 2.74 110.434 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -119.72 -75.95 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 2.85 111.475 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.95 -46.53 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 2.13 111.315 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.83 67.33 1.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.043 0.449 . . . . 1.9 110.307 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t -109.38 -18.94 13.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.92 -0.582 . . . . 2.65 111.168 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 68.1 -68.15 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.58 0.55 . . . . 7.09 110.697 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.0 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.799 -0.619 . . . . 5.98 109.481 177.776 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.132 -0.321 . . . . 8.54 110.132 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.71 -40.08 3.03 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.004 -0.617 . . . . 5.41 113.585 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.65 99.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 6.05 111.341 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.32 80.78 8.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.158 -0.474 . . . . 3.59 110.819 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -177.49 115.18 0.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.96 -0.563 . . . . 3.47 110.367 175.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.95 88.6 3.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 3.01 110.516 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -75.41 71.49 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 3.51 110.281 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.448 ' HB3' HD21 ' A' ' 35' ' ' LEU . 83.2 t80 -162.62 23.43 0.1 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.664 0.745 . . . . 2.32 109.275 -175.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.51 65.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.899 0.857 . . . . 2.13 111.526 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.39 70.34 39.44 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.812 -1.085 . . . . 2.09 108.546 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.841 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 31.3 Cg_exo -61.08 146.69 97.34 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.651 2.901 . . . . 1.88 113.788 -171.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -28.19 37.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.097 -0.956 . . . . 2.04 110.575 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -123.88 146.98 48.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.24 109.936 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.61 -21.63 66.46 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.317 0.386 . . . . 1.42 111.408 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.64 -37.74 80.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.213 -0.449 . . . . 1.99 110.537 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.841 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . 36.3 mt-10 -70.66 -34.77 72.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 1.93 110.271 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -35.12 79.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.076 0.465 . . . . 1.48 110.627 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 2.2 tptm -72.71 -43.77 62.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.753 -0.658 . . . . 2.96 110.373 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -47.29 77.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.599 -0.728 . . . . 1.81 110.599 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.798 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . . . -57.87 -55.1 39.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.5 -0.773 . . . . 1.08 111.275 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.79 -42.86 85.03 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.805 0.298 . . . . 2.69 111.805 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.9 mt -69.43 -55.61 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 1.91 111.266 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -65.66 -35.57 81.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.501 -0.318 . . . . 1.33 111.492 -175.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 3.3 tp10 -63.62 -46.7 84.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.196 -0.456 . . . . 2.78 110.965 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -5.32 41.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 4.4 111.583 -176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.18 -60.52 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.462 -0.335 . . . . 2.01 111.32 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -35.27 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.532 0.567 . . . . 2.85 112.532 -171.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.62 ' HA3' HG12 ' A' ' 32' ' ' ILE . . . -77.32 -69.83 1.36 Allowed Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.578 -0.82 . . . . 1.73 113.505 -172.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t 56.51 54.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.63 0.729 . . . . 1.92 110.129 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.41 -32.9 0.04 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.14 -0.936 . . . . 2.21 110.567 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.47 65.34 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.181 -0.767 . . . . 1.58 111.181 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.62 HG12 ' HA3' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -131.1 -178.09 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.564 0.221 . . . . 3.56 111.413 -175.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.798 ' HA3' ' HA ' ' A' ' 20' ' ' ALA . . . 120.96 31.98 1.13 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.934 -0.651 . . . . 2.28 113.269 175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -156.87 -65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 117.343 0.571 . . . . 2.67 111.982 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 35' ' ' LEU . 1.9 pt? -142.37 33.03 1.49 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.975 0.893 . . . . 2.46 110.052 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.96 1.61 4.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.5 -1.227 . . . . 4.2 112.487 -174.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.451 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 21.2 t-20 74.12 -60.8 0.51 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.111 0.564 . . . . 4.13 112.278 174.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HE1' HG21 ' A' ' 32' ' ' ILE . 25.9 p90 -64.64 -22.71 67.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.331 0.493 . . . . 2.27 112.331 -172.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.447 ' CE2' ' HE2' ' A' ' 69' ' ' PHE . 15.9 t80 -108.16 -16.9 14.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.947 0.403 . . . . 2.01 110.812 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -110.48 0.93 17.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 2.39 111.751 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 37' ' ' ASN . 5.1 tp -88.93 -23.19 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.136 0.493 . . . . 3.23 110.604 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 55.31 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.87 -0.892 . . . . 2.06 110.87 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.87 128.74 29.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.984 -0.627 . . . . 2.17 112.74 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.83 59.4 1.37 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.374 0.607 . . . . 2.26 110.352 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -179.31 6.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.346 -0.843 . . . . 1.31 110.313 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.2 63.04 0.62 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.075 0.464 . . . . 2.37 110.153 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 51' ' ' VAL . 1.9 tptt -130.66 165.8 22.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.834 -0.621 . . . . 2.27 110.428 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.04 87.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 1.64 111.534 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -62.53 -38.08 88.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.171 -0.468 . . . . 2.58 110.824 177.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -71.04 -45.36 64.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.958 -0.565 . . . . 1.06 111.405 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.3 m -70.72 -22.4 23.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.58 -0.282 . . . . 1.46 110.979 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.0 -38.42 88.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 0.97 110.01 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -38.49 76.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.829 -0.623 . . . . 0.93 110.647 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -60.23 -55.97 27.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 1.86 111.041 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 51' ' ' VAL . 2.2 t -78.38 9.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.108 0.48 . . . . 1.82 111.095 -177.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.429 ' NE2' ' HA ' ' A' ' 82' ' ' ALA . 1.5 t-80 -88.56 -9.93 50.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 1.97 110.744 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 57' ' ' ARG . 3.9 ttm180 -137.18 9.41 2.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.609 . . . . 3.57 109.52 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 72.48 -12.97 0.68 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.249 -0.887 . . . . 3.64 112.043 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -169.23 176.08 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.897 0.379 . . . . 4.58 110.517 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.99 -52.5 0.19 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 2.8 109.112 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER 41.8 57.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.132 0.973 . . . . 3.13 112.921 175.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.27 9.51 6.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.482 -0.781 . . . . 4.56 112.555 172.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 61' ' ' VAL . 0.3 OUTLIER -126.95 73.19 76.36 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.759 0.314 . . . . 3.01 110.73 176.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 6.5 Cg_endo -87.92 117.99 1.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.075 2.516 . . . . 1.91 112.265 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tp -143.95 122.16 12.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.204 -0.295 . . . . 2.46 110.204 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 tttt 53.58 55.53 8.46 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.58 0.55 . . . . 2.42 111.123 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.37 -76.1 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.094 -0.503 . . . . 2.11 110.69 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.09 -42.44 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.302 -0.863 . . . . 2.19 109.049 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 49' ' ' MET . 52.4 m-85 -97.55 18.05 16.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.416 -0.811 . . . . 1.87 109.962 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -144.1 134.86 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.877 -1.056 . . . . 1.09 108.233 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 12.7 mp0 70.55 97.1 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 O-C-N 124.324 1.015 . . . . 3.23 109.198 -169.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -63.57 70.59 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.728 2.952 . . . . 1.77 113.066 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.26 53.96 1.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.455 -0.793 . . . . 2.46 108.968 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 74' ' ' ILE . 2.0 mm -51.35 -49.8 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.698 -1.137 . . . . 2.08 112.319 -172.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -64.41 -47.4 79.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 3.8 111.066 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.25 90.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 1.08 111.18 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 mp -66.47 -36.01 81.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.222 -0.444 . . . . 2.41 110.983 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.739 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -72.05 -36.89 69.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 1.57 111.296 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -9.81 59.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.949 0.404 . . . . 2.74 111.062 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -103.95 -76.85 0.58 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 2.85 111.014 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.7 -40.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.681 . . . . 2.13 111.421 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.739 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -79.94 54.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.017 0.437 . . . . 1.9 111.794 -175.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 85' ' ' SER . 4.8 t -168.63 -28.01 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.998 -0.546 . . . . 2.65 110.466 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.89 48.54 7.07 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.185 0.594 . . . . 7.09 111.509 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.413 ' H ' HG23 ' A' ' 83' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.848 -0.596 . . . . 5.98 109.763 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HG3' ' N ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.67 0.272 . . . . 8.54 110.82 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 37' ' ' ASN . . . -174.46 38.65 0.12 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.139 -1.029 . . . . 5.41 112.399 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.41 38.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.936 0.398 . . . . 6.05 110.624 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 m -143.56 131.55 21.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.096 -0.502 . . . . 3.59 110.539 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.06 138.99 30.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.976 0.417 . . . . 3.47 110.394 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.05 118.23 15.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.022 -0.536 . . . . 3.01 110.113 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -81.13 22.58 0.64 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.418 -0.355 . . . . 3.51 111.464 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.49 ' CD2' HD22 ' A' ' 35' ' ' LEU . 85.0 t80 -66.44 -56.48 10.77 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.06 -0.718 . . . . 2.32 109.06 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p 21.95 65.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 124.892 1.37 . . . . 2.13 113.156 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.76 76.39 74.49 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.583 -0.735 . . . . 2.09 110.999 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 23.3 Cg_exo -65.23 115.69 3.45 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.304 2.002 . . . . 1.88 110.5 174.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -34.68 75.39 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.247 -0.433 . . . . 2.04 111.955 -171.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.94 150.73 27.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.741 0.305 . . . . 2.24 110.971 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.09 70.35 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.932 -0.576 . . . . 1.42 112.006 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.51 -36.56 75.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.157 0.503 . . . . 1.99 110.696 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.662 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 21.0 mt-10 -79.53 -23.34 42.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.658 -0.701 . . . . 1.93 111.102 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -71.07 -45.45 63.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.372 . . . . 1.48 110.411 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -63.7 -38.98 93.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.119 0.485 . . . . 2.96 110.666 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -63.64 -47.1 82.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.88 -0.6 . . . . 1.81 110.079 177.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.3 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 1.08 111.083 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -56.23 -53.9 51.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 2.69 110.876 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.501 HG22 HD23 ' A' ' 27' ' ' LEU . 37.7 mm -68.86 -43.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.156 -0.475 . . . . 1.91 111.323 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.916 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 64.4 m95 -71.7 -39.82 69.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.616 0.598 . . . . 1.33 112.616 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HG3' ' HG2' ' A' ' 25' ' ' ARG . 1.6 pt-20 -77.11 -33.48 56.87 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.904 -0.318 . . . . 2.78 111.413 -177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.554 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 8.4 mmp_? -90.08 -57.48 2.84 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.141 0.423 . . . . 4.4 112.141 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.23 -43.23 12.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.064 0.394 . . . . 2.01 112.064 -171.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.916 ' HB2' ' HA ' ' A' ' 23' ' ' TRP . 1.4 mm? -70.54 -69.79 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.998 0.427 . . . . 2.85 111.962 -174.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.59 -22.27 31.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.9 -0.667 . . . . 1.73 113.401 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t 55.76 52.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.678 0.751 . . . . 1.92 110.076 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.4 141.66 32.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.394 -0.821 . . . . 2.21 110.096 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.7 77.27 2.08 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.588 -0.815 . . . . 1.58 111.36 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.503 ' HB ' ' H ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -118.89 -147.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.022 0.439 . . . . 3.56 111.133 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.503 ' H ' ' HB ' ' A' ' 32' ' ' ILE . . . 174.58 -174.97 46.82 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.285 -0.726 . . . . 2.28 111.285 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 16' ' ' GLU . 5.9 mm -80.56 83.26 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.983 0.421 . . . . 2.67 110.295 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.717 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.95 -51.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.845 -0.616 . . . . 2.46 110.671 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.717 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 4.7 t0 178.1 -175.06 0.17 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.864 -0.421 . . . . 4.2 109.864 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.53 ' O ' ' HA2' ' A' ' 2' ' ' GLY . 35.0 m-20 74.22 -3.45 2.54 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.003 0.815 . . . . 4.13 111.86 174.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.7 t80 178.57 163.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.736 0.648 . . . . 2.27 109.333 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER 70.58 -70.23 0.16 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.906 0.754 . . . . 2.01 111.017 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.11 72.34 10.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.851 0.357 . . . . 2.39 110.526 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 172.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.207 -0.451 . . . . 3.23 110.822 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 64' ' ' PRO . . . -76.41 94.61 1.05 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.029 -0.605 . . . . 2.06 112.887 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.71 -159.65 32.99 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.952 -0.642 . . . . 2.17 112.001 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -165.57 127.74 2.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 2.26 110.219 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.19 162.19 22.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.075 -0.512 . . . . 1.31 110.97 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.77 67.2 3.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.489 -0.323 . . . . 2.37 110.92 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.16 127.42 3.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.357 -0.383 . . . . 2.27 111.379 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 23.6 -94.49 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.498 1.519 . . . . 1.64 114.64 171.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.5 ttt -54.05 -42.42 69.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.965 -0.561 . . . . 2.58 112.235 -173.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.41 74.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.907 0.384 . . . . 1.06 110.838 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.5 t -66.31 -46.28 87.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.765 -0.457 . . . . 1.46 109.765 177.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.82 -24.99 67.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.779 -0.646 . . . . 0.97 111.206 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.69 -28.52 66.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 0.93 110.543 177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -25.51 47.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.19 0.519 . . . . 1.86 110.317 177.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -93.03 13.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.863 -0.608 . . . . 1.82 110.161 177.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.99 4.78 49.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.741 -0.663 . . . . 1.97 109.689 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HD2' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -154.99 -165.38 2.02 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.114 -0.948 . . . . 3.57 109.175 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.7 pm0 -79.62 38.47 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.417 -0.356 . . . . 3.64 111.542 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 60.6 78.39 0.28 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.647 0.737 . . . . 4.58 109.524 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 19.2 pm0 -77.68 23.3 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.943 -1.026 . . . . 2.8 112.826 -171.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.47 ' HB ' ' H ' ' A' ' 62' ' ' GLU . 2.9 t 55.0 -100.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.446 0.298 . . . . 3.13 110.877 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' H ' ' HB ' ' A' ' 61' ' ' VAL . 2.5 pt-20 -134.23 32.1 3.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 4.56 110.605 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.569 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 12.8 mt -104.4 100.95 24.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 3.01 110.114 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.477 ' HG3' ' HA2' ' A' ' 42' ' ' GLY . 87.2 Cg_endo -84.4 3.08 7.75 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.856 2.371 . . . . 1.91 113.184 -174.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.86 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.206 0.941 . . . . 2.46 112.64 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 58.31 23.63 10.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.68 -0.691 . . . . 2.42 112.471 175.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.403 HG22 ' HD2' ' A' ' 57' ' ' ARG . 7.5 t -97.06 -51.74 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.153 0.501 . . . . 2.11 109.991 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -170.64 -54.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.499 -0.773 . . . . 2.19 110.012 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . 19.6 m-85 -84.08 35.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.932 -0.576 . . . . 1.87 111.262 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.14 47.52 0.69 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.989 -0.745 . . . . 1.09 108.989 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.03 104.81 0.49 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.326 -1.306 . . . . 3.23 108.692 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.84 40.46 0.65 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.016 2.478 . . . . 1.77 113.485 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.74 94.6 2.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.628 -0.508 . . . . 2.46 109.628 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 77' ' ' LEU . 2.6 mt -67.14 -35.09 73.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.304 -0.407 . . . . 2.08 110.78 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -36.03 79.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 3.8 110.283 176.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.77 83.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 1.08 110.379 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 74' ' ' ILE . 17.4 mt -66.74 -33.38 75.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.93 0.395 . . . . 2.41 110.547 177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.8 -17.07 62.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.57 111.625 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -110.2 12.95 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.982 0.42 . . . . 2.74 110.299 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -126.79 -88.9 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.945 -0.571 . . . . 2.85 110.865 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.36 -17.58 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.963 0.357 . . . . 2.13 111.963 -175.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.05 39.28 3.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.945 0.402 . . . . 1.9 110.787 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 84' ' ' ARG . 14.0 t -80.21 -26.9 38.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.243 -0.435 . . . . 2.65 111.284 -177.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 83' ' ' THR . 48.8 mtm-85 73.23 -49.62 0.69 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.4 0.68 . . . . 7.09 110.925 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.247 0.933 0 N-CA-C 109.314 -0.624 . . . . 5.98 109.314 175.891 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 110.279 -0.267 . . . . 8.54 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.37 89.36 0.16 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.644 -0.789 . . . . 5.41 112.305 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.74 48.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.422 0.629 . . . . 6.05 110.376 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.35 23.1 0.42 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.481 -0.782 . . . . 3.59 109.861 177.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -122.48 109.24 14.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 3.47 110.384 -175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.81 39.99 29.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.823 -0.626 . . . . 3.01 111.19 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -70.49 -57.32 4.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.703 -0.681 . . . . 3.51 111.039 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.451 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 1.2 t80 -103.42 -88.27 0.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 2.32 111.406 -175.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' H ' ' HB3' ' A' ' 8' ' ' TYR . 2.1 t 56.0 52.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.287 0.565 . . . . 2.13 110.822 -174.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.6 86.38 53.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.014 -0.539 . . . . 2.09 110.692 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.633 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 96.3 Cg_endo -89.95 -168.78 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.929 2.42 . . . . 1.88 111.945 177.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -77.68 -69.43 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.122 -0.231 . . . . 2.04 111.15 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -173.43 140.2 0.81 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.861 0.319 . . . . 2.24 111.861 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.15 -84.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.743 1.016 . . . . 1.42 113.743 168.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -61.02 -55.85 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.298 -0.41 . . . . 1.99 111.88 -171.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.731 ' HA ' HD11 ' A' ' 74' ' ' ILE . 13.2 mt-10 -63.89 -35.88 82.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.007 -0.542 . . . . 1.93 111.187 -176.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.403 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -64.97 -47.0 79.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.121 -0.49 . . . . 1.48 111.315 -178.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -74.09 -37.66 64.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.31 -0.405 . . . . 2.96 110.899 -178.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -61.63 -49.9 74.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 1.81 110.932 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.67 97.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 1.08 110.679 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -53.37 -57.14 11.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.769 -0.65 . . . . 2.69 111.024 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.2 mt -65.0 -52.39 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.092 -0.504 . . . . 1.91 111.29 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -61.62 -51.29 69.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.402 0.519 . . . . 1.33 112.402 -172.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -74.88 -10.59 59.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.894 0.331 . . . . 2.78 111.894 -173.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.561 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -100.36 -22.3 15.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.741 -0.384 . . . . 4.4 111.608 177.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 25' ' ' ARG . 53.6 t -103.52 -50.33 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.35 . . . . 2.01 111.437 -176.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -27.52 62.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.202 0.525 . . . . 2.85 110.318 -177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.0 -168.76 14.03 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.037 -0.825 . . . . 1.73 111.037 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -118.01 56.37 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.481 1.134 . . . . 1.92 109.018 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 m -113.49 -127.52 0.29 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.029 -0.987 . . . . 2.21 111.28 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.52 50.26 0.3 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.713 -0.955 . . . . 1.58 110.713 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 tt -118.59 -43.77 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.677 0.275 . . . . 3.56 110.733 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.14 -132.7 13.8 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.75 -0.738 . . . . 2.28 112.729 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -75.32 93.77 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.852 0.358 . . . . 2.67 111.475 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -173.87 -65.09 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.059 -0.719 . . . . 2.46 109.059 177.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -133.03 49.24 2.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.383 -0.969 . . . . 4.2 108.383 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.552 ' O ' HG22 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -62.9 96.36 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.371 -1.286 . . . . 4.13 111.969 -174.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -66.8 -17.9 65.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.569 . . . . 2.27 111.009 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -93.66 -64.27 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.138 -0.483 . . . . 2.01 110.577 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.749 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -84.94 58.98 5.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 2.39 111.726 -173.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.749 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 3.6 tp 156.63 -24.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.934 0.894 . . . . 3.23 110.48 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.27 -25.92 74.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.995 -0.622 . . . . 2.06 112.769 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.88 -104.4 0.25 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.824 -0.703 . . . . 2.17 111.932 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.14 149.28 15.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.56 0.219 . . . . 2.26 110.606 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.69 178.33 8.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.737 -0.468 . . . . 1.31 109.737 174.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -119.15 59.87 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.37 0.605 . . . . 2.37 110.224 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.87 179.04 6.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.539 -0.755 . . . . 2.27 110.059 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.59 73.77 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.048 0.388 . . . . 1.64 112.048 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -36.43 72.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.969 0.414 . . . . 2.58 111.057 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HA ' ' HE2' ' A' ' 69' ' ' PHE . . . -75.06 -38.93 61.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.976 -0.556 . . . . 1.06 110.805 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 55' ' ' VAL . 21.4 t -63.8 -41.59 93.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 1.46 110.236 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 56' ' ' HIS . . . -59.93 -39.51 85.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.577 . . . . 0.97 110.83 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.46 -34.46 74.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.93 110.673 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -50.83 69.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.858 -0.61 . . . . 1.86 110.716 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 51' ' ' VAL . 4.0 t -70.4 -36.85 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 1.82 111.098 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -49.91 -45.73 51.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.668 -0.696 . . . . 1.97 111.573 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.496 ' HB3' ' H ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -87.08 -103.68 0.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.381 -0.372 . . . . 3.57 111.034 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.496 ' H ' ' HB3' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -140.53 36.36 1.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.549 -0.296 . . . . 3.64 111.225 -175.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 53.04 64.58 1.81 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.264 0.555 . . . . 4.58 110.363 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -38.1 78.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.629 -0.714 . . . . 2.8 111.79 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t 70.48 -50.12 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 123.669 0.606 . . . . 3.13 110.963 -175.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.444 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -80.92 -131.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 4.56 111.057 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -71.71 132.17 85.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.159 0.504 . . . . 3.01 110.864 -177.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.1 Cg_exo -78.53 69.82 7.55 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 123.516 2.811 . . . . 1.91 111.917 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -60.09 117.57 5.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.571 -0.74 . . . . 2.46 111.817 -176.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.05 50.63 17.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.501 -0.772 . . . . 2.42 112.213 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 p -126.97 -35.66 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.528 -0.469 . . . . 2.11 110.931 173.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.675 ' HA ' HD13 ' A' ' 77' ' ' LEU . 1.0 OUTLIER 177.09 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.443 0.464 . . . . 2.19 110.781 178.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.584 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 22.1 m-85 -72.59 -51.89 17.83 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.233 0.457 . . . . 1.87 112.233 -173.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.921 0.391 . . . . 1.09 111.546 -176.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -179.51 97.58 0.2 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.556 -0.747 . . . . 3.23 109.63 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HD3' HD13 ' A' ' 41' ' ' ILE . 9.5 Cg_exo -71.84 54.37 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.286 2.657 . . . . 1.77 112.707 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.484 HG22 ' HE2' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -150.97 59.67 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.921 -0.77 . . . . 2.46 108.921 176.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.731 HD11 ' HA ' ' A' ' 16' ' ' GLU . 17.9 pt -64.61 -21.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.525 -0.761 . . . . 2.08 112.446 -170.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.484 ' HE2' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -61.61 -39.65 92.01 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.064 0.459 . . . . 3.8 110.493 175.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -39.77 73.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.923 -0.58 . . . . 1.08 110.648 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.675 HD13 ' HA ' ' A' ' 68' ' ' LEU . 25.5 mt -72.82 -25.31 61.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.264 -0.425 . . . . 2.41 110.441 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.44 -21.5 65.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 1.57 111.331 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' H ' ' HG2' ' A' ' 79' ' ' GLN . 5.4 pt20 -104.53 -39.79 6.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.392 -0.523 . . . . 2.74 111.055 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.14 -65.42 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.995 0.369 . . . . 2.85 111.995 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.92 -25.01 21.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.959 0.409 . . . . 2.13 111.57 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.55 33.83 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 1.9 111.477 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -27.95 68.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.278 0.561 . . . . 2.65 110.707 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 84' ' ' ARG . 8.9 mmm180 -117.6 69.03 0.76 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 7.09 109.156 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.573 -0.727 . . . . 5.98 111.002 -175.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ttp . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 121.056 0.455 . . . . 8.54 110.182 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.4 159.19 14.67 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.07 -0.586 . . . . 5.41 111.771 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.88 -15.17 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.969 0.414 . . . . 6.05 110.762 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 t -126.93 126.23 42.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.071 -0.513 . . . . 3.59 110.067 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.92 93.36 0.06 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.68 -0.691 . . . . 3.47 111.127 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.527 ' HB1' ' HG ' ' A' ' 35' ' ' LEU . . . -80.34 125.02 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.422 -0.808 . . . . 3.01 110.939 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -80.32 58.78 3.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.222 0.534 . . . . 3.51 110.332 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.474 ' HB3' ' H ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -141.58 -94.14 0.14 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.67 -0.696 . . . . 2.32 109.925 178.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.547 HG23 ' HA3' ' A' ' 33' ' ' GLY . 13.0 p 33.09 62.39 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 124.295 0.997 . . . . 2.13 112.697 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.09 100.96 53.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.781 -0.645 . . . . 2.09 110.691 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.1 139.16 23.71 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.147 2.564 . . . . 1.88 112.425 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.7 -47.09 8.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 2.04 110.238 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.6 t-20 -102.95 149.64 24.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.374 -0.83 . . . . 2.24 109.821 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.88 81.73 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.266 0.469 . . . . 1.42 112.266 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -29.38 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.52 -0.309 . . . . 1.99 110.516 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 13' ' ' ASN . 51.9 mt-10 -60.03 -40.18 88.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 1.93 109.808 175.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -37.76 79.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.034 -0.53 . . . . 1.48 110.325 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -46.17 91.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.027 0.441 . . . . 2.96 110.374 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mp -67.05 -53.59 29.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.712 -0.676 . . . . 1.81 110.978 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.24 99.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 1.08 112.092 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -63.25 -53.5 52.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.856 -0.156 . . . . 2.69 111.132 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.602 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 33.5 mm -58.5 -47.95 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 1.91 111.169 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -67.46 -53.53 28.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.786 0.327 . . . . 1.33 111.677 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 32' ' ' ILE . 4.6 tp10 -71.91 -52.15 18.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.548 -0.297 . . . . 2.78 111.743 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -0.69 24.09 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.933 -0.48 . . . . 4.4 111.781 -172.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.602 ' HB ' ' O ' ' A' ' 22' ' ' ILE . 5.1 t -108.59 -43.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 121.075 -0.25 . . . . 2.01 110.758 173.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.08 -51.99 2.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.852 0.316 . . . . 2.85 111.852 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -61.07 -45.2 97.06 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.255 -0.498 . . . . 1.73 113.003 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 33.7 t 76.56 -51.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.553 0.741 . . . . 1.92 111.809 176.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.93 -54.76 42.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.958 0.355 . . . . 2.21 111.958 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.31 57.97 0.66 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.151 -1.023 . . . . 1.58 111.88 -175.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.414 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 22.8 mm -90.64 -52.8 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.639 -0.504 . . . . 3.56 109.639 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA3' HG23 ' A' ' 9' ' ' VAL . . . 56.32 -117.06 8.32 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.488 -0.778 . . . . 2.28 113.152 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.509 ' H ' ' HA ' ' A' ' 9' ' ' VAL . 13.3 mm -81.52 87.78 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 2.67 111.078 -177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.527 ' HG ' ' HB1' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -166.07 26.45 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 2.46 109.327 174.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.876 ' HA ' ' HG2' ' A' ' 40' ' ' GLN . 6.4 p-10 38.47 -150.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.909 -1.041 . . . . 4.2 111.983 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.13 -69.33 0.08 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.23 0.826 . . . . 4.13 113.23 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -56.67 15.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.795 0.331 . . . . 2.27 111.588 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.84 -72.15 0.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.288 -0.415 . . . . 2.01 111.698 -174.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.876 ' HG2' ' HA ' ' A' ' 36' ' ' ASP . 1.9 pm0 -73.62 81.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 2.39 111.803 -174.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 tp 179.08 -26.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.336 -0.847 . . . . 3.23 110.013 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.01 28.07 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.945 -0.645 . . . . 2.06 112.235 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.94 103.23 1.1 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.964 -0.636 . . . . 2.17 112.467 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -130.24 61.62 1.59 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.448 . . . . 2.26 110.305 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.16 162.47 29.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.79 -0.641 . . . . 1.31 110.735 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.61 61.5 4.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.484 0.659 . . . . 2.37 110.719 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.98 155.79 49.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.373 -0.83 . . . . 2.27 109.774 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.98 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.565 0.222 . . . . 1.64 111.506 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.86 -42.51 75.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 2.58 111.203 178.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . . . -76.85 -36.51 56.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 1.06 111.124 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 55' ' ' VAL . 46.5 t -64.15 -42.96 97.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.458 . . . . 1.46 110.4 178.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.45 84.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 0.97 111.019 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.84 -35.12 79.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.93 111.147 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.67 ' HA ' ' HG2' ' A' ' 60' ' ' GLN . 3.5 tt0 -67.64 -40.86 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 1.86 111.017 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 51' ' ' VAL . 22.5 t -79.53 -38.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.845 -0.616 . . . . 1.82 111.483 -176.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -58.57 -30.86 67.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.472 -0.331 . . . . 1.97 111.304 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.587 ' HB3' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -87.15 16.03 5.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.746 -0.206 . . . . 3.57 111.283 -178.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 56.44 65.92 1.31 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.321 -0.4 . . . . 3.64 110.328 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 64.45 76.92 0.33 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.705 -0.68 . . . . 4.58 110.566 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.67 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -84.38 -11.96 55.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 2.8 111.028 -178.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t 53.32 -111.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.027 -0.533 . . . . 3.13 110.385 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 2.1 tp10 -127.26 28.93 5.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.08 0.467 . . . . 4.56 110.121 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.02 87.9 20.3 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 3.01 110.961 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 9.3 Cg_endo -91.82 105.49 0.24 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.639 2.893 . . . . 1.91 112.208 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 mt -118.03 -30.11 5.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.026 0.441 . . . . 2.46 110.884 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -153.83 82.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.957 -0.565 . . . . 2.42 110.301 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.441 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -149.26 -169.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.897 -0.592 . . . . 2.11 110.137 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -60.14 -32.3 70.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 2.19 111.037 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 50' ' ' ALA . 89.1 m-85 -110.17 36.62 2.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 1.87 110.61 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HB3' ' H ' ' A' ' 67' ' ' VAL . . . -158.9 56.54 0.43 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.87 0.367 . . . . 1.09 110.969 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.532 ' HG3' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -164.52 128.34 1.77 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 3.23 109.954 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 6.5 Cg_exo -75.5 13.82 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.994 2.463 . . . . 1.77 112.363 177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -153.85 115.65 4.24 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.3 -0.63 . . . . 2.46 109.3 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -28.83 5.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.44 . . . . 2.08 111.344 -171.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 13' ' ' ASN . 17.6 pttt -57.92 -36.69 72.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.588 -0.278 . . . . 3.8 111.169 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.16 -39.26 89.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.076 0.465 . . . . 1.08 110.801 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HG3' ' A' ' 71' ' ' GLN . 5.4 mt -72.47 -45.41 59.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 2.41 110.133 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -59.22 -42.5 91.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.57 111.749 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.26 1.25 41.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 2.74 111.566 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -129.78 -90.2 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.726 -0.39 . . . . 2.85 111.69 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.3 m -70.6 -18.6 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.51 0.559 . . . . 2.13 112.51 -172.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.85 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -102.25 15.29 29.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.794 0.331 . . . . 1.9 111.77 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.79 9.0 42.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.839 -0.344 . . . . 2.65 111.219 176.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 64.53 9.84 5.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.762 -0.653 . . . . 7.09 112.516 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.963 0 CA-C-O 117.876 -1.059 . . . . 5.98 109.821 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttp . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.722 0.296 . . . . 8.54 110.34 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.72 23.61 27.8 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.947 -0.645 . . . . 5.41 111.667 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -81.9 52.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.326 0.584 . . . . 6.05 111.926 -174.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 m -116.6 -37.97 3.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.522 -0.763 . . . . 3.59 109.776 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -154.35 118.82 4.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.717 -0.674 . . . . 3.47 109.434 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.31 -99.19 0.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.499 -0.319 . . . . 3.01 110.904 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.26 -58.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.68 0.276 . . . . 3.51 110.884 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.468 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . 8.6 t80 -46.97 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.231 -0.895 . . . . 2.32 112.577 -173.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.2 p 42.74 36.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 122.094 0.949 . . . . 2.13 112.524 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.38 84.32 56.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.89 -0.595 . . . . 2.09 111.531 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HG2' ' HA ' ' A' ' 17' ' ' SER . 31.3 Cg_exo -59.71 133.96 54.55 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.353 2.036 . . . . 1.88 111.103 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -45.96 26.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.651 0.612 . . . . 2.04 112.651 -170.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -136.47 107.36 6.65 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.706 1.002 . . . . 2.24 113.706 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 42.09 -85.88 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.961 1.467 . . . . 1.42 114.961 163.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.5 t -53.29 -34.59 22.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.072 -0.513 . . . . 1.99 111.204 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.98 ' HG2' ' HB ' ' A' ' 74' ' ' ILE . 39.5 mt-10 -61.81 -45.97 91.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.463 -0.789 . . . . 1.93 110.69 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.555 ' HA ' ' HG2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -63.25 -35.49 80.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 1.48 110.997 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -60.59 -60.07 4.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 2.96 110.976 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.57 -40.01 77.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 1.81 111.427 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.53 -50.72 66.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.362 -0.381 . . . . 1.08 111.454 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 26.2 mt-10 -62.53 -41.03 98.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.497 0.189 . . . . 2.69 111.428 -175.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.85 -43.67 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 1.91 110.362 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -72.79 -48.72 35.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.09 -0.504 . . . . 1.33 112.065 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.81 -26.49 25.71 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.585 0.587 . . . . 2.78 112.585 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -99.22 -48.05 4.97 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.855 -0.338 . . . . 4.4 111.552 -177.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 t -84.85 -47.68 16.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.688 0.28 . . . . 2.01 111.618 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.54 -65.58 0.98 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 2.85 111.872 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.09 -41.7 17.38 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.942 -0.647 . . . . 1.73 113.306 -175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.6 t 63.77 83.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.16 0.505 . . . . 1.92 110.214 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.28 -83.49 0.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 2.21 111.778 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.14 72.31 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.231 -1.147 . . . . 1.58 110.231 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.555 HG13 ' H ' ' A' ' 33' ' ' GLY . 4.8 tp -96.75 173.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.369 0.604 . . . . 3.56 112.415 -167.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.555 ' H ' HG13 ' A' ' 32' ' ' ILE . . . -152.47 173.85 31.46 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.825 -0.625 . . . . 2.28 111.651 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.649 HG23 ' HB2' ' A' ' 72' ' ' PRO . 19.3 mm -85.97 68.84 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.369 0.604 . . . . 2.67 110.559 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -141.64 -67.31 0.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.491 -0.777 . . . . 2.46 109.041 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -131.07 147.39 52.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.47 -0.937 . . . . 4.2 108.47 173.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -144.71 160.96 40.36 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 121.062 -0.255 . . . . 4.13 110.859 -174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -100.96 -17.17 16.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.136 -0.484 . . . . 2.27 110.475 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.449 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.1 OUTLIER -129.66 -45.44 1.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.947 -0.57 . . . . 2.01 110.683 -176.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.449 HE21 ' HE2' ' A' ' 39' ' ' PHE . 26.2 mt-30 -82.65 62.23 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.25 -0.281 . . . . 2.39 110.662 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 tp -169.5 -22.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 111.916 0.339 . . . . 3.23 111.916 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.22 -36.96 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.426 -0.892 . . . . 2.06 112.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.35 131.21 41.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.037 -0.602 . . . . 2.17 111.884 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -113.19 100.71 8.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.043 0.449 . . . . 2.26 110.336 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.0 154.73 25.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.573 -0.74 . . . . 1.31 111.032 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.83 91.46 1.96 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 2.37 110.485 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.32 156.12 33.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 2.27 110.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -25.6 64.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 1.64 111.064 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 ttt -63.1 -34.75 78.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.058 -0.519 . . . . 2.58 110.601 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HA ' ' HZ ' ' A' ' 69' ' ' PHE . . . -72.29 -38.75 68.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 1.06 110.355 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 55' ' ' VAL . 10.5 t -64.25 -38.58 82.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.87 -0.604 . . . . 1.46 110.315 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.26 93.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 0.97 110.719 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.92 96.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.113 -0.494 . . . . 0.93 110.47 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.479 ' HA ' ' HG3' ' A' ' 60' ' ' GLN . 4.0 mm-40 -58.36 -49.63 76.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.657 -0.701 . . . . 1.86 110.716 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 51' ' ' VAL . 21.7 t -64.63 -31.25 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 1.82 110.769 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -68.79 -18.96 64.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 1.97 111.924 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -120.8 19.18 11.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.715 0.293 . . . . 3.57 110.642 178.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 51.44 60.62 3.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.544 -0.753 . . . . 3.64 111.302 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 68.54 73.29 0.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.315 -0.857 . . . . 4.58 110.879 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -79.68 97.33 6.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.152 -0.931 . . . . 2.8 110.024 178.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -70.11 88.16 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.393 . . . . 3.13 111.115 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.22 43.46 26.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.724 -0.671 . . . . 4.56 111.179 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -154.62 75.0 5.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 3.01 110.584 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.731 ' HG2' ' HB2' ' A' ' 69' ' ' PHE . 4.7 Cg_endo -87.03 47.68 1.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.517 2.811 . . . . 1.91 112.432 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.8 tp -56.83 101.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.682 -0.69 . . . . 2.46 112.268 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.766 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 11.4 mtmm 58.3 31.3 20.7 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.457 -0.792 . . . . 2.42 112.213 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.92 -21.37 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.945 -0.302 . . . . 2.11 110.948 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -175.04 -74.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.101 0.477 . . . . 2.19 109.727 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.731 ' HB2' ' HG2' ' A' ' 64' ' ' PRO . 11.0 m-85 -84.49 53.14 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 1.87 111.056 -177.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.766 ' HB3' ' H ' ' A' ' 66' ' ' LYS . . . -172.09 134.08 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.92 -0.582 . . . . 1.09 109.607 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 70' ' ' ALA . 65.7 tp60 72.88 88.51 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 124.199 0.937 . . . . 3.23 110.455 -175.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.649 ' HB2' HG23 ' A' ' 34' ' ' ILE . 7.6 Cg_exo -72.97 63.59 4.07 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.443 2.762 . . . . 1.77 112.429 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.1 93.88 2.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.827 -0.624 . . . . 2.46 109.506 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.98 ' HB ' ' HG2' ' A' ' 16' ' ' GLU . 1.8 mt -64.88 -35.88 76.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 2.08 111.293 -173.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -59.17 -43.6 92.12 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.923 0.392 . . . . 3.8 110.648 175.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.77 -42.92 69.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 1.08 110.68 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.31 -25.95 67.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.44 . . . . 2.41 110.809 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.24 -44.17 76.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.192 -0.458 . . . . 1.57 111.002 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.36 -13.63 59.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.017 0.437 . . . . 2.74 110.551 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -86.25 -72.93 0.48 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.009 -0.541 . . . . 2.85 111.226 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.4 t -84.29 -43.52 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 2.13 110.976 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.63 30.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.347 0.594 . . . . 1.9 110.841 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.56 -14.16 59.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.788 -0.642 . . . . 2.65 110.129 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.482 ' HB2' ' H ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -97.89 -145.49 0.31 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.655 -0.702 . . . . 7.09 109.56 177.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.482 ' H ' ' HB2' ' A' ' 84' ' ' ARG . 3.3 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.615 -0.707 . . . . 5.98 110.198 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.899 0.38 . . . . 8.54 110.165 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.15 128.3 6.33 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.748 -0.739 . . . . 5.41 112.036 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.98 133.43 64.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.648 0.261 . . . . 6.05 110.411 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.07 -78.84 0.27 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.198 -0.456 . . . . 3.59 110.273 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.49 98.17 9.95 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.111 -0.7 . . . . 3.47 109.111 176.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.31 -21.05 50.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 3.01 112.426 -173.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 68.48 -58.84 0.46 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.272 0.629 . . . . 3.51 111.153 -175.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.83 72.9 2.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 2.32 110.893 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.464 ' HA ' HG12 ' A' ' 34' ' ' ILE . 6.5 p -125.99 5.52 4.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.399 0.619 . . . . 2.13 110.464 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -86.59 109.53 24.66 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 2.09 110.658 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.556 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 5.1 Cg_exo -81.43 -172.41 1.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.385 2.723 . . . . 1.88 111.871 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.98 -49.18 2.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.156 0.503 . . . . 2.04 110.885 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.404 HD21 HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -99.85 159.38 15.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 2.24 110.717 -175.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.8 95.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.145 -0.48 . . . . 1.42 112.12 -175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 HD21 ' A' ' 13' ' ' ASN . 15.3 t -64.09 -39.82 86.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.875 0.369 . . . . 1.99 110.667 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.613 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 27.7 mt-10 -57.36 -42.34 81.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.774 -0.648 . . . . 1.93 110.458 176.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -75.16 -31.28 60.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 1.48 111.428 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -56.03 22.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.172 -0.467 . . . . 2.96 111.043 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.3 mt -67.55 -32.64 73.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 1.81 110.612 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.84 -52.7 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 1.08 110.691 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -56.39 -50.96 70.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.02 -0.536 . . . . 2.69 111.055 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.21 -52.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.693 -0.685 . . . . 1.91 111.129 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -64.07 -42.83 96.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.444 -0.343 . . . . 1.33 111.417 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.729 ' HB2' HG12 ' A' ' 32' ' ' ILE . 5.5 tp10 -60.21 -44.8 94.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.584 -0.28 . . . . 2.78 111.169 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -20.75 39.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 4.4 112.295 -174.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -97.07 -52.39 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.842 0.312 . . . . 2.01 111.842 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.73 -31.47 5.47 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.948 0.351 . . . . 2.85 111.948 -174.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.81 -73.84 0.42 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.306 -0.473 . . . . 1.73 112.72 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 85.9 t 69.15 -63.37 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.049 0.54 . . . . 1.92 111.926 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 m -66.57 -32.76 74.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 2.21 110.616 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.83 127.54 2.76 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.762 -0.733 . . . . 1.58 112.654 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.729 HG12 ' HB2' ' A' ' 24' ' ' GLU . 1.3 pt -104.2 172.18 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.646 0.26 . . . . 3.56 110.535 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.65 163.34 33.53 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.044 -0.598 . . . . 2.28 111.78 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -92.49 -7.53 10.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.038 0.446 . . . . 2.67 110.821 -178.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.627 ' HG ' ' N ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -87.18 -43.16 12.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.509 -0.314 . . . . 2.46 110.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.627 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 20.3 t70 -174.71 161.51 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.141 -0.689 . . . . 4.2 109.141 -177.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.599 ' ND2' ' HA ' ' A' ' 32' ' ' ILE . 6.5 t-20 -169.64 164.11 10.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.207 -0.294 . . . . 4.13 110.207 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -77.51 -24.87 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 2.27 110.807 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -88.2 -33.69 18.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.083 -0.508 . . . . 2.01 111.042 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.4 mt-30 -84.63 33.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.333 . . . . 2.39 111.779 -172.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.465 ' HB ' ' H ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -151.25 -127.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.693 -0.484 . . . . 3.23 109.693 176.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 41' ' ' ILE . . . -84.89 53.91 4.87 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.914 -0.66 . . . . 2.06 111.949 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -139.73 55.44 0.65 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.617 -0.593 . . . . 2.17 111.617 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -73.61 135.36 43.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.626 0.25 . . . . 2.26 110.799 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.99 171.43 14.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.335 -0.393 . . . . 1.31 110.266 175.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.15 67.95 3.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.219 0.533 . . . . 2.37 109.562 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -126.41 170.8 11.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.787 -0.642 . . . . 2.27 110.6 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.71 71.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.274 -0.421 . . . . 1.64 110.766 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.3 tpp -60.38 -35.34 75.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.903 -0.589 . . . . 2.58 110.674 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 54' ' ' GLN . . . -70.13 -44.08 69.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 1.06 110.264 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.01 -44.5 91.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.05 -0.523 . . . . 1.46 110.319 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.91 73.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.97 111.089 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -64.2 -51.09 65.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 0.93 111.147 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -68.11 -33.1 73.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 121.042 -0.263 . . . . 1.86 111.178 -178.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -69.15 -44.1 81.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.356 . . . . 1.82 110.421 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -71.46 -28.01 63.66 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.901 0.381 . . . . 1.97 110.698 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -78.93 -32.63 45.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 3.57 110.695 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.0 OUTLIER 70.1 9.75 7.15 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.742 0.651 . . . . 3.64 110.903 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -172.66 156.63 3.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.033 -1.099 . . . . 4.58 108.033 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.511 ' HA ' ' NE2' ' A' ' 60' ' ' GLN . 3.1 tp60 -143.67 -36.65 0.35 Allowed 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.103 -0.639 . . . . 2.8 112.096 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.1 t 69.01 -73.89 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 O-C-N 123.579 0.549 . . . . 3.13 109.733 -173.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.78 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.483 0.713 . . . . 4.56 109.422 176.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -105.66 107.74 60.02 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.821 -0.627 . . . . 3.01 110.33 178.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 18.6 Cg_endo -92.38 99.27 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.466 2.778 . . . . 1.91 111.915 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.97 -19.65 47.4 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.717 0.265 . . . . 2.46 111.717 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.78 115.94 3.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.645 -0.252 . . . . 2.42 110.364 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.416 HG13 ' H ' ' A' ' 68' ' ' LEU . 2.1 p -171.25 -55.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.46 -0.336 . . . . 2.11 110.781 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.541 ' HA ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -167.02 -37.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.009 0.433 . . . . 2.19 110.225 -176.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -83.0 -67.22 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 1.87 111.106 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 40' ' ' GLN . . . -76.58 88.96 3.3 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.041 0.448 . . . . 1.09 111.625 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.513 ' HB3' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -175.45 85.08 0.3 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.166 -0.925 . . . . 3.23 109.455 175.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -67.12 70.74 0.55 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.433 2.755 . . . . 1.77 112.034 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.52 -24.57 0.09 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.246 -0.888 . . . . 2.46 109.555 177.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.514 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 9.0 mt 71.35 -68.23 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.501 -0.772 . . . . 2.08 111.955 174.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HB2' ' HG3' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -72.28 -15.68 61.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.698 0.259 . . . . 3.8 111.698 -174.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.52 13.77 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.024 0.44 . . . . 1.08 110.8 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -63.44 -38.45 91.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 2.41 109.96 178.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.771 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -75.15 0.42 16.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 1.57 111.529 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -32.41 11.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 2.74 110.454 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.49 -64.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.276 -0.569 . . . . 2.85 112.381 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.45 -40.28 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 2.13 110.96 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.771 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -105.91 159.12 16.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.809 -0.632 . . . . 1.9 109.482 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.68 -61.47 0.41 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.038 0.535 . . . . 2.65 111.551 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -22.6 54.25 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.952 -0.388 . . . . 7.09 109.952 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.022 -0.99 . . . . 5.98 112.159 174.086 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 mmm . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.865 -0.42 . . . . 8.54 109.865 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.27 76.47 0.31 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.693 -0.765 . . . . 5.41 112.642 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.723 ' HA ' ' HB3' ' A' ' 30' ' ' SER . 0.2 OUTLIER -84.67 37.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.218 0.532 . . . . 6.05 110.523 -179.41 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.6 -3.24 20.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.835 -0.621 . . . . 3.59 111.38 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 57.59 77.71 0.27 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.186 0.517 . . . . 3.47 110.389 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.63 125.61 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.462 -0.79 . . . . 3.01 111.42 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.61 63.09 4.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 3.51 111.131 -177.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.633 ' HB2' ' HG ' ' A' ' 35' ' ' LEU . 4.2 t80 -121.89 -86.37 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.938 -0.764 . . . . 2.32 108.938 176.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' H ' ' HB3' ' A' ' 8' ' ' TYR . 94.7 t 73.13 -55.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 O-C-N 123.759 0.662 . . . . 2.13 111.872 173.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -82.32 108.69 12.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.58 0.229 . . . . 2.09 111.033 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.779 ' HG2' ' HB3' ' A' ' 16' ' ' GLU . 20.4 Cg_endo -95.64 -99.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.593 2.862 . . . . 1.88 111.559 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 p -98.87 -80.4 0.46 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.866 0.365 . . . . 2.04 110.239 174.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -134.24 -174.86 3.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.287 -0.415 . . . . 2.24 110.873 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.92 -33.4 56.54 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.63 0.974 . . . . 1.42 113.63 -172.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.82 -34.33 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.955 0.407 . . . . 1.99 110.701 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.779 ' HB3' ' HG2' ' A' ' 11' ' ' PRO . 4.6 tt0 -79.95 -38.01 33.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.253 -0.43 . . . . 1.93 110.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -63.62 -39.01 93.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.312 -0.403 . . . . 1.48 110.884 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HE3' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -69.59 -31.66 69.95 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.448 -0.342 . . . . 2.96 110.803 178.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.496 ' N ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 tp -64.92 -46.13 82.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.605 -0.517 . . . . 1.81 109.605 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 24' ' ' GLU . . . -60.19 -33.87 72.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.484 -0.78 . . . . 1.08 110.778 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 17' ' ' SER . 85.5 mt-10 -57.79 -47.23 83.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 2.69 111.092 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.549 HD11 ' HE3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -71.83 -48.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.042 0.449 . . . . 1.91 111.066 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -68.57 -47.08 67.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.989 -0.551 . . . . 1.33 112.035 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -69.79 -45.55 67.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.623 -0.262 . . . . 2.78 111.17 -175.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.468 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 2.1 mmt180 -71.89 -37.85 70.08 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.005 0.372 . . . . 4.4 112.005 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.29 -59.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.096 0.406 . . . . 2.01 112.096 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.94 40.3 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.1 0.476 . . . . 2.85 111.349 -173.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' A' ' 29' ' ' VAL . . . -172.83 -46.41 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.645 -0.788 . . . . 1.73 112.207 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 7.2 t 78.4 -37.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.352 0.661 . . . . 1.92 110.572 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.723 ' HB3' ' HA ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -74.7 144.77 43.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.128 -0.487 . . . . 2.21 110.406 177.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.58 71.74 2.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.722 . . . . 1.58 113.08 -177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 36.1 mm -101.96 91.34 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.453 0.644 . . . . 3.56 110.359 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 34' ' ' ILE . . . -79.7 79.98 1.62 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.648 -0.787 . . . . 2.28 112.246 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 33' ' ' GLY . 38.8 mm 78.05 -43.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.399 0.68 . . . . 2.67 112.504 174.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.633 ' HG ' ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -35.86 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 2.46 113.527 -174.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.72 110.71 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 4.2 111.089 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -80.05 95.7 6.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.068 -0.515 . . . . 4.13 109.88 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -96.59 -24.58 15.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 2.27 112.637 -174.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -131.79 -9.21 3.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.632 -0.427 . . . . 2.01 111.637 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 8.1 mp0 -72.0 -57.71 4.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.337 -0.392 . . . . 2.39 111.329 -176.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.549 HG23 ' HB1' ' A' ' 70' ' ' ALA . 1.6 mt -105.62 74.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.998 0.428 . . . . 3.23 111.281 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.95 -82.55 0.18 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.369 -0.92 . . . . 2.06 113.257 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.45 80.81 1.76 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.133 -0.556 . . . . 2.17 112.733 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.427 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 2.9 p-80 -65.21 141.7 58.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.01 0.433 . . . . 2.26 110.483 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.74 29.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.589 . . . . 1.31 111.206 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 mt -87.24 -10.96 51.12 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.104 -0.702 . . . . 2.37 109.104 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -56.21 150.53 14.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.595 -1.184 . . . . 2.27 110.989 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.78 -17.83 51.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.197 -0.456 . . . . 1.64 111.964 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.7 tpt -63.1 -48.23 79.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 2.58 110.786 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.71 -28.39 50.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.053 0.454 . . . . 1.06 110.431 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.18 -40.13 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.898 -0.592 . . . . 1.46 110.272 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.82 92.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.97 110.533 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.519 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -64.52 -42.24 95.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 0.93 110.415 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.699 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 tt0 -59.84 -46.92 87.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.587 -0.733 . . . . 1.86 110.777 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -65.95 -39.24 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 1.82 110.903 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -72.71 5.3 3.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 1.97 111.897 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -137.29 24.66 2.97 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.977 0.418 . . . . 3.57 110.362 175.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.08 49.73 11.1 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.438 -0.801 . . . . 3.64 111.965 178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.699 ' HA ' ' HG3' ' A' ' 54' ' ' GLN . 21.7 m-30 66.8 87.97 0.11 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.692 -0.685 . . . . 4.58 112.147 171.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -77.76 -17.79 57.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.607 -0.724 . . . . 2.8 110.988 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 60' ' ' GLN . 53.6 t 77.03 -57.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 123.388 0.675 . . . . 3.13 112.264 174.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 -70.45 0.79 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.823 0.305 . . . . 4.56 111.823 -173.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.51 140.9 28.01 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.569 -0.287 . . . . 3.01 110.899 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' OE1' ' A' ' 60' ' ' GLN . 74.5 Cg_endo -75.84 62.39 6.51 Favored 'Trans proline' 0 C--O 1.237 0.466 0 C-N-CA 122.933 2.422 . . . . 1.91 111.731 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.834 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 22.3 tp -77.08 126.55 31.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 2.46 111.679 -174.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt 64.48 14.9 9.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.416 -0.811 . . . . 2.42 112.487 174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.519 HG11 ' HB1' ' A' ' 53' ' ' ALA . 7.2 p -98.35 -35.15 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.759 -0.376 . . . . 2.11 110.188 174.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER 175.43 -58.8 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.164 0 O-C-N 123.612 0.57 . . . . 2.19 110.585 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.417 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.4 m-85 -66.74 -50.9 61.27 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.964 0.727 . . . . 1.87 112.964 -171.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 65' ' ' LEU . . . -77.95 70.55 4.33 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.184 0.438 . . . . 1.09 112.184 -173.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.71 130.22 1.52 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.58 -0.736 . . . . 3.23 109.509 174.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.665 ' O ' ' HB ' ' A' ' 73' ' ' THR . 39.5 Cg_exo -61.27 105.15 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.499 2.132 . . . . 1.77 111.282 175.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.665 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER 81.94 113.54 0.06 Allowed 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.18 0.925 . . . . 2.46 109.35 -171.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 68' ' ' LEU . 4.2 mm -83.12 -22.69 8.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.044 -0.98 . . . . 2.08 110.322 -174.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -54.08 -37.12 63.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.633 -0.712 . . . . 3.8 111.681 -178.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.06 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.198 0.523 . . . . 1.08 110.968 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.66 -27.74 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.869 -0.605 . . . . 2.41 110.646 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.876 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -60.83 -49.71 76.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.329 -0.396 . . . . 1.57 111.865 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.82 -0.29 57.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.742 -0.383 . . . . 2.74 111.412 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -101.43 -69.08 0.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.94 -0.304 . . . . 2.85 111.283 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.34 -13.43 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 111.854 0.316 . . . . 2.13 111.854 -175.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.876 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . -99.05 21.9 11.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.992 0.425 . . . . 1.9 111.124 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -8.35 54.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.501 0.667 . . . . 2.65 110.692 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -95.73 -3.09 46.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.236 -0.893 . . . . 7.09 109.924 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.46 -0.781 . . . . 5.98 110.641 -176.02 . . . . . . . . 0 0 . 1 stop_ save_